P00001606T0076|37 49|5-nucleotidas
P00008171T0000|30 47|hyperbilirubinemia
P00008997A0472|139 143|slope
P00010943A0733|100 104|night
P00012653T0045|12 17|agents
P00013683A0210|68 78|ventilation
P00015731A0090|226 230|blood
P00022143T0000|42 47|rabbit
P00023348A0601|10 15|polyps
P00024600A0522|44 53|advantages
P00025557A0100|59 68|body weight
P00027739T0000|59 64|cattle
P00027967A0207|161 164|days
P00029555A0861|102 134|shellfish microbiology laboratories
P00029953T0045|17 30|lipase activity
P00030183T0000|33 38|HLA-B5
P00030937A0119|72 79|subjects
P00033873T0001|53 56|flui
P00034935A0545|96 96|%
P00038408T0000|89 91|FLA
P00039271T0000|65 67|rat
P00041512T0067|0 8|Abstracts
P00048373A0377|78 87|epithelium
P00050628A0202|71 81|proteinuria
P00052597T0000|48 60|Professor Dan H
P00054900A0226|50 57|esterase
P00055040A0000|284 288|blood
P00056837A0000|97 105|carcinoma
P00056901A0308|68 75|dilution
P00060529A0695|215 217|A.B
P00061478T0000|48 56|nutrition
P00063680T0000|19 31|galactosaemia
P00064414A1098|36 49|erythropoiesis
P00066874T0000|100 109|experiment
P00072928T0000|27 42|haemochromatosis
P00073344A0367|68 76|treatment
P00074758T0000|16 29|hypothyroidism
P00083846T0000|48 51|chil
P00084275T0063|0 6|Preface
P00086313A0000|143 157|antibody testing
P00088391A0181|72 78|antigen
P00089778A0000|298 313|cataract patients
P00092689A0352|35 39|times
P00094639A0313|67 68|mg
P00096241A0087|157 157|P
P00097989A0106|42 49|patients
P00100540T0000|81 87|aspirin
P00100791A0425|135 144|norcocaine
P00101300A0257|99 104|months
P00105401A0635|210 212|FT3
P00105903A0288|67 69|PEG
P00111174A0351|107 110|eyes
P00112627A0542|157 164|fentanyl
P00113657A0628|39 49|improvement
P00114144A0189|220 231|enzyme defect
P00115974A0576|65 67|age
P00117748T0000|68 78|skin lesions
P00118044A0000|140 146|muscles
P00118810T0001|9 15|disease
P00119339A0400|170 179|oesophagus
P00122718A0500|86 93|activity
P00129659T0000|79 81|IQs
P00130573T0054|0 2|VII
P00131739T0001|48 56|Uzbekista
P00133214T0064|40 43|USSR
P00136175A1137|153 157|ECA.2
P00137671A0896|100 110|coagulation
P00139624A0318|95 98|rats
P00139827A0000|193 200|delivery
P00142718A0156|115 130|chest radiographs
P00146327A0147|110 120|stem bronchi
P00149899T0001|22 38|sandfly developmen
P00150066A0100|52 59|thrombin
P00150066A0554|35 44|prostheses
P00154430A0906|107 114|fragment
P00155973A0387|213 229|minute ventilation
P00159600A0871|149 153|curve
P00163384A0000|103 110|necropsy
P00167544A0067|157 180|surface specimen technique
P00168176A0000|136 141|eluant
P00168431T0000|36 39|term
P00172199A0270|101 115|cross striations
P00173860A0475|179 183|acids
P00176742T0000|50 56|enzymes
P00183063A0300|112 119|patients
P00188387A0975|92 103|heart disease
P00193088A0196|51 59|responses
P00193587T0000|49 56|analysis
P00196255A0000|176 186|bizarreness
P00198510T0000|44 60|Locusta migratoria
P00199012T0000|31 46|thyroid carcinoma
P00201881A0487|72 82|MSH contents
P00205074A0000|55 61|rickets
P00209664A0836|132 148|parallel phenomena
P00210220X0000|34 38|drugs
P00211881A0602|126 128|PBB
P00216939T0001|107 113|chlorid
P00219533T0001|88 91|wome
P00219565A0172|65 68|cent
P00219674A0000|146 155|infarction
P00221136A0984|39 44|humans
P00221725A0523|110 117|decrease
P00222102A0227|172 184|serum-calcium
P00222827A0000|107 121|hyperreactivity
P00224013A0661|392 405|vasodilatation
P00225352T0000|83 90|rat liver
P00227393T0000|63 96|cytochrome P-450 monooxygenase system
P00227610A1593|73 86|polyoma viruses
P00231555T0001|81 98|cortisol production
P00232354A0286|34 43|metyrapone
P00232456T0000|139 143|genes
P00234206T0000|84 89|Brazil
P00234264A0164|121 125|weeks
P00234626T0036|0 2|XXI
P00239014A0000|90 100|blood plasma
P00239169T0000|60 64|study
P00240016T0033|0 0|V
P00240518A0000|78 82|serum
P00242427T0001|34 37|nurs
P00254537T0000|49 59|state boards
P00261981A0434|76 82|litters
P00264240A1843|152 170|X. laevis oocyte 5S DNA
P00265964A0562|34 46|grain boundary
P00267764A0651|91 100|management
P00294502T0001|39 46|division
P00300314A0132|227 241|treatment cycles
P00303189A0247|122 128|process
P00304240A0369|66 72|disease
P00304310A0000|113 116|time
P00304806A0760|136 138|mg%
P00313766A0666|91 95|range
P00316723A0558|31 38|behavior
P00321261A0104|191 195|women
P00330364A0132|230 241|laboratories
P00331128A0000|62 68|failure
P00331936T0000|44 78|immunoperoxidase antiglobulin technic
P00336354A0543|74 85|hypoglycemia
P00336547A0000|266 272|CBA/LAC
P00337102T0058|10 15|August
P00339289T0049|40 46|protein
P00340692T0033|10 36|John Henri Roosegaarde Bisscho
P00342623A0228|87 96|reactivity
P00350465T0000|34 42|disorders
P00352569A0000|105 113|endotoxin
P00354315T0000|32 51|ataxia telangiectasia
P00358945A0225|70 74|weeks
P00361059T0000|69 88|clobetasol propionate
P00361340A0529|213 219|failure
P00369397A0280|134 141|controls
P00369683T0000|73 84|breast cancer
P00377466A0188|173 179|disease
P00378492A0475|200 213|artery stenosis
P00378735A0000|270 281|relapse rates
P00381783T0000|0 29|Bone marrow transplantation-1979
P00383169A0000|198 207|properties
P00384744T0000|23 34|hypofunction
P00385457A0187|101 105|ulcer
P00386251A0899|83 102|sulphonamide residues
P00390932T0001|8 15|antigens
P00393598A0198|47 49|ALS
P00397806T0039|4 15|Algerian case
P00401521A0138|39 49|ticarcillin
P00401676A0414|71 82|radiotherapy
P00406585T0001|23 24|ag
P00409927A0570|127 135|organisms
P00411465A0142|86 93|cavities
P00413854A0958|86 90|blood
P00414575T0000|27 33|calculi
P00415543A0320|133 143|lung disease
P00416758T0001|56 71|laboratory animal
P00417166T0000|36 48|rhesus monkeys
P00417301T0001|43 48|humans
P00418341T0000|31 35|parts
P00420460A0291|150 150|P
P00423649A0259|94 99|regard
P00425547A0000|112 116|weeks
P00427715A0000|137 143|Florida
P00429151T0000|59 69|Glasgow area
P00429893A0000|164 174|stimulation
P00429949A0000|218 228|immunoassay
P00430889T0001|15 21|fistula
P00431832T0001|42 61|beta receptor blockers
P00432615A0541|167 170|RIST
P00435187T0000|14 25|flowers bloom
P00437749A0242|104 107|pain
P00439618T0001|74 81|childhoo
P00439716T0001|67 72|fistul
P00445259T0000|29 48|bone marrow iron stores
P00445720A0263|91 122|high-fidelity pressure transducers
P00450367T0000|120 128|carcinoma
P00450559A0269|94 104|thermometer
P00450760T0001|27 33|syndrom
P00451192A0248|100 119|LV region-of-interest
P00453780A0430|136 141|source
P00454780A0340|118 126|corrosion
P00456424A0000|154 166|cisterna magna
P00463973A0000|166 177|birth weights
P00464387A1185|75 78|ABPA
P00465223A0373|93 96|mmHg
P00465681A0000|149 153|state
P00465829T0000|63 72|potentials
P00473229T0000|108 119|chick embryos
P00473249T0000|80 86|rabbits
P00474064A0205|148 157|sufentanil
P00476020T0000|43 48|growth
P00476572A0139|113 124|radiodensity
P00477794T0000|101 106|oralis
P00478714T0000|33 55|alcohol treatment program
P00479222A0682|176 180|years
P00479246T0000|28 40|osteomyelitis
P00481612A1121|110 117|fentanyl
P00483716A0366|97 107|anastomosis
P00484177A0242|97 98|VT
P00485615A0935|221 227|surgery
P00488534A0308|113 118|MR rats
P00490336A0181|49 54|group C
P00493818A0422|120 128|insertion
P00494659A0391|98 107|toloxatone
P00495097A0663|101 106|tissue
P00497494A0112|32 36|PACO2
P00499588T0000|60 71|sperm studies
P00503336A0285|162 170|diagnosis
P00506559A0000|64 71|hamsters
P00506649T0000|58 63|stress
P00509703A0581|54 62|textbooks
P00510341T0036|11 19|E.O.R.T.C
P00512215A0000|139 140|L2
P00513284A0000|246 250|mg/kg
P00513284A1255|79 83|blood
P00516545T0001|114 130|glomerulonephriti
P00517890A0468|124 131|jaundice
P00519173A0126|39 50|oesophagitis
P00521732T0000|81 107|steroid sulphatase deficiency
P00524451A0136|190 192|rat
P00528144T0000|44 53|tumor cells
P00534613A0000|95 102|collagen
P00535520A0239|74 88|cholangiography
P00540707A0255|257 269|vena cephalica
P00541752A1032|131 135|ng/ml
P00550399A0615|50 55|groups
P00553858A0000|195 204|principles
P00555492A1034|152 164|blood pressure
P00555495T0000|137 144|delivery
P00555583T0000|38 43|review
P00557559A0170|151 159|organisms
P00564032A0724|101 105|gland
P00564943A0444|58 63|calves
P00565136T0000|70 72|Br2
P00565314A0293|0 9|Guinea pigs
P00569989A0239|154 169|pneumotachograph
P00574222T0000|51 60|prostheses
P00574956A0304|253 265|manifestation
P00575231A0422|41 60|detrusor contractions
P00577440A0298|60 81|3H-alpha-acetyldigoxin
P00578648T0048|34 47|administration
P00580106T0000|18 24|disease
P00580151A0706|200 204|doses
P00583004A0445|160 163|skin
P00583522T0001|52 62|inflammatio
P00587791T0054|34 40|disease
P00589073A0000|173 183|infertility
P00590594T0000|7 25|allotransplantation
P00592887T0000|40 51|lymphography
P00593119T0001|90 101|IgE antibodie
P00594466T0001|99 108|stimulatio
P00594617A0192|275 277|ESR
P00597715A0256|152 160|prognosis
P00598012A0174|76 81|change
P00599601A0260|132 141|physiology
P00600943T0001|13 30|lymphomononucleosi
P00601401A0181|96 119|delta log Po2/delta pH ratio
P00602622A0362|116 123|activity
P00602702A0309|84 91|function
P00603783A0647|68 85|observers IgA levels
P00606849T0000|56 62|rabbits
P00614915T0001|18 28|traumatolog
P00616575A0000|138 149|unit activity
P00617815A0215|12 25|L-R differences
P00618078A0367|79 88|meningitis
P00619305A0759|70 79|dimensions
P00619782A0058|94 97|UV-A
P00619948A0000|314 324|propranolol
P00621626T0000|82 96|behavior pattern
P00622556A0111|64 69|tendon
P00623361A0221|51 61|dysfunction
P00626014T0001|20 26|lentigo
P00627039T0000|25 63|Louisiana paper manufacturing plant workers
P00627129A0944|174 191|beta-adrenoceptors
P00627202T0000|49 51|use
P00628990A0000|157 160|loop
P00630713T0000|15 39|Du Pont aca ammonia procedure
P00633909A0000|171 177|control
P00635143T0001|33 45|Cyprinus carpi
P00635194A0093|65 80|dose distribution
P00636526T0033|24 31|diagnosi
P00637637T0000|57 68|hypertension
P00639410T0000|43 61|lipid clearing agents
P00640584A0250|46 54|stability
P00641395A0441|150 165|extraction method
P00644314T0000|46 60|anticoagulation
P00644539A0783|129 141|test solutions
P00646023T0058|51 62|transmission
P00646193T0000|51 60|isoflurane
P00656008T0000|41 59|superoxide dismutase
P00657551T0000|55 60|tracer
P00659962T0000|53 65|acid ingestion
P00663166A0000|181 201|Eisenmenger physiology
P00664320T0000|32 38|pathway
P00665053A0276|67 80|group affection
P00665214A0374|65 69|cycle
P00665336A0908|43 57|EEG-information
P00668122A0414|101 122|liver ferritin molecules
P00669800A0579|55 59|males
P00676416A0320|42 54|liver biopsies
P00676790T0000|27 32|kidney
P00681550A0000|176 181|macula
P00681571T0028|54 74|eccrine sweat duct units
P00682762T0001|0 16|Silicosis mortalit
P00685922A0451|71 73|IHB
P00686836A0000|192 193|kg
P00693987T0001|128 130|lif
P00696680A0000|120 125|cervix
P00696858A0000|116 130|porcine pancreas
P00701144T0000|79 86|implants
P00701462A0722|47 51|cases
P00702773A0327|101 106|output
P00703350A0418|42 48|sulfide
P00703932A0000|106 112|therapy
P00704675A0199|129 135|trachea
P00710217T0001|18 20|hip
P00710372A0302|125 132|features
P00712117A0521|122 130|prototpye
P00713525A0268|137 141|model
P00715180T0074|53 79|plutonium-239 dioxide aerosol
P00715753A0241|104 112|% fraction
P00716366T0001|106 118|liver cirrhosi
P00722298A0619|172 177|famale
P00722652A0118|115 119|cecum
P00725257A0452|52 52|M
P00725336T0000|61 67|poultry
P00725534A0888|228 234|leprosy
P00725752T0001|90 100|vasodilator
P00726581T0122|0 5|Orthop
P00728718T0000|17 25|pregnancy
P00729003A1182|32 39|splicing
P00733067A0188|332 336|lumen
P00736376A0371|101 105|skill
P00737422A0832|144 151|patients
P00740409A0000|74 78|Tonge
P00741476A0000|89 93|birth
P00743335T0001|42 48|stimuli
P00745775A0170|133 133|M
P00747722A0486|120 122|sec
P00748978T0000|42 50|abortions
P00753237A0000|468 478|prophylaxis
P00755245A0000|122 126|sites
P00755671A0485|101 109|hematomas
P00755869A0216|149 156|exercise
P00756511T0036|32 38|diabete
P00757244A0000|62 70|placentas
P00759049A0185|93 96|ICSH
P00759400T0000|65 72|patients
P00762763A0253|44 49|births
P00764737X0000|46 53|deficits
P00767155T0001|47 54|personne
P00767161A0837|103 105|day
P00768220X0000|3 11|motor unit
P00771729X0000|52 59|hormones
P00775582T0000|22 30|sumithion
P00779272T0001|61 72|mononucleosi
P00780639X0000|49 58|evaluation
P00792847A0000|81 86|humans
P00799988A0554|115 121|therapy
P00803867A0315|147 152|months
P00806295A0193|98 105|subjects
P00807356T0001|62 65|vitr
P00808266T0000|44 59|radiation therapy
P00808898A0000|79 82|IPRF
P00811852T0001|61 67|patient
P00812183T0000|10 23|transfer factor
P00818380A0239|128 138|populations
P00819176T0001|123 141|Labidocera wollaston
P00821833A0000|120 125|Panama
P00822611A0467|77 89|binephrectomy
P00823087A0608|28 35|patients
P00825571T0031|0 2|III
P00827364A0000|80 85|vacuum
P00830568A0000|248 250|V&P
P00832096T0000|41 51|sarcoidosis
P00833472A0907|149 152|drug
P00836637A0000|196 205|preference
P00837262A0000|134 139|rabbit
P00837811A0675|121 127|testing
P00838152A0863|175 186|predominance
P00839378A0649|98 104|therapy
P00842406A0771|83 97|recognition task
P00842522T0000|76 84|emphysema
P00843232A0100|81 90|epithelium
P00843670T0000|10 13|self
P00846559A0000|187 194|T-2 toxin
P00847967T0000|55 62|medicine
P00851041A0000|40 46|anomaly
P00851286A0375|141 145|death
P00857024A0888|107 112|median
P00863184T0043|69 71|rat
P00863773T0000|14 31|live-virus vaccines
P00866577A0579|156 162|therapy
P00868301A0043|117 125|condition
P00868903A0000|67 74|patients
P00870859A0121|107 112|factor
P00871237A0601|37 42|angina
P00872442T0000|44 66|LKB reaction rate analyser
P00872922A0204|82 89|activity
P00874942T0000|49 54|report
P00875778T0000|18 38|Gravigard IUCD inserter
P00876722T0000|47 52|septum
P00877857A0763|72 80|mEq/liter
P00879329A0176|148 150|IIp
P00879829A0564|122 127|apnoea
P00881630A0000|187 190|rats
P00885562A0281|135 141|culture
P00890028A0507|140 155|Kolmogoroff scale
P00891370A0000|141 148|patients
P00892353A0686|68 75|degrees C
P00898500A0246|143 161|IgE antibody activity
P00903772A0359|92 94|leg
P00909114A0000|196 203|compound
P00910823A0196|86 95|blood flows
P00911590T0000|83 90|children
P00913623A0242|134 149|passive diffusion
P00915090A0536|110 116|control
P00916099A0000|92 100|treatment
P00917572T0001|66 71|newbor
P00917721A0484|93 104|dream content
P00918556A0000|153 165|liver diseases
P00918965A0728|171 174|PAO2
P00920381T0000|97 100|rats
P00921032T0000|43 48|Beagle
P00921911A0159|122 126|onset
P00926272A0000|95 100|reflux
P00926604A0504|199 208|myocardium
P00926751A0000|89 97|materials
P00927633T0001|74 84|Rattus rattu
P00928529T0001|110 115|bundle
P00929418T0001|63 71|incidence
P00930947A0629|129 133|drugs
P00931089T0001|22 34|operating room
P00932738A0116|91 96|levels
P00932817A0499|124 128|99mTc
P00933251T0000|49 56|ear tumor
P00935526A0000|180 186|columns
P00938594A0149|169 170|RA
P00941050T0000|17 38|procainamide absorption
P00947327A0000|455 461|TMP/SMZ
P00947834X0000|29 36|tendency
P00951909X0001|135 156|Billroth-II gastrectomy
P00952734T0000|90 93|PECL
P00954819A1041|128 139|AChE activity
P00956364A0138|54 60|MSB agar
P00956554A0414|95 107|IgE antibodies
P00958550T0001|33 43|Great Britai
P00959656A0250|39 50|antithrombin
P00961711T0000|34 36|seg
P00962222A0633|102 118|progesterone phase
P00962277T0000|63 69|priming
P00964758T0001|31 41|parotid glan
P00968181A0264|90 98|infection
P00970320A0000|103 115|copper smelter
P00970488A0105|200 207|symptoms
P00970839A0118|105 109|weeks
P00974901A0080|105 118|susceptibility
P00975314T0001|82 94|gonadoblastom
P00975540T0000|75 95|high-accuracy analyses
P00980255T0000|75 83|blood flow
P00984209A0614|154 158|study
P00985110T0001|105 109|corte
P00985276A0000|170 183|weightlessness
P00985279A0493|91 98|CO2 group
P00986800A0325|158 165|delivery
P00986925A0002|111 118|subjects
P00987649T0001|66 75|hypokinesi
P00988572A0000|177 182|source
P00989973A0000|196 203|busulfan
P00992316A0178|127 135|gravidity
P00993176A0066|138 149|2SO4 solution
P00996272A0397|101 112|instructions
P00996364X0000|0 0|E
P00999494A0000|91 106|agent propranolol
P01000378T0000|56 60|sheep
P01003819A0498|66 81|corneal curvature
P01004298A0744|103 107|level
P01009451A0728|103 110|drinking
P01009739T0001|50 58|ECG tracin
P01009841T0001|43 54|lamprey larva
P01010638A0161|34 34|%
P01012640T0001|81 87|syndrom
P01012904A0333|141 146|format
P01019207A0232|113 125|mug ruscogenin
P01021091T0000|110 120|Octapressin
P01027644T0001|10 12|tes
P01035457A0623|73 81|treatment
P01036714A0072|159 164|levels
P01044338A0240|57 63|heating
P01047417T0000|8 32|National Health Dis-service
P01047895T0001|63 70|Patients
P01048020T0000|113 129|Course Information
P01048968A0152|108 121|beta-lactamase
P01050144A0297|114 123|83A complex
P01050400T0000|83 88|infant
P01057137A0192|69 74|groups
P01064124A0560|64 72|specimens
P01067493A0119|78 84|methods
P01071715A0903|36 58|blood pressure recordings
P01078982A0227|142 147|dosage
P01080374A0709|98 104|disease
P01081904A0198|110 117|symptoms
P01082726A0248|44 49|DC-ERG
P01082833A0000|251 254|rats
P01083321X0000|158 162|years
P01083375T0000|27 44|childhood cirrhosis
P01083784T0000|80 85|asthma
P01084413A0271|43 45|EMI
P01087288T0000|93 108|thyroid carcinoma
P01088654T0001|45 47|mas
P01090210A0417|232 242|differences
P01092248T0000|93 101|disorders
P01093055T0000|39 44|uremia
P01093845A0208|148 152|dream
P01093847A0000|126 131|states
P01096741X0000|82 96|supplementation
P01097100A0217|30 37|regimens
P01098179A0167|208 216|ointments
P01098592A0567|83 87|onset
P01099693T0000|21 45|bone marrow transplantation
P01101272T0000|70 84|cyclohexylamine
P01103390A0149|114 124|parasitemia
P01107226A0808|83 96|mg/ml dose level
P01113908A0475|90 99|experiment
P01116254A0000|243 249|minutes
P01116466A0185|133 145|platelet count
P01118293A0150|87 90|eyes
P01119586A0337|122 125|flow
P01119658A0000|262 277|radiation therapy
P01122015A0467|55 62|mg/100 ml
P01123658A0000|145 150|sacrum
P01124944A0830|43 46|g/kg
P01125117A0183|112 117|groups
P01128985A0000|101 108|patients
P01130186A0568|73 83|tolbutamide
P01130531A0224|88 94|percent
P01131946T0001|65 69|organ
P01138215T0001|31 38|fracture
P01138330A0204|110 130|acetylcholine chloride
P01140184A0342|137 139|rat
P01141114A0188|155 165|temperature
P01145884T0028|34 37|stud
P01147436T0000|36 49|progress report
P01147502T0000|27 42|instrument system
P01148868A0284|56 60|1/day
P01150658A0683|70 70|M
P01156631A0658|152 152|P
P01156814T0000|49 69|thromboembolic disease
P01157191A0536|187 191|weeks
P01157614T0000|75 82|children
P01158512T0000|40 49|deficiency
P01158838A0438|62 67|ml/min
P01159822A0353|235 242|granules
P01168607A0672|124 132|intervals
P01168908A0000|175 198|plasma progesterone levels
P01168956A0552|148 152|organ
P01170143A0247|99 107|cylinders
P01171020A0711|26 46|nucleus accumbens septi
P01171935A0313|174 181|striatum
P01172734T0035|19 22|W-27
P01172917T0000|42 54|milk tolerance
P01174873T0000|54 58|cases
P01176905A0094|59 67|mid-light
P01178153A0056|0 0|D
P01178637T0001|0 13|Atherosclerosi
P01185956A0722|97 108|stroke volume
P01186344A0303|179 185|process
P01190120A0832|80 86|storage
P01190251A0335|46 56|lymphograms
P01191955A0077|103 108|reflux
P01191964A0000|253 282|serum thyrotrophin concentration
P01193458T0001|89 93|reflu
P01193770T0000|14 21|bacteria
P01194673A0652|36 46|chemography
P01201977T0000|29 45|disc sensitivities
P01202616A0466|139 144|detail
P01206772T0000|55 64|hycanthone
P01206896T0001|45 63|emergency lung surger
P01208811T0001|49 74|citrate solution-blood syste
P01209618A0409|107 120|d-tubocurarine
P01211754A0192|116 123|deafness
P01215067A0000|179 186|subjects
P01217450A0295|75 78|dogs
P01224116A0576|130 135|family
P01225339A0590|49 58|infarction
P01228258A0000|135 153|Cytosine arabinoside
P01228882A0437|164 171|diseases
P01233561T0001|8 15|lactatio
P01235347T0001|28 36|adriamyci
P01236224T0001|8 15|patholog
P01237206A0199|203 206|eggs
P01241437A0152|81 87|Micoren
P01241588A1470|152 159|neurones
P01241866A0682|89 95|phase-2
P01242636A0678|81 98|beryllium retention
P01243628A0286|80 80|%
P01244236A1122|243 251|thickness
P01245162A0262|109 126|transaminase levels
P01246210A0648|79 83|women
P01247475A0000|100 106|outlook
P01248124A0281|71 79|gestation
P01249198A1097|106 120|hyperthyroidism
P01252223A0347|124 138|complementarity
P01253191T0000|53 68|action potentials
P01256410T0001|52 54|ter
P01259027A0416|271 283|design problem
P01261005A0711|93 118|bandpass spectrophotometers
P01262596T0000|11 20|compromise
P01264640T0028|15 19|Saigo
P01265443A0159|184 189|effect
P01265887T0001|43 49|patient
P01267446A0210|26 29|acid
P01272816A0000|134 143|absorption
P01275335A0158|66 70|phase
P01275541A0405|130 137|delivery
P01276105A0313|81 90|puerperium
P01278251A0000|163 172|sensitizer
P01279197T0000|74 94|saturation mutagenesis
P01279352A0297|29 48|bp sequence GGGGAGGAGG
P01279352A0473|181 195|target sequences
P01279352A1197|133 162|beta-galactosidase reporter gene
P01279374A0396|118 123|PET122
P01279696A0862|70 70|T
P01280413T0001|53 65|microorganism
P01280807A0575|80 103|ThrRS/CGU operator complex
P01281322A0604|115 122|flow rate
P01281472T0000|14 29|muscle glycogenin
P01281771T0000|57 73|expression pattern
P01282014A0275|79 89|saline group
P01282638A0934|279 292|life expectancy
P01284032A0213|90 93|mmol
P01284595A0102|115 120|insert
P01284828T0001|119 125|prostat
P01285009A0000|251 259|micropyle
P01285358A0396|95 101|disease
P01285554T0000|31 37|systems
P01285807A0365|99 103|PaCO2
P01286732A0572|186 204|P. falciparum malaria
P01287197A0761|210 211|iv
P01292230A0283|42 48|filling
P01294345A0591|184 199|breast tenderness
P01295373A0651|105 105|C
P01295500A0366|89 96|Deficits
P01296815A0059|100 109|pseudogene
P01297332A0983|161 167|element
P01297332T0000|68 76|cell cycle
P01298173A0153|168 174|measure
P01298398A0461|73 88|phase composition
P01299489A0788|128 131|RDIs
P01300914A1066|697 702|stasis
P01301171A0979|58 67|chromosome
P01302765A0999|54 56|R2s
P01304515A0178|55 64|volunteers
P01304809T0001|53 55|Jen
P01309244A0798|137 144|promoter
P01309587A0715|118 129|c-myb protein
P01309593A0095|89 108|MuLV promoter activity
P01309593A1092|199 210|protein genes
P01309815A0972|130 141|AEP synthesis
P01309860A0559|103 115|mouse L1 family
P01309894A0807|56 65|nucleotide
P01309910A0428|74 85|CREB2 protein
P01310154A0879|187 200|gene regulation
P01310178A0876|162 186|host transcription shut-off
P01310879A0000|113 121|treatment
P01310899A0339|133 160|serine/threonine kinase domain
P01310935T0000|84 101|protein degradation
P01312005A0600|290 300|replication
P01313715A0461|229 238|CGD patient
P01313846A0850|218 237|cell adhesion molecule
P01313894A1179|148 153|levels
P01313909A0526|115 122|sequence
P01314457T0000|106 117|organization
P01314841A0724|101 108|pressure
P01314953A1266|112 120|complexes
P01315706A0000|67 85|rat L6 muscle cell line
P01316125A0176|152 155|BHPD
P01316125A0382|247 251|yield
P01316459A0311|0 3|Acad
P01316461A1083|200 206|animals
P01316476A0842|71 80|start sites
P01316476A1428|74 78|genes
P01316680A0643|143 150|H-X2-4-C
P01316900A0000|60 63|K-12
P01316903A0296|96 98|IIO
P01316903A1040|83 93|input enzyme
P01317376A0981|119 131|frk mRNA levels
P01318310A0000|135 145|cholesterol
P01318739A0410|69 81|neurotoxicity
P01320255A0795|143 155|transcription
P01320640A0336|80 82|VIP
P01321277A0342|141 143|UR2
P01321277A0664|87 89|ros
P01321280A0494|175 190|E7 fusion proteins
P01321332A0970|241 245|ARP-1
P01321336A0000|52 72|sequence motif ACAGATGG
P01321336A0731|104 113|amino acids
P01321337A0318|196 204|antiserum
P01321337A1161|127 138|growth arrest
P01324172A0880|50 61|mitochondria
P01324385A0329|217 228|control group
P01324404A0813|131 140|amino acids
P01324404A1208|139 156|region II-III domain
P01324406A1250|130 138|sequences
P01324639T0000|125 135|clindamycin
P01325221A0870|133 146|chromatography
P01325386A0766|49 64|heat shock protein
P01326329A0703|266 269|CREs
P01326557T0000|106 110|brain
P01327280A0000|125 134|electrodes
P01327758A0000|103 111|E2 protein
P01327967A0668|132 142|metabolites
P01328197A0985|91 119|ras signal transduction pathways
P01328219A1397|39 47|cell lines
P01328681A0149|197 197|A
P01328681A0348|8 8|M
P01328854T0000|156 166|muscle cells
P01328884T0000|66 79|sequence motifs
P01329039A0239|130 137|proteins
P01329039A0951|115 128|Ig kappa E2 E-box
P01330077A0000|99 102|ALLs
P01330309A1134|113 120|myotubes
P01330975T0000|46 52|myeloma
P01331057A0000|82 99|cytochrome c oxidase
P01331060A0768|73 85|cDNA sequences
P01331086T0000|121 140|transcription factors
P01331292A1425|109 121|vaccinia virus
P01331501A0397|121 124|p130
P01331516A0103|115 125|C2 myoblasts
P01332589A0666|125 137|micrograms/ml
P01332964A0247|68 75|elements
P01333035T0000|74 86|RNA polymerase
P01333047A0404|157 173|threonine residues
P01333053A0110|138 141|cAMP
P01333125A0000|166 177|rhinoviruses
P01333317A1008|98 102|PRF-I
P01334428A1102|81 94|mumol min-1 mg-1
P01334493A0289|100 107|receptor
P01334518T0000|89 98|risk groups
P01337142A2043|114 118|WORDS
P01338867A0503|186 191|system
P01339125A0153|114 124|bleach teeth
P01339373T0000|77 93|SNF1 protein kinase
P01339391A0000|42 60|DNA surrounding HRAS1
P01339468A0272|110 118|analogues
P01339773A0000|127 134|analysis
P01339773A0778|116 141|ventilation-perfusion ratio
P01339815A1545|57 61|tests
P01340470A0000|106 111|domain
P01341119A0450|85 97|others antacid
P01346262A0377|78 81|UC21
P01346534T0000|71 77|protein
P01347476T0000|47 60|sequence family
P01347664A1026|72 77|mutant
P01347908T0000|73 79|disease
P01347944A0964|91 100|regulation
P01348504A0757|68 75|distance
P01348508A0313|194 197|date
P01348590A0000|218 224|outcome
P01349705T0000|42 47|babies
P01349837T0000|116 124|heat shock
P01350780A0184|123 129|lengths
P01350932A1123|115 130|disulphide bridge
P01352113A0002|134 141|measures
P01352113A0231|153 155|min
P01353478T0000|47 65|A20/2J B cell lymphoma
P01354506T0000|105 111|history
P01357190A0726|130 134|cells
P01357528A0084|211 224|enterobacteria
P01358190A0654|110 115|effect
P01358592A0752|125 130|embryo
P01358758A0000|182 189|enhancer
P01358880A0251|65 88|transglutaminase sequence
P01359588A0375|73 80|elements
P01360180A0513|152 159|mutation
P01360180A1568|135 153|reporter gene product
P01360294A0000|126 133|activity
P01363080A0710|143 161|anhydrase inhibitors
P01363166T0001|54 58|ulcer
P01364100A0377|55 58|unit
P01370281A0461|57 63|protein
P01370446A0818|26 54|keratan sulfate attachment sites
P01371181A0688|125 135|copy numbers
P01371272A1167|72 94|yeast DNA polymerase alpha
P01371275T0000|69 75|tissues
P01371413A0742|146 154|cDNA probe
P01371863A0000|70 96|protozoan parasite Leishmania
P01372365A1202|105 114|conditions
P01372456A0426|102 110|% necrosis
P01372802A1481|370 376|protein
P01372900A0448|132 132|F
P01372900A1017|101 134|polymerase chain reaction experiments
P01373374A0735|115 122|sequence
P01374331A0636|62 79|nuclease S1 analysis
P01374392A0341|57 61|NHE-2
P01374398A0951|138 154|amino acid residues
P01374688A0471|113 115|hr E
P01375224A0152|147 162|growth regulation
P01375913A0484|141 147|plasmid
P01376319T0000|43 68|mannose 6-phosphate receptor
P01377696A0000|107 137|antibody perturbation experiments
P01377764A0309|60 64|layer
P01377818A0468|79 88|C/EBP alpha
P01377962A1012|62 67|organs
P01378052A0594|172 189|activator sequences
P01378127A0841|95 103|responses
P01378431A0202|46 47|S.
P01378506A0884|96 108|virus assembly
P01378526A0535|82 87|effect
P01379032A0495|125 127|day
P01379150A0996|157 171|risk arrhythmias
P01380062A0097|121 123|Y-5
P01380076A0165|94 103|components
P01380454A0451|228 241|ATF/CREB family
P01380716A0174|77 90|calcium hydrate
P01380825A0622|165 172|function
P01383690A1023|105 116|ABL SH2 domain
P01383695A0100|90 98|IgM lambda
P01384040A1043|119 123|pCF10
P01384165A0000|144 151|tracheal
P01384229A0175|239 245|pBLCAT2
P01385462A0151|150 159|monoamines
P01386210A0293|100 116|GM2 gangliosidosis
P01386897A0000|133 135|ref
P01387105A0933|241 241|X
P01388160A1102|166 172|Ser-108
P01389362T0000|34 47|dentin adhesive
P01389573A1071|90 91|A2
P01389585A0825|95 100|choice
P01391001A0583|99 105|methods
P01392012A0228|144 147|Hays
P01392277A0000|163 165|DIN
P01392358A0389|39 48|home visits
P01394200A0592|181 185|cells
P01394655A0615b|101 118|Jack bean meal urease
P01395755A1023|220 224|L/min
P01396432A0388|94 110|memory performance
P01396444A0934|172 179|recovery
P01396572A0320|146 155|competitor
P01396583A0204|67 71|probe
P01396592A1113|148 162|differentiation
P01396601A0986|98 105|homology
P01398068A0948|98 111|RGC DNA sequence
P01398071A0526|152 154|III
P01398073A0986|143 150|promoter
P01398074A0697|75 100|RNase MRP enzyme preparations
P01398074A1081|120 123|role
P01398098A0770|73 83|polypeptide
P01398104A0834|101 106|factor
P01398106A0754|186 194|OH termini
P01398140A0488|125 132|location
P01399206A0375|115 134|epidermolysis bullosa
P01400217T0000|91 106|phage sensitivity
P01400396A1265|109 126|protein kinase C beta
P01400401A0065|137 144|criteria
P01400401A0854|128 136|AMPD3 cDNA
P01400775A0435|95 99|brain
P01402647A0114|110 121|phage surface
P01403222A0391|101 111|transfusion
P01403391T0000|34 41|children
P01404401A0740|85 99|chloroplast gene
P01404612A0303|93 109|vaccine candidates
P01406630A0545|185 203|sequence specificity
P01406630A0965|152 167|NF-kappa B complex
P01406656A1075|163 165|ras
P01406677A0000|231 244|luciferase gene
P01406688A0898|98 107|amino acids
P01406703A1435|149 153|cells
P01407286A0427|146 164|tyrosine hydroxylase
P01408090A0572|54 61|arteries
P01408137A0974|114 117|% G+C
P01408219A0670|129 139|hyperplasia
P01408474A0531|47 60|sensor catheter
P01409581A0206|99 102|site
P01409643A0618|233 235|TMF
P01410071T0000|86 108|platelet serotonin uptake
P01413984A0737|289 301|blood pressure
P01414219A0319|149 151|ERY
P01418272A1072|47 47|%
P01418494T0000|26 33|function
P01418542A0000|56 65|arrhythmia
P01418834A0987|125 128|mm Hg
P01418860A0797|204 215|interactions
P01419945A1386|116 120|sites
P01420177A1065|136 143|activity
P01420223T0000|56 66|fiber typing
P01420363A0818|160 167|addition
P01420363T0000|103 115|transcription
P01420579A0292|131 141|vaccination
P01421145A1190|135 144|leaf tissue
P01421390T0000|206 213|lymphoma
P01421609A1067|108 114|support
P01422265A0263|186 200|coeliac patients
P01423454A0309|184 192|treatment
P01423738A0639|129 140|mean delta tau
P01424674A0000|84 96|cicatrization
P01425653T0000|88 92|women
P01425921A1286|161 164|V1J1
P01426635A0496|88 102|dopamine neurons
P01427034A0440|145 150|length
P01427457A0000|188 190|DVT
P01428490A0671|158 161|past
P01428513A0440|45 51|persons
P01429596A1669|123 129|18K-LAF
P01429624A0328|97 111|adenylylcyclase
P01429714A0730|0 3|Clin
P01429724A0664|92 97|Leu455
P01429740A1065|122 127|E2 gene
P01429768T0000|61 65|alloy
P01429836A0457|96 108|Vps1p function
P01429836A1205|98 102|cells
P01431380A0244|416 420|gland
P01431602A0229|93 108|microliters HClO4
P01431809T0000|88 104|polyhedrosis virus
P01432453T0000|30 45|system definition
P01433391A0594|127 133|kittens
P01433502A1163|162 170|repressor
P01433524A0788|92 101|activities
P01435698A0000|135 146|implantation
P01436261A0145|181 196|calcitonin levels
P01437562A0462|129 132|gene
P01438224A0749|49 49|J
P01438287T0000|59 63|genes
P01441120T0000|16 23|minerals
P01441818T0001|56 73|Klebsiella infectio
P01443047A0773|79 94|Id-SCL expression
P01443745T0000|58 66|midazolam
P01443748A1190|128 136|movements
P01446132A0328|63 74|complication
P01446828A1088|114 118|NF-E1
P01447139A0208|0 0|V
P01447189A1546|108 118|lymphocytes
P01447189T0000|83 100|killer cell leukemia
P01448107A0361|89 107|amino acid starvation
P01448806A0135|62 75|bone maturation
P01448917A0775|340 352|cleavage sites
P01448932T0000|0 41|Rice dwarf phytoreovirus segment S12 transcript
P01449183A0795|73 85|fluid otorrhea
P01449301A0710|57 61|hours
P01450815A0337|148 155|decrease
P01451771A0619|203 207|wives
P01452037A0000|266 279|gap amber mutant
P01452584T0000|73 85|Lindberg Award
P01452703A0782|151 159|ELISA kits
P01454518A0336|191 199|ERCC3 cDNA
P01454819A0000|186 206|ADP-ribosylation cycle
P01456888A0074|281 308|myristylation consensus signal
P01457380A0000|101 113|ttk transcript
P01457695T0000a|65 68|year
P01457695T0000b|65 68|year
P01458170A0155|185 189|range
P01459447A0484|69 75|library
P01459451A0478|124 130|embryos
P01459885A0705|118 121|beta
P01459921A0000|198 203|cis C18
P01460054A0478|152 164|amino terminus
P01460054A0968|109 113|cells
P01460772T0001|65 82|interferon treatmen
P01462786T0000|36 49|complex systems
P01464329T0000|61 79|prophase chromosomes
P01464606A0344|161 164|EDTA
P01467088T0075|0 8|Abstracts
P01467828A0542|162 171|antagonism
P01468625A0282|131 136|manner
P01468625A1080|39 42|NSR1
P01469042A0355|192 209|centromere function
P01469047A1606|140 156|acid decarboxylase
P01470243A0871|265 279|viscosity effect
P01470741T0062|36 40|cours
P01471602A0362|234 238|drugs
P01473196A1016|51 59|clearance
P01473207A0582|61 70|hypoplasia
P01473234A1001|65 77|acid formation
P01474990A0000|172 187|epimastigote cDNA
P01475381T0001|0 10|Brucellosis
P01476376T0000|52 59|pH-meter
P01477021A0394|105 105|P
P01478672A0795|79 86|sequence
P01480183A0000|82 88|library
P01480183A1689|102 106|mouse
P01480470A0323|50 59|activities
P01482912A0617|102 119|relational database
P01483755A0000|130 135|muscle
P01483771A1335|46 70|plasma epinephrine response
P01485648A0000|200 207|patients
P01486836A0774|197 198|T4
P01487144A0505|151 166|L cell fibroblasts
P01490493A0416|69 86|triglyceride levels
P01492463T0001|62 65|ocea
P01493864A0619|75 83|GBR-12909
P01495069A0392|92 95|DFAT
P01496348A0000|57 63|mankind
P01496784A0939|71 75|death
P01497582A0593|127 134|placenta
P01498607A0000|79 109|parsley chalcone synthase promoter
P01499213A0185|141 154|L2-L3 disk space
P01499616A0136|169 180|foreskin flap
P01502157A0000|115 124|P2 activity
P01504178T0000|56 62|complex
P01504853A0299|59 65|species
P01505488A0231|76 79|July
P01505516A0928|103 108|dimers
P01506705A0282|16 27|hemodynamics
P01506746A0476|40 43|pigs
P01509798A0520|62 64|UEA
P01511231A0085|98 111|placebo patches
P01511950T0000|96 119|hepatitis B surface antigen
P01512259A0867|104 110|Dfurin2
P01512654A0503|146 152|latency
P01512941A0000|166 169|NFLX
P01513114A1133|91 95|WORDS
P01513213A0231|128 134|HIP data
P01516427T0000|56 67|tuberculosis
P01516829A0113|119 125|complex
P01516829A0460|131 143|lexA operators
P01518396T0000|0 6|George T
P01518833A0397|71 77|spinach
P01518849A0165|188 202|elastin peptides
P01518926T0000|25 39|ultrasonography
P01522699A0092|51 64|recipe analysis
P01523111A0769|86 93|body mass
P01524549A0241|152 160|GH therapy
P01525153A0359|141 141|W
P01525966T0000|25 30|stones
P01526658A0454|86 94|B lineages
P01526690T0000|36 46|lymphocytes
P01527020A0511|140 146|rat gene
P01529530T0000|92 116|ISGF3 transcription complex
P01531086A0127|67 73|protein
P01531214A0885|69 82|administration
P01531632A0000|182 197|arginine residues
P01532229A1264|179 189|muscle cells
P01532796A0107|146 146|S
P01532914A0067|122 128|studies
P01533760T0000|60 72|meta-analyses
P01535242A0557|102 116|factor switching
P01536153A0574|208 214|dyspnea
P01536575A1213|249 260|hydrocarbons
P01537334A0507|60 82|coat colour mutation slaty
P01537845A0571|108 116|cell cycle
P01538401A1244|158 169|DNA fragments
P01538403A1058|213 220|TATA-box
P01539996A0588|276 284|C terminus
P01541556A1040|101 113|Cys-22 residue
P01541577A0000|104 104|J
P01542565A0220|59 71|protein L7/L12
P01542565T0000|160 168|precursor
P01542667A0125|135 144|expression
P01542686A0000|134 142|NF-kappa B
P01542730A1982|279 283|WORDS
P01543909A0787|201 215|ferritin subunit
P01544854A0699|62 64|DMF
P01544918A1240|294 300|RI alpha
P01544928A1252|156 168|cassette model
P01545523A0000|105 121|antistreptolysin O
P01545787A0345|98 104|NFIL-2B
P01545792A0000|135 144|expression
P01545792A0492|87 108|MLC-2 gene transcription
P01545797A0587|97 101|cells
P01545806T0000|76 86|REC107/MER2
P01545818A0696|159 172|v-Src SH2 domain
P01546522A0000|174 181|lymphoma
P01547775A1024|168 195|ORF2a/ORF2b transframe protein
P01547787A0548|0 19|Proprotein processing
P01547942A0120|121 127|CHOP-10
P01547957A1083|276 284|substrate
P01548756A1102|153 167|rhesus monkey DNA
P01548891A0635|132 132|P
P01549118A0000|126 147|hermaphrodite intestine
P01549123A0480|105 114|activators
P01549125A0140|106 121|DNA binding assays
P01549129A0356|121 123|Src
P01549346A0000|69 71|DNA
P01549465A0122|129 142|discrimination
P01551176A0000|58 71|pyrroloquinone
P01551568A1476|79 87|Rif domain
P01551898A1084|128 140|culture medium
P01551910A0313|117 136|transcription factors
P01551910A0978|43 50|sequence
P01552052A0139|128 139|cyclosporine
P01552457T0000|96 100|PT-01
P01552662A0398|77 79|LAD
P01552853A1377|58 67|yop regulon
P01553407T0000|49 62|risk assessment
P01554334A0000|161 169|Australia
P01555556A0565|69 74|W.kg-1
P01556068A0000|146 166|ammonium ion repression
P01556111A0241|25 31|plasmid
P01557217A0272|73 77|h p.i.
P01557411A1282|97 105|promoters
P01558942A1369|49 53|genes
P01559209T0000|40 44|study
P01560021A0379|109 115|rat gene
P01560774A0885|60 67|fliA gene
P01562659A0676|277 294|C. immitis infection
P01563343A0548|98 104|control
P01563635T0000|78 91|deletion mutant
P01564653A0307|33 36|lens
P01565093A0179|208 211|ADPH
P01565882A0737|239 240|Ib
P01566576A0605|5 7|C.J
P01567649A0139|134 140|infancy
P01568960A1129|126 136|VA/Q regions
P01569015A0120|83 91|direction
P01569102A0708|104 112|cysteines
P01569344A0404|158 158|P
P01569581A0482|183 212|translation initiation frequency
P01569584A0672|142 146|genes
P01569945A0529|100 102|kDa
P01572549A0000|191 200|components
P01573270A0000|152 170|EBV-B lymphocyte line
P01577056A0178|169 181|washout period
P01577740A1111|112 127|Northern analyses
P01577819A0709|76 82|domain C
P01579472A1018|76 81|manner
P01579537A0000|59 68|neurotoxin
P01580738T0001|42 47|ascite
P01581409A0398|122 125|test
P01581577A1186|37 51|gene duplication
P01581965A0388|200 206|GTPases
P01582413A0192|186 207|hetero-oligomerization
P01582413A0759|141 150|DNA binding
P01582500A0178|25 29|sleep
P01583819A0377|64 75|Simson method
P01584812T0000|100 124|transcription factor NGFI-C
P01585014A0000|421 425|FSH-P
P01586901A0000|117 122|window
P01587267A1144|166 176|mutagenesis
P01587763A0402|108 111|days
P01588270A1029|124 126|DBP
P01588315A0356|204 207|maps
P01588913A0000|127 134|P. putida
P01588961A0000|129 137|pre-tRNAs
P01588963A1153|77 88|Cdc25 protein
P01588965A0000|49 62|gene expression
P01589576A0170|144 145|T3
P01592545A0726|54 61|patients
P01594554A0845|129 136|function
P01596007A0908|225 229|WORDS
P01597170A0000|191 196|hr/day
P01597272A0077|40 57|withdrawal symptoms
P01597462A0457|44 47|gene
P01600531A0483|60 71|control group
P01601181A0842|104 111|germ band
P01601869A1389|175 188|BC3H1 myoblasts
P01603088A1121|113 118|manner
P01605038T0001|59 61|rat
P01607223A0000|177 187|vasculature
P01608239T0001|13 20|barriers
P01611699A0000|64 88|Albizzia julibrissin DURAZZ
P01612085A0624|111 125|distance runners
P01613640A0158|82 85|Brij
P01615049A0000|74 78|cycle
P01615182A0206|108 118|bromhexeine
P01615493A0408|64 71|daughter
P01615493A0975|113 122|wall damage
P01616475A0756|149 173|panic disorder presentation
P01617242T0000|40 47|products
P01617776A0343|210 213|days
P01617801A0088|110 111|mg
P01618027A1108|168 173|region
P01618243T0000|37 46|volunteers
P01618256A0521|81 81|%
P01619114A0383|67 85|Mini Speech Processor
P01619642A0131|4 10|parents
P01620118A0470|194 198|cells
P01620129A0417|144 144|J
P01620610A1070|185 196|MTI subregion
P01620781A0611|216 220|class
P01621584A0183|140 146|IOP rise
P01623900A0670|314 329|dF administration
P01624425A0907|67 85|consensus amino acids
P01625131A0452|63 71|rejection
P01625527A0000|209 223|transplantation
P01626372T0000|105 133|trimethoprim-sulfamethoxazole
P01626430A1112|95 109|Drosophila genes
P01626440A0449|79 81|day
P01626631A0557|168 172|level
P01627106A0320|134 151|isolation frequency
P01627828A0475|156 162|SmN gene
P01627830A0000|83 86|CKI2
P01628201A0824|95 102|datasets
P01628806A1347|99 112|helicase region
P01628904A0386|54 59|insert
P01629768A0131|89 105|glass micropipette
P01630454A0635|55 74|Act1 promoter activity
P01630455A0448|156 168|IL-1 beta genes
P01630569A0605|43 47|tumor
P01631229T0000|0 11|Cutis aplasia
P01633435A0743|119 125|Gossett
P01633816A0667|183 199|S1 nuclease mapping
P01634308A0191|51 60|techniques
P01634400A1101|55 75|replacement stock costs
P01634464A0163|107 117|haemorrhage
P01634861A1336|86 101|lactate clearance
P01636339A0200|132 136|fungi
P01636714A0845|143 145|CLP
P01637758A0532|176 176|P
P01639092A0776|6 6|N
P01639724A0452|102 110|pill cycle
P01640778A0485|76 84|screening
P01641628A0869|108 115|research
P01642060A0471|121 127|FIGO III
P01643943A0300|55 57|TFR
P01644751A0590|100 114|msgB gene product
P01644796A0374|88 92|cells
P01644814A0068|72 77|T cells
P01644821A1259|219 234|butyrate response
P01644831A0824|149 156|portions
P01645902A1462|178 185|activity
P01645905A0341|160 176|breakdown products
P01646157A0414|187 196|alpha-Gal A
P01646487A0874|150 157|patients
P01646753A0336|184 184|V
P01647070A0232|47 60|DNA replication
P01647656A0000|175 187|regurgitation
P01647813A0512|135 144|expression
P01648142A1170|133 137|PE arm
P01648530A0000|184 187|eggs
P01649173A0160|109 130|transcription start site
P01649318A0734|74 123|herpes simplex virus TK promoter transcription start site
P01649318A1222|126 134|cell genes
P01649539T0000|62 68|surgery
P01649835A0822|154 161|Ro5-4864
P01650524A0837|188 197|colchicine
P01650557T0000|99 114|transplant donors
P01651232A0152|91 98|thio-UTP
P01651918A0000|151 164|bisphosphatase
P01652372A0153|120 126|protein
P01652515A0379|143 153|neostriatum
P01652755A1492|276 278|MHC
P01653173A0619|215 234|preinitiation complex
P01653236A0895|123 139|hamster ovary cells
P01653238A1062|222 235|promoter region
P01653238A1715|59 64|enzyme
P01653918A0286|105 124|corneal pain threshold
P01654349A0327|75 78|gain
P01655126T0000|94 102|tropolone
P01655713A0294|125 132|mutation
P01656220T0000|79 100|receptor tyrosine kinase
P01656221A1319|141 150|FGFR family
P01656235A0946|83 92|CCAAT motif
P01656675A0236|90 97|controls
P01657246A0325|77 79|Met
P01657249A1019|139 146|VH4-HV2a
P01657415A0837|68 75|K. lactis
P01657594A0472|79 82|cgs2
P01657969A1420|157 173|calmodulin binding
P01658356A1369|192 196|mRNAs
P01658356T0000|116 122|viruses
P01658375A0854|197 215|consensus sequence GT
P01658468A0123|148 152|sites
P01658741A1047|97 101|locus
P01659685T0000|77 89|Dictyostelium
P01660486A1756|204 217|gene expression
P01660925T0000|135 141|regions
P01661369A0825|117 124|moieties
P01662609A0398|71 77|R.HgiCI
P01662794A0640|147 154|antisera
P01662807A1182|81 89|infection
P01662884A1029|105 115|prostatitis
P01664192A1577|52 61|vecuronium
P01669611A0142|99 106|diseases
P01671675A0483|197 210|CAD polypeptide
P01671675A0905|76 82|CAD gene
P01673220A0578|67 76|bol3 allele
P01674177T0001|21 28|psoriasi
P01674242A0358|475 491|half-life increase
P01674369A0417|53 67|restriction site
P01674662A0000|245 253|relevance
P01674817A0862|79 87|data banks
P01674817T0000|116 127|RNA15 protein
P01675154T0000|42 54|bypass surgery
P01675424A0991|129 132|site
P01675637T0033|84 105|receptor dimer formation
P01675763A1389|71 75|entry
P01678287A1308|160 167|function
P01678392A0648|99 107|cmH2O l-1 s
P01679068A0000|166 180|Enterobacter spp
P01679124A1368|207 211|WORDS
P01679749A1171|136 156|HSPG2 proteoglycan gene
P01681075A0429|153 174|carbohydrate metabolism
P01682484A0680|178 194|lactate metabolism
P01682509A0539|108 113|HUT-78
P01682542A0690|118 128|individuals
P01684791A0000|60 89|chicken glutamine synthetase gene
P01686909A0299|115 120|kidney
P01687050T0000|78 85|diseases
P01688841A0430|89 101|regulator virF
P01688972A0803|37 43|patient
P01690703A0285|14 14|D
P01690728A1166|161 183|polymerase chain reaction
P01690812A0000|126 129|type
P01691184A0995|127 142|precursor protein
P01692135A0783|184 194|killer cells
P01692837A0390|131 139|kilobases
P01692962A0980|140 160|protein kinase activity
P01694009A0112|97 107|polypeptide
P01694014A0716|135 142|LD78 cDNA
P01694280A0000|75 82|cisterns
P01694525A0000|106 115|N-terminus
P01695098A1116|31 38|patients
P01695116A0078|94 99|months
P01695314A0762|18 30|glucose levels
P01695314T0000|88 103|diabetes mellitus
P01695322A0000|86 95|tumor virus
P01695378A1406|98 105|FKBP mRNA
P01695905A0480|98 110|adipose tissue
P01697611A0738|61 67|growths
P01697683T0000|52 65|cytotactin gene
P01697928A1214|227 235|promoters
P01698761A1059|197 205|phenotype
P01698772A0238|6 6|J
P01699944A1538|164 173|c-fos genes
P01700272A0838|126 136|recruitment
P01701088A1335|77 84|CCAAT box
P01702361A0621|86 107|angiogenesis inhibitors
P01702426A0196|138 153|acid synthase gene
P01702426A1006|122 129|fragment
P01702432A1296|95 106|pollen tissue
P01702972A0613|131 139|G0S30 cDNA
P01703335T0000|94 113|transplant population
P01703632T0000|91 98|proteins
P01707659A0458|91 94|Ch28
P01707800A0354|138 140|N11
P01708098A0922|173 180|receptor
P01708771A1215|132 136|Asn72
P01708774A0203|59 72|promoter region
P01709486A0000|63 67|c-kit
P01709933T0000|93 98|statin
P01710766A0349|109 123|initiation codon
P01710768A1172|167 181|gamma interferon
P01710979T0000|92 95|p110
P01710985A0315|0 3|Chem
P01711041A0348|93 102|beta-chain
P01711041A0962|60 69|beta-chain
P01711048T0000|114 135|osteogenesis imperfecta
P01712296A0157|76 95|amino acid differences
P01713213A0000|183 211|protein tyrosine kinase activity
P01713213A0488|148 150|GST
P01714322A0969|90 94|genes
P01714358A0990|92 94|ATP
P01714452A0559|131 152|carbohydrate attachment
P01714902A0221|189 213|histocompatibility complex
P01715593A0838|56 66|brain levels
P01715975A0885|57 61|cells
P01716292A0000|195 203|H-2E alpha
P01716629A0000|52 76|matrix glycoprotein undulin
P01717718A1255|151 162|prerequisite
P01717833A1223|102 112|CREB protein
P01717833T0000|88 104|rat granulosa cells
P01717925A0477|129 134|region
P01717994T0000|83 90|mutation
P01718043A0384|121 148|erythrocyte sedimentation rate
P01718983A1640|85 88|Cell
P01719684A0494|148 164|sphincter function
P01720555A1087|54 66|alfalfa organs
P01720843A1506|127 146|nitrovasodilator EDRF
P01721261T0000|25 42|transplant patients
P01721884A0962|255 276|RNase H crystal structure
P01722319A0849|159 166|C termini
P01722479A0302|59 69|specificity
P01723619A0766|149 154|factor
P01723962A0165|99 103|Na-Tc
P01724982A0237|77 78|IL
P01725547A0354|96 98|CBF
P01725622A0292|57 59|CCI
P01726211A0502|85 90|action
P01726631T0001|132 136|usage
P01727488A1146|82 95|gene expression
P01727494A0000|107 110|host
P01730412T0000|39 43|c-Myc
P01730747A0205|33 33|C
P01731107A0928|181 186|genome
P01731933T0000a|41 47|protein
P01731933T0000b|41 47|protein
P01731979A1408|79 107|CaMV 35S domain B enhancer element
P01732033A0000|123 127|model
P01732736A1076|131 142|gastrulation
P01732752A0156|74 79|LT mRNA
P01733105A0127|69 76|sense RNA
P01733358A0240|107 121|mucin production
P01734020A1318|147 154|PKC alpha
P01734283A0817|134 138|RAP30
P01734570T0000|122 133|porcine model
P01735347A0482|151 158|necrosis
P01735447A0271|153 161|reticulum
P01735447A0833|131 139|reticulum
P01735721A0185|181 184|tyrZ
P01736093A0731|136 148|constructions
P01736651A0104|43 53|Minneapolis
P01736844T0000|182 189|epilepsy
P01737741A0000|131 135|study
P01737789A0800|147 152|intron
P01738470A0441|86 102|recognition memory
P01738653T0014|7 11|bones
P01738936A0292|70 77|analysis
P01739439A0257|138 148|control mice
P01739956A0638|60 65|type IC
P01740121A0136|54 91|baculovirus/insect cell expression system
P01740330A0329|0 0|J
P01740437A0851|130 140|fibroglycan
P01740448A1735|189 197|membranes
P01740682A0703|162 177|thrombocytopenia
P01741249A0177|0 2|W.G
P01742341A0499|100 109|Beagle dogs
P01742606A0000|124 146|kDa spectrin beta-subunit
P01742879A0471|116 128|water drinking
P01744039A0511|114 137|conformation polymorphism
P01744042A1355|109 118|% glutamine
P01744119A0757|183 191|templates
P01747972T0000|40 55|artery dissection
P01748067A0000|210 214|femur
P01748194A0767|140 140|N
P01748287T0000|68 74|targets
P01748292A0000|91 92|cv
P01748630A0125|210 210|F
P01751163A0000|126 131|calves
P01751255A0529|61 69|MBBF group
P01751970A0209|47 54|sequence
P01752441A0000|183 193|transcripts
P01752792A0000|138 147|albino rats
P01753317A0879|116 126|bone defects
P01754381A0000|220 227|pol alpha
P01756195A1117|84 86|age
P01756539A0354|103 112|infarction
P01757341A0591|127 145|alkaline phosphatase
P01758750A0000|81 91|ventilators
P01759052A0786|0 3|Appl
P01759282A0000|127 138|biomechanics
P01760166A0963|103 110|patients
P01761736A0158|205 216|distribution
P01762053A0557|73 81|particles
P01762914A1218|85 104|translation start site
P01762917A0615|105 114|DNA binding
P01763065A0913|0 0|P
P01763106A0070|84 94|test session
P01764899A0399|114 124|cavity level
P01765095A0680|127 134|myogenin
P01765266A0000|125 131|embryos
P01765269A0308|111 118|features
P01765375A0290|176 180|chain
P01765386A0305|101 109|junctions
P01765407A0866|122 139|mmol/mol creatinine
P01766666A0788|127 133|factors
P01766876A0000|155 171|replacement vector
P01766999A0000|72 81|volunteers
P01767060A0000|229 232|neck
P01767592A0682|177 190|nucleotide-136
P01767899A0136|161 172|envenomation
P01768648A0853|90 93|cRel
P01769189A0000|202 203|UT
P01769919A0393|104 106|kHz
P01770651T0001|102 109|thyroxin
P01771593A1152|74 76|PCD
P01771593A1232|64 72|offspring
P01771959A0442|176 183|segments
P01772201T0001|50 54|perio
P01772341A0852|173 177|agent
P01774062A0257|104 111|YAC B1D12
P01774063A0161|185 194|chromosome
P01774093T0000|72 80|pregnancy
P01774822A0289|88 92|cycle
P01776306A0572|19 20|VT
P01776715A0489|147 149|kPa
P01777841A0744|105 112|neonates
P01779299A0000|101 124|Moniliformis moniliformis
P01779433A0694|275 277|end
P01779769A0000|128 137|kDa protein
P01780235A0094|41 51|transfusion
P01781923A0744|189 193|lines
P01782424A0278|93 101|sentinels
P01782669A0496|57 62|A23187
P01782982A0155|105 123|bronchoconstriction
P01783088A1136|257 261|WORDS
P01783375A1066|114 137|translocation breakpoints
P01784589A0000|77 84|behavior
P01785749A0695|70 75|weight
P01786094T0001|23 27|coppe
P01787085A0331|63 69|colloid
P01788002T0001|32 38|childre
P01791363A0208|86 92|testing
P01791754T0000|107 116|haemolysin
P01792580A0198|77 86|percentage
P01792914T0000|23 39|childhood leukemia
P01797459A0103|56 62|patient
P01797467A0000|73 81|pregnancy
P01798407A1011|144 159|laughing seizures
P01804671A1001|226 231|mmHg-1
P01806314A0322|92 102|muscle actin
P01808049A0262|175 181|atrophy
P01808136T0000|27 46|coagulation factor XII
P01808186A0984|61 63|Exp
P01808602A0000|110 118|excretion
P01808829A0510|73 83|hemorrhages
P01809854A0106|91 103|meta-analysis
P01810108A0000|122 125|cows
P01810154A0491|7 14|children
P01811243A0000|214 226|rCBF technique
P01811948A0289|142 152|cis-element
P01812102A0101|185 189|state
P01812690A0475|40 45|growth
P01814182A0000|131 135|cycle
P01816655T0000|47 50|cyst
P01817497A0715|108 117|population
P01822581A0533|99 111|breath samples
P01822995T0000|60 77|dicot rbcS promoters
P01823520A0183|92 107|haematocrit value
P01823524A0238|209 227|xenobiotics toxicity
P01824713A0964|91 101|stimulation
P01824944A0988|104 106|IgE
P01825027T0000|85 91|ATPases
P01826003A0694|94 98|exons
P01826043A0431|206 208|Ca2
P01827068T0000|81 102|T cell receptor alpha gene
P01827203A0136|63 68|dimers
P01828248A0189|145 160|helicase activity
P01829060A0649|64 73|nifedipine
P01829460A0329|68 80|kappa B element
P01830114A1587|134 140|repeats
P01830928A0361|117 133|attachment domains
P01832019A0265|81 85|weeks
P01832152A0000|81 81|J
P01832152A0902|54 57|ORF2
P01832197T0001|9 25|D2 dopamine recepto
P01833185A0547|201 211|cytokinesis
P01833637A0531|185 191|fashion
P01833716A0990|81 95|HTLV-1 infection
P01837787T0000|45 56|organization
P01837842A1410|58 74|gel shift complexes
P01839414T0000|56 60|Sabah
P01840513A1019|192 203|8-bromo-cAMP
P01840607A0294|105 107|PFP
P01840608A0823|88 114|amino acid sequence comparison
P01840711A0000|44 47|RHDV
P01840902A1089|135 140|dicots
P01842498A0000|199 214|blood lymphocytes
P01842867A0696|83 88|mucosa
P01844017A0410|148 160|sodium nitrite
P01844878A0000|131 142|DNA fragments
P01844982A0324|97 104|controls
P01845829A0158|123 132|brain cells
P01845885A1003|274 281|position
P01845899A0000|114 130|AAV gene regulation
P01846206A0665|68 73|assays
P01846489A1119|65 79|protease domains
P01846491A0459|240 247|ancestor
P01846803A0688|138 151|ATP binding site
P01847464A0856|218 235|localization signal
P01847665A1079|178 193|glia cell lineages
P01848300A0910|49 66|peptide utilization
P01848871A0392|234 244|tachycardia
P01849509T0000|175 202|Thiobacillus ferrooxidans IST2
P01849675A0167|83 84|bp
P01849734A1063|143 151|cell lines
P01850096A0662|129 152|alpha-actin transcription
P01850105A1093|118 138|muscle differentiation
P01850127A0000|111 129|polypyrimidine tract
P01850893A0286|72 76|farms
P01851386T0092|30 36|FONICAP
P01851527T0000|110 118|sequences
P01851756A0743|0 3|Biol
P01851862A0273|47 51|SFV-1
P01851876A0129|45 51|library
P01852438A0928|52 58|percent
P01852603A0000|101 109|radiation
P01853796T0000|55 71|insulin resistance
P01854339A0221|124 133|expression
P01855255T0000|61 66|GTPase
P01856021A0577|146 151|xylene
P01857143A0351|68 80|myelofibrosis
P01857326A0160|76 84|computers
P01860846A0663|128 147|leukemia cell line HL60
P01861034A0798|87 102|scaphoid fragment
P01861188A0000|280 300|ASIF compression plates
P01862027A0212|53 76|Rothmund-Thomson syndrome
P01862455T0000|21 30|management
P01863768A0649|47 52|domain
P01863887A0174|192 204|blood products
P01864510A0946|58 62|cells
P01864821A0000|170 181|blood vessels
P01864837A1029|124 150|rat alpha 1-protease inhibitor
P01865010A0000|240 245|cortex
P01867069A0000|166 171|molars
P01869565A1254|96 98|MLP
P01869907A2146|130 134|WORDS
P01869968A0000|80 87|subjects
P01869968A0673|109 120|significance
P01870194A0302|85 95|homogeneity
P01870428A0677|81 85|women
P01870500A0276|202 219|reciprocity theorem
P01871033A0434|150 155|method
P01871135A0295|130 148|rat liver glucokinase
P01871971A0836|120 125|growth
P01872856A0277|157 163|animals
P01873999A0000|218 225|interest
P01874195A0139|167 188|tyrosine kinase activity
P01874752A0948|111 118|activity
P01875922A0770|96 101|effect
P01876836T0000|46 61|GA binding protein
P01878489A0959|80 99|NADPH oxidase activity
P01878755A0496|115 125|chloroquine
P01881595A0476|153 158|phases
P01881671T0001|8 16|ofloxacin
P01882240A0526|111 121|communities
P01882386A0000|178 181|rats
P01883992A0922|120 133|maize endosperm
P01884435A0088|174 185|measurements
P01884998A1135|93 96|site
P01885006A0995|46 51|subset
P01885613A1298|90 101|collagen gene
P01885752A0198|57 72|methanol fixation
P01885915A0000|104 116|P. haemolytica
P01886043A0380|145 162|inclusion complexes
P01886368A0000|120 128|hyperoxia
P01886774A0000|101 115|octamer sequence
P01888896A0505|142 148|tobacco
P01889753A0441|82 88|regions
P01890362A0305|101 105|years
P01890989A1392|99 108|amphibians
P01892680A0907|81 81|p
P01893195A0000|101 114|virus Issyk-Kul
P01893927A0704|129 134|output
P01894696A0301|0 0|J
P01895358A0000|141 153|energy balance
P01895370A0199|117 123|fashion
P01895384A0746|64 73|expression
P01895393A0745|125 137|RNA polymerase
P01895555T0001|72 81|Tc-99m-MIB
P01896777T0000|91 108|Onchocerca volvulus
P01897515A0348|122 127|anemia
P01898113A0265|66 77|SWA killifish
P01898164A0839|134 144|arch indices
P01898928A0260|125 131|fur gene
P01899209A0883|132 133|r2
P01899287A0726|117 121|cells
P01899409T0000a|137 145|occlusion
P01899846A0862|93 98|growth
P01900194T0000|81 91|hydrogenase
P01901405A0694|68 74|tissues
P01901443A0297|181 187|O stains
P01901664T0064|1 4|case
P01901859A0000|177 191|Old World monkeys
P01901946A0243|218 239|affinity chromatography
P01901950T0000|76 89|mouse c-fos gene
P01903404A0688|232 246|perfusion status
P01903841A0125|97 102|eIF-5A
P01903841A1449|99 108|yeast cells
P01904154A0164|112 135|gene rearrangement process
P01904437A0000|110 126|DNA binding protein
P01904546A0671|93 107|a/alpha diploids
P01905199A0210|166 182|modality treatment
P01905517A1076|86 95|homologies
P01906111A1295|114 128|toxicity profile
P01906166A0119|108 125|drug administration
P01906509A0072|54 64|nidogen gene
P01906692A0321|47 53|aspirin
P01907265A0670|109 127|DNA cleavage activity
P01907941A0275|77 86|kappa B site
P01909027A0922|194 198|HNF-3
P01909621A0119|67 72|ranges
P01909960A0134|160 167|NA levels
P01910505A0000|85 88|mice
P01911767T0000|82 90|catalysis
P01913955A0177|376 379|type
P01915580A0889|115 135|airway hyperreactivity
P01916168A0969|174 181|learners
P01916405A0242|113 118|stages
P01916632A0431|51 54|case
P01917943A0621a|185 224|chloramphenicol acetyltransferase reporter
P01917943A0621b|185 224|chloramphenicol acetyltransferase reporter
P01917962A0152|168 179|SV40 promoter
P01918010A0000|111 120|expression
P01918010A1730|177 192|HepG2 hepatocytes
P01918070A0281|193 202|T3R binding
P01918073A0150|659 665|mammals
P01919831T0000|11 28|management casebook
P01921463T0000|79 91|microcomputer
P01922082A0149|97 102|region
P01922734T0000|66 76|stimulation
P01922739A0336|335 342|pia mater
P01923167A0000|176 183|approach
P01923628T0001|90 95|myxoma
P01923766A0485|193 196|exon
P01923803A0609|68 75|AUA codon
P01923985A0111|24 41|mastocyte mediators
P01924315A0158|76 89|SOD1 expression
P01924920A0115|132 141|atmosphere
P01925092A0000|98 105|meshwork
P01925092A0304|141 146|saline
P01927421A0181|55 63|nystagmus
P01927845A0107|75 81|disease
P01928923A0000|176 181|horses
P01930470A0337|172 176|blood
P01930660T0000|38 45|patients
P01931966A0490|96 101|enzyme
P01932650A0435|123 126|MBRS
P01932695A1155|79 94|barley endosperms
P01933614A0406|59 70|osteoporosis
P01934378A1219|50 61|heart failure
P01934378T0000|60 71|heart failure
P01936213T0000|37 52|membrane fluidity
P01936348A0155|60 63|resp
P01936997A0795|89 107|TAR RNA loop sequences
P01937790A0292|56 61|adults
P01937989A0383|66 67|R2
P01938178T0000|52 55|P300
P01939131A0871|49 59|strain cells
P01939199A0588|153 157|level
P01939827A0150|291 298|degrees C
P01939878A0765|135 141|acidity
P01939899A2043|143 147|WORDS
P01939906A0233|253 259|minimum
P01942033T0000|75 78|exon
P01943184A1050|90 95|% cells
P01945430A0660|131 145|neuroma suspects
P01947449A0191|196 198|PO2
P01947449A1082|188 203|cylinder diameter
P01948783A0000|85 92|patients
P01952827A0215|47 56|test phrase
P01954355A0997|122 129|episodes
P01954835A0000|107 114|Missouri
P01956285A0000|109 137|choline-glycine betaine pathway
P01956491A0095|221 224|rats
P01958368A0556|86 110|vitelliform classification
P01958821T0000|38 48|cell biology
P01960974A0000|65 72|solvents
P01961213A0150|67 71|years
P01961747A0000|122 139|transfection assays
P01961996A0522|65 75|opportunity
P01963419A0501|156 166|18F reaction
P01963438T0000|105 114|electrodes
P01963858T0001|83 94|microdialysi
P01964989A0145|206 212|ammonia
P01967130A0645|103 120|DNA binding proteins
P01968043A0908|88 99|orientations
P01968061A0371|0 2|Sci
P01968156T0000|21 34|botulinum toxin
P01968224A0119|259 264|region
P01970560A1024|286 295|efficiency
P01970801A0925|160 164|mouse
P01970926A0000|58 75|concentration rises
P01970984A0668|70 75|group C
P01971191A1271|170 178|histamine
P01972379T0042|70 79|protein CAD
P01973384A0206|123 129|embryos
P01974550A0362|140 146|% saline
P01974876A1051|104 114|enzyme BglII
P01975157A0836|44 50|results
P01975428A0151|121 132|cell division
P01976638A1135|68 76|sequences
P01977585A0222|135 147|protein kinase
P01977856A1036|103 109|infarct
P01978834A0076|86 112|rabbit H,K-ATPase beta subunit
P01978857A0504|53 65|CD4 cell counts
P01982061A0615|50 76|transcription initiation site
P01982061T0000|53 66|hamster CAD gene
P01982190T0001|51 59|hepatitis
P01982997A1104|182 191|Jun-B mRNAs
P01983026A0483|121 131|study period
P01984665T0000|132 144|baculoviruses
P01985301T0000|61 71|brain damage
P01985920A0156|118 130|pair cDNA clone
P01985920T0000|71 75|cDNAs
P01985924A0554|193 197|delta
P01986225A0250|39 50|fission yeast
P01986241A0117|85 92|CUP1 gene
P01986254A0452|122 130|HeLa cells
P01986360A0000|222 226|probe
P01988041A0281|55 70|BAL cDNA structure
P01989561A0100|133 137|heart
P01989999A0000|147 149|AMP
P01990254A0791|52 61|cell origin
P01990266A0678|204 207|site
P01991521A0481|108 114|muscles
P01992459A0000|237 245|cytoplasm
P01992742A0000|74 79|period
P01992953A0247|110 117|patients
P01992953T0000|33 40|practice
P01993181T0000|100 105|region
P01993656A1860|94 101|proteins
P01995951A0000|108 116|factor Sp1
P01996312A0454|91 100|Dd kinase-2
P01997465A0276|93 103|irradiation
P01999035A0383|98 106|IHD events
P01999999T0001|62 69|treatmen
P02000093A0794|18 19|cv
P02001033A1907|229 236|pressure
P02002051A0276|95 103|C-subunit
P02002051T0000|70 82|protein kinase
P02002511A0637|75 82|examples
P02004521A0266|68 74|disease
P02004705A0686|100 101|Mr
P02005547A0121|229 235|illness
P02006558A0000|55 60|vision
P02007045A0092|100 107|distress
P02008982A0463|75 85|sputum smear
P02010912A0366|129 142|pulCp promoters
P02011924A0729|132 143|cell leukemia
P02012097T0000|45 71|Plasmodium falciparum malaria
P02012789A0051|10 22|family history
P02014928T0000|73 90|serum albumin powder
P02015921A0523|81 85|nodes
P02016053A0752|165 182|DNA binding activity
P02016769A0720|67 74|contexts
P02017159A0646|0 5|Grasso
P02017271A0502|93 100|controls
P02017414A0307|55 59|Line F
P02019572A0000|400 407|CHO cells
P02020082A0356|239 241|PCW
P02020314A1290|191 196|future
P02021630A1104|182 195|protein binding
P02022188A0112|182 185|HMGs
P02022188A1463|123 136|gene expression
P02022920A0334|86 88|UTR
P02023097A0000|136 151|virus replication
P02023421A0343|168 173|agents
P02023904A0120|95 102|proteins
P02024252A0000|103 108|Norway
P02024488A0506|103 120|neomycin resistance
P02024625A0202|114 121|features
P02024791A0582|134 134|P
P02024816A0521|72 88|pneumonia patients
P02025515A0979|32 40|doses/day
P02026144A0741|133 142|domain UAS1
P02026147A0000|138 147|CaM kinases
P02026461A0760|85 90|probes
P02026491A0399|102 105|pain
P02027839A0250|150 157|distance
P02028125A0101|168 176|functions
P02029468A0296|92 95|week
P02030910A0000|84 95|organization
P02030910A1070|97 104|splicing
P02033038A0309|130 137|fraction
P02033062A1169|110 124|reporter plasmid
P02034655A1224|47 64|transfection assays
P02034655T0000|27 46|integrin gene promoter
P02034669A0293|116 121|system
P02034676A0267|18 30|rhombotin gene
P02035805T0000|44 54|obstruction
P02036066A0000|131 139|rat hearts
P02038293A0919|127 136|VSD closure
P02038326A0538|230 240|temperature
P02038784A0317|28 34|failure
P02041088A1053|178 188|39K promoter
P02044785A0000|67 70|cyst
P02044950A0258|59 67|organisms
P02044975A0380|152 152|%
P02045366A1149|155 161|domains
P02045524A0000|202 213|drug sponsors
P02045809A0331|118 126|reduction
P02046202A0625|26 39|IgA nephropathy
P02047597A0149|108 114|strains
P02052544A0641|162 172|replication
P02052592A0000|409 413|blood
P02053289A0701|114 120|strains
P02054754A0919|100 108|disorders
P02055484A0538|50 53|ATG2
P02056553T0000|44 53|swine model
P02060052A0954|78 89|mitochondria
P02061282A0447|145 169|recombination junction site
P02061333A0784|42 49|acvA gene
P02061333A1359|189 201|ACV tripeptide
P02062116A0688|61 63|max
P02062933A0738|121 127|partner
P02064119A1172|138 142|WORDS
P02065022A0747|133 138|effect
P02066246A0258|81 85|cases
P02068085A1273|88 105|activation sequence
P02069738A0000|39 45|ethanol
P02069873X0000|140 161|differentiation lineage
P02070227T0000|11 21|cell seeding
P02072238T0000|19 23|child
P02072798A0330|73 77|ulcer
P02073222A0269|115 124|conditions
P02075876A0408|60 68|amplitude
P02075876T0001|81 83|cat
P02076620A0548|85 95|gemfibrozil
P02076620T0000|82 88|actions
P02076816T0000|82 107|IME1 transcript accumulation
P02077560T0000|35 50|safety assessment
P02078080T0040|40 51|disadvantage
P02078570A0287|50 58|integrins
P02079811A0407|148 155|bleeding
P02080902A0183|83 90|controls
P02081463A0110|129 139|interaction
P02083199A1175|70 76|EGFR-IC
P02083230A0938|169 178|amino acids
P02083253A1512|167 185|transcription factor
P02083546A0000|282 300|motor neurone disease
P02088781A0653|126 137|compensation
P02089054A0121|165 174|UV detector
P02091890A0614|180 187|sedation
P02092131T0000|66 79|transfer factor
P02093033T0001|94 104|thymus gland
P02093741A0211|149 165|analysis technique
P02093888A0293|82 90|computers
P02094221A0247|46 49|ml/h
P02094257T0000|56 64|effusions
P02095150T0000|98 104|canines
P02099622A1046|178 193|Campylobacter spp
P02102823A0492|85 103|reporter gene systems
P02102831A1282|118 120|DNA
P02103140A1088|149 165|retransplantation
P02103403A0149|80 87|steroids
P02105497A1092|162 171|eukaryotes
P02106287A0478|32 37|coupon
P02107073A0584|139 144|levels
P02107548A0727|108 110|ARF
P02109544A0000|251 259|treatment
P02110145T0000|131 158|Bacillus cereus beta-lactamase
P02110148A0423|255 258|gene
P02111015A0574|142 146|IRF-2
P02113015A0295|49 52|cent
P02113174A0064|56 77|transcription factor Sp1
P02113174A0957|51 59|activator
P02113455A0207|97 111|threshold levels
P02113699A0372|88 89|IM
P02113901A0000|131 140|difference
P02115111T0000|103 115|strain PCC7120
P02115115A1053|128 137|yeast genes
P02115116A1137|61 76|promoter elements
P02115118A0565|112 152|sucrose density gradient ultracentrifugation
P02115121A0000|180 186|complex
P02115122A0562|109 119|truncations
P02115572A1323|69 82|U266 lambda gene
P02115889A0436|80 88|kilobases
P02116071A0000|322 324|IgG
P02116537A1237|58 60|AMK
P02117799T0000a|79 99|kidney transplantation
P02117799T0000b|79 99|kidney transplantation
P02118519A0516|141 160|neurofilament protein
P02118525A0737|196 201|manner
P02118612A0629|150 155|effect
P02119530T0000|60 71|fibrinolysis
P02119626A0471|47 56|dimensions
P02119946T0000|41 52|introduction
P02120707A0594|103 129|HLA-DRA X-box oligonucleotide
P02120833A0000|111 115|units
P02121371T0000|62 77|yeast IRA proteins
P02122454A1042|137 144|molecule
P02123029A0478|161 167|regions
P02123293A0227|9 9|S
P02123295A0645|34 42|phenotype
P02123300T0000|98 117|Factor VIII Study Group
P02123466A0272|115 124|DNA binding
P02123467A0811|149 156|presence
P02123820A0000|196 199|rats
P02123875A0223|349 355|apoA-II
P02123877A1452|218 230|gene induction
P02124433A0235|187 192|group C
P02124710A0193|99 128|osteoblast phenotype development
P02124710A1624|140 143|VDRE
P02125016A0145|35 45|SOS response
P02125153A0410|145 153|isoniazid
P02126417A0408|117 125|advantage
P02126504A0602|78 86|Rh-system
P02129338A0568|64 97|alga Scenedemus obliquus plastocyanin
P02131652A0883|185 191|VTP-Cas
P02131666A0483|62 70|anomalies
P02131902A0000|140 143|S-LV
P02132636A0188|70 83|nonsuppressors
P02133731A1572|107 107|p
P02135343A0131|169 188|ANGLE3 classification
P02135536A0621|196 203|degrees C
P02137704A0000|577 589|diameter ratio
P02138707A0198|245 249|genes
P02138915A1060|124 128|WORDS
P02138992A0911|122 129|approach
P02139473A1603|161 182|Shine-Dalgarno sequence
P02139891A0532|175 186|ATF/CREB site
P02141425A0175|160 164|level
P02142240A0506|141 148|patients
P02142486A0367|108 112|cases
P02142921T0000|175 179|depot
P02142955A0248|157 160|days
P02142993A0176|196 201|France
P02143023A0729|137 151|repeat sequences
P02143186A0867|122 133|coding region
P02143186A1306|131 141|shoot tissue
P02143768T0000|40 43|wall
P02143961A0400|93 101|analgesia
P02144290A1444|0 2|Sci
P02144558A1022|23 30|families
P02144610A1306|271 286|TCR beta promoters
P02145195A0253|99 108|Sm proteins
P02145268A0746|143 152|COL3A1 gene
P02145268A1454|79 98|collagenase digestion
P02146266A0000|215 239|N. crassa amino acid sequence
P02146495A0706|139 141|CRE
P02147223A1047|93 101|PC12 cells
P02147422A0000|49 66|U1-70K snRNP protein
P02148219A0508|130 136|muscles
P02148291A0173|155 163|screening
P02148508A0374|6 9|AVLF
P02148508A1478|98 105|patterns
P02148799A0000|140 149|expression
P02149487A0348|143 163|androstenedione levels
P02149566A0478|102 111|LVH baboons
P02149570T0000|31 48|protein S deficiency
P02150473T0067|8 11|stud
P02151229A0000|257 264|subjects
P02151229A0921|43 47|group
P02153243A0965|149 154|tumors
P02153683A1579|100 105|ATPase
P02153977A0364|114 124|culmination
P02154467A0709|138 145|molecule
P02154474A1504|109 118|P-450 genes
P02154599A0382|154 156|DSL
P02154599T0000|149 163|enhancer regions
P02154602A0092|60 73|influenza virus
P02154686A0185|193 198|levels
P02154885A0153|141 146|enzyme
P02155017A1106|213 220|dialyses
P02156828A0164|146 152|protein
P02157067A0610|8 15|Virology
P02157141A0923|188 196|base pairs
P02157764A1115|104 115|cDNA sequence
P02157882T0000|98 102|cells
P02158099A0487|125 146|pSV2CAT reporter plasmid
P02158927A0000|158 162|yeast
P02159470A1432|206 220|phosphorylation
P02159559A0779|48 63|DNA amplification
P02160502A0471|58 75|recombination point
P02160622A0000|199 202|rats
P02160955A0899|99 100|bp
P02162049A0291|66 76|DNA sequence
P02162103A0000|244 253|amino acids
P02162467A0311|88 102|cAMP/CAP complex
P02162754A0339|88 92|mouse
P02162754A0801|133 155|glucose-transport system
P02162835A0989|126 132|enzymes
P02163347A0472|138 149|ets-1 protein
P02163382A0169|206 223|target DNA sequences
P02163394T0000|92 106|antiterminators
P02164585A0416|48 54|regions
P02164585A0814|121 127|leucine
P02164588A0266|160 173|HN glycoprotein
P02164604A0399|87 95|promoters
P02164604A1574|147 158|E2 expression
P02164637A0515|150 160|cdc25 mutant
P02165181A0299|51 55|stage
P02165589A0000|126 151|hormone receptor superfamily
P02165589A0888|153 167|fos oncoproteins
P02166040A0385|462 494|chloroamphenicol acetyltransferase
P02166416A0419|80 85|origin
P02166825A0198|200 213|promoter region
P02167321T0000|189 200|phorbol ester
P02167467T0000|94 98|genes
P02167784A0109|127 140|CO2 measurement
P02168640A0268|151 159|disorders
P02169887A0360|125 134|initiation
P02170687A0000|85 101|transforming genes
P02172672T0001|20 27|syndrome
P02173399A0333|122 132|sensitivity
P02173405A0270|76 89|calcifications
P02174105A1232|75 79|cells
P02174427A1574|103 145|ubiquinol-cytochrome c oxidoreductase activity
P02174861A0736|164 168|sites
P02174974A0000|133 140|presence
P02175433A0575|95 100|copies
P02175908A0805|73 77|locus
P02176021T0000|44 76|electron spin resonance spectroscopy
P02176152A0896|114 126|HSV tk promoter
P02176209A0954|113 121|cell types
P02176232T0001|58 62|stage
P02176822A0000|159 174|glycogen synthase
P02179052A1044|117 125|evolution
P02179188A1223|84 96|cytochalasin B
P02179815A0582|170 177|sequence
P02180935A0535|125 166|chondroitin sulfate proteoglycan intermediate
P02181760A0311|155 158|fold
P02182240A0355|109 116|symptoms
P02182323A0121|149 154|region
P02182618A0168|150 155|region
P02183467A0668|220 224|exons
P02185140A0000|216 220|pPHO5
P02185250A0726|95 107|translocation
P02187091A0721|87 102|relaxation period
P02187871T0000|47 84|protein synthesis initiation factor eIF-4D
P02188096A0955|70 82|c-myb function
P02188168A0000|258 262|years
P02190122A0633|115 122|primates
P02190134A0572|192 202|hemorrhages
P02193033A0195|0 0|R
P02194273A0913|69 81|Streptococcus
P02194972T0000|109 112|mice
P02195025T0000|12 20|yeast LEU2
P02195715A0143|152 159|embolism
P02195715T0000|19 36|protein C deficiency
P02196176A0749|51 55|TREB5
P02196311A1034|83 85|RNL
P02196450A0870|218 225|promoter
P02196565A0606|239 251|gal11 mutation
P02196565T0000|116 173|factor I/repressor/activator site binding protein 1/translation
P02198259A0685|146 153|activity
P02198289A0436|117 119|DNA
P02199311A0620|142 154|tRNA templates
P02200150A1381|134 147|plastic surgeon
P02200315A0278|85 94|A60 antigen
P02200736A1003|111 119|sequences
P02201770A0188|109 114|adults
P02201901A0229|59 69|SSN6 protein
P02201905A1004|123 136|gene expression
P02202496T0000|24 29|horses
P02203672A1542|22 35|cytocentrifuge
P02204029A0184|150 162|transcription
P02204621T0000|136 140|yeast
P02204623A0000|298 300|C.R
P02204625A1130|88 95|mitogens
P02204810A1080|37 46|expression
P02206430A0197|79 88|DA turnover
P02206789A0002|122 132|environment
P02206858A0000|122 126|years
P02208762A0228|135 144|appendages
P02209237A0239|142 155|liver cirrhosis
P02209243A0237|61 71|improvement
P02209540A1362|61 65|genes
P02209605A0510|127 130|mass
P02209811T0000|63 75|iliac arteries
P02212540A0473|121 150|transmission electron microscopy
P02213566A0000|144 153|infarction
P02217307T0000|62 77|emptying response
P02217741T0001|76 81|animal
P02218094A0395|67 68|Fm
P02219751A0517|71 75|speed
P02220102A0271|58 64|disease
P02220304A0501|153 158|Europe
P02223652A0939|70 71|UH
P02223773A0000|88 100|actin monomers
P02223928T0069|22 37|serotonin agonist
P02225687A0546|115 140|pregnancy management options
P02227438A0492|135 144|start codon
P02228615A0974|161 168|reaction
P02229068A0156|151 160|rev protein
P02229072A1012|112 121|metabolism
P02229282A0454|57 77|serum T3 concentrations
P02229541T0000|45 54|literature
P02231162T0000|43 54|tooth contact
P02231479A0585|128 139|task activity
P02233626T0000|63 79|strabismus surgery
P02233680A1115|133 138|region
P02233715A0914|178 179|GR
P02233729A1065|126 134|abundance
P02234345A0215|51 60|epithelium
P02234731A0503|118 126|dysplasia
P02236002A0958|112 130|chicken TCR beta cDNAs
P02236022A0000|150 154|genes
P02236060A1671|95 101|protein
P02236064A1178|107 121|phosphorylation
P02236276T0000|70 74|odors
P02237431A0000|134 150|C alpha gene segment
P02237431A0833|69 74|T alpha
P02241742A0766|50 51|HD
P02241892A0681|150 156|regions
P02242222T0000|12 18|address
P02243093A0000|134 141|U3 region
P02243386A0113|104 110|virions
P02246362T0000|86 91|traits
P02246447A0460|112 119|r2 values
P02246803A0692|108 113|output
P02247069A0261|62 64|V.L
P02247072A0794|112 123|ram mutations
P02247081A0223|154 171|growth temperatures
P02247924A0078|63 73|nephrectomy
P02248732A1113|167 178|DOPAC changes
P02249872A1051|112 116|phase
P02250919A0404|152 163|muscle cramps
P02251119A0319|123 140|hsc70 heat shock gene
P02252891T0000|88 92|sites
P02252953A0300|174 188|eating behaviour
P02253274A0000|155 162|elements
P02253663A0687|123 123|%
P02254282T0000|87 103|glucose metabolism
P02254418A0641|88 90|CNS
P02254749A0133|147 149|TAA
P02256678A1224|131 146|protein complexes
P02257251T0000|36 42|animals
P02257899T0000|53 55|man
P02258918A0242|91 106|sampling fraction
P02259334A0205|103 110|function
P02259795A0570|132 137|uptake
P02261254A0168|161 166|tissue
P02262439A0508|77 79|QBA
P02264601A0000|120 124|taste
P02265055A0417|151 156|ng ml-1
P02266679A0740|40 49|drug course
P02268461A0224|49 53|years
P02269281A1276|164 177|control signals
P02269426A0428|206 219|mRNA expression
P02270096T0000|36 46|nitrosamine
P02270587A0000|56 64|magnitude
P02270834A0123|21 29|HML method
P02272095A0832|94 108|cluster headache
P02273690T0001|62 68|hormone
P02274343A0064|137 148|neuropathies
P02274509A0623|101 121|indicator liver enzymes
P02276891T0000|35 40|demand
P02277005A0227|44 53|literature
P02277319A0211|106 120|bioburden levels
P02277452A0116|166 168|ECG
P02278217A0372|100 107|delivery
P02278474A0000|109 117|treatment
P02280777T0000|61 67|element
P02281118A1191|117 126|situations
P02281330A0556|126 131|trauma
P02281948A0245|102 110|ingestion
P02282815T0000|56 63|children
P02283148T0000|62 76|immunopathology
P02283378A0385|97 115|ultrafiltration tube
P02283378T0000|95 108|chromatography
P02283873A0308|128 135|enhancer
P02284393A0751|74 103|EE/low EE research classification
P02284573A0943|105 120|brushing material
P02287860T0001|81 92|X-ray exposur
P02289102A0114|53 66|hallucinations
P02289639A0989|85 96|control group
P02290216T0001|42 56|serum SPan-1 leve
P02291144A0493|122 134|basophil count
P02291628A0264|151 163|endocrinology
P02292272T0000|57 59|cat
P02293019A0000|149 159|cathepsin-G
P02293664A0946|143 153|mRNA cap site
P02294048A0881|93 110|Bacillus megaterium
P02295521A0922|198 208|development
P02296509A0997|81 95|serum p24 antigen
P02298741A0809|226 238|alpha antibody
P02299543A0317|43 49|outlook
P02300541A0000|180 187|rat lungs
P02300577A0852|148 157|side chains
P02300759A0000|154 160|surgery
P02303158T0000|68 78|trk oncogene
P02303470A0242|20 22|kbp
P02303874A1643|113 116|mean
P02305014A0226|111 119|ventricle
P02306539T0000|51 62|Daphnia pulex
P02307067A1348|192 199|habitats
P02307371A0263|246 253|vesicles
P02307613A0783|196 200|study
P02307848A0347|110 123|Eco-R1 fragment
P02307848T0042|57 61|genes
P02307850A0000|123 137|serine proteases
P02307850A1197|114 139|killer lymphocyte activities
P02308496A0000|174 179|GHM-10
P02310261A0115|71 81|pericardium
P02310300A0298|38 39|CT
P02310350A0221|104 111|subjects
P02310496X0000|313 327|reference memory
P02311544A0086|82 88|disease
P02312470A0774|220 225|lavage
P02312689A0360|56 69|standard method
P02315151T0020|45 47|age
P02315472A0583|102 102|%
P02317413A0364|188 199|heart disease
P02317554T0000|57 72|microscope system
P02318208A0817|158 163|Ad2MLP
P02319610A1527|128 132|route
P02320008A0651|105 110|region
P02320999A0606|183 191|compounds
P02322535A0658|39 45|introns
P02323517A0557|113 144|prostaglandin generation technique
P02324102A1157|159 163|David
P02324104A0151|149 157|C. elegans
P02324104A0516|73 83|development
P02324104A0929|133 141|C pre-mRNA
P02324104A1195|188 198|nucleotides
P02325208A0209|7 7|M
P02325895T0000b|119 136|squirrel monkey hand
P02326716A0139|168 179|displacement
P02326946T0000|118 137|liver transplantation
P02327159T0001|41 44|home
P02328328A0419|164 171|patients
P02329840A0383|86 86|K
P02330041A0335|230 235|manner
P02330110A1085|73 79|outcome
P02330333A0325|88 93|plasma
P02331361A0268|72 87|autopsy specimens
P02332018A0538|159 159|P
P02332798A0725|53 66|EVS stimulation
P02333239T0000|15 21|problem
P02333545A0313|97 104|controls
P02333749A0411|140 145|eczema
P02334972A0145|152 157|vision
P02335034A0584|81 84|LBNP
P02335521T0000|87 119|Xenopus laevis vitellogenin promoter
P02335713A0905|61 75|stearate workers
P02335815A0530|104 111|activity
P02336338A0931|83 89|account
P02339005T0000|54 57|rats
P02339447A0162|270 278|pregnancy
P02340595A0124|106 122|plant mitochondria
P02341669A0000|168 170|LGS
P02342477A1292|254 261|function
P02343033A0000|35 43|placentae
P02344529T0000|40 53|erythropoietin
P02347102A0000|102 105|rash
P02347407A0217|49 57|SE-sector
P02347655A0193|214 224|consumption
P02348225A0192|222 229|controls
P02348408A0126|81 87|samples
P02348728A1153|95 103|carcinoma
P02349827A0193|28 36|Videoplan
P02349942A0287|83 88|recall
P02349998A0297|28 37|electrodes
P02351239A0693|268 284|antisecretagogues
P02351297A0000|157 161|level
P02353453A1249|177 183|viruses
P02353875A0800|103 107|cases
P02354381A0207|206 206|N
P02355293A0749|192 198|modulus
P02355765A0220|69 73|weeks
P02355920A0681|87 120|proenkephalin germ cell cap site region
P02356823A0063|96 110|alarm properties
P02357537A0451|111 117|animals
P02358975A0709|120 132|IgA deficiency
P02360336A0574|72 76|vials
P02361008T0000|36 40|years
P02361575T0000|80 89|B6C3F1 mice
P02361812A1110|162 170|treatment
P02362161T0000|48 65|anhydrase inhibitor
P02362803A0608|89 99|Arabidopsis
P02368931A0587|2 31|addition serum IgE concentrations
P02370571A0663|181 186|factor
P02371273A0144|68 70|kbp
P02371517A0747|8 15|patients
P02372496A0782|159 175|5FU administration
P02372712A0002|134 141|broilers
P02373686T0000|147 162|receptor isoforms
P02373810A1118|82 82|p
P02374886A0305|189 197|admission
P02376023A0307|153 156|kU/l
P02378615A0807|141 152|carbohydrate
P02378945A0487|94 102|vagal tone
P02383693A0301|136 160|chemiluminescence detector
P02383771A0544|158 166|cytoplasm
P02384265A0947|109 119|polypectomy
P02384389A0854|97 105|fed cattle
P02386485A0554|133 136|tail
P02386895A0496|108 119|hypertension
P02388685A0577|258 262|tibia
P02390538A0000|163 164|mm
P02390633T0000|55 61|disease
P02390989A0745|131 142|reading frame
P02391344T0000|79 82|gene
P02392032A0657|171 181|ambiguities
P02392511T0000|84 91|disorder
P02393001A0324|143 149|results
P02393895A0918|243 246|ones
P02394707A0789|150 168|nucleotide stretches
P02394718A0130|164 169|enzyme
P02395868A0322|103 114|hydrogen bond
P02396415T0001|66 76|hypertensio
P02398897A0000|128 136|RNA chains
P02399053A0153|87 90|life
P02399053A1032|41 54|recoil pressure
P02400070T0000|73 79|therapy
P02400457A0469|202 207|phases
P02402678A0463|230 244|housefly control
P02403035A0621|68 75|fumarase
P02403634A0788|302 308|cap site
P02403926A0000|279 281|N.E
P02403926A0307|182 192|NIH3T3 cells
P02404451A1532|233 238|GM-CSF
P02405393T0000|66 76|c-ets-2 gene
P02405589A0000|78 94|drug-use decisions
P02405818A0550|118 127|infarction
P02406570A0466|83 94|test plasmids
P02406570A0898|144 153|activation
P02406992A0192|183 202|carotid artery studies
P02408248A0414|53 68|enzyme inhibitors
P02409297A0984|155 171|HBsAg determinants
P02411513A0667|154 163|positivity
P02417023T0001|92 99|material
P02417669A0218|177 183|animals
P02418701A0000|244 252|technique
P02419327A0998|189 192|site
P02420432A1060|133 141|diagnosis
P02423533A1314|162 178|nerve growth factor
P02423533A1790|104 112|sea urchin
P02423773T0001|44 47|bloo
P02423850A0292|101 113|yeast CYC1 gene
P02424743A0280|64 70|periods
P02427024X0000|169 178|phenomenon
P02427797A0199|228 234|vessels
P02427812A0865|94 96|rat
P02427869A0939|63 65|BHT
P02431314A0834|92 97|Wright
P02436005A0707|107 118|mobilization
P02437625A0197|103 105|AMD
P02437792T0000|93 104|pancreatitis
P02437895A0000|280 287|subjects
P02438637T0000|46 52|history
P02442837A0060|196 201|period
P02443028A0695|71 81|reperfusion
P02443924A0083|93 100|survival
P02444507A0240|83 90|patients
P02445751A0925|130 139|hem2 mutant
P02446871A1021|149 157|molecules
P02449431A1121|72 76|ddATP
P02451872A0391|44 44|%
P02452313A0114|214 214|M
P02454390T0000|102 112|hepatocytes
P02454976A0944|230 237|primates
P02455821A0099|150 154|right
P02456827A0899|89 91|Ba2
P02457922A0991|166 169|size
P02458080T0000|31 37|myeloma
P02458234T0000|76 88|EEG recordings
P02458699A0650|0 7|Svensson
P02459309T0000|186 194|detection
P02461368A0162|110 112|DNA
P02462047A0208|147 151|flaps
P02462305A1071|118 128|polypeptide
P02462523A0394|148 170|germ-line transformation
P02463050A0514|125 129|males
P02464097T0000|121 131|arrhythmias
P02466414A0000|222 228|% wt/vol
P02466665A0202|51 55|fluid
P02468795A1086|126 134|parameter
P02469451A0239|119 126|subjects
P02470955A0101|70 81|meningitides
P02473156A0000|126 141|adhesion proteins
P02473198A0613|91 96|effect
P02473619A0202|220 232|IgE antibodies
P02473693A0174|48 51|HGB F
P02473718A0000|251 256|stress
P02473907A1338|63 72|Fc epsilon R
P02473942A1207|99 119|transmembrane segments
P02474093T0000|115 121|effects
P02474110A1039|210 225|echocardiography
P02474204A0105|99 104|marker
P02474356A0559|159 164|animal
P02475506A0878|42 73|polymerase chain reaction technique
P02475717A0565|145 158|collateral flow
P02476030A0000|68 90|laser scanning tomography
P02476664A0563|58 58|D
P02477373A0930|55 81|transcription initiation site
P02479635A0659|120 129|expression
P02479823A0727|76 82|TATA box
P02480419A0735|88 96|infection
P02480959A0470|222 225|cAMP
P02481230A1258|77 80|mice
P02481429T0000|62 67|smears
P02481779A0213|289 290|SD
P02482293A1518|164 171|receptor
P02482511A0860|197 200|rats
P02483210A0000|89 109|relapsing pancreatitis
P02483438A0498|120 125|agents
P02484714T0000|40 60|mouse estrogen receptor
P02484994T0001|11 23|gamma globulin
P02485188A0415|228 246|chondroitin sulfates
P02486634A0632|129 149|collateral development
P02487898A0315|74 77|ways
P02488148A1156|95 98|time
P02489032A0000|190 197|VL region
P02489753A0581|122 128|GF group
P02489895T0001|79 86|children
P02492111A0670|123 128|adults
P02492111A0868|252 264|micrograms/dl
P02493644A0588|117 134|serum growth factors
P02495745T0000|97 106|thrombosis
P02496090A0252|108 124|sampling technique
P02496100T0000|100 104|study
P02496109A0754|300 310|L17 interval
P02497340A0989|84 85|Vk
P02498322A0226|142 147|region
P02498652A0460|118 129|cell cultures
P02500432A1416|168 174|CAT gene
P02502096A0462|56 73|excretion processes
P02502602A0323|119 121|p50
P02502960A0762|8 8|p
P02504603T0000|59 64|sample
P02505087A1037|91 94|GCN4
P02506390T0001|36 41|animal
P02506740A0742|98 106|blood flow
P02507523A0791|110 119|amino acids
P02507815A0000|70 73|cats
P02508306A0528|114 122|follicles
P02508726A0498|256 261|agents
P02509123A0371|82 99|baseline conditions
P02510242A0313|209 211|CMV
P02511069A0532|136 158|polytene chromosome bands
P02511150T0025|22 32|perspective
P02511207A0282|0 0|K
P02511430A0000|146 152|factors
P02511898A0000|93 100|research
P02512010A0801|105 115|circulation
P02514498A0000|210 218|electrode
P02515953A0459|42 54|effectiveness
P02517008A0481|55 65|monotherapy
P02518645T0001|61 63|lif
P02518691A0251|200 222|IL2R alpha gene expression
P02519327T0001|11 19|rheumatis
P02519679T0000|38 42|ticks
P02520622A0200|193 203|group design
P02521217A1035|74 85|mitochondria
P02521674T0000|97 100|nsP4
P02522297A0000|147 150|dogs
P02523800A1178|172 172|J
P02525044A1026|108 120|suxamethonium
P02526165X0000|108 117|malignancy
P02527365T0000|87 100|Xenopus oocytes
P02527745A0865|104 114|vertebrates
P02528329A0000|139 142|uncB
P02528730A1073|117 120|gene
P02529378A0536|253 258|HIV LTR
P02530413A0195|44 48|pg/ml
P02530470A0604|83 86|area
P02531203A0241|98 106|SSTS model
P02532032A0385|96 105|parameters
P02532210A0000|75 79|genes
P02534067A0316|257 267|alpha OH DHEA
P02535460A1443|49 52|gene
P02536096A0327|263 270|sequence
P02536160A0518|122 128|pUTKAT1
P02537441A0231|88 94|disease
P02537485A0841|86 90|mg/kg
P02538450A0000|78 99|Na,K-ATPase beta subunit
P02538656A0172|172 177|genome
P02538720A0582|93 100|sequence
P02541251A1327|192 197|T1 gene
P02541882A0251|72 79|patients
P02542194A1496|140 147|survival
P02542270A0000|189 193|maize
P02542612A0530|183 196|RNA transcripts
P02543226A1559|298 301|case
P02543621A0788|141 144|gene
P02543679A1291|129 145|lambda replication
P02543734A0414|143 152|expression
P02544059A0377|42 44|PHe
P02545357A0000|60 65|intron
P02545903A0639|116 135|BTV-10 virus particles
P02546234A1382|101 107|outcome
P02547079A0910|125 133|excretion
P02547611A0318|78 83|intron
P02547706A0928|109 111|IIP
P02547706T0001|147 170|bone marrow transplantatio
P02547778A0786|97 106|expression
P02548683T0001|46 54|hepatitis
P02549036A0000|191 200|properties
P02549343A1008|340 349|complement
P02549417A0000|79 87|functions
P02550118A0610|57 60|days
P02550682A0411|46 46|%
P02551886A0332|91 99|fragments
P02552143A0748|52 87|chloramphenicol acetyltransferase gene
P02552316A0526|125 131|percent
P02554310A0419|75 80|effect
P02555177A0488|168 182|mRNA translation
P02555418A0973|39 47|sequences
P02555519A0798|203 215|hapten binding
P02555703T0000|177 181|v-abl
P02556264A0278|167 181|cell specificity
P02556269A0187|246 256|topoisomers
P02556603A0606|104 117|bile duct cancer
P02557217A0000|108 125|IU salmon calcitonin
P02557217A0398|80 109|corticotrophin-cortisol release
P02557350A0632|77 84|SRP54mam
P02559630A0270|130 165|fibrin/fibrinogen degradation products
P02560415T0012|47 56|face region
P02562787A0637|40 43|CNBP
P02562825A0413|55 60|agents
P02565405T0000|9 21|trauma victims
P02565683A0841|108 118|tachycardia
P02565807A1198|144 148|WORDS
P02566613A0831|73 83|nucleotides
P02566613T0000|105 112|proteins
P02566680A0820|178 190|response rates
P02567030A0482|99 106|reversal
P02568930T0000|112 123|T lymphocytes
P02569411A0151|66 80|nucleus amygdala
P02571924A0000|168 182|carboxy terminus
P02572777T0000|39 54|distress syndrome
P02572928T0000|22 30|arthritis
P02573303A0000|134 149|contractile state
P02573336A0000|164 172|magnitude
P02573829T0000|124 139|segmentation gene
P02573836A0244|173 178|GXGKST
P02574016A0428|139 146|children
P02574052A0910|62 86|beta-adrenoceptor blockade
P02574193A0663|296 313|regression analysis
P02574551T0000|16 21|asthma
P02575174A0229|144 160|airflow limitation
P02575490A1021|131 135|liver
P02575567T0001|59 62|wire
P02575959A0643|87 88|T2
P02576405A0223|169 169|%
P02577458A0412|122 139|calcium antagonists
P02577867T0000|28 38|oncogene jun
P02580830A1131|123 134|mouse AFP gene
P02582240A1009|117 125|dCCC sites
P02582918A0000|190 192|T12
P02584969A0119|110 123|protection time
P02585492A1005|132 142|P7 mutations
P02586485A0511|17 19|SB3
P02586513A0622|262 267|Thr Ser
P02590097A0093|134 142|Type Kappa
P02590391A0442|242 248|lesions
P02590540A0741|69 72|U/ml
P02590615A0636|148 154|tablets
P02590869A0743|129 136|bacteria
P02591078A0000|204 207|time
P02591969A0961|99 104|region
P02592543A0106|142 149|organism
P02592640A0466|75 79|cream
P02592961A0327|65 86|psychomotor performance
P02595451A1136|115 118|MIC1
P02595451T0000|57 71|J1 series hybrids
P02597484A0624|133 141|materials
P02597549A0964|178 196|thromboplastin times
P02598034A0000|118 123|cortex
P02598745A0251|41 45|cases
P02599995A1031|149 149|%
P02600306A0140|138 144|AM tones
P02601707A0986|218 223|region
P02602150A0993|202 214|virus replicon
P02603374A0383|97 109|complications
P02603923A0220|187 193|fashion
P02604420A0234|113 121|year study
P02605160A0000|128 131|rats
P02605182A0936|125 135|polypeptide
P02605679A0306|173 180|ester k24
P02607766A0000|354 358|salts
P02609112A0000|93 104|laboratories
P02614668A0971|48 52|serum
P02615078A0283|54 57|M.f.
P02617623A0740|98 104|village
P02620085A0656|133 139|results
P02621983T0001|56 59|test
P02623038A0632|70 85|saline injections
P02627159A0899|59 71|immunotherapy
P02629109A0000|206 215|1880 levels
P02630543A0210|172 177|volume
P02631505A0382|70 74|cases
P02631566A0151|229 253|chloromethyl alkyl sulfides
P02631743A0275|98 103|plates
P02631887A0000|47 55|lymphomas
P02632904A0619|78 78|p
P02634490A0186|165 171|therapy
P02634872A0000|87 94|approach
P02636920T0001|28 69|Pharmacopoeia Heparin Sodium Reference Standar
P02637597A0362|122 123|C4
P02638964A0372|91 95|water
P02641762T0001|107 115|eye displa
P02642466T0000|47 63|membrane immunogen
P02642976A1474|52 59|elements
P02644735A0427|133 148|host cell sequence
P02645276T0088|68 74|mutants
P02645431A1562|94 101|function
P02646007T0000|76 93|protein C deficiency
P02647403A0000|85 89|years
P02647918A0423|147 150|U/ml
P02647918A0588|293 304|TRH/GnRH test
P02647937A0191|88 95|problems
P02648396A0565|108 111|mice
P02648396A1033|92 138|tumor promoter phorbol 12-tetradecanoate 13-acetate
P02648646A0216|138 141|Vp30
P02648646A0932|150 173|platelet activating factor
P02649445A0412|104 106|men
P02649811T0000|25 43|family planning study
P02650663A0178|157 165|diagnosis
P02651448A0000|165 169|Type B
P02651487A0000|206 220|glucagon release
P02655381A0000|254 265|neuropathies
P02656257A0000|135 142|enhancer
P02657388A1011|63 76|RNA polymerase I
P02657883A0000|106 108|FAV
P02657883T0001|47 53|dialysi
P02664229A0138|240 257|hypospadias repairs
P02666034A1520|172 184|placebo course
P02666404A0220|279 285|maltose
P02666568A0000|55 68|protocol TCL821
P02667259A0331|101 104|flow
P02668691A0570|89 92|nagD
P02669199A0000|88 90|LPS
P02670457T0000|54 60|explant
P02674141A1202|77 85|proenzyme
P02674327A0493|75 88|polyhedrin gene
P02674671A0601|111 116|allele
P02674674A1308|119 129|replication
P02674679A1237|164 183|start site utilization
P02675492A0806|85 87|CRP
P02677002A0205|138 159|equilibrium Pi exchanges
P02677429A0366|282 288|complex
P02677666A0356|96 103|mutation
P02679804A2000|71 92|orotidine monophosphate
P02680843A0724|64 76|investigation
P02684159A0870|57 65|kilobases
P02684585T0001|28 34|rhGM-CS
P02685331A0523|151 161|nucleotides
P02685461A0380|57 64|patients
P02685565A0165|118 127|c-myb genes
P02686588A0592|108 112|group
P02686749A0000|243 247|years
P02686980A0000|138 142|yeast
P02686985A0811|183 191|component
P02688772T0000|16 19|skin
P02689136A1851|35 38|time
P02689439A0000|130 139|substrates
P02689439A0402|177 186|rat Yb2 gene
P02689544A0456|38 44|incisor
P02691557A0273|164 169|period
P02691811A0355|129 141|concentration
P02691998A0672|128 131|ET-1
P02692881A0354|298 302|level
P02693208A0166|145 153|sequences
P02693593A0866|39 48|amino acids
P02694731A0241|176 182|testing
P02695914T0000|22 31|drug action
P02700977A0444|85 95|combination
P02702566A0000|113 122|neck cancer
P02702849A0418|182 193|micrograms/l
P02703121T0000|64 91|serum alanine aminotransferase
P02703925A0359|812 815|zone
P02704579A1078|166 178|lung mechanics
P02705072A0464|73 77|death
P02705296A0231|72 74|kDa
P02705556A1049|52 62|flow reserve
P02707909A0209|100 107|dialyses
P02708288A0139|153 162|soybean oil
P02708288A0621|249 261|oxidation mode
P02708353A1080|149 158|P-450e gene
P02708353A1452|161 166|tissue
P02709081T0000|54 74|type A behaviour pattern
P02709819A0495|32 51|ciprofloxacin therapy
P02711145T0000|23 26|AIDS
P02711167A0818|125 131|animals
P02711601A0601|91 91|%
P02712246T0042|29 43|characteristics
P02712450A0989|211 216|groups
P02713310T0000|93 98|report
P02713520T0000|65 79|ptilochronology
P02713994A0482|63 71|cord blood
P02714525A0529|139 146|exposure
P02714852T0000|60 71|HLA-B alleles
P02717133T0001|51 73|summary oxygen consumptio
P02717349A0311|48 52|women
P02718683A0142|46 53|patients
P02720966A0455|161 170|efficiency
P02721169A0171|99 111|relationships
P02723503T0000|48 58|spermatozoa
P02724227T0000|60 67|ischemia
P02725495A0929|151 162|trypanosomes
P02725513A0617|128 135|position
P02727909A0383|142 144|CHD
P02729666A0267|81 102|tissue profile variables
P02731611A0134|145 167|Mental Research Institute
P02731671A0000|186 190|weeks
P02732341A0000|198 206|diagnosis
P02733116T0000|27 32|Health
P02733690T0000|85 91|tobacco
P02735364A1330|182 189|survival
P02736482A0550|43 57|brain metastases
P02739739T0000|37 62|steroid receptor superfamily
P02740196A0704|90 102|target numbers
P02740347A0644|99 100|kb
P02740627A0137|243 248|horses
P02740874A0957|70 72|SO2
P02740955A0333|86 95|deliveries
P02743842A0000|353 357|ml/kg
P02743981A0347|181 183|ORF
P02744123A0237|175 193|background luminance
P02744490A0894|203 209|domains
P02745280A0276|207 227|resonance spectroscopy
P02745444A0391|45 61|S1 nuclease mapping
P02745666A0000|143 149|failure
P02746099A0000|108 113|facets
P02747653A0910|110 114|stage
P02748188A0091|217 223|studies
P02748595A0492|74 81|ADH-beta
P02749215A0000|64 70|finding
P02751080A0176|76 77|dB
P02752303A0000|115 124|weight loss
P02752629A0163|107 114|fracture
P02752651A0480|150 160|disturbance
P02756731T0001|17 25|gallstone
P02756878A0075|125 126|AF
P02757033A0905|144 156|transcription
P02757862T0000|58 70|defibrillator
P02758382A0478|147 152|levels
P02760922A0000|92 101|S particles
P02761008X0000|198 216|carbamate pesticides
P02761150A0000|149 157|pregnancy
P02761492A0124|80 87|patients
P02761537A0168|245 261|transcription unit
P02761540A0873|82 97|enhancer activity
P02762006A0071|54 60|lesions
P02762198T0001|35 40|period
P02763467A0903|259 264|N1L ORF
P02764797A0182|158 174|gradient waveforms
P02765001A0105|194 206|family history
P02765214A0486|60 68|arguments
P02766330A0779|125 135|application
P02766508A0421|84 95|mean IQRST map
P02766745T0000|73 81|dairy cows
P02767166A0368|171 176|myopia
P02767733A0690|101 101|%
P02772495A0641|81 89|INTR group
P02773507A0750|167 171|CLunb
P02773930T0000|50 55|humans
P02774271A0000|154 161|fluoride
P02774808A0194|99 104|winter
P02775136A1151|212 217|effect
P02775333A1137|121 128|decrease
P02776471A0235|93 100|response
P02776742A0000|298 299|FE
P02776823A0000|217 226|volunteers
P02777797A0720|77 97|PtdIns transfer protein
P02778237A0585|84 111|maintenance prednisone therapy
P02778873A0761|105 109|DR-A2
P02779752A0000|161 169|5-HT1 site
P02779752A0776|224 233|ketanserin
P02780157A0576|263 273|stimulation
P02781495T0001|57 62|failur
P02781567A0544|63 76|stratum corneum
P02783181A0000|117 131|mucus secretions
P02784507A0000|133 139|periods
P02787430A0124|55 70|cytophagocytosis
P02789062A0000|166 181|T-cell activation
P02789062A1420|141 165|NF-4FB recognition sequence
P02789180A0407|88 95|patients
P02789217A1323|92 100|kilobases
P02790009A0375|105 110|region
P02790009A1052|115 122|residues
P02792270A1220|149 160|flexion phase
P02792430A0000|194 201|vagotomy
P02793216A0876|131 133|CgA
P02793620A0214|106 113|pastures
P02793753A0354|84 88|sites
P02794828A0214|103 111|pacemaker
P02795923A0000|162 168|surgery
P02796216A0063|94 100|roseola
P02796988A0735|80 95|gel shift analysis
P02797877A0475|102 112|antibiotics
P02798953A0307|168 182|administrations
P02799892A0154|111 113|PNH
P02800417A0332|88 102|histamine values
P02800435A0000|143 145|leg
P02802280A0495|51 53|PTS
P02805945A0000|308 315|seawater
P02806916A0000|208 212|probe
P02807780A0143|125 133|diagnosis
P02808232A0681|71 71|%
P02809116A0237|127 131|wives
P02809651A0492|98 106|questions
P02809722A0926|67 77|GH secretion
P02809831A0799|46 58|bone formation
P02810911A0372|92 103|tumor markers
P02811378A0250|120 127|mandible
P02811378A0379|132 143|cell epulides
P02813369A0390|126 134|neighbors
P02813404T0000|77 91|spermatogenesis
P02814182A1211|79 83|WORDS
P02814820A0967|215 220|solids
P02815229A0139|101 109|diltiazem
P02816251A0397|143 152|ventricles
P02817724A0075|56 61|planes
P02818122A0000|164 169|nuclei
P02818260T0000|9 14|glioma
P02820128A1333|136 141|ORF T3C
P02820128A1670|249 253|units
P02821340A0434|153 157|grade
P02824334A0972|77 87|chromosomes
P02825139A0661|66 78|acid sequences
P02825750A0260|41 41|%
P02826127A0709|186 194|cell lines
P02826717A0179|76 84|water flow
P02826729A0790|73 76|rats
P02828926A1870|166 186|muscle differentiation
P02829183A0117|66 76|translocase
P02830214A0000|97 117|microelectrode methods
P02830265A0341|67 78|reading frame
P02830282A0155|135 144|amino acids
P02831398A0346|11 11|W
P02831556A0173|109 116|morphine
P02831796A0000|174 179|humans
P02832149A1009|226 241|mouse myb oncogene
P02832293T0000|62 68|obesity
P02832744A0403|89 94|testes
P02833012A0428|130 131|MW
P02833021A1185|158 173|promoter function
P02833049A0630|56 64|deletions
P02833049A1041|292 300|cell types
P02833101T0000|62 80|parvovirus infection
P02833517A0467|61 67|element
P02834478A0000|97 104|Xa factor
P02834843A0000|289 293|H37Rv
P02836623A1094|79 85|delta Mo
P02837575A0979|119 121|DNA
P02837763A0259|105 123|% nucleotide identity
P02838246A0225|228 228|P
P02838319A0527|35 35|p
P02838710A0299|84 92|treatment
P02839488A1314|177 181|error
P02839716A0673|86 112|HPV-11 enhancer-SV40 promoter
P02839716A1907|167 171|WORDS
P02840034A1266|109 115|account
P02840376A0461|13 18|Holmer
P02843495A0544|119 127|mechanism
P02843694T0001|55 63|case repor
P02844767A0191|173 178|Malkin
P02844767A0596|137 152|chloroplast genes
P02844767A1022|133 141|gene probe
P02844797A1225|278 294|glycosylation site
P02845654A0510|218 227|processing
P02846640A0643|60 61|pI
P02846852A1459|94 108|L strand promoter
P02848842A0643|109 113|cells
P02849100A0441|114 127|plasma membrane
P02849759A0865|41 44|fold
P02850472A0112|42 55|DNA replication
P02850967T0000|109 115|element
P02850971A0180|168 185|cosmid vector pVK102
P02852805A0216|78 87|treatments
P02852894T0000|60 71|Thai villages
P02853799T0001|90 97|carcinom
P02853922A0596|49 53|study
P02856622T0001|81 86|thyroi
P02859434T0000|45 56|serum lithium
P02861067A0000|151 165|beta agonist drug
P02861144A0242|94 97|kDal
P02861238T0000|7 11|virus
P02862656T0000|54 66|alcohol intake
P02863492A0544|121 128|IgG index
P02863747T0000|48 56|sequences
P02865502T0000|101 110|infarction
P02868446A0184|228 245|core enzyme subunits
P02868848A0167|154 164|gas gangrene
P02869125A0120|182 188|arousal
P02870249T0000|12 23|chemotherapy
P02870720A0188|121 134|tracheal muscle
P02870851A0349|62 82|parotid saliva flow rate
P02872786A0147|114 122|blood flow
P02873593A0581|203 209|effects
P02874078A0252|64 71|patients
P02874635T0000|108 115|hamsters
P02875224A1059|146 146|%
P02875967A0377|97 109|fertility rate
P02876820A0841|67 68|mV
P02876899A0568|108 122|absorption phase
P02877124A0000|464 469|sacrum
P02878100A0674|139 146|activity
P02879906A0000|164 179|nerve innervation
P02879951T0000|46 67|rat platelet aggregation
P02880841A0313|262 273|mitochondria
P02882893A0301|98 99|sp
P02883327A0413|102 102|L
P02883871A1075|127 132|agents
P02883963A0000|113 119|methods
P02884860A0329|104 110|therapy
P02885517T0000|32 40|hepatitis
P02889352A0000|130 146|calcium antagonist
P02889495A0000|150 163|mg flupenthixol
P02890200T0001|64 80|neurofibromatosis
P02892762A0296|73 84|promoter site
P02894689A0000|124 139|diiodosalicylate
P02894741A0000|84 99|NLA II anaesthesia
P02894789A0954|83 83|%
P02895472A0178|105 119|mRNA translation
P02895566A0187|117 122|effect
P02895754A0000|234 241|syndrome
P02897651A0000|64 71|abortion
P02898752A0683|86 102|platelets recovery
P02899177A0605|158 164|regions
P02899792T0000|16 23|overdose
P02900760A0073|206 213|3T6 cells
P02901498A0354|135 158|chicken embryo fibroblasts
P02901763A0977|243 258|protein synthesis
P02902615A0000|126 133|patients
P02902656A0481|158 171|TR/TE sequences
P02902844A1219|133 145|cyanobacteria
P02902927A0145|38 55|rat GHF-1 cDNA clones
P02903500A0278|159 163|chain
P02904322A0002|76 82|studies
P02906027A0553|128 143|CpG dinucleotides
P02906027A1156|85 90|intron
P02906249A1195|108 116|PGF2 alpha
P02906673T0000|99 108|California
P02907308T0001|26 48|Richner-Hanhart syndrome
P02907533A0362|94 114|diazepam concentration
P02907533T0000|66 72|albumin
P02909528A1081|80 89|start sites
P02910496A0583|147 158|RNAase MRP RNA
P02910989T0000|59 71|QT/QS2 changes
P02911540A0478|111 114|care
P02913368A1037|111 116|influx
P02914422A0409|152 156|slurs
P02914492A0183|169 183|hypermagnesemia
P02916764A0253|124 136|family history
P02918474A0817|126 138|subepicardium
P02919483A0091|48 56|half years
P02919530A0000|184 194|alterations
P02919832A0144|74 96|Doppler echocardiography
P02920591A0251|106 122|micrograms/kg/min
P02923687A0218|93 103|cleft palate
P02925013A1112|111 123|citrate ligand
P02925568A0460|155 169|psychopathology
P02926499A0340|192 196|blood
P02927391A0238|225 232|lineages
P02928112T0000|54 60|protein
P02928376A0312|110 110|%
P02929056T0000|84 90|failure
P02930623A0404|88 93|impact
P02934778A0702|82 88|species
P02934889A0558|160 169|D viviparus
P02934891A0845|175 177|end
P02935638A0000|63 99|sea urchin Strongylocentrotus purpuratus
P02936163T0000|90 117|platelet lipoxygenase activity
P02936284A0357|97 116|elimination half-life
P02938185A0223|225 233|CREF cells
P02939260A1553|209 224|Edman degradation
P02940334A0141|89 97|schedules
P02941237A0160|257 261|roles
P02943562T0000|62 71|importance
P02947866A1416|123 133|angioplasty
P02949170A0184|242 250|treatment
P02950216A0084|121 125|volts
P02957125A0601|87 108|plasma ANP concentration
P02958204A0175|237 248|acne vulgaris
P02958233A0123|60 80|serum sickness reaction
P02958660A1094|96 105|experiment
P02959089T0000|41 50|vasospasms
P02960012A0838|41 41|%
P02962859A0276|110 117|A antigen
P02963517A0453|166 168|mm2
P02964329A0000|125 139|microangiopathy
P02965149A0727|24 24|C
P02966671A0151|171 175|weeks
P02966671A0551|272 283|radiotherapy
P02967496A0182|132 137|region
P02967915A0000|129 141|target tissues
P02967915A0968|126 132|signals
P02968055A0984|38 40|ANF
P02969316A0002|218 223|pacing
P02969819A0814|103 116|Cmu transcripts
P02970061A0271|83 88|weight
P02970640A0341|116 122|zinc ion
P02971603A0883|45 47|day
P02971710A0734|134 135|CO
P02971957A0287|113 120|bleeding
P02973304A0000|142 156|cardiosclerosis
P02975680A0000|272 274|MDD
P02975753A1333|118 127|yeast cells
P02976332A1277|46 52|surface
P02979426T0000|22 28|Denmark
P02979834T0000|150 156|A/J mice
P02981457A0368|0 0|D
P02981840A0907|95 101|repeats
P02982332T0001|35 40|tumors
P02983316A0310|333 336|time
P02983331T0000|97 102|stress
P02985812A0984|80 91|reading frame
P02985820A1287|130 132|MH2
P02986279A0000|107 109|CMV
P02987220A0472|134 139|region
P02987777A0000|48 53|rectum
P02988457A0650|88 97|malignancy
P02989637A0671|284 286|men
P02989786A0328|67 81|CATase synthesis
P02991060A0465|107 110|ages
P02993630A1190|158 163|strand
P02994253A0482|235 241|animals
P02994336A0864|123 128|change
P02995967T0000|128 146|gland adenocarcinoma
P02995999A0000|316 337|base-pair substitutions
P02997622A0916|104 110|patient
P02997777A0609|283 297|delta top1 top2 ts
P02998016A0527|190 194|c-mil
P02998043A1199|156 157|G2
P02999267A0606|111 117|sternum
P02999267A0885|175 176|GS
P03000457A1554|101 107|species
P03000489A0822|172 187|blood lymphopenia
P03001054A0703|65 69|sites
P03001084A0406|105 112|psi alpha
P03001086A0587|145 159|dnaK gene product
P03001110A0546|166 174|phosphate
P03001353A0146|149 152|mRNA
P03001645A0785|89 90|bp
P03001705T0000|91 101|gene product
P03001952A0958|157 162|effect
P03002501A1327|131 137|regions
P03002786A0143|70 74|mg i.m
P03003695A0395|131 139|c-sis exon
P03004364A0775|96 101|MMCLIP
P03004739A0753|148 164|CAT binding protein
P03004982A0199|109 112|fbcC
P03004982A1094|91 106|fbcF reading frame
P03005231A0649|141 149|promoters
P03006066A0653|95 102|P54c-ets
P03007281A0905|90 96|maximum
P03008094A0697|60 68|sequences
P03008405A0532|60 64|HVC-1
P03009366A0438|181 185|weeks
P03009826A0201|61 66|repeat
P03010281A0220|54 67|gene expression
P03011793A0582|69 85|amino acid residues
P03013477A0000|290 295|group B
P03013841A0207|12 12|J
P03014515T0000|73 78|enzyme
P03014593A0681|67 74|Ro 5-4864
P03015611A0331|105 108|site
P03015628A1078|208 215|subjects
P03015953T0000|94 101|DNA clone
P03016301A0605|124 129|region
P03016506A0611|260 270|animal cells
P03016883A0000|133 146|virus isolation
P03017225A0706|203 208|theory
P03017996A0731|150 161|cleavage site
P03018491A0840|183 197|receptor binding
P03019505A0390|56 60|tumor
P03020001A0781|177 186|insertions
P03020513T0000|71 76|gyrase
P03021050A0501|46 54|sulbactam
P03021088A0135|165 171|average
P03022129A0842|189 192|gene
P03023067A0779|63 73|transcripts
P03023679A0624|129 140|modification
P03023682A0271|85 94|expression
P03023859A0000|154 176|breakpoint cluster region
P03023887A0470|156 157|Sa
P03023970A0922|124 133|amino acids
P03024343A0372|49 54|origin
P03024703A1036|114 126|hsp108 protein
P03025606T0000|122 125|mRNA
P03025655T0000|117 147|Fujinami sarcoma virus P130gag-fps
P03025661A0260|8 12|EMBO J
P03025862A0860|118 129|addition site
P03026915A1024|107 123|lacZ fusion vectors
P03027661A0000|31 42|miniF plasmid
P03027779A0000|124 130|normals
P03027905A0632|66 75|lisinopril
P03029111A0155|40 62|pet complementation group
P03031602A1001|68 72|genes
P03032143A0218|185 200|yeast kinetochore
P03032964T0000|81 88|activity
P03033283A0837|230 235|region
P03033283A1415|304 311|HCMV IE68
P03034570A0943|190 196|vectors
P03034956A0666|136 136|P
P03035056T0000|90 98|cell lines
P03035218T0000|100 105|repeat
P03035658A0355|139 143|ng/ml
P03036415T0000|144 147|dogs
P03036817A0213|91 96|yeast R
P03036933A0774|62 74|ACTH treatment
P03037334A0932|91 104|sequence motifs
P03038643A1374|122 125|gene
P03038891A0935|63 75|p11 mRNA levels
P03039177A0503|135 144|enzyme SmaI
P03039387A0920|178 187|levamisole
P03040023A0113|52 62|tachycardia
P03040403A0155|59 69|YEp13 vector
P03041046A0127|209 217|potential
P03041802A0975|186 193|disorder
P03042778A0643|36 41|growth
P03045117A0936|228 232|Leu47
P03045725A0872|139 150|chemotherapy
P03046655A0000|122 127|period
P03046931A0247|82 101|nucleotide difference
P03048024A0418|63 69|NIB rats
P03049570A1242|33 42|E2 proteins
P03050147A0896|113 129|mRNA transcription
P03050147A1520|170 177|C protein
P03052327A1474|110 117|patients
P03052641A0204|59 63|gases
P03053713A0752|57 61|bases
P03057259A0514|68 78|thyroiditis
P03059171A1232|134 146|deterioration
P03060846T0000|38 44|23S rRNA
P03060953A0481|79 87|outbreaks
P03061301A0624|245 254|cigarettes
P03061301A1409|124 133|creatinine
P03061383A0000|173 193|agar dilution technique
P03062370A0000|59 63|genes
P03062370A0384|100 120|amino acid availability
P03064524A0160|35 39|drugs
P03064811A0485|146 148|Asp
P03065140A0273|69 97|transcription activation domain
P03065141A0448|158 163|pMS185
P03065610A0375|58 76|Western blot analysis
P03065621T0000|123 130|ribosome
P03066131A0000|244 257|aggressiveness
P03066208A0310|71 83|cell carcinoma
P03066625A0756|177 185|questions
P03067505A0688|60 69|ear vessels
P03069046A0126|48 58|sensitivity
P03069980T0000|77 83|dentine
P03072021A0696|111 122|polypeptides
P03072580A0455|11 11|R
P03073091A0338|105 109|mg/dl
P03073091A0449|266 270|drugs
P03073192T0000|63 86|immunodeficiency syndrome
P03075154T0000|53 71|ciclosporin A therapy
P03076124A0496|312 312|%
P03078268A0529|201 208|steroids
P03079276T0029|72 79|flare-up
P03080793T0000|76 84|workplace
P03083441T0000|54 59|people
P03088643A0000|105 115|control rats
P03090237A0202|102 108|work key
P03090372A0607|87 91|weeks
P03091849A0000|233 240|membrane
P03097509A0654|75 83|base pairs
P03097643A1357|151 160|expression
P03098018A0139|88 97|micropenis
P03102289A0786|194 199|pmol/l
P03104245A0402|143 147|range
P03104248A0322|136 137|G3
P03104914T0000|98 105|partners
P03104982A0690|116 120|years
P03108171A0088|99 104|system
P03109147A0000|139 143|mouse
P03109147T0127|58 63|effect
P03109954A0945|318 330|atherogenesis
P03110119A0267|149 154|carina
P03110678A0702|230 242|urea clearance
P03110692A0156|346 348|day
P03110746A0146|142 146|group
P03110794A0991|42 48|effects
P03110801A0532|49 58|micrograms
P03111946A0309|26 33|behavior
P03112028A0404|68 77|parameters
P03112412A0985|187 192|change
P03114188A0907|170 174|areas
P03114829T0000|33 43|panic states
P03114995T0000|55 58|dogs
P03115087A0515|52 59|standard
P03115787A0633|164 169|months
P03117046T0000|59 69|fibroblasts
P03117147A1059|138 150|investigation
P03118631A0140|77 85|perfusion
P03119227A0079|182 203|tyrosine kinase activity
P03119485A0476|188 203|distress syndrome
P03120334A0893|100 104|veins
P03123310A0000|91 99|synthesis
P03123983T0000|39 43|drugs
P03125420A0421|0 3|Biol
P03125422A0202|106 114|galactose
P03126531T0000|89 116|dopamine agonist pretreatments
P03127034A0591|58 67|resistance
P03127463A1017|148 161|cord blood cells
P03132498A0730|149 153|hours
P03133250A0000|193 199|program
P03133360A1215|97 104|trpE mRNA
P03134872T0029|0 6|Apropos
P03137105A0146|222 237|embryo recipients
P03137346A0319|100 106|protein
P03137601A0212|185 200|NE neurotoxin DSP4
P03138190A0347|124 134|inoculation
P03138449A0759|93 100|w6 supply
P03139750A0000|55 60|rabbit
P03142875A0366|95 103|structure
P03143048A1091|71 84|concentrations
P03143485A0366|173 199|liverwort chloroplast genomes
P03144705A0859|208 223|Alu family repeats
P03146017A0983|161 163|mol
P03146150T0000|77 83|heparin
P03146784A0158|225 227|IPC
P03147912A0422|126 131|PETCO2
P03149774A0173|260 266|barrier
P03150015T0001|45 52|hepatiti
P03150296A0594|259 266|practice
P03154072A0862|34 45|soybean flour
P03159903A0352|122 124|IHF
P03166458A1356|52 62|nucleotides
P03167060A0000|126 129|gene
P03168709A0000|86 107|suprathreshold strategy
P03171221A0531|75 92|elastin transcripts
P03171279A0158|185 188|vein
P03172863T0000|76 79|rats
P03175942A0706|74 83|experiment
P03178097A0000|81 87|atresia
P03178161A0000|197 210|Southern Africa
P03178626A0137|80 91|aircraft type
P03179496T0000|78 99|blood volume replacement
P03180595A1040|107 113|disease
P03181276A0422|72 88|allergen challenge
P03182802A0278|0 2|Sci
P03182872A1122|0 3|Chem
P03183103A0000|101 110|volunteers
P03183127A0068|106 126|CT myelocisternography
P03184267A0000|178 183|humans
P03185322A1305|165 173|dysplasia
P03185540T0000|130 134|TFIID
P03186091T0000|105 116|hypertension
P03186270T0001|10 18|diagnosis
P03190481A0292|197 203|capsule
P03190914A0149|107 111|group
P03192537A0370|177 183|protein
P03192724A0000|93 112|FIRO-B interpretation
P03192799T0000|31 46|Implant Dentistry
P03192950A0566|78 82|range
P03194410A0771|95 104|UOxase gene
P03195167A0104|189 200|test chambers
P03198436T0000|73 79|iridium
P03198525A0164|176 183|mg MGA/hd
P03199043A0248|195 203|constants
P03199436A1060|87 103|psbE-psbF clusters
P03200488A0439|131 134|mice
P03200844A1211|146 151|family
P03207975A0709|47 66|plasma concentrations
P03208493A0849|66 66|%
P03209019A0662|163 174|test material
P03212551T0001|28 37|contractur
P03212929A0000|71 97|Dirofilaria immitis infection
P03214709A0559|103 107|group
P03216131A0559|52 62|enterotoxin
P03218714A0000|92 94|TOF
P03219107A0212|68 73|births
P03220077A0274|58 62|years
P03223123T0001|79 82|flui
P03227288A0542|70 72|age
P03227568T0001|88 92|cattl
P03228518A0339|110 119|dimensions
P03228785A1047|216 220|WORDS
P03229917A0099|57 72|remnant infection
P03232410A1467|89 95|smoking
P03233862T0000|54 62|sclerosis
P03234790T0001|70 76|toxicit
P03235487A0404|104 112|diltiazem
P03237446A0377|62 72|lymphopenia
P03239106A0856|74 82|magnesium
P03243027T0000|81 103|Dictyostelium discoideum
P03243920A0591|106 115|regression
P03246999A0483|103 110|controls
P03249792A0241|174 187|manifestations
P03249840A0411|225 231|smoking
P03251210A0981|113 123|dysfunction
P03253219T0000|77 81|study
P03256150A1866|47 50|task
P03257146A1037|148 158|neutropenia
P03258069A0000|225 228|time
P03259437A0140|137 140|IU/l
P03261005A0216|132 137|period
P03261223A0644|76 78|TCT
P03261331A0563|127 134|disorder
P03263357A0112|188 195|activity
P03263465T0000|120 127|antigens
P03264073A0224|145 154|albino rats
P03264299A0679|90 100|ip injection
P03264886A0000|174 183|physicians
P03267732A0788|153 159|therapy
P03268555T0000|60 80|millipore filter method
P03270085A0382|43 48|kidney
P03274204A0642|93 109|cent alkaline fuxin
P03275867A0187|166 178|MAT alpha genes
P03275873A0379|164 168|cells
P03276246A0037|93 104|appendicitis
P03276924A0090|75 88|MoMuLV provirus
P03278829A0082|120 128|deformity
P03280021A1615|165 167|T/O
P03280807A0000|157 176|UAG nonsense mutations
P03280807A1447|222 229|activity
P03280912T0000|0 21|Antituberculosis agents
P03280946A0375|202 224|bacteriophage T7 promoter
P03282232A0743|91 101|immunoblots
P03282813A0794|134 138|slope
P03283881A0216|62 73|inflammation
P03285764A0675|253 260|failures
P03286611A1198|7 7|H
P03287597T0000|22 34|prostate gland
P03292076A0820|208 229|eicosanoid biosynthesis
P03292082A0486|141 149|neurinoma
P03293844T0000|13 18|eczema
P03296019T0000|54 63|Silicoater
P03296212A0603|408 413|agents
P03296254A0556|135 143|factor VII
P03297181A0127|157 160|SR-F
P03298134A0000|111 113|HCL
P03300118A0392|56 59|pigs
P03304015T0000|8 16|chemistry
P03304866T0001|52 59|osteotom
P03305875T0000|32 42|microstomia
P03306340A0537|146 160|pancreaticogram
P03308909A0485|27 35|cartilage
P03309892A0637|149 167|initiation start site
P03311954A0000|150 167|reflux oesophagitis
P03312033A0501|107 116|tobramycin
P03312514A0756|202 215|control animals
P03315359A0732|137 144|fissures
P03317796A0853|48 61|osteoarthritis
P03319621A0707|80 87|myotubes
P03319646T0000|62 75|chlorthalidone
P03319912A0000|190 196|dysuria
P03320875A2090|89 97|infection
P03322829A0952|203 214|prescription
P03325081A0524|113 117|cause
P03326381A0423|163 170|pancreas
P03329716A0187|126 134|calf serum
P03330711T0000|34 51|Azadirachta indica A
P03331525T0001|82 90|isocyanat
P03331933T0048|2 14|Felix Lagrange
P03332022A1094|235 250|cysteine clusters
P03332848A0000|94 114|carotid artery stenosis
P03334950A0000|177 185|radiation
P03335127A0176|55 63|procedure
P03335398A0568|91 116|passive transfer experiments
P03335444A0000|61 62|Pu
P03335651A0000|194 210|hydrogen weighting
P03335923A0257|236 242|disease
P03337024A0000|173 179|testing
P03338154T0000|66 73|patients
P03340548A1018|100 117|lipopolysaccharide
P03340726A1103|101 102|Gy
P03340774A0328|71 72|Gy
P03343730A0486|88 107|calcium stone patients
P03344586T0000|45 54|malignancy
P03344812A0924|315 324|population
P03345706A0561|68 76|judgement
P03346157A0000|256 260|doses
P03346210A0000|157 169|EGF activation
P03348382A0785|47 55|secretion
P03351478A0371|41 50|% G residues
P03352254A0203|80 88|syllables
P03352439T0000|50 60|anastomosis
P03352727T0000|24 34|specialists
P03352947T0001|38 48|health worke
P03354295A0157|70 81|micrograms/l
P03354341A0177|151 154|acid
P03355122A0238|73 75|min
P03359860A0000|184 207|New York Longitudinal Study
P03360667A0000|184 195|mid-altitude
P03360948A0477|121 152|Behavioral/Emotional Control scale
P03361653A0459|114 120|objects
P03366720A1335|113 122|glycolysis
P03366864A0099|81 85|blood
P03368701A0113|91 107|imaging techniques
P03370815T0000|72 81|vitamin B12
P03371139A0829|63 68|groups
P03371806A0000|163 168|stains
P03371894A0355|62 71|components
P03372422A0558|153 157|lungs
P03373755T0001|94 117|gastrin receptor blockader
P03375184A0000|135 145|n-1 CH2CH2OH
P03377864A0000|95 107|Maxwell stress
P03377891A0652|234 254|psychoticism subscales
P03378994T0000|64 67|dogs
P03379058A0188|129 134|region
P03380547A0169|32 39|aversion
P03381039A0364|94 100|maximum
P03382310A0903|175 182|outcomes
P03382772A0319|115 120|trials
P03382855A0368|101 107|picture
P03383897A0189|161 169|treatment
P03384033A0155|170 179|modalities
P03384272A0145|91 96|lesion
P03387665A0000|131 156|Glossina morsitans centralis
P03390074A0000|89 99|dysfunction
P03395009A1750|265 276|intervention
P03395164A0000|50 51|FU
P03395249A1044|192 196|WORDS
P03396437A0321|36 42|strains
P03396628A0207|146 154|incidence
P03398433T0001|51 58|infectio
P03398714A0594|106 131|propagation transition state
P03398823A0459|150 157|exposure
P03400694A0245|144 154|sarcoidosis
P03401060A0000|4 12|melanomas
P03402183A0171|185 202|voltage stimulation
P03403313A0298|137 152|radiation therapy
P03403412A0000|124 135|grain content
P03403480A0299|194 215|collagen concentrations
P03403826T0000|201 247|exercise/redistribution thallium-201 scintigraphy
P03404334T0000|50 58|cartilage
P03404495A0172|38 47|admissions
P03406054A0351|135 145|polystyrene
P03407676A0585|7 15|infection
P03407843T0000|37 43|Surgery
P03413681A0659|113 120|function
P03413890T0001|50 55|region
P03417104A0536|95 101|animals
P03417588T0000|67 70|rice
P03417668A1233|149 152|form
P03418727A0992|120 129|treatments
P03420266A0000|147 152|cancer
P03420324A0178|134 147|h/day beginning
P03420466A0000|99 105|Kinyoun
P03421425A0878|72 85|determinations
P03423732A0341|152 157|dmPGE2
P03427474A0853|87 104|saccharin solutions
P03427613A0659|107 111|brain
P03428084A0430|148 154|origins
P03428274A0000|186 200|recognition site
P03429306T0000|39 44|cortex
P03429371A1051|65 74|phagocytes
P03430221A1236|66 74|detectors
P03434347A0358|67 70|side
P03436119A0000|93 107|reproducibility
P03436529A1066|167 174|template
P03436877A0950|268 272|WORDS
P03439248A0000|179 191|artery disease
P03440780A0779|211 214|beds
P03441587A0000|173 181|reference
P03443144A0409|87 95|reactions
P03443566A0675|73 74|CR
P03443573A0329|125 130|tissue
P03443609A0000|138 154|column methodology
P03446332A0831|53 56|LHRH
P03448035T0000|15 23|pregnancy
P03449358T0001|22 33|polyarteriti
P03450438A0446|54 59|method
P03451761A0215|109 111|RNV
P03452920T0001|13 16|past
P03457330A0271|71 79|operation
P03459385T0000|20 27|syndrome
P03459736A0184|75 82|capsules
P03463537T0001|63 65|bit
P03463543A1613|57 59|UTI
P03465957A1008|0 18|Mean fluorosis scores
P03466730A0210|42 47|pupils
P03473253A0000|159 171|U.S. companies
P03473379A0183|57 67|gland biopsy
P03476002A0148|115 120|months
P03478354A0436|65 84|prostaglandin F2 alpha
P03479897A0961|89 96|Class III
P03484075T0001|49 55|injurie
P03484894A0782|99 99|V
P03485064A0135|41 48|patients
P03486405A0341|98 106|IL-1 alpha
P03487348A0000|82 84|AHP
P03488532A0235|83 100|acyclovir treatment
P03491190A0233|74 86|stress studies
P03493240T0000|60 64|drugs
P03494649A0472|80 83|MABP
P03499608A1054|163 173|hyperplasia
P03499657A0000|241 242|HM
P03499822A0182|150 152|age
P03504971A0000|149 161|vulcanization
P03507689A0000|191 212|beta-galactosidase gene
P03508698A0535|109 114|groups
P03510185A0187|0 3|Natl
P03513989A0580|61 67|animals
P03513989A1149|194 199|agents
P03515840A0000|176 180|death
P03516189A0406|39 44|mg kg-1
P03517388A0763|62 63|CC
P03520729A0381|73 96|aldosterone concentration
P03522105A1011|75 82|recovery
P03526279T0000|23 32|nursing R.N
P03528748A0414|51 56|weight
P03531317A0930|92 97|Fisher
P03534581A0976|138 149|control group
P03536682A0572|29 36|patients
P03536864A0000|15 15|E
P03537686A0099|289 298|background
P03537711A0181|0 0|W
P03537721A0491|84 96|chromosome XVI
P03537721A0876|164 173|hydrolases
P03537727A0243|79 85|protein
P03540591A0330|149 160|reading frame
P03540853A0652|58 75|DNA binding proteins
P03541263A0368|54 61|diabetes
P03542945T0000|33 43|experiences
P03543485A0069|62 79|space flight effects
P03543936A0000|78 94|ras oncogene family
P03544858A0374|122 126|males
P03545955A0751|250 256|lactose
P03545955A1378|3 22|serum insulin response
P03549045A0878|91 97|animals
P03550444T0000|42 52|specificity
P03552363A0568|142 149|subjects
P03553149A0299|95 98|LexA
P03553439A0404|90 99|tumor cells
P03555318T0000|17 25|carnitine
P03556834T0000|39 42|mice
P03559193A0000|142 151|correlates
P03559232T0000|27 35|arthritis
P03559287T0000|44 54|consumption
P03561036T0000|57 66|lipofundin
P03561622A0659|186 206|term vancomycin therapy
P03563399A0534|100 109|difference
P03563604A1075|85 100|drug intervention
P03567017A0000|153 160|subjects
P03568311A0273|117 124|function
P03568311A1361|143 147|TMFP3
P03570455A0433|103 108|TSST-1
P03571135T0000|77 84|children
P03572706A0329|179 189|MMPI profile
P03575656A0120|129 132|time
P03577670A0102|59 77|matter hypodensities
P03577670A0236|127 133|sisters
P03578948A0448|77 83|c X min-1
P03581160A0583|148 155|controls
P03582149T0001|100 113|Jiangxi Provinc
P03582184A0448|61 76|dosage adjustment
P03582982A0000|41 43|RNA
P03583001A0111|148 157|vitrectomy
P03584426A0706|199 206|material
P03586925T0001|112 125|Medinform syste
P03590911T0001|45 59|light sensitivit
P03591464A0840a|68 93|calcium antagonist treatment
P03591464A0840b|68 93|calcium antagonist treatment
P03592297A0138|223 234|vasodilation
P03592297A0679|141 144|mmHg
P03595418A0688|110 116|regions
P03597218A0901|225 234|inhibitors
P03597269A0409|71 74|cVO2
P03600633A1069|0 3|Cell
P03600705T0000|41 57|cryptosporidiosis
P03601275A0601|180 185|groups
P03601533T0001|82 91|thyroiditi
P03602261A0238|286 298|growth hormone
P03605895A0888|99 108|population
P03607109A0370|92 99|controls
P03607961T0001|58 72|diabetes mellitu
P03608916A0790|112 119|increase
P03608989A0668|115 123|rod region
P03610663A0201|166 171|states
P03610674T0000|63 76|rat hippocampus
P03612316A0102|115 118|days
P03612648A0085|103 113|cardiolipin
P03615550A0000|126 133|schedule
P03615550A1094|90 97|naloxone
P03615763A0170|295 303|hostility
P03616174A1069|180 190|circulation
P03616237T0001|42 49|cisplati
P03618039A0126|103 132|catecholamine biotransformation
P03619249A0428|214 219|non-Bc
P03622423A0000|165 169|vapor
P03622571A0208|72 81|myocardium
P03625688A0372|77 83|methods
P03625762A0308|203 224|behaviour problem rating
P03626129T0001|44 52|newt embry
P03627720A0196|48 54|sac cyst
P03628532A0000|63 73|experiments
P03628596A0000|117 121|fluid
P03628713A0961|162 168|trap AIB
P03628794A0648|101 106|choice
P03629973A0240|0 0|W
P03629974A1468|206 214|precursor
P03632739T0000|35 46|polymyositis
P03635597A0377|126 126|P
P03637037T0000|40 47|patients
P03645733T0001|0 13|Hyperthyroidis
P03649340A1119|137 151|splicing process
P03651330T0000|22 28|lesions
P03651840A0266|120 128|pargyline
P03652083A0720|79 86|collagen
P03653226A0833|97 107|perhexiline
P03658866A0081|8 25|lupus erythematosus
P03659603A0797|78 91|CO2 sensitivity
P03659805A0404|128 138|IMB computer
P03659994A0150|160 161|T2
P03663789A0568|105 114|conversion
P03664038A0000|151 164|suggestibility
P03666957A0219|144 147|cats
P03668003T0000|42 52|skin lesions
P03668396A0171|72 87|convex polyhedron
P03668736A0177|134 138|block
P03672532A1111|42 46|doses
P03673640A0533|243 261|platelet MAO activity
P03673881A0000|222 233|valve disease
P03676054A0865|134 148|injector cannula
P03676174A0730|99 101|day
P03678269A0633|138 142|years
P03678372A0170|54 64|pellets/day
P03679407A0556|159 171|bladder cancer
P03679756A0830|110 118|terminals
P03680791A0230|82 86|sites
P03682805A0375|136 138|Day
P03684378A0653|145 153|secretion
P03684517A0462|79 84|fibers
P03685073A0200|105 117|atropine doses
P03687078T0001|81 84|lung
P03687148T0187|13 21|September
P03687313A0000|101 110|conditions
P03688202A0377|63 64|CN
P03688301A0129|154 160|bladder
P03688676A0487|77 85|infection
P03690262A0428|177 180|rami
P03691316A0560|33 36|K-CG
P03692331A0000|84 88|women
P03693543A0405|255 260|genera
P03694102A0000|126 130|leads
P03696899T0001|92 97|infant
P03697587T0000|57 64|syndrome
P03697798T0001|46 61|stretch receptors
P03697971A0311|122 130|diet group
P03698251T0000|63 72|infarction
P03700952A0273|90 106|laboratory setting
P03701640A1178|172 176|WORDS
P03703493A0654|67 93|RPE-choriocapillaris complex
P03704087A0394|167 189|State Anger Reaction Scale
P03709191A0125|122 128|neurons
P03709627A0247|152 162|metabolites
P03710973A0817|132 149|Tre-to-Tsk gradient
P03712050T0000|50 58|arthritis
P03712106A0000|132 136|women
P03712153T0000|78 88|risk factors
P03713187A0691|228 237|comparison
P03714348A0833|177 184|serum IgG
P03714473A0496|42 50|heat shock
P03717475A0208|115 125|infertility
P03717936A0252|76 85|conditions
P03720615A0434|79 85|infants
P03720966A1043|39 45|N intake
P03721594A0000|316 322|animals
P03721666A0000|118 118|%
P03722016A0797|45 56|meal interval
P03728230A0104|40 43|cyst
P03732252A0556|262 269|delta VO2
P03733563A0716|78 102|cholesterol concentrations
P03733563A0820|10 32|serum NEFA concentrations
P03734641A0203|100 111|biomechanics
P03736081A0465|342 352|% saturation
P03738919A0000|121 130|tomography
P03743683A0000|99 101|age
P03743702A0158|207 208|SD
P03744168T0001|86 109|methano-1H-4-benz azonine
P03745833A0258|203 212|cerebellum
P03746053A0670|123 134|dorsal column
P03746107A0192|41 47|tumours
P03746508A0390|54 63|conditions
P03746601A0299|96 103|exposure
P03746896A0890|143 155|Type A behavior
P03746906A0000|100 112|Type A behavior
P03747493A0000|73 82|infections
P03749226A0506|105 109|doses
P03750700T0001|36 48|endoprosthesi
P03751308T0001|124 128|state
P03753022A0000|58 65|behavior
P03755623A1233|86 89|DLIS
P03755673A0054|12 16|cases
P03757294A0414|81 90|liver cysts
P03758250A0000|131 137|muscles
P03759330A0713|102 115|trunk adiposity
P03759731A0992|46 50|group
P03761122T0000|87 94|children
P03761523A0000|76 83|emulsion
P03763241A0446|34 44|extremities
P03763836T0001|43 46|site
P03765552A0582|144 160|antibody synthesis
P03765731A0918|80 90|hypertrophy
P03766370A0546|92 98|regions
P03768208A0879|112 115|mass
P03769224A0000|74 81|biopsies
P03770143A1209|119 125|lesions
P03771670T0058|36 45|combinatio
P03771703A0000|90 97|analysis
P03771749A0465|177 206|microtiter broth dilution systems
P03772471A1054|141 144|case
P03774111T0000|43 50|response
P03776080A0400|110 120|CWE antigens
P03776438A0000|86 102|mineralocorticoid
P03776779A0238|42 49|steroids
P03777398A0156|30 40|therapy unit
P03779182A0370|93 98|deaths
P03779205A0459|120 130|secondaries
P03780248A0274|213 222|PCO2 values
P03780371A0792|108 113|region
P03780704A0573|151 152|CC
P03781000A0101|118 124|disease
P03781948T0000|46 49|rats
P03783160A0285|59 70|21-O-tigloyl
P03785212A0091|55 59|cDNAs
P03785212A1128|28 39|Alu sequences
P03788231A0802|207 211|chest
P03789052A0527|173 179|effects
P03791645A1124|89 91|OSA
P03795488A0487|99 99|%
P03799323A0501|101 111|sickle cells
P03799790A0146|155 160|plaque
P03802195A0481|148 154|portion
P03805090A0645|220 235|Maffucci syndrome
P03806696A0000|227 231|trial
P03810361A0576|168 175|syndrome
P03810867A0305|105 116|Sisson-Jesse
P03811852A0109|192 199|maturity
P03814493T0000|49 56|lymphoma
P03818467A0180|157 164|activity
P03818866A0116|102 106|women
P03820222A0203|124 128|group
P03824908A0116|182 196|paramyxoviruses
P03826871A0000|61 70|Greyhounds
P03827071T0040|0 1|II
P03828209T0000|54 59|adults
P03828500T0001|63 71|blood seru
P03829848T0001|97 104|extremit
P03830147A0000|486 493|students
P03830255A0074|55 66|distribution
P03835413A0616|128 147|duration space flights
P03836777T0001|99 111|hepatitis stag
P03836853A0204|35 35|%
P03836854T0000|92 96|agent
P03837609T0000|64 76|mononucleosis
P03838797A0903|127 130|rise
P03840480T0000|46 61|peptide sequences
P03841627T0001|27 37|breast cance
P03843496A0919|154 167|risk assessment
P03843676A0381|100 104|doses
P03848527T0020|70 73|year
P03857577A0413|116 124|HeLa cells
P03860162A0000|125 131|potency
P03861687A0000|169 185|system stimulation
P03862898A0563|172 181|components
P03863231A0530|35 40|factor
P03863561A0405|129 137|clump size
P03865743A0859|123 134|heart disease
P03866085A0795|184 191|vomiting
P03869442A0223|131 148|vasopressin therapy
P03871298A0217|149 151|CAD
P03871445T0000|55 79|positron emission tomograms
P03873141A0304|114 114|%
P03874921A0862|175 182|drawback
P03875231A0627|181 184|cyst
P03877298A0718|147 165|emulsion formulation
P03878585A0507|248 271|machine/min CPB time/m2 bsa
P03880838T0000|44 66|captopril administration
P03881260A0000|64 107|arginine pathway carbamoyl-phosphate synthetase
P03882029A0000|149 161|cat epithelium
P03883052T0001|10 26|Magdelaine Comtess
P03883541A0200|67 73|effects
P03885983A0254|61 68|activity
P03887085A0000|178 183|F1 mice
P03887769A0093|21 35|micrograms J/g Cr
P03887769A0584|83 83|%
P03888621A0185|73 74|Da
P03890486A0000|157 167|obstruction
P03891766A1473|93 107|latex adsorbents
P03894482A0549|125 136|control serum
P03896991T0000|44 51|products
P03898382A0000|197 201|image
P03904004A1577|203 206|124I
P03904952T0000|21 38|computer obligation
P03908196T0000|44 55|glass ionomer
P03908493A0246|94 101|sections
P03910310A0666|44 52|pathology
P03911052A0909|85 92|patients
P03911702A0530|201 210|conditions
P03911965A0513|179 185|placebo
P03912247A0282|149 156|flap ages
P03913522A0000|29 42|function change
P03914875T0001|4 13|candidiasi
P03915540A0863|107 111|cells
P03920700A0491|93 105|adrenoceptors
P03921727A0523|106 113|controls
P03922116A0197|210 228|luc type installation
P03923828A1031|153 162|procedures
P03923976T0001|48 65|factor XII deficienc
P03925712A0229|73 91|transport mechanisms
P03928357A0340|104 108|PCDDs
P03928442A0463|122 144|modification specificity
P03928678T0000|67 72|muscle
P03929486A0309|235 239|doses
P03929610A0268|35 42|patients
P03930549A0209|121 136|gas chromatograph
P03930894T0000|121 128|vagotomy
P03931293A0437|97 104|% albumin
P03931797A0134|54 58|women
P03933232T0000|56 71|animal morphology
P03933784A0420|26 37|CSF prolactin
P03934667A0124|231 236|pUB110
P03935117T0000|67 73|rat lung
P03935375A0414|218 226|carcinoma
P03935797A0183|230 234|delta
P03936828T0000|52 63|thyroid gland
P03937294A0404|113 125|acid secretion
P03937481T0001|78 88|preparation
P03939317A0352|77 98|soybean HS-protein genes
P03940426A0618|213 223|agar culture
P03940733A0755|115 127|malabsorption
P03940818T0000|28 37|HBV carrier
P03944212A0166|127 130|MCAO
P03944239A0780|135 136|T3
P03946125T0000|7 26|nutrient interactions
P03952387A0336|95 98|HbO2
P03953361A0000|234 237|dogs
P03956647A1063|154 175|iridium microelectrodes
P03956695A0617|105 110|stress
P03959045A0000|112 115|MCAT
P03963860A0137|73 77|group
P03964489A1195|23 26|NADH
P03964855A0254|83 92|angiograms
P03965012A0163|162 177|paper mill workers
P03966687A0000|108 112|years
P03967144T0001|0 11|Hypersplenis
P03970191A0275|110 114|sites
P03972038A0000|116 124|technique
P03972185A0137|146 150|times
P03974790A0053|64 69|tumour
P03976323A0821|52 61|SCR-change
P03977577T0000|36 43|shoulder
P03977603A0326|68 79|indomethacin
P03978045A0857|223 233|alterations
P03978132A0108|103 120|distribution curves
P03979084A1019|91 94|IBPK
P03980386A0000|158 162|lambs
P03981421A0246|76 82|results
P03981640A0168|46 50|mRNAs
P03981952T0000|78 87|salt intake
P03982288T0000|28 40|union pitfalls
P03984683A0000|81 94|stroke patients
P03985849A0221|196 208|IgA deficiency
P03987818A0440|63 74|heart failure
P03987857A0733|119 129|stimulation
P03988001A0227|89 92|ClO2
P03989827T0000|33 46|Aymara children
P03992022A0330|223 238|enzyme activities
P03995513T0000|95 108|leiomyosarcoma
P03997467A0000|84 91|ischemia
P03998071T0000|65 76|osteoporosis
P03998813A0406|145 150|system
P03999219A0463|164 170|changes
P04000347A0442|168 172|signs
P04001413A0093|123 127|scans
P04001490T0001|80 83|Skin
P04002131A0506|102 102|P
P04002667A0181|150 163|lung parenchyma
P04004168A0000|186 207|motor neuron involvement
P04005190A1288|23 32|PCA content
P04011338A0620|202 208|taurine
P04011466T0000|62 65|data
P04013576A0981|194 204|carbon atoms
P04013604A0412|92 112|slow-release tablet use
P04014833A0400|129 136|mitogens
P04014861A0000|176 179|rats
P04015988T0000|49 58|starvation
P04017295A0139|64 71|patients
P04018444A0000|86 88|man
P04019066A0000|178 181|rats
P04021281T0001|78 84|trainin
P04021305A0530|186 199|catecholamines
P04021431A0000|224 229|pupils
P04021437A0000|71 85|ear dysfunctions
P04024685A0650|238 240|RBV
P04025178A0126|126 126|%
P04025179A0955|25 33|variables
P04026903A0512|213 218|manner
P04026972T0000|10 32|alcohol reaction profiles
P04027182T0000|10 25|diabetes mellitus
P04028871A0133|145 147|day
P04031488A1091|95 103|syndromes
P04032268A0358|121 124|drug
P04032349A0000|165 178|Lys Plasminogen
P04032716A0299|215 221|oviduct
P04033402A1112|127 152|triglyceride lipase activity
P04034220A0205|182 189|children
P04034666T0000|94 104|hemiparesis
P04036838A0918|126 144|pressure differences
P04037809A0964|38 44|KW-2083
P04038454A0984|141 156|cancer recurrence
P04038702A0768|296 300|gilts
P04039109A0139|137 141|W/cm2
P04039307A0613|77 91|treatment groups
P04039439A0000|128 130|age
P04039439A0842|84 90|rodents
P04039525A0475|185 192|toxicity
P04039667T0000|90 98|monocytes
P04039744A0141|147 150|days
P04040083A0000|75 80|saline
P04040307A0145|81 88|NE levels
P04040339T0001|105 110|Pre-pa
P04040858A0000|62 67|cancer
P04041307A0614|95 102|function
P04041346T0000|39 47|quinidine
P04043489A0648|33 42|re-reading
P04048245A0331|71 84|serum CPN levels
P04050771A0474|99 106|survival
P04050821A0531|131 138|hospital
P04051521T0001|84 86|5-F
P04052919A0205|411 417|results
P04055593A0523|149 159|temperature
P04056218A0463|54 55|L2
P04056256A0416|177 185|histamine
P04058985A0000|83 97|plasma prolactin
P04061342A0512|120 124|state
P04062128T0028|20 64|Health Consensus Development Conference Statement
P04063732A0509|75 75|%
P04066194A0163|180 201|stimulation arrangement
P04066274A0265|108 111|S.P.
P04067540A0413|297 302|spouse
P04068663A0452|122 134|mouse CRF flora
P04068774A1292|97 100|bone
P04068969A0300|81 86|system
P04069756T0025|31 49|leukoencephalopathy
P04070725A0442|104 112|generator
P04071063A0863|98 102|alpha
P04073848T0000|46 61|myasthenia gravis
P04074214A0000|70 80|environment
P04075021T0000|97 122|monoamine oxidase inhibitors
P04075061A0355|43 46|race
P04079738A0677|108 115|degrees C
P04081425T0016|18 23|therap
P04082267A0720|99 103|virus
P04082592T0000|30 35|Taenia
P04084607A0663|172 192|Watson-Crick base pairs
P04084896A0569|99 120|intervention strategies
P04085589A0264a|133 149|tract colonization
P04085589A0264b|133 149|tract colonization
P04086403A1016|134 140|control
P04086657T0000|56 58|rat
P04086993T0000|109 118|conditions
P04088233A0309|3 13|transit time
P04088396A0145|68 78|abnormality
P04088733T0001|81 87|childre
P04088936T0001|88 102|thrombophlebiti
P04093211A0560|63 74|orientations
P04101003T0001|88 92|rabbi
P04102280T0000|18 24|disease
P04103248T0000|30 37|averager
P04113011T0000|21 35|ragweed hay fever
P04114211T0000|48 55|subjects
P04115870T0000|46 63|Urat-I lithotriptor
P04123217T0000|36 56|Cryptococcus laurentii
P04123662T0000|12 26|thyroid function
P04138224T0095|84 89|rabbit
P04139081T0001|30 36|patient
P04139943T0001|78 90|silver stainin
P04140567T0001|44 47|shoc
P04143528A0394|26 37|nomenclature
P04145244T0000|35 40|muscle
P04152725T0001|18 28|liver injury
P04160980T0000|45 47|dog
P04164595T0020|73 81|infection
P04164669T0000|45 48|skin
P04172166T0000|18 24|vaccine
P04175007T0001|63 69|animals
P04176249T0001|41 48|diptheri
P04176268T0000|53 59|failure
P04176625T0000|36 43|myopathy
P04179445T0036|0 0|D
P04189158T0000|49 56|globulin
P04194466T0000|17 36|infant hypothyroidism
P04196986T0000|76 81|system
P04213917T0001|39 45|fibrose
P04214345T0000|74 93|Zambian African adults
P04226360T0001|43 50|leukemia
P04239041T0045|81 86|cortex
P04246054T0028|106 126|incubation temperature
P04247472T0001|48 55|Kirghizi
P04247966T0000|25 46|protein maintenance diet
P04262268T0001|32 41|ear ossicle
P04263748T0042|21 25|revie
P04281856T0001|42 65|Ornithodoros tatarovski Ol
P04282315T0001|75 82|pancreas
P04284435T0000|34 38|chick
P04289156T0000|28 35|chickens
P04291759T0048|57 63|control
P04295031T0062|16 24|guinea pig
P04305850T0000|12 17|growth
P04308979T0000|122 131|lymph nodes
P04311951T0001|76 81|otolog
P04315233T0128|21 29|experimen
P04316696T0001|56 59|hors
P04321861T0001|76 85|erythrocyt
P04323641T0000|9 26|swine enteroviruses
P04325736T0001|27 36|laboratory
P04328746T0073|21 44|cytochrome oxidase activit
P04335965T0000|31 33|lip
P04350410T0000|51 58|Cloforex
P04364369T0000|62 73|heart disease
P04369884T0000|61 63|CSF
P04371279T0000|58 71|botulinum toxin
P04377003A0000|184 189|tumors
P04385060T0000|37 44|motility
P04387103T0000|67 70|dogs
P04392584T0000|34 50|hemisphere monkeys
P04394290T0000|77 79|cat
P04407649T0000|63 84|99mTc brainscintigraphy
P04418687T0000|63 67|fetus
P04423347T0001|78 84|disease
P04428800T0001|66 68|rat
P04428981T0000|10 26|calcium metabolism
P04429269T0000|55 61|systems
P04437406T0000|103 110|exchange
P04445874T0001|37 40|hors
P04446923T0001|42 60|Platynothrus peltife
P04460692T0000|16 39|laboratory animal medicine
P04468264T0053|29 41|anesthesiolog
P04482661T0001|81 93|buckwheat chaf
P04487835T0001|2 7|parent
P04487920T0001|7 32|Icelandic Red Cross activitie
P04488232T0001|24 28|famil
P04488271T0001|46 48|com
P04495034T0000|49 67|Ancylostomum caninum
P04506738T0000|31 41|enamel organ
P04510102T0000|23 27|month
P04511139T0001|12 30|restoration material
P04512496T0000|9 15|disease
P04515631T0000|49 61|liver function
P04518624T0000|47 53|disease
P04524081T0000|80 106|tissue displacement materials
P04533208T0083|27 33|surgery
P04536964T0000|56 72|bullfrog toe muscle
P04539552T0001|22 27|SF-837
P04543036T0001|27 29|car
P04544430T0001|68 78|heart defect
P04544704T0001|61 66|studie
P04546974T0000|42 57|bundle recordings
P04547933T0000|81 83|eye
P04548483T0001|83 94|rhesus monkey
P04551650T0001|25 30|enzyme
P04552263T0000|32 35|R.N.
P04562038T0001|62 71|lymphocyte
P04563045T0000|81 86|review
P04578686T0000|42 58|transplant patient
P04579436T0000|97 103|pigment
P04580044T0047|27 42|development phase
P04583791T0000|34 40|Nigeria
P04598670T0000|47 63|immunosuppression
P04600603T0001|0 5|Letter
P04613073T0001|36 51|Shigella virulenc
P04615525T0001|74 81|immunity
P04615828T0001|14 35|colonel prof. e.cerny m.d
P04621188T0000|28 44|Klebsiella bacilli
P04622430T0000|43 54|Rhesus monkey
P04624863T0001|86 94|shigellae
P04627477T0001|68 77|lividomyci
P04632967T0000|83 98|aminorex fumarate
P04638365T0001|52 58|activit
P04640155T0045|10 14|birth
P04645078T0001|26 35|cervix uter
P04646045T0001|27 34|esophagu
P04653144T0000|64 70|parents
P04654249T0000|71 73|cat
P04656185T0000|126 133|newborns
P04661961T0001|65 70|hamste
P04676734T0000|90 92|age
P04679438T0001|28 31|hevi
P04679807T0000|39 57|breathalyzer ampules
P04704137T0001|55 62|abortion
P04704186T0000|65 71|heifers
P04712626T0000|65 87|Swertia chirata Buch.-Ham
P04718233T0000|27 36|rat kidneys
P04727344T0000|50 62|isotope method
P04729063T0000|62 68|Koreans
P04730467T0000|92 95|rats
P04733391T0000|28 40|thiabendazole
P04746559T0053|70 84|vein renin levels
P04752455T0000|30 37|security
P04753073T0000|8 13|vessel
P04753286T0000|33 39|tung oil
P04757217T0000|50 63|LCAT deficiency
P04758799T0000|32 47|steroid treatment
P04759722T0000|0 16|Polycythemia-1973
P04760826T0000|36 49|undergraduates
P04764049T0001|16 30|nephronophthisi
P04766888T0000|40 54|meningococcemia
P04778129T0000|28 49|estradiol 3-methyl ether
P04782788T0001|46 63|kidney insufficienc
P04784432T0001|60 65|animal
P04787472T0001|93 95|bod
P04787716T0000|35 53|Chrysops caecutiens L
P04788701T0001|68 72|uteru
P04789916T0001|30 40|bengal-I-13
P04791420T0000|62 67|possum
P04794218T0001|11 16|K agent
P04796997T0000|100 104|bitch
P04801663T0049|27 35|propertie
P04803629T0001|34 40|allergy
P04810131T0000|36 42|smoking
P04813394T0000|50 67|acid determinations
P04820791T0001|66 72|childre
P04824747T0000|44 52|compounds
P04826272T0074|0 2|VII
P04828587T0000|44 50|strain T
P04837183T0000|46 57|hypergravity
P04839176T0001|36 56|blood coagulation syste
P04843031T0000|85 92|fibrosis
P04852635T0000|67 87|isonicotinylhydrazine
P04863895T0000|92 98|poultry
P04871589T0001|64 66|fla
P04878680T0000|70 75|survey
P04884060T0000|28 51|Pomeranian Medical Academy
P04890336T0001|91 102|FTA antibodie
P04909355T0000|15 29|Actinomycetales
P04911925T0001|54 59|QRS loo
P04919613T0001|61 75|collagen disease
P04921762T0000|7 18|preservation
P04925617T0000|6 8|bar
P04941419T0000|0 23|Yusuf Dawood Docrat L.R.C.P
P04941951T0000|0 1|Dr
P04942414T0000|30 43|5-fluorouracil
P04947347T0000|41 58|homograft rejection
P04948325T0000|89 104|Ehrlich carcinoma
P04959816T0000|34 42|component
P04967824T0000|59 62|newt
P04970131T0001|61 68|embolism
P04970918T0069|0 9|LA-3848-MS
P04973523T0000|33 40|antigens
P04975676T0000|58 76|allotransplantation
P04976988T0000|20 31|serum albumin
P04989251T0000|10 24|corticosteroids
P04990556T0000|34 41|globulin
P04992478T0000|70 83|administration
P04999086T0001|97 98|ma
P05000171T0000|92 112|toad bladder epithelium
P05005311T0000|94 100|species
P05012220T0000|53 61|ileostomy
P05015678T0000|43 50|chlorins
P05020660T0000|45 58|chlorpromazine
P05021912T0000|67 75|pigeon eye
P05025918T0000|23 30|bone cyst
P05027799T0000|26 32|failure
P05028628T0001|73 79|arterie
P05031074T0001|41 60|calcium administratio
P05031659T0000|36 49|transfer factor
P05034373T0000|83 85|rat
P05045351T0000|34 40|infants
P05049711T0000|35 43|screening
P05060388T0000|47 51|ovary
P05065548T0075|19 36|Dryopteris polylepi
P05066316T0001|80 94|aluminosilicate
P05068271T0000|24 35|VMA excretion
P05075857T0000|61 71|sweep speeds
P05081814T0000|22 26|acids
P05083872T0000|59 67|audiology
P05087496T0000|8 15|arteries
P05091970T0000|9 14|agents
P05093030T0001|97 118|partition chromatograph
P05095988T0001|37 49|system injurie
P05101762T0000|15 22|syndrome
P05110049T0001|38 47|scleroderm
P05114515T0000|72 84|polyarthritis
P05119546T0001|18 25|neoplasm
P05120197T0000|26 29|pigs
P05123884T0000|21 42|4-chlorophenoxyacetate
P05124707T0001|30 41|ulcer patient
P05128149T0001|46 51|infarc
P05132558T0000|55 80|monoamine oxidase inhibitors
P05133723T0000|45 52|rat liver
P05135168T0000|22 42|Erythrophleum ivorense
P05138738T0001|7 20|M hemoglobinosi
P05145925T0000|73 83|spleen cells
P05152314T0001|25 43|gas dilution indicato
P05154132T0000|61 64|calf
P05162342T0001|17 25|childhood
P05170106T0034|133 138|method
P05172320T0001|79 85|triradi
P05172970T0001|117 121|years
P05174753T0001|13 21|dysostosi
P05177935T0001|56 63|hospital
P05203499T0001|112 119|131-I-RB
P05210791T0001|11 17|childre
P05253274T0001|20 33|3,4-benzopyren
P05274128T0001|41 45|tarta
P05274526T0000|31 39|remission
P05276380T0000|33 53|blood coagulation tests
P05284310T0000|55 57|rat
P05285978T0076|26 38|Cancer Society
P05299993T0000|71 79|mechanism
P05303700T0066|0 11|SAM-TR-68-54
P05305671T0000|18 34|color deficiencies
P05308271T0000|0 2|BIM
P05309471T0000|49 65|influenza vaccines
P05316745T0000|43 55|Singapore City
P05322558T0000|83 86|mice
P05322747T0034|83 90|subjects
P05340801T0000|20 24|foods
P05344097T0000|59 72|Vibrio cholerae
P05353667T0000|29 39|micturition
P05356107T0001|59 61|dog
P05357390T0001|20 29|conjunctiv
P05359464T0000|59 76|radiation dosimetry
P05362866T0000|39 50|hypertension
P05363816T0001|81 86|action
P05364951T0001|44 49|virose
P05368978T0000|60 74|amine mechanisms
P05372511T0105|0 15|Diethylene benzen
P05379901T0000|14 26|flood channels
P05388567T0000|59 64|muscle
P05389125T0000|44 47|mice
P05394352T0000|25 30|states
P05394461T0001|22 37|animal experiment
P05410590T0000|38 58|bladder tumor formation
P05410641T0000|38 50|airway disease
P05412122T0000|60 72|benzomorphans
P05412687T0000|71 83|tract neurones
P05413428T0000|64 79|combat casualties
P05414186T0001|30 39|Netherland
P05417431T0001|54 57|cure
P05421537T0001|30 43|sputum viscosit
P05424220T0001|97 108|sodium conten
P05425195T0001|146 161|body X-irradiatio
P05437405T0000|92 94|man
P05441564T0001|49 55|mutants
P05445187T0000|68 78|heat balance
P05451324T0000|57 68|CO saturation
P05456002T0000|13 26|doctor shortage
P05460466T0001|55 69|drug preparation
P05463837T0023|43 46|acid
P05466177T0001|20 31|actinomycin D
P05471866T0000|46 49|lamb
P05472485T0000|31 37|rodents
P05474466T0001|38 42|assay
P05488121T0000|42 52|filter paper
P05492285T0000|12 30|Hyostrongylus ruidus
P05496619T0000|17 45|air pollution control activities
P05497793T0000|110 121|environments
P05500957T0001|91 98|pregnanc
P05501347T0001|75 81|ischemi
P05502054T0000|42 46|cases
P05525652T0064|11 16|report
P05529283T0000|48 54|disease
P05532854T0001|40 47|sclerosi
P05533214T0001|25 35|thyroiditis
P05536803T0001|71 79|furosemid
P05544291T0031|0 0|V
P05552149T0000|40 52|arthropathies
P05552642T0000|69 72|rats
P05553261T0000|20 28|reticulum
P05555149T0001|46 55|S-S-groups
P05556977T0001|62 85|phasmid Carausius morosus B
P05560428T0001|67 73|reptile
P05567721T0000|32 50|factor VII deficiency
P05572662T0000|49 65|electrocardiogram
P05574818T0000|102 107|muscle
P05593469T0001|14 20|injurie
P05594277T0051|85 89|mediu
P05595036T0001|35 42|disorder
P05621339T0001|28 42|Cs137 irradiatio
P05627251T0000|46 50|sleep
P05642051T0000|17 36|department management
P05671267T0000|64 70|azepine
P05672903T0001|0 11|Osteogenesis
P05683363T0001|65 77|analysis metho
P05683809T0000|110 116|studies
P05684081T0001|64 76|osimeter VA-J1
P05689427T0052|69 82|hydrochlorides
P05692759T0001|20 24|cattl
P05693602T0001|21 37|blood cell counters
P05693605T0001|34 44|autoanalyze
P05715613T0000|9 14|pollen
P05718386T0001|68 72|herni
P05718500T0001|53 60|pregnanc
P05718994T0000|71 75|aorta
P05719031T0000|44 52|compounds
P05719746T0001|21 25|visio
P05722341T0000|79 92|chromatography
P05725509T0000|33 36|rats
P05727222T0000|62 76|Callionymus lyra
P05732641T0001|29 41|mosquito larva
P05733952T0001|84 86|viv
P05733953T0001|58 65|Parameci
P05734847T0000|49 54|Lisbon
P05740389T0001|48 53|effect
P05742879T0000|20 33|morphine series
P05749438T0001|71 76|CI-581
P05750950T0001|49 51|rat
P05751819T0000|80 90|Hariana cows
P05758469T0001|30 34|fligh
P05760665T0000|27 32|office
P05763347T0000|62 72|propranolol
P05769307T0000|0 15|Automatic view box
P05774062T0000|35 46|conductivity
P05779953T0000|70 73|rats
P05781385T0000|89 103|Nocardia species
P05782943T0001|50 52|ski
P05787318T0000|54 56|man
P05789870T0001|69 74|newbor
P05792868T0000|50 55|phloem
P05792911T0000|92 99|subjects
P05794247T0000|82 85|dogs
P05796272T0000|12 34|chlorpromazine cataracts
P05798063T0000|40 45|doctor
P05799686T0001|124 133|idoxuridin
P05805644T0001|107 118|colloidal ThO
P05806615T0001|97 103|control
P05806936T0000|74 81|subjects
P05807222T0052|0 11|Ion injection
P05810259T0001|19 33|solution mediato
P05819249T0000|19 25|iron ore
P05822499T0034|14 25|digiprogenin
P05823624T0031|17 24|hospital
P05833022T0001|70 76|epileps
P05836483T0000|31 39|childhood
P05837169T0001|22 28|functio
P05839844T0000|76 84|ducklings
P05847772T0001|50 55|surger
P05850652T0001|78 81|body
P05857301T0000|73 86|administration
P05858571T0000|55 64|NSC-409962
P05859016T0000|62 79|electron microscopy
P05879595T0094|20 23|year
P05881833T0001|53 62|Lower Saxon
P05884183T0001|114 118|metho
P05890093T0000|123 131|pregnancy
P05890351T0001|30 34|wealt
P05893495T0001|37 43|rabbits
P05896996T0001|39 40|ag
P05901778T0000|43 46|mice
P05902458T0001|43 51|toxicolog
P05909034T0000|17 28|preparations
P05917315T0026|36 40|study
P05919308T0001|46 70|monoamine oxidase inhibitor
P05930797T0000|47 62|Australia antigen
P05933228T0000|31 44|neurosecretion
P05938720T0000|29 54|employee orientation program
P05939748T0000|15 22|Pap smear
P05947377T0001|58 72|growth deficienc
P05949971T0000|31 35|lakes
P05959588T0000|24 38|virus infections
P05960999T0001|155 158|seru
P05967610T0000|93 110|reserpine treatment
P05969185T0001|21 23|cor
P05982700T0000|23 43|Cysticercus pisiformis
P05985275T0000|36 47|acorn extract
P05992157T0001|67 72|animal
P05994421T0045|58 65|Santiago
P05995140T0001|54 59|tumors
P05999607T0001|53 55|rat
P06012827T0000|74 77|rats
P06027841T0000|48 63|emission spectrum
P06035001T0000|64 73|trypan blue
P06048505T0000|13 20|fluorene
P06051644T0000|47 56|creatinine
P06054411T0000|59 76|combination columns
P06065507T0000|40 43|rats
P06070204T0025|0 2|XXI
P06072512T0000|39 42|urea
P06073427T0001|76 81|rabbit
P06074093T0001|25 32|pregnanc
P06074640T0001|26 41|encephalopathies
P06084279A0218|64 67|ERCP
P06084810A0169|100 106|library
P06084864T0001|53 60|prognosi
P06085839A0721|63 70|etiology
P06088722A0171|40 55|myelosuppression
P06089575A0464|101 103|min
P06090369A0000|59 65|studies
P06090458A0407|86 91|TK gene
P06091914A0000|158 162|int-1
P06092048A1111|54 61|fibrosis
P06092588T0000|18 25|hepatoma
P06093354A0000|130 143|Balb/c mouse DNA
P06093363A0612|97 100|gaps
P06094591A0000|171 185|carboxy terminus
P06095372A0435|56 73|radiation treatment
P06095774T0001|32 39|nephroma
P06096246T0000|90 93|rats
P06096380A0662|151 153|rat
P06096863T0000|114 120|TATA box
P06097027A0000|140 151|tumor viruses
P06097285A1077|97 110|motor behaviour
P06098719A0369|55 58|drug
P06098828A0352|128 135|elements
P06099656T0000|109 119|HSV-1 tk gene
P06101359T0000|40 46|tumours
P06108610A0518|32 50|modality shift effect
P06109017A0000|283 286|dogs
P06110026T0000|25 29|death
P06111283T0032|33 54|des-Tyr-gamma-endorphi
P06113084T0000|78 91|cardiomyopathy
P06113443T0000|91 109|separation technique
P06119262T0000|34 42|pregnancy
P06120429T0000|79 91|thyroid cancer
P06121577A0280|174 192|plasma renin activity
P06130348T0000|24 29|faeces
P06131038A0000|165 168|beds
P06131378A0818|89 110|polyadenylation signals
P06136374A0151|58 73|swimming velocity
P06137028A0624|47 52|tremor
P06138015T0114|5 10|report
P06138313A0948|95 100|volume
P06141764A0339|120 130|information
P06142279T0000|31 43|haemodialysis
P06143734T0000|52 57|testis
P06147504A0086|76 79|mass
P06150069A0422|68 80|neurotoxicity
P06151518A0000|130 137|dexazone
P06151942A0235|164 170|obesity
P06152670T0000|69 83|failure patients
P06152844T0000|62 69|subjects
P06153936A0784|150 156|changes
P06155967A1132|149 152|time
P06158844A0000|126 135|malignancy
P06161823A0129|109 119|hypertrophy
P06162419A0118|128 131|cent
P06163433T0000|101 108|rat brain
P06165068A0547|41 48|duodenum
P06165132A0000|205 209|virus
P06165551A0793|232 252|segmentation algorithm
P06167806A0000|215 224|infarction
P06173032T0000|69 78|dipivefrin
P06173860A0000|129 145|segment elevations
P06175691T0000|32 45|maternity-unit
P06181216A0070|80 84|years
P06182979A0807|104 132|cisplatinum diammine dichloride
P06184276T0001|15 27|plasmocytosis
P06184487A1485|182 209|HindIII-A/EcoRI-C/SstI-G cDNA
P06185014A0642|99 106|increase
P06185493A0468|122 141|muscle pyruvate kinase
P06189698A0246|135 146|P3 amplitudes
P06191243T0000|47 57|brain damage
P06193351A1010|108 122|artery occlusion
P06198241A0209|152 156|cells
P06198532A0982|179 188|comparison
P06199132A0179|115 120|sepsis
P06200300A0409|56 70|scalp electrodes
P06203843A0757|116 121|agents
P06204120T0001|66 76|cell culture
P06208024A0168|86 95|hydrolysis
P06208477A0000|96 103|Acids Res
P06209403A0562|38 46|U2/4 locus
P06209499A0682|127 137|tachycardia
P06212776A0000|164 173|prevention
P06214605A0123|83 93|experiments
P06216125A0470|99 100|mm
P06217859T0000|39 42|flap
P06218005A0948|47 57|A-P diameter
P06223586A0000|112 123|mouse systems
P06223586A0460|145 148|mice
P06224974A0833|95 99|agent
P06225279A0498|84 89|tissue
P06227570A0523|47 64|suppressor response
P06229542T0045|69 87|template rescue assay
P06230499A0128|316 332|dose fractionation
P06233924T0000|70 76|disease
P06234369T0000|11 21|vaccination
P06234786A0606|77 80|bone
P06237518A0117|139 149|chloramine T
P06238540A0798|167 171|slope
P06238704T0001|23 45|acid diethylamide tartrat
P06239545A0649|113 120|activity
P06240448A0652|263 270|decrease
P06241900A0000|169 177|ischaemia
P06241980A0855|96 101|models
P06242113T0001|22 38|Codonopsis pilosul
P06244732T0000|78 87|infarction
P06245672T0000|65 74|metastasis
P06246254A0676|161 166|length
P06251469A0830|138 145|position
P06252520T0000|35 40|review
P06252883A0100|133 141|occasions
P06254403A0000|86 98|blocking assay
P06254973A1757|277 284|residues
P06258699T0000|72 81|cystoscopy
P06258806A0963|144 149|enzyme
P06259220A0000|218 230|shock exposure
P06259220A0464|115 119|shock
P06259389A0000|88 101|Gifu prefecture
P06270347A0740|76 86|DNA fragment
P06272844A0000|202 214|SV40 chromatin
P06277159T0033|1 10|hypothesis
P06278424A0145|125 130|MPC-11
P06278544T0027|13 26|Physiopatholog
P06279309A0000|138 148|oncogenesis
P06281759A1086|133 144|int synthesis
P06281786A1222|134 139|length
P06281891A0399|97 112|pain transmission
P06286191T0000|43 49|animals
P06286443A0498|13 27|serum ACTH levels
P06286549A0000|174 194|gamma-radiation injury
P06287212A1352|206 209|AUGs
P06287231A0914|101 118|bulk yeast chromatin
P06287737A0477|339 350|type B disease
P06290859A0426|131 143|liver function
P06290899T0000|68 72|Japan
P06291369A0000|234 241|pressure
P06295429A0412|143 152|protection
P06296833A0000|93 98|strain
P06298014A0647|104 110|columns
P06298720A0893|111 124|MuLV proviruses
P06300662T0000|63 67|cells
P06300836A0285|199 213|rotavirus genome
P06304771A1284|167 177|JCV sequence
P06306342A1156|169 183|Heidenhain pouch
P06307099A1005|65 71|animals
P06308536T0001|52 63|liver disease
P06308607A0375|141 158|polymerase sequence
P06309020A0473|67 84|lipopolysaccharide
P06309855T0000|36 48|porcelain frit
P06310159A0000|69 81|retrovirus MH2
P06310457A0000|57 60|carp
P06310553T0000|53 67|muscle actin gene
P06310608A0749|154 158|M-MSV
P06314276T0000|99 110|gene promoter
P06314312A0359|237 237|P
P06316347A0852|72 97|beta-galactosidase activity
P06316623A0188|99 117|immunodiffusion test
P06318078T0000|94 109|alpha gene product
P06318091A0395|3 20|splice acceptor site
P06318322A0350|189 200|messenger RNA
P06319040A1627|207 214|pressure
P06319071A0173|214 223|creatinine
P06319072A0711|162 186|beta-adrenoceptor function
P06319421A0937|140 161|alpha 2-adrenoreceptors
P06319740A1331|147 161|Rauscher disease
P06320380T0001|28 37|metastases
P06321505A0401|193 202|rat PTH mRNA
P06321634A0123|134 149|TRs/IRs sequences
P06321770A1353|137 145|promoters
P06322183A1070|157 163|absence
P06323556A0126|100 107|catheter
P06324089A0453|97 101|genes
P06324121A0256|120 125|region
P06325415A0757|129 138|Ad5 protein
P06327039A0743|247 254|patients
P06327292A0846|81 91|start codons
P06327638A0155|114 116|DNA
P06328002A0000|95 98|mice
P06328012A0549|108 121|I1f subfragment
P06328485A0277|236 255|chicken proto-myc gene
P06328504A0161|93 114|phosphoglycerate kinase
P06330478A0304|83 87|doses
P06331684A0607|77 89|stomach cancer
P06333433A0000|174 176|LPS
P06333878T0000|11 22|acid overdose
P06336045A0261a|125 127|TRP
P06336045A0261b|125 127|TRP
P06340643A0598|69 79|donor organs
P06340703A0324|26 38|Masson Fontana
P06341139A0213|188 195|g carrots
P06341661T0001|64 71|operatio
P06342141A0226|506 510|study
P06345840A0348|117 119|TPR
P06346427A0000|96 105|test-meals
P06349364A1051|172 180|infection
P06350092A0916|189 193|death
P06354594A0114|65 74|processing
P06355483A0134|82 91|base-pairs
P06360426A0501|89 99|pH indicator
P06361318A0440|127 127|%
P06361318A1127|211 220|difference
P06362143A0565|81 88|patients
P06362239T0001|18 27|physicians
P06362602T0001|93 97|swine
P06364265T0062|7 26|gamma-ray spectroscop
P06367414A0000|113 126|crossover trial
P06369355A0834|147 156|plasmid RK2
P06369954T0000|49 60|hemodynamics
P06370553A0444|164 170|plasma E
P06372563T0000|87 98|hyponatremia
P06373409A1163|115 119|teeth
P06373855A0000|169 192|immunoperoxidase technics
P06374369A1112|125 130|events
P06374418A0877|80 86|hormone
P06376227A0217|59 68|conditions
P06379363A0415|130 137|practice
P06381438A1280|0 25|Lung prostacyclin production
P06382374A0206|198 212|control subjects
P06384983T0000|12 23|hypertension
P06385474T0001|42 47|allerg
P06388189T0001|47 56|recipients
P06388818A0000|232 235|ABMT
P06391496T0000|79 86|antacids
P06394228T0073|20 23|stud
P06394347A1024|79 91|noradrenaline
P06395804A0382|56 58|min
P06397009A0204|172 184|possibilities
P06401749T0000|39 66|arginine vasopressin secretion
P06402480A0373|219 227|treatment
P06402859A0000|115 125|coagulation
P06404842A0127|142 146|years
P06406060A0000|74 80|Sarcoma
P06407348A0516|185 189|beta2
P06411659A0264|59 62|rate
P06411659A0793|90 98|mg/kg/day
P06412385A0356|297 305|pneumonia
P06413492A0990|0 5|Commun
P06414990A0057|150 153|area
P06415299A0233|55 56|m.
P06419251T0000|53 64|requirements
P06426493A0331|181 191|pancuronium
P06428116T0000|68 78|thyroiditis
P06429992T0000|46 52|DZ twins
P06433442T0000|48 48|C
P06434572A0157|283 291|GH reserve
P06434587A0551|98 100|LRH
P06435565A0648|172 179|dynes/cm
P06437579A0727|122 130|treatment
P06439114A0677|76 85|infections
P06439135A0250|89 98|procedures
P06441624A0263|54 67|bone metabolism
P06443550T0000|27 33|patient
P06443639T0001|53 68|circuit televisio
P06443714T0001|37 51|babassu palm tree
P06444119A0340|133 146|toxin formation
P06446048A0356|102 108|problem
P06451557A0777|108 114|Weseloh
P06452461A0930|58 71|post AVR studies
P06452827T0001|28 43|Huntington chorea
P06453290A0000|113 117|weeks
P06454625A0000|186 204|magnification factor
P06459831T0001|59 73|tobacco poisonin
P06460889A0111|145 147|PBF
P06460889A0512|128 137|LVdP/dt max
P06463429A0414|31 31|%
P06466804A0686|188 195|dyne/cm2
P06467241A0000|96 107|hyperthermia
P06467797A0233|148 153|Swedes
P06468565A0000|181 182|Gm
P06468632A0135|108 113|vessel
P06468673A0358|112 112|P
P06468694A0441|187 195|behaviour
P06473219T0000|47 62|diabetes mellitus
P06473252A1073|111 115|WORDS
P06479362A0680|102 108|hormone
P06479976A0386|158 167|nerve signs
P06480542A0000|75 78|unit
P06482179A0497|76 80|years
P06482318A0117|70 88|platelet shape change
P06482665A0735|252 257|animal
P06483863A0000|239 244|silica
P06486932A0000|113 120|symptoms
P06487290A0000|219 223|cycle
P06492188A0615|52 59|implants
P06493655A0415|97 104|patients
P06494215A0248|79 86|schedule
P06494297A0939|114 124|stimulation
P06494766A0241|104 114|explanation
P06495195A0536|143 153|liver damage
P06497671T0001|43 50|response
P06501086A0165|238 266|sperm agglutinin antibody titers
P06503132A0784|29 30|Hn
P06503329A0588|99 99|P
P06503885A0342|267 284|interscan intervals
P06505014A1192|41 45|Vinca
P06506074A0456|46 46|C
P06507629A0717|113 127|mumol X min-1 X g-1
P06508393T0000|78 88|Testryp CATT
P06513456T0001|77 84|treatmen
P06516369T0001|50 56|problem
P06516847A0393|55 63|mortality
P06516977T0000|15 22|organism
P06517816A0388|121 137|saline experiments
P06520418A0325|111 133|LVIT flow velocity pattern
P06521802A0251|164 172|framework
P06521999A0677|64 74|enucleation
P06524202A0167|179 195|motor coordination
P06524727A0601|121 133|blood dilution
P06524761A0596|274 281|RH strain
P06527379T0044|74 84|DNA sequence
P06527872T0000|174 179|method
P06531286A0382|82 91|HPLC column
P06535384A1115|165 169|WORDS
P06539738T0000|49 51|CFC
P06541019A0555|42 49|response
P06541932A0000|120 129|analgesics
P06542372A0159|147 156|similarity
P06542918A1131|114 124|P3 latencies
P06545651A0346|144 146|NH3
P06546392A0542|136 148|antiproteases
P06548953T0001|29 42|thyroid disease
P06555107A1227|104 116|beta-mimetics
P06568939A0000|135 143|brainstem
P06571587T0000|97 106|conditions
P06579147A0060|120 126|disease
P06579152A1061|97 112|feed-back control
P06582285A0222|103 111|gestation
P06584416A0157|108 110|PGF
P06585277A0000|192 200|carcinoma
P06588306A0076|73 86|AIEOP protocols
P06588501T0059|23 27|study
P06591992A0569|43 50|solution
P06593862T0001|0 15|Hepatitis B vaccin
P06594105A0560|203 213|temperature
P06597709A0596|174 178|cases
P06599282T0001|56 61|gingiv
P06600533T0000|75 83|CT variant
P06602580A0664|145 151|normals
P06602600A0582|84 91|cannulas
P06606043A0598|114 121|activity
P06607427A0000|229 231|rat
P06607714T0000|40 51|cyclosporin A
P06609166A0209|130 152|C18 reversed-phase column
P06610347A0581|85 90|AV node
P06612373A0000|130 134|1970s
P06615053A0202|142 147|RVEDVI
P06615403A0718|105 112|ligation
P06625058A0666|67 72|capita
P06627123A0000|92 98|sucrose
P06627569T0001|4 27|type oculomotor stimulator
P06629370A0252|156 163|syndrome
P06630319A0244|115 133|halothane anesthesia
P06634712A0557|92 97|uremia
P06643612A0000|92 96|urine
P06648156T0034|12 18|remarks
P06652293A0353|88 98|specificity
P06653755A0192|85 92|AP levels
P06654047A0694|150 165|rhabdomyosarcoma
P06654686T0001|72 74|gir
P06655634A0195|134 142|morbidity
P06656249T0000|31 38|practice
P06657559A0489|227 234|half hour
P06658029A0086|93 108|hazard evaluation
P06658445A0140|75 80|intake
P06658586T0001|52 56|kidne
P06659982A0231|302 305|life
P06662623A0124|102 109|n cm-2 s-1
P06667015A0832|131 145|serum CK-MB level
P06667868T0001|116 125|BR-1 benzen
P06668316A0178|243 245|min
P06669864T0001|21 22|il
P06670732A0000|217 226|parameters
P06671047A1124|292 298|factors
P06671065A0000|115 122|patients
P06671385A0856|115 131|body sodium content
P06671925T0000|85 94|impairment
P06672094A0390|170 176|mammals
P06674374T0000|74 93|hepatitis B endemicity
P06674516A0350|119 123|field
P06674977A1181|88 94|table VI
P06675047A0000|137 140|urea
P06683807A0160|54 63|alcohol use
P06683876A0244|86 98|daughter cells
P06684624A0298|80 86|diet 41B
P06684624A0736|85 90|groups
P06685004A0000|132 136|women
P06685177T0000|24 41|hydrochoerus subgen
P06685536A0502|76 86|enucleation
P06685643A0179|99 104|stages
P06686454A0585|150 156|Proteus
P06687953T0000|43 58|leukocyte enzymes
P06689413A0174|148 153|iodine
P06689513T0001|46 51|infant
P06691304A0284|129 137|age groups
P06692517T0000|125 140|echocardiography
P06692631A0129|69 72|bone
P06694380A1483|111 115|WORDS
P06694778A0000|104 109|course
P06698047A0445|99 103|cases
P06700231A0259|111 114|year
P06700469T0000|7 27|hospital accreditation
P06702257T0001|17 25|hip surger
P06702643A0000|154 155|SA
P06704467A0539|89 99|pineal gland
P06705456A0346|42 44|min
P06707357A0180|171 184|volume overload
P06709310A0000|55 58|girl
P06709700A0230|197 205|treatment
P06711642A0093|219 226|oliguria
P06712314A0148|50 61|institutions
P06713200A0630|142 150|phenytoin
P06713204A0867|77 87|V1 component
P06714298X0000|286 291|output
P06714354A0194|87 92|cortex
P06715792A0295|49 60|accumulation
P06716977A0136|94 101|mg% range
P06718064T0001|46 55|neutrophil
P06719057A0181|112 118|urogram
P06720371T0000|30 41|gout patients
P06721188A0200|59 70|contrast test
P06723849A0197|87 97|transection
P06726257A1179|259 263|WORDS
P06726257T0000|119 147|serotonin autoreceptor function
P06728580A0291|99 106|students
P06731302A0930|79 89|branch block
P06732946A0281|153 157|scale
P06734713T0000|30 38|poisoning
P06735247A0803|112 120|excretion
P06738410T0000|15 22|children
P06740373A0891|105 120|drug testing model
P06740697A0318|45 60|guinea pig strains
P06740919A0162|90 93|calf
P06743061A0239|85 92|tinnitus
P06744024A0000|124 127|pain
P06748227A0423|106 111|thorax
P06749072A0116|129 132|hour
P06750608A1442|49 57|phenotype
P06751455A0117|96 102|placebo
P06753902A0437|124 128|death
P06754662T0001|35 45|eosinophili
P06755468A0180|89 105|amino acid homology
P06755986A0382|122 139|hospital infections
P06760394T0001|95 100|implan
P06762025A0171|97 102|effect
P06762321T0000|82 94|Streptococcus
P06763897A0216|91 93|ALL
P06764669T0001|77 82|reagen
P06767648A0734|69 75|therapy
P06772370A0342|150 153|ages
P06772612A0000|151 154|cats
P06775834A0000|114 120|relapse
P06776918T0000|0 15|Trypanosoma cruzi
P06777229A0243|72 78|disease
P06781339A0501|104 118|hypoventilation
P06781728A0690|199 202|rats
P06782612A0142|102 104|CLi
P06782869A0263|148 171|serum alkaline phosphatase
P06784123A0286|85 89|locus
P06784123A0771|115 120|mu chin
P06784123T0000|77 87|development
P06785113A0337|92 99|patients
P06786756T0000|69 92|immunoglobulin delta genes
P06788388A0000|145 152|interest
P06790572A0330|105 114|anisomycin
P06791500A0622|78 87|management
P06793764T0001|23 31|infection
P06794480A0785|58 63|others
P06794666A0208|141 168|cardiomyocyte adrenoreceptors
P06795119T0000|44 52|cataracts
P06795654A0434|128 129|FR
P06795832A0148|72 85|HBe-antibodies
P06795900A0000|164 167|rats
P06795971A0000|51 61|amelgenesis
P06796300A0759|73 96|oestradiol administration
P06797063A0000|137 139|DIC
P06798609A0000|142 148|periods
P06801778T0001|98 110|commissurotom
P06802500T0001|19 35|thyroid gammagraph
P06803634A0810|144 148|Paco2
P06805504A0629|92 101|N excretion
P06805537T0001|55 64|concentrat
P06807149A0222|81 83|EIB
P06807149T0000|119 123|study
P06807192A0312|126 130|Duffy
P06807659T0001|31 41|macrophages
P06808287T0001|11 29|hemophilia A carriers
P06808529A0167|90 95|mmol/l
P06809474A1156|77 89|investigation
P06809586T0000|34 51|diabetes management
P06810070A0502|52 64|control spores
P06810694A0328|111 116|apo A-I
P06810694A1000|79 87|adiposity
P06812389A0658|29 38|teratogens
P06815368A0203|45 52|patients
P06816053A0849|83 94|mast cell test
P06816123A0526|122 129|selenium
P06816442T0001|53 58|diseas
P06816609A0639|86 92|CBF fall
P06817410A0982|159 169|drug addicts
P06818113A0384|205 212|infusion
P06821147A0468|57 62|flours
P06822645T0039|10 37|increase growth hormone release
P06823837A0562|105 116|outflow tract
P06825641A0076|124 128|waste
P06826813A0264|49 51|UVA
P06828396A0095|60 82|biopsy fixation technique
P06829082A0187|183 186|rats
P06830033A0661|67 69|min
P06830351A0397|62 67|Type Ib
P06833047A0000|120 123|HFOV
P06833422T0000|84 96|ion monitoring
P06835516A0000|43 49|cistern
P06835914A0192|159 166|industry
P06837312A0000|183 189|lesions
P06838388A0896|172 174|day
P06840803A0397|99 102|days
P06842629A0446|51 65|treatment groups
P06848729A0000|39 40|St
P06849842T0000|45 58|granulopoiesis
P06851280A0144|71 75|units
P06851327A0000|107 112|period
P06853042A0282|116 123|capacity
P06854957T0066|43 58|echocardiography
P06856306T0000|59 70|significance
P06856669A1004|123 133|circulation
P06858449A0335|23 32|maturation
P06858640A0262|87 97|fibroblasts
P06858805A0314|82 91|Tuberculin
P06858967A0167|64 72|bilirubin
P06863087A0664|76 82|control
P06864837T0000|18 43|spine immobilization methods
P06864955T0000|12 15|MMWR
P06868345A0000|52 55|time
P06869215A0347|35 52|hypocomplementemia
P06869986A0000|103 111|ruminants
P06872800T0000|45 56|HBV infection
P06873504T0000|84 97|liver cirrhosis
P06875478A0542|23 23|%
P06876006A0930|90 94|cases
P06876317T0033|34 51|deficiency syndrome
P06880563A0516|168 181|chlorpropamide
P06880604A0167|127 133|January
P06880650A0316|45 55|researchers
P06882578A0464|199 211|hours training
P06883385A0509|88 93|values
P06884450A0234|58 60|TBN
P06886031A0898|120 122|day
P06886948A0750|73 84|requirements
P06890622A0067|158 170|pre-eclampsia
P06890935T0001|8 14|syndrom
P06891051A0587|85 97|platelet count
P06891270A0000|102 110|rat atrium
P06895559A0000|146 154|gestation
P06895663A0810|97 97|P
P06897114A0240|73 75|CAP
P06902722T0000|44 53|infarction
P06911559T0000|13 25|nurse managers
P06916588A0304|49 64|Hickman catheters
P06919347T0001|79 98|laboratory assistants
P06928974T0000|3 19|electrocardiogram
P06931124A0109|78 82|water
P06935514A0000|183 191|component
P06938948T0001|90 97|leukemia
P06946314T0000|16 31|Tauranga children
P06946693T0000|38 43|cattle
P06948398A0523|63 72|importance
P06948493T0026|29 37|potential
P06948868A0082|45 62|faculty evaluations
P06950004T0047|73 80|specimen
P06953957A0503|166 176|correlation
P06957125T0000|56 71|stimulating drugs
P06957633T0001|110 114|years
P06959130A0996|120 132|Arg180-Val181
P06962492A0612|99 107|bone bases
P06962634A0190|118 126|clearance
P06963337T0000|54 65|hypertension
P06966678A0523|283 289|ear vein
P06969638A0180|163 175|complications
P06972179A0556|73 77|range
P06972443A0375|60 72|abnormalities
P06972501A0615|51 57|outcome
P06973664A0000|51 57|patient
P06975206A0279|110 119|growth rate
P06977605T0000|18 23|issues
P06978566A0197|123 132|M. pulmonis
P06981991A0756|199 211|artery disease
P06984225A0367|35 45|patent graft
P06986168A0304|103 112|V8 protease
P06992600A0405|76 82|outflow
P06993660A0000|283 290|controls
P06994035T0001|42 56|radioimmunoassa
P06994049T0001|50 55|infant
P06997203A0325|126 143|antibody conversion
P07004236A0741|186 202|methanol poisoning
P07007181T0000|43 52|microflora
P07007591A0324|209 210|RR
P07015018A0395|69 74|assays
P07015262A0396|134 138|group
P07016141A0238|70 78|clearance
P07018810A0002|183 191|cat kidney
P07021505A0510|74 77|mmHg
P07026328A0369|132 138|glucose
P07034479A1050|68 74|AC group
P07037479T0000|18 25|syndrome
P07038189A2301|103 107|field
P07038684A1050|188 194|residue
P07040659A0212|64 67|PEFR
P07044389T0000|71 82|audiologists
P07044562T0000|9 12|ApUp
P07044842A2062|88 95|syndrome
P07045156A0204|130 137|antibody
P07049690T0000|24 33|allografts
P07053251A0666|96 100|study
P07061263A0293|82 83|Px
P07061350A0042|143 150|pressure
P07062036A0072|32 44|sham operation
P07062269A0798|140 148|mechanism
P07063606T0000|40 57|barrier alterations
P07064662A0222|123 133|dorsal roots
P07064923T0000|46 60|phenylketonuria
P07065206A0398|97 99|min
P07068493A0414|145 147|SIP
P07068493A0636|98 100|SIP
P07068496A0000|149 158|techniques
P07068887A0000|172 185|symptomatology
P07072635A0000|80 81|DF
P07073520A0153|110 120|fluid volume
P07075024A0540|58 61|CMIR
P07075438T0000|11 31|serial xeroradiography
P07076222A0543|40 45|issues
P07078263T0000|104 107|type
P07079595A0848|165 179|sperm production
P07080496A0097|217 223|attacks
P07081327A0546|120 126|samples
P07084198T0000|34 46|United Kingdom
P07084617A0204|88 96|treatment
P07084814T0000|42 58|coagulation assays
P07088195T0019|35 39|birds
P07090151A0165|91 98|category
P07094856A0115|79 87|gestation
P07094905A0644|112 122|hippocampus
P07096587A0267|158 165|material
P07097182A0480|93 102|overgrowth
P07105635A0412|117 123|beating
P07106323A0560|92 100|pregnancy
P07106534A0160|125 127|rat
P07107287A1083|62 75|99Mo generators
P07107462A0202|92 95|Hill
P07107773A0000|303 348|trifluoroethyl-pentafluoropropionyl derivatives
P07109788A0333|56 67|pyloroplasty
P07110999A0160|64 82|oculomotor paralysis
P07112320A0086|54 57|time
P07112471A0639|133 139|factory
P07112654A0388|122 129|patients
P07113365A0737|120 130|measurement
P07113897A0285|228 236|exercise r
P07114083A0153|136 140|cells
P07116298A1079|229 232|DTIC
P07116962A0299|83 87|edema
P07119890T0000|57 62|Tc-99m
P07124743A1223|371 375|lungs
P07125064T0000|89 106|Schistosoma mansoni
P07125238T0000|65 70|system
P07126067T0000|51 59|Bali cattl
P07126413A0000|129 137|Eudragit S
P07130335A1081|153 157|ng/dl
P07132408A0387|30 50|magnesium cardioplegia
P07134924A0640|54 60|coeloms
P07135112T0000|57 60|flap
P07136524A0180|120 142|retinoblastoma survivors
P07136569A0000|101 104|ages
P07137927A0000|92 99|diseases
P07140060T0000|31 37|patella
P07140493A1045|99 111|acid secretion
P07141130A0615|228 233|groups
P07143347T0000|22 30|disorders
P07147622T0000|29 34|cattle
P07149047A0260|55 62|Torr/cm2
P07149303T0000|67 70|cats
P07154928T0001|43 48|therap
P07155579T0001|30 37|fertilit
P07158726T0001|25 29|polic
P07160491A0547|90 108|dose reduction factor
P07162146A0000|107 123|gas chromatography
P07165767T0000|0 11|Mastocytosis
P07168531T0001|50 55|Senega
P07169630A0983|111 114|type
P07172690A0547|256 264|blood flow
P07173729A0000|83 93|interaction
P07174046T0000|31 41|Maharashtra
P07174122A0000|113 123|lifting task
P07174437A0181|52 59|counties
P07175474A0102|137 146|difficulty
P07179412A1131|46 46|X
P07180901A0539|132 139|necrosis
P07181985A0107|148 150|min
P07182523A0462|60 75|SOA concentration
P07183576A0157|177 180|bone
P07184375T0001|117 123|lymphom
P07184598T0001|19 32|hyperthyroidis
P07184774T0000|19 27|ED01 study
P07184795A0517|72 76|liter
P07190627T0000|81 86|dog leg
P07190869A0316|41 48|lymphoma
P07191183A0505|88 93|lipids
P07191804A0000|132 137|h sleep
P07191972A0391|85 89|phase
P07192369T0000|111 114|rats
P07192722A0682|121 124|sera
P07194905A0332|118 132|brain maturation
P07195615A0087|159 163|brain
P07195880A0621|49 55|leprosy
P07202224A0452|111 117|females
P07202525A0200|115 122|stimulus
P07202919A0142|77 84|42nd week
P07203410T0000|50 62|state hospital
P07205120T0000|42 53|ECG wave forms
P07205967T0000|56 66|improvement
P07208984A0000|136 143|diseases
P07214230T0000|85 111|soil bacterium Arthrobacter sp
P07214665A0000|166 177|breast cancer
P07217329A0000|274 275|nm
P07217523A0364|83 94|vowel context
P07218008T0000|108 117|comparison
P07219297T0000|38 46|allergens
P07219821T0028|21 33|consideration
P07221179A0156|135 141|minutes
P07221354T0000|48 56|symposium
P07225300A0968|94 104|sensitivity
P07225540A0193|115 124|techniques
P07226440T0000|57 59|rat
P07228955A0000|128 135|caffeine
P07234308A0121|101 107|disease
P07234755A0838|46 46|%
P07234974T0000|23 34|Jat dentition
P07235317T0000|37 52|Phadebas RAST test
P07235355A0462|111 127|density dependence
P07236351A0812|89 91|CA4
P07237123T0000|88 91|bulb
P07237560A1038|173 185|transcription
P07237817T0000|17 34|theophylline RIA kit
P07240343A0000|63 66|p.c.
P07242929T0001|101 107|methods
P07243380A0327|93 96|torr
P07247059A0775|183 184|N2
P07249497A0688|164 170|courses
P07249544A0343|68 75|patients
P07249660T0000|61 72|hypertension
P07249895A0177|255 262|recovery
P07251564A0569|82 93|ASDC nosology
P07252346A0223|35 41|problem
P07253335T0000|103 106|rats
P07256543A0814|191 202|airway injury
P07259325A0394|59 67|diagnosis
P07260389A0221|100 105|effect
P07260987A0336|137 146|impairment
P07262239T0000|83 85|cat
P07262625A0000|279 284|course
P07263374T0000|32 44|pneumonectomy
P07263421A0351|51 57|control
P07263745T0000|38 46|procedure
P07264787A0351|100 114|hyperthyroidism
P07266969A0246|56 77|breast cancer management
P07267675A0000|110 119|infections
P07268828A0000|187 192|tracer
P07270163A0684|187 194|controls
P07270991A0149|92 97|values
P07274042A0249|72 79|patients
P07274428A0000|254 263|liver cells
P07274482A0000|148 152|deg/s
P07274505A0660|21 31|differences
P07276210T0000|78 85|fibrosis
P07277222A1391|160 171|interactions
P07278104T0001|69 77|bronchiti
P07278578T0001|39 44|diseas
P07280654A0000|53 67|averaging method
P07282444A0075|90 94|shunt
P07282552A0990|132 145|subendocardium
P07282943A0097|177 183|tension
P07283110A0000|56 63|exercise
P07286057A0159|149 162|administration
P07293100T0001|48 60|system disease
P07293327T0001|31 39|KZM-1 mete
P07295033A0513|76 80|urine
P07295417A0092|101 112|phase imaging
P07296303A0418|87 93|latency
P07296997A0125|67 93|Tc-99m-PyG cholescintigraphy
P07297576A0454|62 68|Aludrox
P07297978A0570|83 83|C
P07298209A0291|129 144|bicycle ergometer
P07298259T0000|21 25|blood
P07298523T0000|58 62|swine
P07299857A0294|257 263|females
P07304905A0336|63 78|Heparin-ACD-B etc
P07306839T0001|61 67|degrees
P07308849A0817|107 112|weight
P07309562T0000|80 84|acids
P07310206A0154|102 119|resin casting method
P07311881T0000|25 38|health director
P07312707T0000|26 32|F344 rat
P07320153T0000|140 149|body fluids
P07323063A0000|249 256|recovery
P07323573A0644|26 37|dissociation
P07326596A0061|33 35|IgE
P07327097A0647|132 143|granule cells
P07328000T0000|22 33|timber wolves
P07330073T0000|57 66|blood cells
P07337609A0531|202 210|challenge
P07340196T0001|80 101|hepatitis B virus carrier
P07341346A0174|95 100|system
P07345217A0000|75 84|malignancy
P07347728T0000|9 12|cyst
P07349416A0337|16 25|summer coat
P07354367A0162|30 33|tilt
P07355527A0467|57 62|adults
P07356273T0022|48 54|tissues
P07365183A0000|206 209|SECT
P07369183T0000|26 43|coagulation testing
P07369458A0606|117 131|amputation level
P07372433A0000|107 109|age
P07372928A0105|128 134|cochlea
P07375836T0000|64 72|carcinoma
P07375864A0431|161 168|findings
P07376165T0001|14 20|disease
P07377378A0143|196 203|controls
P07377954A0117|376 386|extremities
P07379334A0503|114 120|placebo
P07380615A0478|245 257|collar workers
P07385543T0001|92 99|infectio
P07385920A0189|129 132|acid
P07385933A0085|142 145|hour
P07386500A0174|93 106|determinations
P07386864T0000|20 27|dialysis
P07387242A0236|136 152|clotting functions
P07392519T0001|39 45|childre
P07393856A0314|83 93|Experiments
P07393976A0000|203 207|water
P07394364A0738|213 215|VO2
P07395750A0294|66 78|methodologies
P07396545A0217|56 63|disorder
P07397066T0000|21 40|blood aspirin esterase
P07401318A0823|96 97|Hz
P07405701T0000|79 88|alcoholism
P07406527A0212|148 158|HCB controls
P07408970A0706|99 108|difference
P07410037A0752|215 224|propensity
P07413144T0018|19 28|population
P07413242A0000|60 64|T1-L3
P07413441T0070|58 63|kidney
P07413781A0169|132 143|conditioning
P07413806T0000|44 47|rats
P07414817T0001|27 33|glaucom
P07415340A0280|39 52|pneumocytes typ
P07416204A0437|113 114|t1
P07418498A0217|153 163|lung abscess
P07418829A0191|32 41|pediatrics
P07419485A0158|144 157|simplification
P07423803T0001|22 31|peritoniti
P07425838A0182|67 75|pregnancy
P07426101A0124|216 229|training period
P07426604A0397|111 115|acids
P07426745A0177|124 125|Gy
P07428037A0989|238 257|corn chloroplast rRNAs
P07429009T0121|21 42|cell population dynamics
P07431059A0000|341 346|nerves
P07432288A0218|83 91|infection
P07434431A0203|106 111|famine
P07434456A0286|183 191|osmometry
P07435185A0074|96 106|drill biopsy
P07436187A0147|141 150|disability
P07436459A0245|173 178|stress
P07436702A0156|37 40|DNFB
P07436794A0148|41 43|CCA
P07438346A0381|115 118|Vmax
P07438482A0145|113 114|E2
P07440085T0061|0 15|Arm function tests
P07440430A1074|185 208|hemoglobin concentrations
P07445971A0241|77 80|week
P07449221A0086|82 87|tendon
P07449253A0411|134 134|%
P07450031A0691|179 182|NF20
P07450388A0406|107 123|duodenofiberscope
P07453919A0000|345 350|finger
P07455042A0457|247 258|measurements
P07455521A0414|30 38|NEXT study
P07456774A0448|26 30|drugs
P07457931A0655|93 97|study
P07458171A0086|63 71|Crustacea
P07461226A0958|82 101|norepinephrine levels
P07461848A0230|134 139|matter
P07462481A0422|88 96|occlusion
P07463294A1216|45 54|responders
P07463465A0297|68 73|infant
P07466831A0714|141 156|porphyrin pattern
P07467975A0316|317 322|Europe
P07469692A0000|131 138|families
P07471210A0384|162 170|positions
P07472582A0993|157 163|defects
P07472736A0278|59 66|eminence
P07473169A0133|104 121|catalase activities
P07473742A0187|140 146|element
P07474078A0838|158 176|integration activity
P07474085A0932|74 81|V protein
P07474124A1360|184 196|F glycoprotein
P07474140A1036|216 223|activity
P07474451A0000|93 107|signal intensity
P07474617A1035|54 62|PRL levels
P07474772A0274|138 145|function
P07475733T0000|45 50|Africa
P07475793T0000|6 16|farmworkers
P07476164A1602|145 155|CspB protein
P07476701A0654|86 99|correspondence
P07476963A0000|124 128|acids
P07476971A0381|57 80|transcription factor Pit-1
P07476975A0492|184 192|cell types
P07477245A0625|139 143|mg/kg
P07478514A0237|40 44|clone
P07478523A0551|124 140|RET protein isoform
P07478525A1177|79 90|dimerization
P07479004A0421|123 127|cells
P07482069A0606|56 73|vasculitis symptoms
P07483276A0139|204 224|varicella-zoster virus
P07483285A0322|184 196|E7 gene product
P07483857A0350|95 134|connective-tissue-protein frei meat protein
P07487067A0592|172 190|plastid localization
P07487363A0447|51 63|food allergens
P07487811A0000|165 169|PSE-2
P07487908A0230|177 179|IEC
P07488247T0000|121 126|system
P07488291A0934|115 124|structures
P07488959T0000|35 51|lymphocytopoiesis
P07489502A0000|151 166|pre-mRNA splicing
P07490079A0825|107 114|STEP gene
P07490079T0000|114 117|loci
P07490083A0000|77 83|tissues
P07490156A0647|102 112|correlation
P07490278A0799|55 70|mother cell cortex
P07490742A0636|98 107|subdomains
P07490766T0000|167 184|heterodimerization
P07490770A0267|154 168|DNA endonuclease
P07491111A0221|63 76|cell lung cancer
P07491305A0102|182 188|reports
P07491791A0263|92 94|Ad5
P07493327A0507|62 69|U6 snRNAs
P07493627A0882|135 148|EC-1 expression
P07494244A0335|93 108|ATF/CREB proteins
P07494274A1015|165 180|virion maturation
P07494293A0585|133 142|activation
P07494303A0000|116 136|monocytes/macrophages
P07494306A0240|208 218|protein VP22
P07494314A1287|223 226|EBVs
P07495059T0078|12 39|ECAT Angina Pectoris Study Group
P07495120A0260|129 138|recurrence
P07495726A1189|150 159|T-ALL lines
P07496184T0001|63 83|Vienna University Clini
P07496400A0525|201 214|inflorescences
P07498727A0724|107 119|substitutions
P07498791A0680|135 157|osmolarity stress pathway
P07499242A0898|49 63|RAFTK expression
P07499252A0150|131 140|activation
P07499394A0187|0 0|J
P07499401A0444|47 47|F
P07499409A0367|107 123|targeting sequence
P07499421A0237|127 173|chloramphenicol acetyltransferase reporter plasmid
P07499848A0409|129 137|cytokines
P07500386A0870|154 157|IRA1
P07500597A0212|71 72|SD
P07500950A0000|100 119|Nicotiana tabacum L. cv
P07500953A0305|92 95|copy
P07501016T0000|34 51|galaxy TXFS2226-184
P07501458A0578|50 56|CHOP-10
P07501700A0000|184 187|dogs
P07501992A0125|180 185|dentin
P07504171A0715|136 152|PDGF-R binding site
P07504171A1214|130 141|Src SH2 domain
P07504712A0843|51 71|cell substrate adhesion
P07505349A0702|78 83|months
P07505798A0000|180 183|CTLs
P07506253A0742|52 60|HeLa cells
P07507187T0000|113 122|plasmid DNA
P07507207A0991|124 138|IRF-1 expression
P07507458A0250|130 140|RIBA methods
P07508082A0821|89 96|chlorine
P07508140A0448|59 81|hepatitis C virus antibody
P07508250A0537|231 243|investigation
P07508441A0487|350 369|binding protein family
P07508954A0000|144 152|technique
P07509053A0139|108 114|lineage
P07509449A0000|187 198|SH3 sequences
P07509450A0705|155 171|HSV tk gene activity
P07509472A1320|88 111|alpha interferon treatment
P07509624T0000|114 118|yeast
P07509811A1357|436 450|chromaffin cells
P07510461A0731|20 36|test abnormalities
P07510635A0479|190 192|Pol
P07510724A1208|140 150|sarcoidosis
P07511444A0728|123 127|years
P07511444T0000|82 106|bone marrow transplantation
P07511496A1511|96 100|death
P07511818A0485|248 254|protein
P07512159A0992|117 135|branchpoint mutation
P07512258A0441|138 142|G-CSF
P07512552A0270|7 7|F
P07513703T0000|111 136|insulin receptor substrate-1
P07514295A0000|154 171|signaling machinery
P07514301A0000|211 220|properties
P07516337A1119|112 122|Jurkat cells
P07516466A1054|214 224|NIH 3T3 cells
P07516469A1025|64 68|cells
P07516597A1017|174 189|T cell determinant
P07516866A0000|136 158|polymerase chain reaction
P07517544A0515|242 250|mg/kg/day
P07517869A0411|185 203|sodium orthovanadate
P07518257A0351|100 101|P2
P07518426A0000|72 86|C-X-C chemokines
P07518460A0771|119 129|phosphatase
P07518561A0496|177 182|p56lck
P07518578A0000|263 268|matrix
P07519447T0000|55 67|oxide synthase
P07519463A0000|123 128|inflow
P07519481A1275|163 174|oocyte growth
P07519606A1269|102 112|homogenates
P07520098A0211|115 122|sequence
P07521009A0377|162 166|1989a
P07521285A1109|303 314|F wave studies
P07521601A0000|107 120|cancer patients
P07521916T0000|82 92|replication
P07522163T0000|215 228|CTL recognition
P07523363A0440|91 119|USF2 translation initiation site
P07523710T0000|107 121|ultrasonography
P07524265T0000|80 92|complications
P07525548A1380|118 120|CS1
P07525596A0584|122 135|PPIase activity
P07525843A0859|309 316|H-2d mice
P07526609A0736|59 78|PKR activator sequence
P07527168A0524|63 74|angiogenesis
P07528028A1192|217 221|WORDS
P07528325A0165|217 230|gene expression
P07528531A0904|140 142|CRP
P07528667A0834|31 39|positions
P07528746A1049|218 221|RHL1
P07528772A0616|319 337|CD3 epsilon TAM motifs
P07528772A1539|105 110|ZAP-70
P07529124A0119|195 202|residues
P07529504A0000|149 155|studies
P07529516A0474|66 74|mg/m2/day
P07530128A0578|51 55|ng/ml
P07530502A0974|106 123|protein degradation
P07530502T0000|127 130|form
P07530549A0956|201 205|genes
P07531321A0369|69 80|CI evaluation
P07532278A0833|0 6|Horvath
P07533527A0128|127 136|marker loss
P07533758A1038|88 97|similarity
P07533858A1503|121 127|GP64 EFP
P07533880T0000|82 96|duplex formation
P07534285A0155|117 125|BaF3/mMpl
P07534286A0842|95 103|paxil-lin
P07534297A0141|135 137|CAT
P07534306A0444|275 282|D-isomer
P07535593A0714|46 59|rearrangements
P07535768A1076|108 128|MAP kinase phosphatases
P07537267A2094|252 255|life
P07537362A1112|70 90|coimmunoprecipitation
P07537736A0453|166 192|cytokine receptor superfamily
P07537851A0000|178 186|TNF-alpha
P07537851A0891|145 148|site
P07538068A1094|109 122|Hoxa-7 enhancer
P07538122A0800|101 102|nM
P07538173A0307|117 124|strength
P07538818A0197|244 256|FDCP cell lines
P07539119A0291|201 207|reasons
P07539119A0985|101 105|assay
P07539314T0000|109 114|P-7138
P07540607A0709|68 81|immunoglobulin
P07540773A0576|53 55|PVB
P07540866A1069|125 133|Y/F2 cells
P07541589A0652|103 121|lymph node metastasis
P07541912A0485|99 100|P2
P07542577A0438|104 111|epitopes
P07542616A0313|61 64|GCN4
P07542616A0486|217 221|steps
P07542698A0137|83 93|probe RH-414
P07543592A0624|118 132|down-regulation
P07543684A1027|125 133|cell types
P07543868A0414|136 139|tail
P07544357A0808|188 208|prostate tumor behavior
P07545510A0735|136 145|cotS region
P07545920A1336|80 82|DNA
P07546256A0000|112 121|Casablanca
P07546293A0968|71 80|expression
P07546294A0000|120 130|sporulation
P07546794A0100|92 100|tamponade
P07547220A0229|60 65|slides
P07547500A0066|140 144|yeast
P07547510A0261|269 279|hepatocytes
P07548425A0000|200 208|S2-3 level
P07548858A0000|80 87|pressure
P07549005A0530|78 82|place
P07550216A0195|27 33|latency
P07551787A0917|127 147|radiotherapy technique
P07552974A0217|61 68|arginine
P07553942A0810|95 113|Marchantia rps10 gene
P07554541A0587|68 90|electrolyte disturbances
P07555373A0000|76 83|controls
P07557091A0314|74 83|volunteers
P07557276A0526|92 100|infection
P07557387A0241|120 137|NIH-3T3 fibroblasts
P07557424A0124|67 79|fusion library
P07557446T0000|108 112|gland
P07557717A0184|88 96|morbidity
P07558263T0000|75 80|device
P07558583A0562|213 219|enzymes
P07559233A0534|120 124|R rats
P07559347A0000|97 103|fusions
P07559355A0066|190 195|detail
P07559356T0000|115 122|fnrN gene
P07559402A0622|109 111|PKA
P07559430A0909|0 0|R
P07559478A0389|21 21|T
P07559488A0440|157 162|type ER
P07559510A0000|143 143|L
P07559524A0000|48 65|G1 phase progression
P07559524A0741|123 131|base pairs
P07559555A0557|82 88|complex
P07559563A0282|54 61|activity
P07559639A0996|97 100|HSE2
P07559640A1230|137 145|core motif
P07559650A0558|56 58|E2F
P07560137T0000|53 61|subscales
P07560662A0496|25 39|saline challenge
P07562775A0596|73 77|nadir
P07563072A0773|108 123|hypersensitivity
P07563076A0766|229 244|splicing proteins
P07563090A0124|206 209|PPT2
P07563090A0624|286 308|RNA reverse transcription
P07563994A0488|145 146|ml
P07564004A0292|55 55|%
P07564210A0557|108 112|signs
P07565031A0454|317 323|ricotta
P07565049A1032|152 157|weight
P07565104A0084|59 62|ToxT
P07565113A0000|172 179|plasmids
P07565669T0000|116 122|factors
P07565672A0798|124 133|components
P07565685A0420|79 89|Notch motifs
P07565688A0797|174 178|cells
P07565688T0000|113 117|forms
P07565709A0000|98 111|T-cell receptor
P07565712A0286|138 153|quasipalindromes
P07565713A0634|107 119|Hsp60 activity
P07565720A0256|86 105|Schistosoma japonicum
P07565723A0200|79 93|differentiation
P07565731A1629|96 113|ribonucleoproteins
P07565736A2134|90 94|cells
P07565740T0000|94 104|transporter
P07565775A1265|158 160|RNA
P07565775T0000|107 117|GMP transfer
P07565776A0612|190 206|salt concentration
P07565797A0116|64 71|CRY2 mRNA
P07567079A0014|181 193|contamination
P07567300T0000|68 74|patient
P07567830A0072|140 144|years
P07567979A1266|96 100|hERR1
P07567980T0000|55 62|elements
P07568026A0622|51 60|amino acids
P07568116A0902|86 98|signal peptide
P07568118A1267|152 186|growth factor tyrosine kinase receptors
P07568576A0074|67 83|emotion dimensions
P07568865A0305|179 184|Figure
P07569075A0585|148 156|histology
P07569532T0001|58 63|locale
P07569640A0539|80 81|G2
P07569770A0298|139 143|years
P07571766A0122|194 201|arteries
P07571953T0000|60 65|smears
P07572582A0000|110 123|calcium channel
P07574064A1416|165 184|response relationship
P07574682T0000|51 69|alkaline phosphatase
P07575416A0000|207 216|properties
P07575416A1970|98 108|PKC zeta mRNA
P07575438A1409|56 64|E1 element
P07575947T0000|13 21|electives
P07576178A0000|90 98|receptors
P07576179A0781|37 52|CpG dinucleotides
P07576307A0144|128 146|enkephalin phenotype
P07576307A1654|130 133|HeLa
P07577904A0141|142 155|microphthalmos
P07579023A0214|120 131|liver enzymes
P07579164A0409|72 80|atp9 genes
P07579328A0653|79 93|cell lines NIH 3T3
P07579328A1345|92 100|cell lines
P07579683A0660|152 159|activity
P07579695A0336|154 163|CEP3/CBF3B
P07579695A0693|143 149|complex
P07579704A0085|120 129|cell growth
P07580058A0000|171 181|blood stasis
P07580330A0331|161 163|HCB
P07580782T0000|52 62|correlation
P07581364A0500|83 86|C212
P07582316A0696|115 124|MTB strains
P07582592A0545|190 198|achalasia
P07583190A0306|270 279|assignment
P07583562A1826|124 135|hypertension
P07585246T0000|67 95|Caenorhabditis elegans pre-mRNA
P07585559A0000|225 229|cells
P07586403A0765|106 112|weights
P07588240A0000|166 170|CPP32
P07588245T0000|103 104|TR
P07588603A1054|72 76|sites
P07588608A1687|196 202|effects
P07588628A0318|52 54|LCL
P07588633A0362|182 184|Mos
P07588750T0061|123 129|protein
P07588777A1524|96 112|p44mapk MAP kinases
P07589069A1245|160 166|CD6-PB1
P07590264A0373|250 263|gene expression
P07590268A0350|113 121|MAPKAPK-2
P07590268A0740|131 138|germline
P07590283A0820|301 301|J
P07590525A0811|63 66|dogs
P07590657A0624|99 106|patients
P07590744A0829|95 102|GAR1 gene
P07592072A0217|150 158|gestation
P07592220A0846|101 103|Hyp
P07592337A0891|67 70|nfxB
P07592439A0000|43 63|Listeria monocytogenes
P07592467A0000|14 36|peroxisome proliferation
P07592485A0734|148 164|ure2 delta mutation
P07592647A0797|60 68|complexes
P07592647T0000|94 122|DNA Pur alpha recognition element
P07592658A0309|54 71|p50/p65 heterodimer
P07592676A0466|122 138|repressor activity
P07592706A1465|142 152|specificity
P07592710T0000|78 100|immunoglobulin kappa gene
P07592711T0000|107 117|beta subunit
P07592721A0827|79 81|DNA
P07592723A0814|134 146|PKC substrates
P07592730A0204|228 232|liver
P07592771A0258|116 120|alpha
P07592790A1457|139 145|protein
P07592946A0261|158 165|promoter
P07592946A0997|302 309|factor-5
P07593266A1174|71 87|pair stem structure
P07593896A1053|127 135|lung model
P07594047T0000|120 129|QT syndrome
P07594592A0755|92 99|proteins
P07595221A0733|128 139|transfection
P07595374A1215|202 213|LMP1 promoter
P07595857A0521|389 402|cardiomyopathy
P07596283A0396|100 108|emulsions
P07596287A0183|240 252|export systems
P07596287A1724|94 108|mutagenesis data
P07596558A0824|99 108|hemorrhage
P07596697A0971|112 123|control group
P07597030A0260|104 111|hTAFII32
P07597488T0000|43 53|kernicterus
P07597804A1007|68 87|glycoprotein gene EUS4
P07598106A0709|195 200|groups
P07598303A1728|102 116|survival benefit
P07599449A0445|75 87|control groups
P07599653A0898|143 148|organs
P07600111A0000|227 239|Guinea-Bissau
P07600986A0605|139 156|transcription units
P07601078A1003|138 140|% CI
P07601121A0153|153 161|sequences
P07601445A0207|197 208|RNA helicases
P07601827A0778|118 123|region
P07601828A0095|87 100|orfX-fliP locus
P07603726T0000|64 79|neuroma resection
P07603956A0115|127 134|chickens
P07604047A0704|245 248|GA19
P07604783A0952|84 102|bile acid composition
P07604794A0958|48 53|mg/day
P07605990A1110|190 195|levels
P07606548T0000|39 53|pharmacotherapy
P07606587A0266|115 122|bacteria
P07607197A1048|82 89|controls
P07607213A0140|154 163|expression
P07607233A0186|101 118|nucleotide sequence
P07607342A0703|154 163|drug trials
P07607537A0954|98 117|VP16 activation domain
P07607607T0000|39 54|fructose infusion
P07607669A1112|92 94|Sp1
P07608268A0194|164 171|controls
P07608649A1429|67 76|ET-1 levels
P07608968A0836|149 151|TBP
P07609037A0775|245 253|sequences
P07609079A0387|243 251|sequences
P07609372A0261|51 60|LR patients
P07610052A1064|203 216|rat APP promoter
P07610324A0319|176 182|centers
P07610716A0117|119 126|latitude
P07610735A1471|77 87|sinus rhythm
P07612174A1064|85 90|humans
P07612557A0635|61 65|pairs
P07614762A0224|46 63|latex agglutination
P07615541T0000|51 88|mouse porphobilinogen deaminase gene locus
P07615634A0535|101 102|kD
P07616056A0278|65 86|chain gene rearrangement
P07616563A0532|143 154|GATC sequence
P07616569A0168|264 268|rpl16
P07616802A0315|164 173|responders
P07618280A0550|55 83|density gradient centrifugation
P07618548T0000|3 23|Babcock Surgical Clinic
P07620491T0000|33 39|smoking
P07622058A0411|96 115|segmentation gene runt
P07622060A0967|90 104|thyroid hormones
P07622521A0418|219 229|PIP2 binding
P07622932T0000|35 41|leprosy
P07623807A0162|141 145|cells
P07623814A1040|155 171|breast cancer cells
P07623821A0649|78 82|motif
P07623821T0000|96 109|enhancer factor
P07623825T0000|83 88|stress
P07623838A1112|0 0|D
P07623840A0352|143 161|amino acid limitation
P07623844A0639|176 181|levels
P07624119A0528|183 191|cell types
P07624581A0312|261 263|T45
P07624615A0267|250 251|Pi
P07626378T0000|29 36|problems
P07626469A1341|117 124|CHO cells
P07626806A1098|70 77|proteins
P07627317A1502|100 120|microgram/g creatinine
P07628389A0145|108 123|mouse Leydig cells
P07628438T0000|112 129|signaling potential
P07628451A0114|107 113|F9 cells
P07628456A0000|201 203|PKR
P07629103T0000|112 134|beta-casein gene promoter
P07629113A0726|84 99|N-ethylmaleimide
P07629122A0323|87 100|protein kinases
P07629123A0885|131 140|activation
P07629150A0155|202 227|signal transduction pathways
P07629163A0770|154 167|transformation
P07629196A0274|176 182|pathway
P07630687A0010|280 284|event
P07630934A0343|6 8|E.M
P07631267T0001|49 56|carcinom
P07633444T0000|116 129|dystrophy locus
P07633756A0690|254 272|artefact propagation
P07635140A0172|126 135|mechanisms
P07635312A0692|112 119|interest
P07635572A1153|123 146|CIITA mRNA induction levels
P07636179A0000|132 141|inhibitors
P07636187A0585|111 118|promoter
P07636337A0687|105 109|women
P07636408T0000|112 133|intervertebral foramina
P07636648A1229|196 203|children
P07636962A1288|119 126|activity
P07636962A1883b|115 129|carboxyl termini
P07636984A1349|77 81|cells
P07637718A0218|115 129|trypomastigotes
P07638517A0000|135 154|police investigations
P07639106A0678|104 112|body TBBMC
P07639703A1703|142 165|islet cell differentiation
P07640309A0000|173 173|X
P07640422A0649|175 178|test
P07642490A0318|46 53|analysis
P07642538A0138|375 381|residue
P07642538A0744|90 100|stimulation
P07642544A0868|127 143|NF-kappa B activity
P07642633T0000|150 154|TEF-1
P07644127A0000|273 281|glutamate
P07644466A0578|209 218|substrates
P07644503A0729|117 127|target genes
P07646439A0535|91 118|mAb F11 affinity chromatography
P07647303T0000|119 124|plants
P07647570A0713|124 133|deiodinase
P07648338A0815|163 172|laparotomy
P07649098A0676|498 510|PGE2 treatment
P07650958A0123|119 128|indicators
P07651131A1407|140 146|protein
P07651141A0265|77 82|p-gvpE
P07651340A0286|141 146|levels
P07651386A0925|88 95|promoter
P07651398A0257|139 146|tyrosine
P07651398A0803|61 63|DER
P07651398T0000|53 77|DER receptor tyrosine kinase
P07651400A0335|110 126|consensus sequence
P07651424A0487|128 135|proteins
P07651424A0743|128 136|Ssm1p pool
P07651734A0961|125 127|rat
P07651835A0652|40 45|motifs
P07652066A0677|235 242|contours
P07652575A0435|114 125|DNA synthesis
P07652582A0000|56 58|CML
P07653094A0169|240 248|HeLa cells
P07653812T0000|100 103|rats
P07653892A0306|110 116|U50488H
P07654239A0698|54 73|cell cycle progression
P07654712A0774|145 146|pH
P07654740A0563|246 262|contraindications
P07655184A0852|147 156|ER sequence
P07655505A0527|167 192|phytochrome A gene expression
P07655509T0000|103 114|Pisum sativum
P07656588A0101|234 240|D19S571
P07657162A1412|140 148|HMG domain
P07657668A0642|95 106|Fyn SH3 domain
P07657705A1181|77 87|development
P07658262A0944|160 166|factors
P07658471A0000|51 55|genes
P07658777A0400|45 61|contraindications
P07659085A1520|179 196|androgen regulation
P07659515T0000|84 117|Crithidia fasciculata miniexon arrays
P07659529A0135|140 147|EpoR gene
P07659746A1464|87 92|ovules
P07659757A0191|106 124|autophosphorylation
P07660712A0118|109 111|VHB
P07663138A0835|56 58|PBF
P07663160A0287|209 219|preferences
P07663963A1588|179 192|control animals
P07663998T0000|51 59|aneurysms
P07665172A0000|135 141|systems
P07665187A0208|67 76|Nramp1 mRNA
P07665187A0824|147 161|initiation sites
P07665477A0901|66 69|esaI
P07665567A0495|267 276|expression
P07665605A1127|80 87|DD dimers
P07665633A0284|125 143|Laboratory Standards
P07665948A0591|130 138|infection
P07666414A0614|160 176|anti-tropomyosins
P07666415A0000|54 60|Zea mays
P07666523T0000|98 111|RNA transcripts
P07666538A0000|140 145|manner
P07666966A0207|59 66|segments
P07667097A0267|138 153|splicing products
P07667195A0146|105 114|Beagle dogs
P07667621T0001|74 80|syndrom
P07668009A0172|24 41|hepatitis A diseases
P07669351A1278|23 38|SSB-ssDNA complex
P07670504A0834|152 154|GBF
P07670943A0308|115 121|sibling
P07672821A0763|131 138|proteins
P07672822T0000|58 74|receptor alpha gene
P07673128A0989|48 50|CRE
P07673154A0688|112 122|fibronectin
P07673178A0982|182 188|factors
P07674649A0508|70 91|treatment effectiveness
P07675445A0463|97 100|SSLP
P07675449A0848|72 76|PDGFR
P07676492A1000|112 114|IHD
P07676587T0000|26 40|livestock export
P07676655A0214|68 73|mmol/l
P07677573A0000|153 161|gastritis
P07677715A1076|48 50|OCD
P07677836A1356|140 151|chemotherapy
P07678006A0472|150 155|manner
P07678006A0901|110 112|RNA
P07678051A1303|97 114|inositol phosphates
P07678242A0473|89 94|growth
P07678593A0708|60 78|V. cholerae fur mutant
P07678602A0153|134 140|parents
P07678695A0604|98 107|activation
P07679390A0721|178 191|splice junction
P07679836A0387|61 81|kidney transplantation
P07680035A0221|49 60|GnRH response
P07680120A1008|133 143|aFGF protein
P07680629T0000|114 136|Dictyostelium discoideum
P07681147A1420|177 186|signalling
P07681513A0000|69 89|vasodilator properties
P07681539A0000|101 103|mSv
P07682842A0294|211 218|sequence
P07682842A0771|96 104|sequences
P07683131A0885|109 114|domain
P07683375A0000|239 246|activity
P07685263A0503|109 127|Tropheryma whippelii
P07685823A1234|104 112|start site
P07685874A0258|214 221|controls
P07686619A0704|0 3|Chem
P07687320A0526|89 91|ge6
P07687541A0200|175 182|degrees C
P07687541A0992|120 123|CNR2
P07687745T0000|33 47|amino acid import
P07688112A0274|84 98|acid phosphatase
P07689154A0168|260 272|uPA mRNA levels
P07689501A0420|7 14|carriers
P07691837A1359|193 197|GC box
P07691885T0000|137 148|c-kit product
P07692366A0000|162 173|pathogenesis
P07692668A0326|229 232|ORFs
P07692754T0000|80 90|blood donors
P07693132A0100|62 75|Zm-ERabp5 genes
P07693372A0115|92 103|cyclosporine
P07693672A0259|60 69|protection
P07693699A0831|100 103|urea
P07693708A0000|103 109|fasting
P07693967A0905|63 73|translation
P07693975A1418|115 125|proteolysis
P07693975T0000|99 103|cells
P07695629A0489|31 40|disruptant
P07696183A0567|454 460|nucleus
P07696450A0271|217 221|weeks
P07696878A0222|144 161|homeodomain protein
P07697294A0329|42 46|roots
P07698219A0551|124 130|PE cells
P07698727A0386|64 75|HIV infection
P07699632A0522|86 88|PsA
P07699632A0715|99 105|HLA-B27
P07699845A0537|400 403|days
P07700361A0125|63 71|molecules
P07701266A0808|117 120|days
P07702327T0000|46 71|tissue plasminogen activator
P07702378A0668|76 78|VO2
P07702752A0545|322 337|Leydig MA-10 cells
P07702808A0427|116 118|ABP
P07704040A0000|184 185|EC
P07704273A0000|174 186|plasmid pNU305
P07704456A1014|126 136|HMS subjects
P07704689T0000|8 20|thyroid nodule
P07704730T0000|29 34|future
P07705476A0292|86 96|urine volume
P07705627A1107|84 94|development
P07706273T0000|79 88|THP-1 cells
P07706287A0698|95 111|cell division cycle
P07706291T0000|122 132|development
P07706299A0563|166 195|oligosaccharide-protein binding
P07706307A0914|107 107|C
P07706396T0000|93 108|membrane vesicles
P07707523A0704|90 92|LMP
P07707531A0550|129 132|ICP4
P07707544T0000|97 107|transcripts
P07708058A0178|118 139|c-jun/c-fos heterodimer
P07708488A0151|74 76|ref
P07708497A0000|155 160|AGGTCA
P07711667A0766|320 331|airflow rooms
P07711730A0000|112 117|muscle
P07713421A1435a|138 142|SxlM1
P07713421A1435b|138 142|SxlM1
P07713936A0393|129 136|presence
P07714608A1252|113 125|glucose levels
P07714758A1193|42 47|mg kg-1
P07715200A0000|89 101|blood pressure
P07715602A1088|58 77|cytochrome c haem lyase
P07715922A0188|121 123|PRK
P07717823A0328|128 136|functions
P07719527T0000|70 79|volunteers
P07720572A0701|117 124|position
P07720572A1584|197 206|mechanisms
P07720709A0755|197 214|AP1 transrepression
P07720710A0861|9 20|HMG2 proteins
P07721074A0766|137 150|trigger factors
P07721422A0241|99 110|receptor gene
P07721878A1163|151 158|identity
P07723247A0187|224 235|outflow ports
P07723247A1161|81 96|radioimmunoassay
P07724452A0344|50 55|chicks
P07728201A0660|148 168|penicillin prophylaxis
P07729427A0942|145 152|hTAFII30
P07730273A1309|115 128|NarL-phosphate
P07730328A0000|125 129|genes
P07730336A0606|94 100|kappa E3
P07730337A1439|71 81|development
P07730337T0000|92 101|RC3 protein
P07730795A0104|95 101|regions
P07731686A0000|89 93|T-ALL
P07731898A0823|237 272|erythrocyte membrane lipid peroxidation
P07733075A1200|238 239|wk
P07735590A0990|141 164|micrograms Fel d milligrams
P07735833A1078|117 120|core
P07737024A1003|91 97|pylorus
P07737118A0317|115 119|yeast
P07737508A0649|53 59|tRNAIle
P07737944A0000|203 216|erythropoietin
P07738026A0216|63 65|ADH
P07738839A0173|96 99|mmHg
P07739382A0457|141 148|ancestor
P07739520A1250|101 109|rpL7a gene
P07739542A1419|98 126|retinoblastoma protein function
P07739544A0364|149 156|proteins
P07739566A1076|163 173|specificity
P07740487A0167|220 230|Haemostasis
P07740490T0000|63 71|serotonin
P07741255A0194|46 55|population
P07742024A0121|184 189|extent
P07742363A0135|209 213|eIF-2
P07742363A0941|108 129|casein kinase activities
P07742550A0407|273 276|SNCL
P07742917T0001|47 56|Brazzavill
P07743472A0181|177 185|diagnosis
P07743515A0223|163 172|lymphatics
P07743697A0703|245 275|hydralazine/isosorbide dinitrate
P07744763A0514|198 202|HNF-4
P07744776A0617|60 73|U6 RNA synthesis
P07744846A1006|299 309|combination
P07744954A0418|161 165|stalk
P07745008A0892|65 74|constructs
P07745311A0264|45 52|findings
P07745684T0000|94 106|RNA processing
P07745685A1442|118 134|CAT fusion partners
P07745693A0914|130 138|component
P07745696A0932|194 206|repeat regions
P07745726A0960|157 169|relationships
P07745726A1496|169 176|half site
P07746397A0233|206 210|value
P07746794A0000|133 137|agent
P07746937A0100|72 77|months
P07747462A0332|200 217|replicator proteins
P07748451A0343|133 152|medium-viscosity poly
P07748493A1045|157 161|gland
P07748502A0794|84 92|water maze
P07748848A0263|19 38|papillary haemangioma
P07748952A0462|115 135|translation start sites
P07748952A1329|179 192|RNase E activity
P07749088A0119|23 28|images
P07749461A0632|108 119|sGTH alpha-G1
P07749461A1022|174 183|expression
P07750217T0000|56 75|carcinoma recurrences
P07751848A0222|179 186|subjects
P07752223A0960|63 74|Myc inability
P07752454A0341|75 79|DMPPC
P07752644A1031|108 117|conduction
P07752886A0595|42 58|amino acid residues
P07753027A0240|61 67|strands
P07753030A0173|138 160|Xanthomonas campestris pv
P07753796A0625|94 116|liver eIF-2B alpha subunit
P07753796A0743|80 101|SDS/polyacrylamide gels
P07753837A0724|106 117|accumulation
P07754713A0227|129 138|amino acids
P07755884A0000|165 178|dopamine system
P07755914A0000|162 165|DMAC
P07757315A1227|144 148|WORDS
P07758167A1488|98 106|clone ME10
P07758246A0469|62 66|exons
P07758459A1277|171 198|ABF1 consensus binding sequence
P07758837A1118|222 231|P1 promoter
P07759094A0634|92 114|microsatellite PCR marker
P07759525A0417|133 138|region
P07759529A0288|64 86|gp91-phox gene expression
P07760790A0327|82 104|MEF2 site binding activity
P07760819A0731|132 146|differentiation
P07760841A0221|41 54|regulator Adr1p
P07760841A0647|177 186|helix phase
P07760844A0413|79 88|c-fos genes
P07761091A0294|54 58|MKP-1
P07761216T0000|56 63|patients
P07761420A0909|60 62|Ca2
P07761434A1084|116 127|antioxidants
P07761467A0666|43 59|protein components
P07762431A0356|88 92|litre
P07762504A0648|84 88|doses
P07763727A1035|141 156|wine yeast strains
P07765118A0967|82 102|maximum enzyme activity
P07766885A0405|160 173|junction region
P07767011A0689|103 110|mutation
P07768824A0167|131 138|proteins
P07768836A1126|99 107|start site
P07768848A1880|202 211|components
P07768898A0492|166 172|protein
P07768953T0039|110 116|IQ motif
P07770033A0978|163 199|Neurospora crassa copper metallothionein
P07771671T0000|44 59|carbon electrodes
P07771745A0442|94 103|cheekbones
P07772036A1000|104 110|CTF/NF1
P07774137A0000|169 174|clinic
P07774807A0405|134 146|family members
P07774925A0084|142 145|head
P07775428A0172|92 97|region
P07776685A0000|182 191|lung cancer
P07776711A0295|137 150|polyneuropathy
P07776882A0000|85 95|reperfusion
P07776979A0702|53 72|reporter gene activity
P07777518A0483|90 94|genes
P07779558T0000|55 77|selenium supplementation
P07779811A0901|79 94|reporter activity
P07779812A0000|110 118|cell types
P07780148A1153|88 94|G1 phase
P07780525A0495|85 96|health inputs
P07780719A0477|25 31|driving
P07780738A0091|104 117|DNA replication
P07782087A0559|166 177|RACE analyses
P07782113A0726|72 82|blood levels
P07782302A0479|141 152|HTF9A/RanBP1
P07782775A0889|83 97|BBTV coat protein
P07783064A0452|80 85|levels
P07783641A0591|33 42|data-bases
P07783822A0000|98 113|district hospital
P07784061A0894|104 115|kb transcript
P07784078A1064|98 110|APL cell growth
P07784079A1018|181 183|FGF
P07784197A0827|176 200|BALB/c 3T3 mouse fibroblasts
P07784199A0000|181 185|Abf1p
P07784870A0119|226 237|microbiology
P07784942T0001|51 58|prospect
P07786820A0284|94 98|weeks
P07786821A2292|107 115|mg/m2/day
P07787179A0312|126 137|reporter gene
P07789275A0325|125 141|transcription unit
P07789342A1352|148 157|TSH binding
P07789396A0504|35 38|EDTB
P07789809A1246|168 182|differentiation
P07789971A0758|208 212|GSTT2
P07790271A1185|65 74|techniques
P07790377A0561|67 78|hamster cells
P07790719A0098|56 69|family violence
P07791760A0424|121 138|complex kinase assay
P07791763T0000|124 146|Xenopus oocyte maturation
P07791764A0357|80 97|adapter protein Grb2
P07791768A0930|178 186|silencing
P07791769A0826|108 122|ICP4 binding site
P07791771A0183|5 7|Mol
P07791776T0000|92 102|conjugation
P07791783A0000|127 155|rainbow trout testis cDNA library
P07793783A0189|121 129|donor site
P07794556A0000|171 186|mutation analysis
P07795104T0000|57 62|review
P07795576A0126|91 109|plasma renin activity
P07796935A0284|228 234|TRE-LAP
P07797077A0842|177 186|ISGF3 gamma
P07797346T0000|42 50|Amsterdam
P07797476A1001|127 134|residues
P07797583A0222|307 311|flies
P07798134T0000|116 121|member
P07798207A0759|174 178|group
P07798217T0000|80 93|gene expression
P07798217T0095|46 59|gene expression
P07798271A0330|113 124|Ets-1 protein
P07799437A0656|93 107|control plasmids
P07799925A0526|175 184|SH2 domains
P07799931A0287|146 151|system
P07799931A1232|53 64|c-Maf actions
P07799939A0628|123 130|3T3 cells
P07799948A0777|138 147|mechanisms
P07799950A0282|141 144|CREB
P07800479A0201|130 136|nucleus
P07800505T0000|54 72|phospholipase A2 gene
P07801180A0197|54 68|study approaches
P07802355T0000|108 119|Technicon H-1
P07802655T0000|108 119|protein genes
P07803809A1852|182 186|WORDS
P07806492A1162|71 79|precursor
P07806507A0121|198 214|activation cascade
P07806532A0659|73 74|nM
P07806651A0097|115 120|MMPI-2
P07806820A0091|102 111|fascia flap
P07807002A0500|182 184|IgE
P07808210A1510|43 46|NCEP
P07809128T0000|22 29|E2F1 gene
P07809410A0606|191 197|therapy
P07811639A0222|154 159|midgut
P07811964A1252|119 130|dimerization
P07812450A0849|58 65|nspC gene
P07813466A0074|147 151|hsc70
P07813786A0641|61 75|XMyoDa TATA motif
P07814321A0850|69 89|sporulation efficiency
P07814323A0313|96 112|flagellum assembly
P07814388A0662|98 128|pertussis toxin substrate activity
P07814403A0433|0 3|Chem
P07814405A1170|156 163|proteins
P07814717A0669|100 102|Met
P07815546A0411|0 4|Virol
P07815811A1487b|163 168|bypass
P07816025A0196|134 140|domains
P07816049A0686|211 223|transcription
P07816049A1157|184 188|roots
P07816617A0763|51 55|genes
P07816619A0000|141 161|cAMP phosphodiesterase
P07816619A0872|156 178|transcription initiation
P07816630A1333|138 145|H4-I gene
P07816808A1102|140 147|Chordata
P07818416A0895|148 158|revision THR
P07819225A1094|212 216|WORDS
P07820057A0000|121 130|properties
P07821790A1084|166 186|co-transfection assays
P07822161A1172|136 143|residues
P07822329A0773|149 151|kDa
P07822333A0376|0 3|Chem
P07823919A1422|102 106|ARP-1
P07823951A1100|192 196|cells
P07823953A0777|400 407|subunits
P07823964A0922|102 106|trans
P07824325A0714|249 260|micrograms/g
P07824464A0169|227 240|artery stenosis
P07824657A1456|78 86|leaf discs
P07824726A0454|151 155|type b
P07825888A0715|78 91|cortisol levels
P07826412T0112|100 108|transduci
P07826625X0000|361 382|polyglutamine stretches
P07828584A0681|53 70|AP1 bearing promoter
P07828600A0095|175 179|cells
P07828811A0556|96 102|ability
P07828824A0307|95 103|deletions
P07828852A0153|55 63|functions
P07829057A1097|32 37|RH maps
P07829057T0000|52 61|chromosome
P07829097A0000|103 107|genes
P07829102T0000|103 111|parasites
P07829519A1251|196 200|locus
P07829554A0257|263 268|metals
P07830112A0532|271 277|normals
P07831310A0000|155 164|TEV mutants
P07831799T0000|85 101|polyhedrosis virus
P07831829A1324|97 114|genome organization
P07832086A1023|125 127|FOM
P07832779A0719|84 104|oligosaccharide chains
P07834582A0115|136 147|hypertension
P07835088A0238|130 151|chromosome 1p13.1 region
P07835214A0603|52 52|%
P07835273A0000|61 75|insulin receptor
P07835273A0411|171 179|5000/cell
P07835710T0000|53 56|gene
P07835826A0195|77 87|3-vitamin D3
P07835886A0894|195 202|globulin
P07835888A0402|119 131|backcross mice
P07836218A0128|112 119|acidosis
P07836228A1052|103 110|pressure
P07836364A0000|148 150|APC
P07836390A1152|176 186|conjugation
P07836406A0884|163 176|chromatography
P07836471A0375|72 88|osteosarcoma cells
P07838156A0789|169 184|ROR alpha function
P07840643A1006|180 185|enzyme
P07841230T0000|47 60|antimicrobials
P07841663A0685|153 158|medium
P07841663A0845|162 170|viability
P07844142A0640|129 145|GTPase superfamily
P07844155A0327|194 201|splicing
P07844201T0000|39 45|results
P07844425A0289|42 46|urine
P07844555A0406|116 120|birth
P07845672A0368|129 137|% identity
P07846153A0403|16 20|EMBO J
P07846163A0422|58 64|introns
P07846199A0000|80 94|startle response
P07846942A0717|127 131|drugs
P07846942T0001|40 44|syste
P07847036A0353|62 70|inhibitor
P07848358A0254|76 83|d onwards
P07851643A1365|112 132|oocyte differentiation
P07851758A0330|53 57|spt14
P07852037A0548|53 55|TBF
P07852361A0868|93 98|S phase
P07852400A0519|67 70|Rac1
P07853448A0601|86 99|sport performer
P07853476A0159|8 8|J
P07853488T0000|136 150|P1 capsid protein
P07853524A1944|132 136|WORDS
P07854130A1387|112 129|twitching-motility
P07854130T0000|123 138|prepilin proteins
P07854324A0281|148 152|yeast
P07854324A0742|101 116|growth conditions
P07856102A1616|84 96|virus assembly
P07857086A0949|92 96|Class
P07857163A0551|53 63|derivatives
P07857344A0591|76 106|pidotimod administration schedule
P07857762A0611|80 88|responses
P07858986A0310|168 190|glutaraldehyde treatment
P07859238A1150|9 19|side effects
P07859301A0325|121 145|transcription factor family
P07859371A1246|90 97|extracts
P07859665A0498|75 86|microseconds
P07859739T0000|70 108|p16INK4/MTS1 tumour suppressor gene product
P07859777A0000|196 203|chloride
P07860208A0000|259 266|controls
P07860646A1363|96 100|FGF-2
P07862092A0302|243 249|vectors
P07862108A0987|80 82|kDa
P07862129A1391|132 138|TTR gene
P07862141A0317|92 106|differentiation
P07862141A1412|78 82|genes
P07862150A0429|183 191|responses
P07862154A0340|83 86|RAF1
P07862162A0408|104 116|UASINO element
P07862165A0184|166 179|helix formation
P07862168A0000|106 112|stimuli
P07862533A0000|175 179|EGR-1
P07863047A0229|208 216|parameter
P07863619A0098|145 151|objects
P07863992A0908|218 225|exercise
P07864652A0753|207 215|construct
P07864652A1901|132 140|processes
P07864709A0324|213 221|M2 protein
P07865129A0293|61 66|region
P07865786A0457|77 82|plants
P07865787A1086|156 173|wheat histone H3 gene
P07865876A1292|145 148|cell
P07865888A1309|125 134|maturation
P07865895A0896|175 181|absence
P07865917A0191|120 126|results
P07867604A1777|249 258|conditions
P07867622X0000|212 217|events
P07867944A0365|130 138|promoters
P07869721A0000|89 108|heart valve prosthesis
P07869913A1076|113 120|subjects
P07869937A1142|133 138|P group
P07870305A1015|188 207|haloperidol influence
P07871718A1132|125 134|activation
P07871721A0000|121 124|p223
P07871721A0392|170 182|histidine1075
P07871754A0857|142 154|cooperativity
P07871755A0521|64 79|characterization
P07871757A0846|71 86|promotor sequence
P07871891A0227|60 69|protein S13
P07872673A0332|133 151|SV40 promoter complex
P07872788A1717|172 181|divergence
P07873631A0114|15 27|tooth fracture
P07873831T0000|77 80|mass
P07873876A1035|139 145|cloning
P07874060A0810|111 124|administration
P07875595A0910|134 155|chicken microchromosome
P07876134A0348|116 127|reading frame
P07876191A0808|57 61|liver
P07876192A0443|102 118|ICE autoprocessing
P07876194T0000|110 129|tyrosine kinase domain
P07876210A0275|147 162|Barbie box element
P07876210A0751|229 234|levels
P07876300A0994|55 67|protein import
P07876562A1646|128 141|HIV-1 infection
P07877308A1175|53 58|cohort
P07877619A1284|163 168|region
P07878029A0721|76 80|CBF-B
P07878040A0505|124 127|mice
P07879204T0000|148 156|US studies
P07880442A0236|75 94|S1 nuclease protection
P07880449A0091|151 159|cGy X-rays
P07880650A0493|172 193|crotoxin complex crystal
P07881077A0195|86 93|patients
P07883167A0157|192 196|mRNAs
P07883168A0090|104 113|decay rates
P07883193A0000|175 198|glutathione S-transferase
P07883754A0993|107 117|NRE fragment
P07885999A0000|122 150|methylation interference assays
P07886610A0000|85 94|prevalence
P07887226A0858|240 246|disease
P07887859A0315|109 115|indices
P07887859A0998|70 84|ulcer management
P07888156A0169|210 215|issues
P07888156T0000|15 27|telepathology
P07888306A1659|230 234|WORDS
P07888623A0721|146 152|alfalfa
P07888629A0344|237 257|lipid transfer proteins
P07888788A1010|158 168|Aspergillus
P07888828A0765|65 72|primates
P07890485A0827|152 155|cats
P07890599A0132|255 259|Sec1p
P07890674A0916|118 124|absence
P07890680A1193|130 143|primer terminus
P07890740A0997|121 131|PSD activity
P07891638T0000|49 64|chest radiographs
P07891685A1051|128 139|CAT8 promoter
P07891708A0690|60 68|HeLa cells
P07891708A1192|117 127|HNF-4 delta C
P07891709A1542|106 118|deadenylation
P07891713T0000|74 97|NF-E2 transcription factor
P07891720A0818|67 77|calcium ions
P07892076A0578|65 80|transmission mode
P07892353A0667|174 185|brain regions
P07894021A1130|76 86|desiccation
P07894359T0000|61 64|rats
P07894761A0000|169 175|surgery
P07896088A0720|189 202|telomere length
P07896291A0693|127 138|WAGR syndrome
P07896615A0554|151 164|water immersion
P07896817A0204|184 194|Immobilon-P
P07896846T0000|121 129|chain gene
P07896852T0000|45 77|apolipoprotein AI gene transcription
P07897359A0354|118 135|T7 polymerase system
P07897696A0000|280 287|subjects
P07898178A0849|177 188|patient death
P07898275A0254|273 298|volume localization sequence
P07898589T0000|4 15|tobacco issue
P07898840X0000|389 395|results
P07899581A0000|188 191|rats
P07899634A0000|128 129|mu
P07900915A0000|249 258|hematocrit
P07901121T0000|50 52|DNA
P07901125A0416|121 140|yeast Candida albicans
P07902532A0312|99 105|EC cells
P07902532A1655|121 127|EC cells
P07902583A0545|100 108|complexes
P07903099A0918|92 105|splice acceptor
P07903670A1202|51 56|tua1-1
P07905413A0585|233 236|time
P07905453A0281|95 97|ORF
P07906265A0897|121 128|assembly
P07906616A0191|122 132|anaesthesia
P07907846A0623|191 201|stimulation
P07908012A0678|172 181|LNNB scores
P07908187T0000|5 17|possibilities
P07908827A1200|225 231|element
P07909936A0672|202 208|factors
P07910716A0359|231 244|SC rIFN-alpha 2b
P07910946A0323|203 209|L2 cells
P07911736A1715|58 73|myelosuppression
P07912123A0711|15 37|lymphocyte proliferation
P07913080A0564|108 116|horse gene
P07913891A0174|204 220|tissue specificity
P07913926A0878|132 141|transcript
P07914192A0211|207 218|HER2 promoter
P07914192A0844|215 235|GAGGAA response element
P07914507A1029|92 104|addition sites
P07914700A0000|81 83|DNA
P07915144A0000|102 106|hours
P07916003A0688|110 121|octamer motif
P07916326A0000|106 110|Msx-1
P07916327A0250|95 101|protein
P07916577A0190|161 165|cDNAs
P07916588A0471|186 196|potyviruses
P07916685A0455|142 151|activities
P07916689A0312|101 112|carbon source
P07916689A1407|104 123|Y. lipolytica LEU2 gene
P07916729T0000|83 98|enhancer function
P07916983A0623|109 120|prescription
P07917016A0581|24 54|zinc finger domain protein sequence
P07917540A0000|185 192|melanoma
P07918097T0000|104 118|neuroepithelium
P07918128A0000|130 141|chemotherapy
P07918494A1163|156 161|enzyme
P07919540A0240|108 111|exon
P07919540A1119|135 139|level
P07922709T0000|72 82|application
P07925022A0285|52 57|stages
P07925097A1205|74 82|8-Br-cAMP
P07925282A0705|135 144|ER membrane
P07926729A0000|137 153|gene transcription
P07926739A0766|143 161|trichome development
P07926748A0383|95 107|not2 mutations
P07926749A0471|203 206|RORE
P07926774A0652|67 74|E2F sites
P07926775A0895|170 171|hh
P07926789A0960|134 140|fusions
P07927130A0625|165 174|myocardium
P07927267T0000|110 120|hepatectomy
P07927711A0698|84 90|regions
P07927838A0000|184 194|extremities
P07928954A0545|163 199|consensus prolipoprotein processing site
P07929165T0000|103 104|A3
P07929238A0734|6 13|Genomics
P07929411A0087|202 215|enzyme activity
P07929431A0949|149 158|INS-1 cells
P07929559A0000|177 186|organelles
P07929560T0000|97 113|filament anchorage
P07931490A0237|168 180|micrograms/kg
P07932095A0000|125 143|Oroxylum indicum Vent
P07932943A0113|132 147|control condition
P07933066T0000|116 119|DP-1
P07933076A0211|65 80|membrane proteins
P07933095A0000|162 185|chicken embryo fibroblasts
P07933101A0131|81 99|HIV-1 gene expression
P07933107A0991|127 137|% similarity
P07933116A0412|86 89|U937
P07934331T0037|35 44|improvemen
P07934666A0158|85 87|T2s
P07935094A0516|121 128|FDG study
P07935370A0000|101 105|T cell
P07935375A1197|68 72|v-src
P07935379A0347|98 106|apoptosis
P07935383A0108|178 198|adenovirus L3 pre-mRNAs
P07935395A0094|112 119|molecule
P07935415T0000|118 121|gene
P07935418A0447|124 132|receptors
P07935426A0714|87 104|TdT promoter binding
P07935447A0972|242 246|genes
P07935451T0000|143 151|c-rel gene
P07935468T0000|59 78|growth factor receptor
P07935471A0613|182 186|state
P07935472A0276|221 227|phorbol
P07935472A0790|99 117|mobility shift assays
P07935491A0495|98 111|gene expression
P07935491A1182|80 122|acid receptor-retinoid-X receptor heterodimers
P07935577A0305|131 133|CSF
P07935626A1249|57 68|mitochondria
P07935997A0000|177 180|year
P07936635A1134|110 116|nucleus
P07936640A0900|215 220|levels
P07936650A0656|145 152|sequence
P07936650A1752|107 115|evidences
P07937106A0100|228 236|mutation C
P07937108A0325|52 64|RNA polymerase
P07937112A0220|72 83|denaturation
P07937127A0645|123 139|pseudorabies virus
P07937132A0819|86 92|28S rRNA
P07937147A0205|136 136|J
P07937656A0182|291 297|minimum
P07937841A0790|108 124|myb oncogene family
P07937954A0612|108 116|MAP kinase
P07937965T0000|74 95|3T3-L1 mouse fibroblasts
P07938137A0384|115 124|withdrawal
P07941174T0001|20 27|carcinom
P07941739A0000|89 95|mapping
P07941750A0344|89 103|hydatoinase HyuB
P07942076A0497|155 158|type
P07942448A1227|69 73|WORDS
P07942722T0000|83 88|agents
P07943556A0694|58 67|Og4C3 assay
P07944461A0321|49 51|mm3
P07944542T0000|20 27|Calcutta
P07945134A0079|136 149|head microphone
P07945330A0103|58 66|Rex-1 gene
P07945937A0358|216 226|Egr1 protein
P07947930A0499|71 71|%
P07948129A0297|217 219|NEO
P07948921A0051|77 81|probe
P07949137A0000|113 119|January
P07949137A0532|68 82|body irradiation
P07949164A0799|117 121|cells
P07949205A0286|90 104|breast carcinoma
P07949551A0000|44 65|cadaver transplantation
P07949770T0000|85 88|pigs
P07951235A0277|72 77|muscle
P07951410A0647|167 172|others
P07951410A1332|106 116|E1A promoter
P07951874A0320|102 107|system
P07953785A0648|136 163|marble spleen disease infection
P07954475A0714|207 225|tumor suppressor gene
P07954891T0000|69 75|genomes
P07956578A0851|112 118|removal
P07956869A0000|189 203|S-phase fraction
P07957085A0207|32 36|Cbf3b
P07957106A0471|65 88|glutathione-agarose beads
P07957106A0875|100 111|VP16 contacts
P07957158A1532|171 184|Starling forces
P07957243A1316|42 48|domains
P07957559A1557|90 108|p70 S6 kinase activity
P07957632A0000|223 230|pmol/rat
P07958446A0000|163 182|helix DNA binding motif
P07958865A1152|136 147|interactions
P07958898A1050|132 136|NTF-1
P07958911A0500|130 136|complex
P07958915A1507|184 197|protein kinases
P07958920A1157|147 155|RNase P RNA
P07959011A0379a|95 98|Arch
P07959011A0379b|95 98|Arch
P07959015A0478|131 138|nt levels
P07959734A0194|101 117|glycoprotein Gp135
P07959760A0763|334 342|Fli-1 gene
P07959952A1446|155 166|mast cell line
P07959953A0423|80 82|DNA
P07960608A0228|28 32|weeks
P07960796A0154|38 43|ruling
P07961545A1314|125 135|ejaculation
P07961755A0474|113 127|leader sequences
P07961957A1565|96 117|alpha-MHC gene EM element
P07961958T0000|0 24|Rat kidney carboxylesterase
P07963540A0795|185 205|kappa B oligonucleotide
P07963782A0000|129 132|pain
P07964162A0941|124 132|responses
P07964458A0179|183 189|animals
P07964459A0845|106 112|regions
P07964624A0491|154 157|P191
P07964770A0172|47 58|arthroplasty
P07964814T0000|43 50|epilepsy
P07964918A0000|92 96|signs
P07965152A0764|125 145|dobutamine stimulation
P07966565A0901|142 150|infection
P07966583A1268|166 168|kDa
P07966602A0130|8 8|J
P07966873A0693|90 95|Chagas
P07967360A1048|116 133|glomerulonephritis
P07967725A0262|131 146|carboxyl terminus
P07968409A0123|185 188|July
P07969115A0000|206 220|promoter regions
P07969116A0196|131 137|stimuli
P07969132A0268|183 190|gcn2-507
P07969135A0913|74 80|protein
P07969136A0273|150 153|gene
P07969152A0721|260 270|hsp70 family
P07969181A0313|123 132|p53 protein
P07969954T0000|143 158|cyclophosphamide
P07971282A0000|95 103|metazoans
P07971709A0907|88 92|state
P07972012A0956|226 242|phosphatase domain
P07972237A0665|107 113|cosmids
P07972831A0563|85 93|ioxaglate
P07973364A0325|174 181|NMRI mice
P07973397T0001|44 46|sal
P07973825A0445|67 79|pulse pressure
P07975763A0000|117 132|detection methods
P07975882T0000|32 37|fibers
P07977239A1283|273 282|dorsal duct
P07977648A0880|106 111|tumors
P07978229T0000|35 41|patient
P07978406A0998|143 147|WORDS
P07979810A0340|126 134|pregnancy
P07979827A0722|70 78|blood flow
P07980440A0138|145 150|effect
P07980468A0298|0 3|Acta
P07980669A0373|104 110|samples
P07981143A0633|122 128|factors
P07981246A0112|158 171|c-fos induction
P07982964A1017|92 104|monophosphate
P07982995A0000|203 207|cells
P07983011A0617|431 450|domain binding regions
P07983704A0330|153 156|type
P07983712A0914|69 79|replication
P07983715A0996|217 238|luciferase reporter gene
P07983716A1082|178 183|levels
P07983744A0920|81 98|punctate structures
P07984088A0592|113 116|PrfA
P07984105A1509|86 99|mouse virulence
P07984261A0536|89 95|tissues
P07985305T0001|30 36|childre
P07987924A0670|110 122|probe hypotube
P07988559A0836|37 44|affinity
P07988730A0220|211 234|transactivator tax protein
P07988731A0002|180 187|CCACGTGG
P07988731A1301|69 85|GBF protein complex
P07988945T0000|64 73|antibodies
P07990136A1124|197 205|complexes
P07991437A1032|46 53|patients
P07991582A1023b|95 108|enzyme function
P07992027A0485|67 81|transplantation
P07993559A0233|76 81|review
P07994021A1223|166 172|protein
P07995173A0585|59 59|P
P07995910A0119|116 125|laparotomy
P07997174A0936|92 107|A. vinelandii NifL
P07999066A0238|246 280|acetyltransferase reporter constructs
P07999363A0000|157 168|kinase domain
P07999604A0139|67 73|lesions
P07999982A0086|183 186|gene
P07999995A0000|57 67|Oryza sativa
P08000074A0162|132 139|fragment
P08000112T0000|51 75|membrane oxygenator support
P08000427A0000|158 159|pI
P08000497A0179|124 126|VTG
P08001136T0000|52 71|CTD kinase TFIIH/TFIIK
P08001792A0284|90 122|adenylate cyclase activation pathway
P08001966A0563|146 166|Caenorhabditis elegans
P08002564A0249|140 148|rpoAL290H
P08002857A1070|180 183|bile
P08003700T0000|137 144|atpA loci
P08004442A0265|205 217|adrenalectomy
P08005230A0222|146 163|luciferase activity
P08005412A0608|169 171|DNA
P08005438A1185|134 147|gene expression
P08006101A1142|104 115|study samples
P08006772A0000|74 78|women
P08006773A0836|117 127|hypotension
P08007835A0538|165 168|news
P08007954A0374|130 137|enhancer
P08007975A0000|70 74|yeast
P08011017A0169|105 125|repeat polysomnography
P08011166A0207|156 163|segments
P08012448T0000|80 98|bud pattern formation
P08012566A0254|123 134|plasma sample
P08013348A0143|88 94|species
P08013457A0342|71 110|tyrosine kinase receptor signal transduction
P08014228A0278|99 110|racemization
P08014377A1277|174 182|divisions
P08014919A0530|149 151|DGR
P08015672A1282|41 44|Type
P08015850A1076|177 184|compound
P08016102A1238|238 249|tissue injury
P08016189A0741|97 103|regimen
P08017290A1347|120 125|pacing
P08018361A0636|53 57|n/cm2
P08020702A0000|130 135|lipid A
P08020702A0137|144 167|antibodies administration
P08020806A0187|191 197|peptide
P08020962A1226|100 102|MER
P08020965A0465|107 110|ends
P08021175A0486|147 151|sites
P08021177A0000|184 193|conditions
P08021225A0000|142 149|DNA probe
P08022212A0071|307 323|ion relaxation time
P08023662T0000|94 100|monitor
P08024139A0393|182 191|impairment
P08025074A0000|146 152|prolene
P08025669A0724|69 76|activity
P08028671A0687|108 115|promoter
P08029001A1020|173 194|transcription machinery
P08029334T0000|32 46|acid desaturases
P08030239A0833|221 235|EHV-1 IE promoter
P08030243A1011|85 92|activity
P08030704A1503|117 128|preterm labor
P08031424T0000|52 62|ventilation
P08033490A0875|180 185|ml/min
P08034318A0724|141 160|transcription factors
P08034486A0579|127 131|areas
P08034680A0180|131 133|kDa
P08034682T0000|72 85|3T3 fibroblasts
P08034708A0000|139 153|differentiation
P08034741A0000|120 131|border myosin
P08034742A0307|6 6|D
P08035498A0833|96 113|AAV promoter regions
P08035499A0941|196 197|TR
P08035505A0586|21 32|B polyprotein
P08035517A0753|77 81|IEP72
P08035796A0890|226 241|growth conditions
P08035833A1556|84 98|import machinery
P08036004A0292|191 200|expression
P08037338A0000|155 158|life
P08039422A0000|87 101|mouse Chromosome
P08040336A0435|131 132|bp
P08040391T0000|109 123|tumour behaviour
P08040468A0303|149 157|reactions
P08041362T0000|119 127|auxotroph
P08041793A0242|127 131|COX5b
P08043523A0000|136 145|dyskinesia
P08044794A0000|62 68|protein
P08044800A0550|105 109|sites
P08044802A0462|132 140|cell lines
P08045431A0894|75 82|bacteria
P08045834A0783|70 81|ATP synthesis
P08046923A0000|90 98|resection
P08048582A0821|111 119|LAD region
P08048916A0000|79 86|pathways
P08049401A0428|109 123|thyroid hormones
P08049444A0351|214 222|MARs/SARs
P08049521T0000|107 111|yeast
P08049885T0000|19 36|multisystem disease
P08051019A0365|52 60|mechanism
P08051059A1000|99 111|RhlR regulator
P08051074A0000|142 150|digestion
P08051102A0532|89 93|forms
P08051151A0347|133 141|cell lines
P08053697A0000|184 193|correlates
P08054281A0731|171 180|malignancy
P08055939A0159|138 145|variants
P08055939A0707|165 170|domain
P08055941A1264|104 109|enzyme
P08056474A0438|27 27|%
P08057356A0531|90 95|region
P08057356A1824|112 118|spacing
P08057421A1583|196 201|Cp site
P08057762A0878|55 56|T2
P08057833A0573|118 129|reading frame
P08058326A0463|140 151|counterparts
P08058948A0810|91 93|CRF
P08062824A0626|134 140|FKBP-12
P08062833A0000|194 203|expression
P08063108A0109|70 76|protein
P08063766A0595|137 141|rates
P08063775T0000|52 65|gene expression
P08063791A1370|133 137|yeast
P08063836A0904|76 85|DNA binding
P08064351A1020|76 77|ms
P08065310A1144|168 185|receptor gene family
P08065324A0458|124 136|transcription
P08065327A0000|112 121|protozoans
P08065331A0279|162 170|leukemias
P08065338T0000|113 125|transcription
P08065365A0000|98 105|assembly
P08065366A0918|59 79|chromosome segregation
P08065368A0839|6 12|Biochem
P08065901A0997|209 217|apparatus
P08066094T0000|27 36|reactivity
P08067013T0001|105 111|disease
P08067123A0248|195 207|HBsAg carriers
P08067546A0000|254 256|dog
P08067607A0568|108 119|control group
P08069298A0492|152 154|LMC
P08069427T0000|55 65|gallbladder
P08069481A0736|43 53|calf muscles
P08070004A0782|147 154|mg/m2 PCZ
P08070393A0631|42 48|time lag
P08070654A0000|90 103|SPB duplication
P08070654A0574|153 156|body
P08071356A0232|148 164|template positions
P08071982T0000|32 39|syndrome
P08072352A0567|119 127|IgE levels
P08072547A0690|130 137|activity
P08072547A1009|94 109|activation domain
P08072547T0000|86 88|ERK
P08073505T0000|70 84|ExPASy WWW server
P08075070A1632|179 186|proteins
P08075421A0621a|50 54|HrpJ2
P08075421A0621b|50 54|HrpJ2
P08076631A0000|232 252|osteosarcoma cell lines
P08076937A0851|137 156|Tru9I restriction site
P08077236A0243|70 78|COS7 cells
P08078167A0000|86 93|measures
P08078416A0581|102 115|concentrations
P08078473A1107|43 55|ste13 mutation
P08079268T0028|46 51|surger
P08082215A0230|65 68|RTID
P08082286A0748|72 75|area
P08082292T0000|90 101|tuberculosis
P08082360A0411|39 42|SaO2
P08082440A0339a|10 16|LH/FSH P
P08083011A0584|171 177|females
P08083220A0988|161 173|serum response
P08083963A0795|121 149|methylation interference assays
P08083998A1723a|124 132|sequences
P08083998A1723b|124 132|sequences
P08083999A0501|159 171|transcription
P08084339A0907|185 204|amino acid polypeptide
P08084592A0145|55 68|tumorigenicity
P08085228A0000|196 198|Tex
P08085609A0384|117 135|crown fissure termini
P08085782A0164|37 38|cm
P08086450A0467|190 192|GCF
P08086453T0000|60 67|APEX gene
P08087887A1067|102 109|cleavage
P08088022A1417|144 151|ischemia
P08088513A0419|131 136|snRNAs
P08088777A0754|144 147|Acra
P08088818A1053|140 148|RAD52 gene
P08089184A0825|42 50|dagA locus
P08089834A0561|65 80|amino acid residue
P08089887A0742|56 65|evaluation
P08090571T0001|42 50|xenograft
P08090746A1288|134 159|tomato fruit-ripening E4 gene
P08090767A0000|172 191|DNA methylation damage
P08091655A0000|87 89|DNA
P08091665T0000|80 90|TNF receptor
P08091669A0828|117 127|ie1 promoter
P08093450A0688|181 184|loss
P08093616A1214|116 124|sequences
P08093616T0000|176 182|antigen
P08093642A0600|265 271|testing
P08094464A0869|96 99|aroF
P08094464A2014|152 158|regions
P08094498A0614|64 72|prognosis
P08094927A0311|99 105|virions
P08095698T0000|100 120|nephropathia epidemica
P08095872A1672|159 177|contraction efficacy
P08095875T0000|61 64|rats
P08096066A0623|136 149|drug resistance
P08096944A0951|109 113|women
P08097666A1135|119 124|spikes
P08097732A0000|174 189|Spec1/Spec2 genes
P08098228A0625|38 40|PPO
P08098842A0660|234 243|regulation
P08098914A0400|133 139|mmHg/ml
P08099443A0359|118 132|GCN4 translation
P08100057A0577|99 109|dendrocytes
P08100765A0361|121 132|compartments
P08100843A0134|162 163|kb
P08101134A0376|65 77|MPTP treatment
P08101171A0924|137 146|regulators
P08101839A0000|104 120|cell proliferation
P08101843A0151|99 125|transcription initiation site
P08102364A0000|35 53|Nicotiana tabacum var
P08103379A0577|106 127|amino acid substitutions
P08103935T0000|30 49|SRF accessory proteins
P08104189A1168|145 150|ATPase
P08105727A0099|83 91|perfusion
P08105994T0000|72 81|infarction
P08106087A0139|135 154|polyadenylation sites
P08106245A0325|147 158|measurements
P08106313A1492|166 170|genes
P08106325A0000|140 158|diphtheria toxin gene
P08106369A0000|203 212|messengers
P08106398A1003|66 80|nisin maturation
P08106512A0522|166 171|factor
P08107167A0222|178 184|IFA-ABS
P08107208A0673|104 107|DNAs
P08108099T0000|68 76|disorders
P08108343A0000|251 270|gonadotropin reserves
P08108413A0964|148 158|transcripts
P08111035A0098|207 212|fusion
P08111974A1034|152 163|trans-factor
P08112341A1128|12 17|Carter
P08112526A0443|124 131|bladders
P08112601T0000|98 104|protein
P08112611A0404|59 68|amino acids
P08112870A0484|141 143|kDa
P08113736A0309|188 190|ORF
P08114702A0000|159 163|genes
P08114710A0137|91 97|TATA box
P08114745A0953|182 184|pol
P08115744A0462|86 92|microns
P08115744A0846|99 121|quality assurance program
P08116245A0174|79 88|infant rats
P08118044A0318|79 89|FDC-P1 cells
P08119149A0000|112 115|bone
P08119907A0000|93 109|signaling pathways
P08119958A0273|173 180|subgroup
P08119995A0814|186 193|sequence
P08120019A1500|120 129|mechanisms
P08120029A0864|107 115|R2 message
P08122364A0954|169 175|protein
P08122370A0331|111 115|EHV-1
P08123787A0554|192 199|analysis
P08124785A0445|217 217|P
P08124912A0456|97 103|glucose
P08124956T0000|88 91|pigs
P08125258A0142|142 154|perturbations
P08125319A1085|98 110|data libraries
P08125337A0940|91 104|Erg24p activity
P08125949A1162|246 255|eubacteria
P08126096A0478|220 224|forms
P08126096A1071|127 139|reading frames
P08127950A0000|328 335|subjects
P08128629A1164|106 111|LTR RNA
P08129955A0572|80 89|unclamping
P08130942A0051|58 64|problem
P08131545A0158|248 256|Chlamydia
P08131746A0140|92 100|MEK kinase
P08132541A0000|49 55|MAL gene
P08132574A0831|99 118|cytochrome CYP1A1 gene
P08132667T0000|73 81|promoters
P08133502T0105|29 58|Disease Collaborative Study Group
P08134108A0277|113 120|elements
P08134115A1161|174 182|A/TCTA/TA
P08136383A0359|33 40|patients
P08138180A0593|120 128|functions
P08138364T0000|18 27|experience
P08139001A1235|119 133|tubule formation
P08139004A0278|68 79|UGC sequences
P08139017A1465|191 200|Tpl-1 locus
P08139031A1168|312 327|ORF4 inducibility
P08139539A0446|146 159|protein kinase A
P08139542A1229|45 52|arginine
P08139542T0000|93 111|yeast gene transcript
P08139543A0427|68 84|suppression screen
P08139543A1520|74 77|SLT2
P08139562A0404|140 152|GCN4 start site
P08139577T0000|121 125|genes
P08139914A0554|86 90|cells
P08139928T0000|35 39|yeast
P08140847X0001|343 350|controls
P08142875A0877|115 119|cases
P08143198T0001|93 115|m. extensor hallucis brevi
P08143236A1055|113 118|trials
P08143667A0222|140 144|ratio
P08144035A0387|71 79|C terminus
P08144037A0000|84 89|plants
P08144470A0711|126 139|protein product
P08144497T0000|104 110|GTP-ras
P08144504T0064|32 44|ATP hydrolysis
P08144572A0786|132 135|DnaK
P08144615A0533|155 157|DNA
P08144631A0000|105 127|tyrosine phosphorylation
P08144668A0802|162 178|membrane anchoring
P08144852A0000|218 227|metyrapone
P08145646T0000|118 138|nifU2-rpoN superoperon
P08145770A1078|133 156|differentiation processes
P08148463A0000|154 164|interleukin
P08148756A0358|121 125|lungs
P08149484A0151|86 94|PKC delta K
P08149484A1551|157 165|sequences
P08150970A0434|67 74|patients
P08151787A0355|260 271|localization
P08151787T0000|135 152|herpes simplex virus
P08151790A0354|160 170|infectivity
P08151980T0001|10 17|emphysem
P08152800A0357|183 185|ERM
P08152800A0709|159 169|Ets proteins
P08153130T0000|90 93|rats
P08153146A0327|173 181|pressures
P08154171A0649|156 163|embolism
P08154182A0955|91 119|Neurospora crassa cDNA libraries
P08156332T0000|76 84|ischaemia
P08157009A0264|140 169|plasma membrane AP-2 sigma subunit
P08157009T0000|149 160|Golgi complex
P08157663A0882|181 189|evolution
P08157674T0000|101 105|cells
P08159174A0581|41 56|Southern analysis
P08160054A0224|126 137|coagulopathy
P08160387T0000|109 119|deprivation
P08160905A0217|59 63|HBsAg
P08163183T0000|104 114|XylA enzymes
P08163498A0789|127 140|trypsinization
P08163528T0000|13 38|Mas70p signal anchor sequence
P08163546A1230|198 211|sorting pathway
P08164302A0547|133 139|glucose
P08164661A0414|151 157|factors
P08164679A0809|93 102|Runt domain
P08164680A1086|65 69|cells
P08164684A1266|89 95|complex
P08166402A0631|74 88|hyperosmolality
P08167396A0154|65 83|substantia nigra pars
P08167555A0972|131 138|relation
P08169201A0291|154 163|amino acids
P08169709T0000|40 44|cases
P08170400T0000|82 84|FNR
P08172416A0860|164 174|development
P08172598A0237|86 98|kb mRNA species
P08172653A1589|146 151|family
P08172905A0000|136 146|U70 base pair
P08173532A0000|145 156|facilitation
P08173693A0390|78 96|angina pectoris class
P08173814A0132|128 141|host physiology
P08175031A0566|0 8|Treatment
P08175188A0685|108 110|CBF
P08176742A0190|58 77|transposition pathway
P08177143T0000|49 58|experience
P08178446A1160|115 131|signaling pathways
P08178490A0879|66 74|K SA domain
P08178572A1118|96 101|region
P08179827T0000|74 78|Korea
P08180129A1256|59 69|transcripts
P08181755A0989|99 102|mRNA
P08182041A1067|170 182|hepatoma cells
P08182056A0695|121 133|NQO gene family
P08182171A0000|106 113|infusion
P08183552T0000|76 79|maps
P08183915A0000|169 178|amino acids
P08183915T0000|122 131|activities
P08184923A0829|86 93|exposure
P08185288A0106|168 170|kg m
P08187085A0086|103 114|end sequences
P08187088A0530|202 204|19q
P08187177A0405|63 73|interaction
P08188258A0000|153 160|pathways
P08188290A0544|144 160|TCRAJ gene segments
P08188603A0230|159 163|CPS-A
P08188606A1034|184 193|chromosome
P08188978A0822|123 141|pulse-synchronicity
P08189174A0148|119 125|Utrecht
P08189498T0000|117 127|polypeptide
P08189503A0000|162 174|mRNA synthesis
P08189533A0203|165 170|vTF7-3
P08189533A0919|182 187|matrix
P08190633A0000|69 76|HLA locus
P08190633A0273|71 73|DNA
P08191910A0228|122 126|ruler
P08192140A0209|97 108|San Francisco
P08192451A0885|79 87|NAO uptake
P08192795T0000|43 60|lupus erythematosus
P08193147A0831|170 171|Pf
P08194139A0498|83 85|men
P08194549A0000|129 132|OBLA
P08194753A0157|116 121|region
P08194970A0000|106 115|Trudy Wynne
P08195186A0000|266 271|Kakuda
P08195216A1022|177 180|TRP3
P08195217A0799|158 161|gels
P08195233A0147|150 162|tumorigenesis
P08196607A0280|199 210|reporter gene
P08196616A1112|203 209|binding
P08196618A0473|109 116|activity
P08196624A0593|158 166|receptors
P08198524A1134|2 4|kDa
P08199204A0746|110 121|P2 production
P08199878T0000|74 86|brain ischemia
P08200528A0970|156 159|REP2
P08201352A0239|96 107|skin necrosis
P08201758A0125|83 87|times
P08201932A0355|65 70|joints
P08202546A1206|107 113|adducts
P08203260A1204|53 62|ventilator
P08204348T0000|50 63|cell lung cancer
P08204403A0000|162 171|antibodies
P08204426T0001|104 113|indication
P08204824A0000|139 143|cells
P08205827A0940|187 191|shock
P08206848A0296|80 82|kDa
P08206867A0874|69 77|rat genome
P08206991A0466|163 168|serine
P08207022T0000|78 93|Bacillus subtilis
P08207232A0503|134 145|IL-8 promoter
P08207405A0372|188 197|HSP70 genes
P08207795A0409|84 104|mutagenesis procedures
P08207805A0000|117 125|repressor
P08208247T0030|71 91|acid decarboxylase gene
P08208540A0000|101 111|alterations
P08208540A0417|215 230|carboxy-terminus
P08208540A1114|171 178|NFKB2 p52
P08208618A1334|56 65|Sp1 binding
P08209051T0000|59 62|home
P08209423T0000|110 125|glycoprotein gene
P08209772A0167|121 124|mass
P08212571A0597|154 160|mutants
P08212571A0971|201 219|tat expression vector
P08212897A0404|86 105|transmembrane domains
P08213235A1024|85 91|infants
P08213747A0000|495 504|Los Angeles
P08216115A0158|162 167|parity
P08217862A1336|219 224|states
P08218056A0000|96 103|subjects
P08218230A1505|130 138|positions
P08218230A1920|212 222|liver tissue
P08219072A0287|0 3|Acad
P08219081A0000|68 84|PR-1 protein family
P08219227A0830|131 141|replacement
P08220494A0231|166 178|tobacco plants
P08220621T0000|42 47|system
P08221251A0239|56 59|area
P08222384A0455|78 80|ECG
P08222556T0000|34 40|muscles
P08222618A0000|72 77|curves
P08223425T0000|102 110|reticulum
P08223554A0574|92 99|residues
P08223576A1261|56 65|conditions
P08223592A0424|176 195|polyadenylation sites
P08223613A0105|148 160|cif1 mutations
P08223613A0519|183 190|function
P08223823T0000|46 65|Stroop Color-Word Test
P08223875A0711|136 141|p59fyn
P08224260A1248|139 149|specificity
P08224907A0000|103 123|cDNA subfragment probes
P08225657A0000|153 157|trial
P08226616A0000|118 129|assimilation
P08226776A0990|75 82|delta Hva
P08226777A0936|40 45|DdPTPa
P08226780A0160|101 108|proteins
P08226794A0501|37 44|activity
P08226798A1124|178 186|functions
P08226956A1397|82 91|type plants
P08227129T0000|86 106|immunoglobulin C2 motif
P08228805A0540|146 154|mechanism
P08228997A0866|69 79|oxygenation
P08229102A0768|88 95|patients
P08229330A0000|28 34|smoking
P08229826A1145|148 154|objects
P08230418A0812|260 266|protein
P08230445A0000|161 163|Gag
P08230452A0551|381 394|capsid proteins
P08230452A1489|178 184|virions
P08231398A0802|242 244|CD4
P08231577A1027|90 94|apnea
P08231816A1473|187 193|IPNS tsp
P08232304A1166|133 173|chloramphenicol acetyltransferase construct
P08232412A1342|155 160|levels
P08234166A0425|115 126|RT conditions
P08234276A0556|87 107|NF-kappa B binding sites
P08234308T0000|8 17|retraction
P08237112A0553|58 65|proteins
P08237171A0000|83 95|hydrocephalus
P08237578A0253|185 200|preinsertion mean
P08238626A0248|106 110|min-1
P08239164A0551|120 125|values
P08239586T0000|54 60|rabbits
P08240170A0000|68 70|sea
P08241139A0378|102 112|nucleotides
P08241656A0189|96 103|syndrome
P08242861A0368|38 42|p.p.b
P08243476A1177|114 129|Paracoccus enzyme
P08244034T0000|95 111|metalloproteinase
P08245013A0000|152 164|understanding
P08245125A0822|99 106|degrees C
P08245456A0501|175 187|protein levels
P08245461A0700|108 118|development
P08245933A0617|32 41|treatments
P08246984A0512|75 83|cell lines
P08246984A0923|150 152|p85
P08246987A0260|118 123|region
P08247005A0584|104 111|subunits
P08247043T0000|13 32|liver transplantation
P08248246A0838|126 141|R1 gene expression
P08248253A1785|59 74|chicken L-CAM gene
P08248688A0726|113 120|molecule
P08249319A0578|88 92|field
P08249390A0111|108 117|infarction
P08251506A0503|225 235|cross-links
P08251622A0000|146 155|expression
P08252067A0917|112 123|conservation
P08252976A0467|108 113|system
P08253386A0800|194 212|branch site sequences
P08253387A0801|169 172|site
P08253387A1291|169 175|factors
P08253777A0301|130 135|manner
P08253958A0000|95 97|IgG
P08254738A0428|161 175|T-antigen kinase
P08255022A0827|123 137|blood cell counts
P08255341A0554|87 96|diloxanide
P08255758A0000|131 143|homeoproteins
P08257666A0662|119 137|learning performance
P08257754A0711|107 110|ones
P08258025A1131|158 166|mortality
P08259650A0640|69 77|phenotype
P08260635A0926|133 138|plants
P08261398A0392|148 161|P388/4 cell line
P08261398A0838|144 158|P388/ADR/7 cells
P08262041A0727|89 97|cell cycle
P08262054A0565|186 204|B cell transformation
P08262067A1608|164 183|cell wall biosynthesis
P08263933T0000|42 70|cyanobacterium Synechocystis sp
P08264579A1209|91 110|peptide transport gene
P08264582A0750|200 208|signaling
P08264583A0520|137 157|test plasmid substrates
P08264591A1190|204 211|proteins
P08264617A0000|151 166|ligand activation
P08264628A0418|99 104|TFIIIB
P08264631A0746|99 119|ADH2 promoter sequences
P08264650A0925|131 137|meiosis
P08264664A0128|94 97|gene
P08265602T0000|79 97|phage M13 coat protein
P08265955T0000|20 22|NHS
P08267658A0391|152 171|drug transport studies
P08267667A0748|372 387|h memory retrieval
P08268718A0676|47 55|complexes
P08268833T0000|72 80|arthritis
P08268912A0657|102 122|SDS polyacrylamide gels
P08269424A0339|97 104|patients
P08269439X0000|112 115|pain
P08270257A0551|141 147|species
P08270580A0155|64 76|cotrimoxazole
P08270985A0590|0 16|Response durations
P08273122A0708|176 196|component transfusions
P08274774A0958|169 187|ribgrass mosaic virus
P08275618A0457|178 188|sensitivity
P08276234A0119|130 141|DNA structure
P08276336A0371|130 135|polyps
P08276732A0799|109 114|trauma
P08276762T0000|79 95|proline activation
P08276851A0347|257 266|regulation
P08276854A1894|180 196|gene transcription
P08276865A1188|189 204|p21ras activation
P08276871A1001|133 139|domains
P08276900A0543|3 3|K
P08277632A0997|82 82|%
P08278423A0147|106 129|disaccharide intolerances
P08278480T0002|0 0|G
P08278548A0597|134 144|psaE product
P08278929A0866|153 162|% incidence
P08279098T0001|42 54|myopia patient
P08280476A0602|127 130|site
P08280925A0261|170 179|antibodies
P08281153A0543|84 90|species
P08281536A0626|53 58|myxoma
P08281634A1801|79 82|risk
P08281740A0000|147 156|ELISA assay
P08282501A0358|183 188|events
P08282576A0297|65 69|cases
P08282749A1474|128 133|arrest
P08283292A0779|188 199|control group
P08283531A0700|157 162|gantry
P08284227A0336|172 179|cultures
P08284337A0825|134 141|distress
P08285710A0634|129 144|protein synthesis
P08286035A0587|170 176|methods
P08288240A0304|108 112|genes
P08288240A1343|124 141|stathmin/Lap18 gene
P08288554A0295|113 131|mouse BALBc/3T3 cells
P08288596A0663|253 260|sequence
P08288606A0240|194 204|cDNA library
P08288622A0725|167 170|exon
P08288633A0144|253 264|Rho subfamily
P08289339A0527|126 134|sequences
P08289341A1202|80 84|E2-RS
P08289342A0931|83 87|assay
P08289357A0724|85 87|LTR
P08289593A1404|242 249|urethane
P08289783A0000|107 130|differentiation decisions
P08289783A1476|190 196|EC cells
P08289784A0381|17 17|M
P08289793A1226|122 129|enhancer
P08289831A0290|137 145|gamma RE-1
P08289834A0341|85 91|protein
P08290278A0374|52 80|candidate tumor suppressor genes
P08290421A0165|111 117|patient
P08291233A0000|117 135|Rous sarcoma virus LTR
P08291620A0372|82 92|anthropoids
P08291761A0416|58 78|serum IgG concentration
P08291886T0024|14 22|expansion
P08293412T0000|187 192|emesis
P08293992A0432|56 61|K/NPAG
P08293993A0948|103 125|invertase signal sequence
P08294386A0000|205 214|blood level
P08294429A0153|159 177|hGH promoter activity
P08294459A0446|171 176|region
P08294511A0639|150 160|interaction
P08294865A0236|89 107|peptide/DR complexes
P08294906A1315|130 138|transport
P08296434A1141|105 113|condition
P08297376A0236|168 173|region
P08298129A0274|85 96|gene promoter
P08298129T0000|64 75|integrin gene
P08299181A1148|54 54|%
P08299568A1401|84 99|glucose transport
P08299725A0724|146 148|end
P08299896A0626|43 50|subjects
P08299896A0880|119 119|P
P08300463A0581|135 139|drugs
P08300527T0000|87 112|Saccharopolyspora erythraea
P08300601A0745|70 89|E12/MyoD heterodimers
P08300605A0432|224 237|initiation site
P08300605A0671|79 88|regulation
P08300611A0341|155 171|amino acid residues
P08300611T0000|107 116|plasmid RP4
P08300625A1352|134 138|lysis
P08301702A1083|179 192|immunoblotting
P08301841A0000|97 99|UAP
P08302589A1132|128 136|ionophore
P08303233A0313|75 78|text
P08304301A0331|106 109|HCCs
P08304342A0605|232 236|HLA-A
P08305058T0000|58 63|hiatus
P08306356A0000|103 111|gestation
P08306834A0866|56 66|irradiation
P08306959A0278|124 126|GAS
P08307338A0227|125 129|cells
P08307564A0233|94 95|kb
P08308008A0201|148 160|COXIV promoter
P08309726A0000|268 276|pneumonia
P08309912A0306|70 73|drug
P08309953A0776|140 159|reaction time response
P08309957A0000|114 127|agent reserpine
P08309975A0662|157 163|lab chow
P08312243A0177|165 169|diets
P08314163T0000|119 132|administration
P08314922A0941|92 103|tissue damage
P08316100A0586|124 132|influence
P08316209A0000|144 159|sulfur catabolism
P08316240A1068|204 208|yeast
P08317092A0304|214 225|tobraviruses
P08317094A0778|127 141|initiation codon
P08319396A0448|258 263|matter
P08319907A0754|156 164|structure
P08320120A0361|177 183|nodules
P08321199T0000|107 114|HMR locus
P08321203A0840|72 81|C/EBP delta
P08321227A0854|64 71|COS cells
P08321741A0396|235 246|increase-CML
P08322117A1019|155 160|cutoff
P08322823A0839|58 69|UTS phenotype
P08323294T0000|116 125|expression
P08324107A0000|73 85|plasma protein
P08324280A0098|72 81|ulceration
P08324792T0000|76 86|rabbit heart
P08325504A0226|54 63|heat stress
P08325639A0129|203 211|ubiquitin
P08325720A0840|192 211|muscle buffer capacity
P08325883A0368|164 176|alpha-helixes
P08327488A0839|108 119|helper genome
P08331064A0440|84 93|structures
P08331067T0000|127 143|bacteriophage PK1E
P08331728A0686|23 39|ribonucleoprotein
P08332033T0000|102 118|neurotropin effect
P08332492A0145|146 156|replication
P08332495A0408|168 176|liposomes
P08333643A0000|74 80|urology
P08334158A0660|80 91|Fe/S proteins
P08334304A0473|113 123|p21 rasVal12
P08334989A0070|225 241|NIH3T3 fibroblasts
P08335710A0338|37 46|resolution
P08336012A0632|102 103|FN
P08336543A0243|109 116|terminus
P08336698T0000|85 107|transcription activation
P08336738A1273|46 65|PSTAIRE sequence motif
P08337828A0895|80 104|Spodoptera frugiperda cells
P08337841A0612|243 268|GNS protein termination codon
P08340400T0000|86 92|protein
P08342703A0966|145 150|vessel
P08343041A0000|60 79|hospital laboratories
P08343216A0883|52 64|IgG subclasses
P08343961A0000|137 143|domains
P08344248A0910|76 80|cells
P08345191A1140|116 119|MCL1
P08347677A0308|247 252|microM
P08348919T0000|46 50|spasm
P08349104A0000|180 183|UASG
P08349104A0450|267 277|sporulation
P08349499A1169|63 66|head
P08349632A0679|126 134|stop codon
P08350061A0209|86 108|T cell development program
P08350398A1616|158 163|chains
P08352066A0000|127 130|rats
P08352268A0000|105 109|route
P08355062A0000|171 180|impairment
P08355063A0456|45 45|%
P08355539A0133|263 265|EAI
P08355680A0824|162 192|glucose 6-phosphate dehydrogenase
P08355696A0236|102 107|region
P08355697A0000|128 142|differentiation
P08355857A1293|65 73|subgroup B
P08356792A1275|161 170|proviruses
P08356792T0000|53 62|T-cell line
P08356944A0589|169 174|wastes
P08357834A0285|258 269|counterparts
P08360112T0036|0 2|XII
P08360180A1041|178 187|progenitor
P08361754A0733|81 88|proteins
P08361755A0734|151 157|CArG box
P08361761A0174|332 349|kappa B binding sites
P08363332A0365|232 236|heart
P08365944A1537|184 188|boost
P08366034A0637|135 139|cells
P08367388T0035|27 34|syndrome
P08367487A1014|190 210|mRNA-splicing activity
P08369887A0781|64 73|RA patients
P08370119A0642|151 177|muscle cell AT1a receptor cDNAs
P08370119A1521|161 174|luciferase cDNA
P08370275A0290|103 112|preference
P08371650T0000|66 73|training
P08371713T0000|65 72|rat brain
P08371936T0000|64 74|self ratings
P08373274A0546|85 95|endotoxemia
P08373972A0335|0 3|SvO2
P08374753A0335|64 68|water
P08375651T0000|79 86|organism
P08376397A0788|91 101|competitors
P08376796A0172|305 306|Ag
P08377199A1432|87 97|recognition
P08378082A1031|123 128|states
P08380736A0895|77 89|amino terminus
P08380896A0938|95 112|preinitiation stage
P08381121A0773|52 57|domain
P08382296A0766|10 10|F
P08382300A0341|124 130|mutants
P08382303A0507|118 124|E1 genes
P08382303T0000|106 131|p34cdc2 phosphorylation site
P08382359A0469|267 276|activities
P08382769A0924|129 140|SRP54 protein
P08382778A0891|114 133|transcription factors
P08383129A0776|185 195|cell surface
P08383214A0389|83 94|RNase H domain
P08383217A0357|145 148|VP16
P08383287A0611|104 125|hormone response element
P08383323A0000|43 49|signals
P08383492A1205|177 193|c-type cytochromes
P08383526A0591|77 80|exon
P08383622T0000|126 134|promoters
P08383850A0206|171 174|rats
P08384309A0000|228 249|dioxin response elements
P08385131A0000|108 115|proteins
P08385337A0282|135 139|bZIP2
P08385581A0126|128 134|mitosis
P08386279A1621|136 158|HIV-1 promoter activation
P08386280T0000|72 83|gag enhancers
P08386317T0000|107 117|stimulation
P08386318A1102|173 181|C/EBP beta
P08386319A1229|140 152|Mpk1p function
P08386592A0089|198 208|Elk-1 kinase
P08386637A1220|126 134|receptors
P08387155A1248|121 125|assay
P08387507A1015|219 241|myoblast differentiation
P08387519A0000|171 179|myoblasts
P08387662A0302|167 175|intensity
P08387743A0624|134 155|Mn-superoxide dismutase
P08387994A0980|105 112|attB site
P08388496A1117|303 307|mRNAs
P08388510A0891|93 105|glycoproteins
P08388543A1263|190 197|cell line
P08388600A0000|83 87|girls
P08389074A1227|129 137|structure
P08389365A1344|99 108|correction
P08389453A0193|102 110|duplex DNA
P08390120A0785|90 93|life
P08390665A0000|170 186|resonance oximetry
P08390747A0586|105 114|phenotypes
P08390831A0143|143 154|risk patients
P08391534A0828|8 8|P
P08391748A0452|138 151|QT prolongation
P08392221A0449|244 252|genistein
P08392623A1374|114 123|amino acids
P08393143A1281|66 74|tat factor
P08394019A0695|85 94|PI 3-kinase
P08394255A0000|163 181|hormone receptor cDNA
P08394464A1080|116 122|species
P08394862A0565|62 73|CMV hepatitis
P08395004A0141|147 160|HIS4 mRNA levels
P08395004A0558|119 129|protein HMG1
P08395010T0000|125 142|homodimer formation
P08395014A1364|114 117|PPZ2
P08395654T0000|97 103|tissues
P08395681A0388|276 294|adenovirus E1A mutant
P08396120A0690|63 73|translation
P08396261A0388|443 455|C alpha protein
P08396657A0452|4 4|B
P08396667T0000|80 96|lymphocyte subsets
P08396713A0305|194 209|heat shock protein
P08396749A1112a|124 128|mg/dl
P08396749A1112b|124 128|mg/dl
P08396913A1379|88 94|DGK gene
P08397123T0000|140 150|transcripts
P08399970T0000|42 51|inoculants
P08400240A0166|162 177|gamma-globin mRNA
P08400928A0318|158 170|bromocriptine
P08401570A0828|146 165|transcription factors
P08401614A0187|135 145|bean tissues
P08403245A1234|69 75|piglets
P08403804A0754|173 176|dose
P08405433A0000|79 80|P4
P08406004A0691|183 189|portion
P08406352A0172|209 215|receipt
P08406419A0155|127 128|MA
P08406497A0000|82 95|Marfan syndrome
P08407784A0850|85 94|phenotypes
P08408194T0000|141 149|epithelia
P08408825A0000|77 86|La antigens
P08408841A0281|91 99|mutations
P08408963A0048|8 8|L
P08409284A0262|187 193|cholera
P08409593A0357|126 129|time
P08410042T0000|65 69|cases
P08410097A0356|206 215|covariates
P08411024T0000|47 68|fibrosis carrier testing
P08411276A0302|295 302|injuries
P08412120A0839|26 28|DO2
P08412620A0688|131 134|VirF
P08412662A0333|113 127|kb EcoRI fragment
P08412665A0000|134 137|ScrR
P08413186A0077|213 219|pathway
P08413186A1199|45 68|N. plumbaginifolia species
P08413205A0733|153 171|recognition sequence
P08413209A0159|94 101|proteins
P08413215A0327|91 102|IL-8 promoter
P08413223A0847|162 175|gene expression
P08413239A0490|193 200|mutation
P08413260A1437|106 112|G2 phase
P08413274A0452|123 131|MDBP sites
P08413291A1473|91 96|muscle
P08414410A0270|213 227|nerve fiber layer
P08414502A0244|125 133|promoters
P08415637A0000|117 125|G proteins
P08415643A0555|83 89|mitosis
P08415712A1153|172 193|Huntington disease locus
P08416952A0956|173 181|acylation
P08416977A0892|73 77|Mono Q
P08417117A0592|45 53|abundance
P08417330A0149|145 145|N
P08417331A0745|148 151|Tup1
P08417349A1633|115 130|mutation fixation
P08418183A0000|247 247|W
P08419318A1695|0 3|Biol
P08419333A0126|86 90|clone
P08419338A0273|76 76|H
P08419376A0357|106 112|domains
P08420230A0544|86 96|angioplasty
P08420571A1880|22 24|PC4
P08421295A0365|111 123|LexA repressor
P08421687A0397|3 24|selenocysteine residues
P08421823A1041|109 117|condition
P08421897A0000|172 192|animal retrovirus genes
P08421910A0599|122 141|uv cross-linking assay
P08422975A1205|94 98|mRNAs
P08423831A0523|127 136|parameters
P08425050A0898|101 104|date
P08425221A0000|127 131|cells
P08427501A0221|168 172|types
P08428722A1123|209 213|ileus
P08428750T0000|72 90|chromosome 10p13-ter
P08428907A0653|91 93|RNA
P08428940A1763|162 169|merR mRNA
P08428952A0399|152 158|tissues
P08428952A1957|116 124|intestine
P08428953A1718|377 395|L-plastin expression
P08428965A1868|101 105|WORDS
P08429019A0735|142 164|GATA-1 consensus sequence
P08429019A2022|174 178|WORDS
P08429020A0495|93 104|glycoprotein
P08429568A0000|151 162|alfalfa roots
P08430087A0467|172 179|Sf9 cells
P08430095A0161|88 92|PRP38
P08430095A0913|103 111|stability
P08431100A0108|184 186|sex
P08432137A0000|294 299|others
P08432526A0580|100 120|fibroblast cDNA library
P08432696A1117|141 145|media
P08435755A0938|125 138|stage-3 seizure
P08435755A1078|177 181|group
P08435794A0658|0 10|CONCLUSIONS
P08435885A0787|67 94|thyroid hormone concentrations
P08437521A0000|245 255|areA control
P08437737A0100|62 65|duty
P08438584A0524|94 98|V1 ORF
P08438584T0000|83 99|C1-C2 gene products
P08439564A0883|152 159|homology
P08439597A0000|165 174|blood spots
P08439597A0176|87 102|screening centres
P08440238T0000|182 191|metastasis
P08440688A1509|112 125|hormone signals
P08440720A1404|117 123|protein
P08441379A0912|211 228|IL-1 beta expression
P08441394A1297|147 159|Ras activation
P08441411A1260|263 271|cell cycle
P08441423A0145|127 136|conditions
P08441869A0334|46 53|relation
P08442384A0430|126 141|amino acid peptide
P08442384T0000|59 70|reading frame
P08443122A0657|95 97|CyA
P08443339A1374|133 136|root
P08443340A0522|205 217|tobacco plants
P08443341A0384|151 167|MB type myrosinases
P08444184A0245|0 8|Sudomoina
P08444344A0000|70 77|proteins
P08444345A0403|126 133|protein B
P08445299T0000|64 67|rats
P08445655A1009|124 132|mutations
P08445729A0657|87 96|RNA binding
P08445792A0469|103 108|stages
P08446579A0784|169 177|C terminus
P08446579A1210|64 79|estrogen addition
P08447005T0001|68 77|vaccinatio
P08449133A0578|79 86|T4 tumors
P08449943A0225|127 139|leukemia cells
P08449978A0000|229 233|times
P08449986A0455|72 81|mouse brain
P08450015A0175|127 154|n-propyl carbamate derivatives
P08451187A0267|51 62|ars sequences
P08451331T0000|109 112|mice
P08453101A0128|83 88|T cells
P08453950A0498|104 108|level
P08454077A0956|372 376|WORDS
P08454591A0692|110 131|transcription start site
P08454591A1322|114 120|NF-IL-6
P08454858A0285|160 177|signal transduction
P08455598A0000|175 184|repression
P08455611A0000|143 152|globin gene
P08455611A0154|166 171|origin
P08455623A0630|151 156|strain
P08455629A0335|10 10|L
P08456378A0134|101 105|model
P08456879A0000|100 104|blood
P08457205A0240|141 145|cDNAs
P08457291A0170|119 131|c-fos oncogene
P08458660A0855|36 43|variable
P08458849A0364|153 156|ftr3
P08458906A0827|64 70|persons
P08459012T0000|33 37|tibia
P08459465A0257|265 276|stress factor
P08460270A0205|42 47|larvae
P08460346A0350|62 66|study
P08460918A0252|312 329|hyperbilirubinemia
P08461946A0386|102 102|%
P08461981A0882|101 104|rats
P08463284A1531|94 102|cell cycle
P08463320A1219|214 222|structure
P08463485T0000|55 69|oxytocin release
P08464056A0000|91 103|Xenopus laevis
P08464056A0510|210 220|chromosomes
P08464924A0243|95 106|eIF-5 protein
P08466864A0878|229 244|promoter activity
P08468320A0941|6 6|J
P08468475A1280|272 290|F42A binding reaction
P08469831T0001|133 139|rat mode
P08470021A0195|133 142|Mexico City
P08470895A1617|85 101|enhancer sequences
P08471241T0000|65 69|women
P08471629A0816|132 138|peptide
P08471796A1654|70 82|A. caulinodans
P08472750A0999|153 162|activation
P08473731A0149|97 102|B cells
P08473967T0000|35 59|Myers-Briggs Type Indicator
P08474438A0000|235 247|mRNA transport
P08474439A0877|234 241|CArG site
P08474456A1041|142 151|D' activity
P08474464A0348|58 71|TR binding sites
P08475104A0341|179 194|p33cdk2 complexes
P08476087A0814|91 94|mmHg
P08476854A0097|126 134|base pairs
P08479742A0985|109 117|processes
P08481004A0321|29 40|endonuclease
P08482539A0913|95 99|xylan
P08483412A0000|127 137|NifA protein
P08483479A1056|237 240|bone
P08484514A1536|70 80|stimulation
P08484689T0000|77 83|decline
P08484891A0000|194 201|memories
P08485317A0000|92 104|protein kinase
P08486035T0000|55 69|minithoracotomy
P08486276A0419|231 244|symport protein
P08486705A0181|115 126|eIF-5 protein
P08488700A0283|227 233|disease
P08490002A0620|79 84|breads
P08491124A0517|104 112|materials
P08491383A0154|40 42|DNA
P08491383A1291|129 146|interaction domains
P08491683A0651|101 108|prostate
P08492164T0000|90 108|interaction measures
P08492290A0306|93 99|log beta
P08495786A0085|89 93|donor
P08496157A0000|108 124|splicing mechanism
P08496184A0772|98 112|type counterpart
P08496185A0484|98 103|region
P08496475T0000|73 83|matruchotii
P08496599A0310|78 88|mRNA species
P08496601A1153|315 335|consensus CK-1 sequence
P08496848A0692|95 107|SE counterpart
P08497190T0079|51 57|mutants
P08497248A0000|159 170|trophoblasts
P08497259A0452|81 84|type
P08497269A0999|169 189|translation elongation
P08497273T0000|89 109|B-cell differentiation
P08497280A0266|114 130|SWI4 transcription
P08497280A1397|86 89|SWI6
P08497280T0000|74 82|cell cycle
P08498570A1118|101 102|Ra
P08499376A0000|69 79|corrections
P08499903A0883|37 42|origin
P08499916A0000|128 147|epidermolysis bullosa
P08500524A0424|120 137|intron organization
P08500938A0408|109 118|metaphysis
P08501030A0456|90 92|M.H
P08501678A0498|99 108|Hib disease
P08503348A0226|67 72|agents
P08504707A0376|83 91|accidents
P08504928T0000|112 115|TATA
P08504932A0123|145 149|cells
P08504933A0000|107 111|gland
P08505075A0236|73 79|S. typhi
P08505312A0285|0 3|Biol
P08505340T0000|98 111|granulosa cells
P08505495A0253|14 21|75SeHCAT
P08505605A0461|117 120|time
P08506317A0000|129 142|enhancer motifs
P08506384A0146|75 95|GDP-GTP exchange factor
P08507921A1021|189 193|death
P08508774A0242|71 76|region
P08508778A0112|129 138|processing
P08508861A0294|108 123|balloon inflation
P08509051A0316|49 49|%
P08509333A0843|129 143|membrane protein
P08509335T0000|39 56|1,3-beta-glucanase
P08509419A0785|110 122|TyrRS activity
P08509430A0372|184 189|medium
P08510320A0000|176 178|ABK
P08510320A1249|156 167|beta-lactams
P08510647A1347|99 113|barley globulins
P08510924A0490|74 84|Myb proteins
P08511994A0000|99 112|micrograms/dm3
P08512728A0991|180 183|msec
P08513025A0000|115 122|readings
P08514757A1100|124 138|protein function
P08514766A0732|105 111|p21 rac1
P08515619A0184|217 224|controls
P08515776A0971|49 55|regions
P08516301A0080|48 54|introns
P08516308A0669|37 49|microcolonies
P08516324A0000|224 231|FLI1 gene
P08517737A0889|122 129|bacteria
P08518797T0000|53 65|candidate gene
P08519621A0150|194 198|tract
P08519862T0001|52 53|ki
P08520646A0000|95 99|aging
P08521414A1384|200 212|p16INK4A locus
P08521717A0126|204 213|LNG-IUD-20
P08521780A0485|0 9|Umweltchem
P08522175A0306|211 216|Nature
P08522511A1250|39 40|pH
P08522511A1578|159 171|transformants
P08522530A1342|168 172|sigma
P08523031A0737|103 112|recurrence
P08523545T0000|150 172|Oct-1 DNA binding activity
P08523566A1106|96 101|nature
P08524036A0747|200 206|regions
P08524229T0000|110 117|cleavage
P08524235A0695|164 169|max RNA
P08524241A0212|83 89|cascade
P08524260A0835|253 258|LTBP-1
P08524267A1022|181 190|myc mutants
P08524272T0000|98 122|tyrosine phosphatase SHPTP1
P08524284A0309|151 162|HeLa extracts
P08524292A1022|147 156|DNA binding
P08524294A0652|8 11|gene
P08524314A0216|159 166|proteins
P08525186A0288|121 129|odds ratio
P08526620A1344|140 145|bypass
P08528479A0000|120 127|deficits
P08528796A1470|64 72|parameter
P08529098A0549|250 263|transport motif
P08529630A0840|59 63|roots
P08529654A0589|120 124|Cyp-1
P08529662A0507|85 92|labeling
P08530105A0308|163 171|endpoints
P08530107A1003|124 130|factors
P08530149A0689|100 104|YYYNY
P08530342T0000|8 19|gp39 promoter
P08530345A0880|181 203|peroxisome proliferators
P08530369A0099|96 119|Src family tyrosine kinases
P08530384A0559|176 179|Oct2
P08530418A1182|146 174|acid signal transduction pathway
P08530432A0093|81 90|repression
P08530503A1004|89 99|3T3-L1 cells
P08531373A0470|86 104|SS-A/SS-B antibodies
P08531669A0950|129 135|species
P08532516A0000|55 66|fission yeast
P08532536A0925|160 182|growth factors/cytokines
P08532967A0364|62 68|therapy
P08533472A0777|196 200|ILF-2
P08533473A0375|80 91|EST sequences
P08533757A0204|140 144|BRCA1
P08534217A0402|93 105|Viskovo region
P08534367A0984|69 74|exon E1
P08534848A0188a|32 33|cv
P08534848A0188b|32 33|cv
P08534855A0000|121 125|acids
P08535138A0857|143 154|DNA synthesis
P08535537A0000|90 101|hypertension
P08536694A0000|56 64|processes
P08537388A0825|163 178|promoter activity
P08537403A0336|167 170|VIII
P08538052A0000|353 361|c-myc gene
P08538382A1012|88 93|levels
P08538483A0207|175 185|leiomyomata
P08538702A0214|164 181|Dirofilaria immitis
P08541499A0306|78 91|tobacco operons
P08541793A0796|39 41|hrs
P08542026A0792|178 181|size
P08542027A1471|88 91|CD44
P08542746T0000|76 84|standards
P08543173A0314|71 93|primer extension analysis
P08543275A0130|207 214|host fish
P08543595A1093|58 69|radiotherapy
P08543810A0000|169 172|ESTs
P08544820T0000|97 105|Lsp-2 gene
P08545502A0914|38 51|activation task
P08546707T0000|86 97|NF-kappa Bp50
P08547205A1060|159 162|dogs
P08548291A1059|159 171|transcription
P08549706T0000|63 69|Iceland
P08549859A1604|56 98|Centre d'Etude du Polymorphisme Humain pedigrees
P08550425A1401|100 108|% identity
P08550460A0374|121 153|membrane lipoprotein leader sequence
P08550461A0284|9 9|S
P08550462A0815|43 52|amino acids
P08550467A0863|144 152|start site
P08550470A1021|59 68|kinase CheA
P08550476A0610|129 140|epiA promoter
P08550564T0000|130 151|interleukin-8 receptor B
P08551572A0155|144 164|reticuloendotheliosis
P08551577A0000|154 160|src mRNA
P08552042A1497|216 226|generations
P08552045A0973|202 219|centromere function
P08552082A0480|120 131|protein Abp1p
P08552086A0150|77 81|c-fos
P08552092A1678|199 206|rep3 gene
P08552093A0657|130 138|G proteins
P08552095A0686|64 70|nucleus
P08552095A0758|134 137|PAF1
P08552095A1115|74 83|yeast genes
P08552096A0151|144 157|cdc34 mutations
P08552387A0000|164 178|factor gene ATF-1
P08552643A0261|138 149|IFN treatment
P08552670A0665|72 74|A.T
P08552670T0000|100 111|fission yeast
P08553580A0102|61 71|FIV isolates
P08554069A0743|149 159|RNA splicing
P08554540A1480|26 52|HIT protein similarity regions
P08554723A0187|238 241|chow
P08555076A0333|110 116|Candida
P08555168A0390|58 65|affinity
P08555289A0207|70 77|purposes
P08555446A0000|150 155|leaves
P08555498A0427|111 129|vertebrate evolution
P08555597A0808|61 66|months
P08555753A0591|129 133|lobes
P08556707A1390|183 193|SNU-C5 cells
P08558187A0403|24 28|weeks
P08561607A1443|38 52|transplantation
P08561893A0100|193 205|family members
P08561897A0604|164 177|CRE/TRE element
P08562688A0968|65 70|length
P08563483A0094|116 123|activity
P08564488A1359|52 61|thrombosis
P08564588A1318|129 133|WORDS
P08565330A1783|79 88|expression
P08565548A0196|129 134|DA rats
P08566747A0756|106 112|ability
P08566751A0455|127 134|function
P08566751A0788|75 77|lab
P08566754A0783|168 174|ASF/SF2
P08566756A0752|128 130|BPS
P08566773A1023|121 126|fungus
P08567556A0000|288 296|immersion
P08567683A0401|75 76|Mr
P08567717T0000|76 85|checkpoint
P08567847A1005|150 157|features
P08569443A0123|161 171|compartment
P08569680A0636|114 121|function
P08569684A0000|243 265|fungus Trichoderma reesei
P08570615T0000|83 91|apoptosis
P08572616A0000|66 74|neoplasms
P08573083A0645|147 161|insulin promoter
P08573637A0434|109 114|fluids
P08574414A1037|84 92|pathovars
P08574583A0658|128 137|sim mutants
P08575609A0526|100 107|patients
P08575614A0264|158 168|sporulation
P08575618A1138|93 127|pigmentation/phaeomelanin phenotypes
P08575754T0000|111 117|kinases
P08576042A0765|246 256|temperature
P08576131A0151|157 164|splicing
P08576131A0685|128 138|USF proteins
P08576179A0126|119 144|polypeptide chain initiation
P08576245A0000|172 194|glycoprotein trafficking
P08576262A0160|107 109|G16
P08576546A0975|86 98|dose regiments
P08580083A0259|218 223|Jurkat
P08580671A0137|173 184|liver disease
P08581174A0472|124 134|QUTA protein
P08582143A0614|180 186|species
P08582633T0000|100 116|telomere structure
P08583783A0870|51 54|calf
P08583846A0121|82 90|perilymph
P08583846A0807|105 111|setting
P08584026A0115|34 35|P2
P08584035A0740|183 184|R4
P08584074A0000|147 166|Bethel Epilepsy Center
P08584530A0545|143 153|test results
P08585324A0467|37 41|Smith
P08585324A0823|69 78|tau element
P08585639T0000|79 90|risk analysis
P08585883A0381|159 164|period
P08585957A0101|197 217|mobility group proteins
P08585994A0567|218 223|embryo
P08586643A0951|78 80|CMP
P08586874T0000|108 113|stages
P08587075T0000|56 74|polyarteritis nodosa
P08588852A0236|153 158|tibiae
P08589315A1029|153 160|patients
P08589358A0235|94 98|weeks
P08589358A0841|128 137|milligrams
P08589735A0577|148 159|CaMV 35S genes
P08590465A0773|100 114|URA2 gene product
P08591700A0972|63 67|women
P08592590A0822|144 153|proportion
P08592713T0001|22 25|drug
P08593813A0967|120 129|transcript
P08595012A0817|69 72|rest
P08595184A0407|114 117|LFPs
P08595414A0000|220 230|orientation
P08595627A1513|151 152|VF
P08595658A0961|141 153|RNA processing
P08595836T0000|74 82|materials
P08595878A0201|188 200|Drosophila eye
P08597108A0642|81 85|NOAEL
P08597177T0000|60 62|EEG
P08597596A0135|36 49|ABC transporter
P08597636A0000|120 133|gene regulation
P08598051T0000|98 104|domains
P08598359X0000|174 180|factors
P08598449A0784|260 273|concentrations
P08599945T0000|128 138|transitions
P08599946A0999|173 191|example coiled-coils
P08600028A1129|119 128|Myc protein
P08600048T0000|111 114|case
P08601283A0875|199 211|SECIS function
P08601284A0000|133 140|U3 snoRNA
P08601490A0659|5 11|animals
P08601616A0726|112 126|spindle assembly
P08601806A0875|90 102|ganglion cells
P08602169A0484|110 121|HML alpha loci
P08602608A1056|122 139|reference procedure
P08603921A1346|126 131|manner
P08604338A0198|115 130|promoter elements
P08604338A0885|174 189|complex formation
P08604708A1086|132 134|BTG
P08605302A1770|217 221|assay
P08605324A0434|23 30|promoter
P08605326A0772|11 20|cDNA clones
P08605705A0676|77 91|disease activity
P08605931A0777|118 127|U1A protein
P08606267A0740|216 224|variables
P08608126A0811|177 182|lipids
P08608222T0000|109 131|STAT1 homodimer formation
P08608447A0806|88 95|splicing
P08608448A0353|202 206|loops
P08610272A0265|231 237|disease
P08610328A0228|122 126|world
P08610582A0150|81 89|MR imaging
P08611280A0820|117 123|systole
P08612852A0553|99 106|controls
P08614403A0557|142 149|myotubes
P08614403A0989|225 232|silencer
P08614410A0000|166 172|activin
P08615012A0627|106 110|cells
P08615025A1214|346 350|cells
P08615183T0000|47 53|disease
P08616743T0000|12 13|Dr
P08617216A0584|93 102|luciferase
P08617237A0489|140 151|localization
P08617238A0334|211 215|hsp27
P08617243A0336|97 102|region
P08617311A0979|125 135|Xenopus mIgY
P08617800A0150|63 80|receptor expression
P08617800A0675|112 140|core recognition sequence TGGGAG
P08617802A0993|108 110|Ras
P08618433A0000|126 130|STK-1
P08618433A1720|140 151|cell lineages
P08618864A0754|107 114|activity
P08618882A0343|103 115|BZLF1 activity
P08619866A0000|105 117|heart diseases
P08619910A0000|304 306|SNc
P08620003T0000|70 84|splicing process
P08620856A1172|280 290|spermatozoa
P08620889A0771|106 110|cells
P08621017A1186|168 170|TRE
P08621384A0935|125 155|PKCdelta tyrosine phosphorylation
P08621420A1166|101 106|effect
P08621448A0862|95 101|protein
P08621451A0552|0 3|Biol
P08621453A0815|112 122|fibroblasts
P08621542A0535|121 137|CD28 costimulation
P08621628A1233|62 77|hGRalpha activity
P08621659A0189|102 108|domains
P08621661A1035|135 140|intron
P08621664A1430|98 100|PKN
P08621714A0361|65 69|Cys25
P08621719A0000|114 137|T cell receptor stimulation
P08621719A0568|91 104|Grb2 SH3 domains
P08621730T0000|110 126|growth factor-beta
P08622030A0667|157 161|level
P08622070A0889|57 67|progression
P08622596A0189|82 85|week
P08622645A1026|89 95|element
P08622668A1155|178 185|pre-mRNA
P08622675A0587|105 115|factor Lef-1
P08622698T0000|98 107|virus EBNA2
P08622887A1026|221 230|affinities
P08622893A0000|166 183|signalling pathways
P08623554A1058|51 56|plants
P08624445A0257|186 189|gene
P08625806A0263|117 128|mouse embryos
P08625900T0000|190 196|hormone
P08625924A0411|142 146|mRNAs
P08625987A1086|179 184|B cells
P08626065A0000|118 127|chromosome
P08626290T0000|84 87|OmpA
P08626313A1037|44 50|msp gene
P08626325A0543|118 128|heterodimer
P08626437A0332|159 166|tyrosine
P08626493A1468|191 197|type E1A
P08626529A0000|167 167|B
P08626529A0799|300 318|neuroendocrine cells
P08626539T0000|89 97|receptors
P08626540A1007|114 129|lactosylceramide
P08626596A0000|166 173|pathways
P08626610A0931|171 178|splicing
P08626667A1372|125 143|type oligonucleotide
P08626667A1517|147 163|GPT gene expression
P08626698A0989|170 183|gel kinase assay
P08626777A0537|146 158|cartilage gene
P08626785A0674|391 403|RXR homodimers
P08626809A0729|114 135|eIF-2alpha kinase family
P08627354A0000|86 108|neurotransmitter release
P08627649A0734|217 221|GC box
P08627667A0132|99 111|specificities
P08627688A1520|57 64|activity
P08627719A0784|250 253|IE63
P08628251A1455|52 58|stimuli
P08628254A0665|111 114|foci
P08628255A0932|144 156|H2A.1 promoter
P08628260A0895|165 180|promoter activity
P08628284A0181|113 117|TRE-1
P08628302A0683|69 90|transcription apparatus
P08628681A0364|80 91|X.laevis cDNA
P08628681A0821|100 112|DNA polymerase
P08629348A0237|214 226|hydrocephalus
P08630542A1421|105 113|procedure
P08630548A0000|131 139|TNF-alpha
P08630583A1056|55 55|Q
P08630599A0534|213 222|coal miners
P08631667A0851|227 234|plasmids
P08631685A0000|146 155|chromosome
P08631760A0609|93 111|Crk-SH2 binding motif
P08631797A0982|154 163|EGF binding
P08631817T0000|96 138|deoxyuridine triphosphate nucleotidohydrolase
P08631820A0755|141 145|Karst
P08631822A0677|139 153|cell mitogenesis
P08631908A0224|63 80|mobility shift assay
P08631934A0000|147 149|G/A
P08631944A0663|188 196|secretion
P08631958T0000|86 88|p53
P08632009A1067|180 202|DNA binding specificities
P08632015A0879|52 77|DNA polymerase alpha promoter
P08632015A1226|229 240|DRE sequences
P08632018A0587|94 104|MC induction
P08632463A1508|94 116|transcription elongation
P08632779A0351|172 180|HeLa cells
P08633855A1064|149 154|NZ6091
P08634290A0000|82 84|end
P08634357A0527|95 99|range
P08634420A1784|122 142|UT-7 cell proliferation
P08634423A0498|160 170|neutrophils
P08634697A1155|148 154|domains
P08635771A0000|149 155|samples
P08636031A1413|185 198|Fur preparation
P08636124A0410|155 163|evolution
P08636149A0220|118 125|response
P08636211A0983|0 4|EMBO J
P08636428A1363|147 154|mitogens
P08637006A0000|189 195|ATF site
P08637711A1121|203 213|JRE-IL6-BCs
P08637717A0817|114 125|cyclin E/Cdk2
P08637717A1231|110 128|p21-PCNA interaction
P08638435A0522|103 114|A. hydrophila
P08639310A0548|139 139|h
P08639521A1032|113 118|motion
P08639561T0000|258 262|1H NMR
P08639742T0000|65 87|wheat zinc finger proteins
P08639837A0268|83 91|Ets family
P08640866A0473|140 147|activity
P08641705A0986|200 210|Hb Costa Rica
P08642282A1009|113 120|molecule
P08642285A1548|112 116|STAT5
P08642313A0770|165 169|Bcl-3
P08642313T0000|152 157|T cells
P08642693T0000|93 103|mutagenesis
P08643111A0855|295 308|antigen binding
P08643382A0752|104 121|chloroplast protein
P08643513A0361|178 202|osteocalcin gene expression
P08643557A0259|60 70|target genes
P08643578A0000|164 188|mating pathway reporter FUS1
P08643578A0532|119 132|lacZ expression
P08643633A1187|54 57|CBF1
P08643646A0479|196 205|conditions
P08643682A0268|113 123|NIH 3T3 cells
P08643759A0338|73 77|group
P08644734A0404|73 92|segment-polarity gene
P08645214A1052|164 169|enzyme
P08645219A1377|142 155|binding domains
P08647086A0622|36 41|system
P08647086A0720|182 194|Cdk2-cyclin-A
P08647086T0000|116 128|Cdk7-cyclin-H
P08647091A0592|144 151|ADH genes
P08647264T0000|175 187|substrate PARP
P08647434A1124|141 150|holo-TFIID
P08647451A0663|92 98|tissues
P08647802A0000|109 112|Grb2
P08647822T0000|100 112|reductase gene
P08647884A0547|107 117|cell surface
P08648408A0792|93 98|CSA-GO
P08648665A0956|85 89|cells
P08648665A1320|123 135|pZipNeo vector
P08648726A0713|117 119|TPA
P08649372A0501|94 99|M phase
P08649372A0755|54 57|Swi6
P08649373T0000|79 87|c-myc gene
P08649386A1032|93 96|site
P08649389A0000|187 204|amino acid sequences
P08649389A0692|143 151|c-myc gene
P08649393A0000|161 180|kinetochore integrity
P08649403A0963|94 106|protein kinase
P08649405T0000|96 108|transcription
P08649424A0000|126 128|AMP
P08649425A0373|84 100|B-cell development
P08649425T0000|74 81|enhancer
P08649427A0689|99 114|GTPase regulators
P08649428A1227|120 123|Cdc2
P08649440T0000|24 27|IgG2
P08649773A1374|116 127|cell lymphoma
P08649841A0956|183 189|CAT mRNA
P08650818A0000|223 239|Mediterranean area
P08651853A0607|176 184|CA4 region
P08651853T0000|14 22|sclerosis
P08652081A1953|182 185|IL-4
P08654200A0274|203 205|ICG
P08654375A0544|152 156|Oct-2
P08654390A0000|89 102|carbon monoxide
P08654435A0540|148 153|assays
P08654946A0475|122 125|gene
P08654946A0986|107 114|sequence
P08654972A0000|76 95|cell cycle progression
P08654983A0000|183 188|DNA Res
P08655497A0000|151 156|vector
P08655555A0772|135 141|hexamer
P08655555A1368|113 121|promoters
P08656672A0678|127 153|cervix carcinoma cell line HeLa
P08657135A1444|135 142|elements
P08657150A1049|124 133|activators
P08657157A0000|166 188|octamer sequence elements
P08657183A0145|63 66|DHFR
P08657918A0360|188 197|dissection
P08659545A0000|165 169|genes
P08660733X0000|64 68|April
P08660748X0000|81 98|population patterns
P08660866A0504|196 201|socket
P08660892A1044|151 156|Mef-2C
P08660998A0851|165 178|initiation site
P08661007T0000|75 100|protein domain relationships
P08661100A0285|148 152|parts
P08661101A0396|70 76|rat CRP1
P08661104A0687|113 117|colon
P08661114A0564|74 81|proteins
P08661116A0963|169 170|bp
P08661119A0085|113 128|blood lymphocytes
P08661613A0691|139 159|enforcement activities
P08662193A0404|123 126|NIT4
P08662499A0484|50 52|RNA
P08662617A2051|146 154|cell lines
P08662789A0673|83 88|RPS30A
P08662852A1297|143 151|rhodopsin
P08662928A1153|65 76|STAT proteins
P08662928T0000|111 130|IL-6 response elements
P08662936A0428|152 157|factor
P08662980A0762|188 193|effect
P08663000A0000|134 142|TGF-beta1
P08663120T0000|80 86|pathway
P08663127A0697|182 188|regions
P08663141T0000|120 138|angiotensinogen gene
P08663172A0311|27 39|amino terminus
P08663219A0246|161 171|E-box region
P08663310A0157|172 186|differentiation
P08663326A0000|118 124|phenols
P08663392A0215|84 93|expression
P08664229T0000|61 85|Nidek AR-1000 autorefractor
P08664347A0923|143 148|enzyme
P08664462A1404|187 197|hypothermia
P08664667A0093|20 24|India
P08665853A0228|161 166|ErbB-2
P08666102A0820|100 103|FEV1
P08666238T0000|83 87|cells
P08666241A0930|71 87|Dex responsiveness
P08666383A1252|153 158|genome
P08666398T0000|57 69|16p12.1-p11.2
P08666404A0311|186 191|rat PPT
P08666913A0000|70 79|chromosome
P08668124A0744|78 81|sun2
P08668142A1048|90 99|Sec7p pools
P08668158A0765|218 221|RPM1
P08668158A1252|118 134|biogenesis defects
P08668190A1364|132 136|yeast
P08668201A1059|173 180|interval
P08668203A1230|128 134|tissues
P08668209A0406|7 26|Cold Spring Harbor Symp
P08668210A0000|131 144|transformation
P08669274T0000|47 54|approach
P08669676A1644|151 165|treatment groups
P08670556A0425|93 102|0-infinity
P08670853A0000|87 94|adhesion
P08670910A0156|84 101|polypeptide complex
P08672242A0517|111 120|expression
P08673026T0000|46 61|replication study
P08675026A0420|128 131|Homo
P08675395A0751|60 76|acuity outcome data
P08675608T0000|25 38|hypothyroidism
P08675763A0788|94 97|g/kg
P08675769A0158|230 241|AI technician
P08675821A0657|68 77|malignancy
P08676266A0838|92 99|baseline
P08676383A0518|52 62|cis peptides
P08676454A0731|107 113|virions
P08676456A0879|115 134|VP16 activation domain
P08676495A0129|173 177|warts
P08676858A0309|187 192|RNases
P08676858A1084|54 59|plants
P08677443A0238|228 228|%
P08677678A0258|176 184|phenomena
P08678959A0640|82 82|%
P08679131T0000|21 38|hypersensitivities
P08680702A0548|284 291|Vo2INDIR
P08680706A0889|185 200|Donor Aerosol dogs
P08682155A0902|114 124|differences
P08682317A0900|102 106|cells
P08682868A0738|109 123|Cdc31p stability
P08683106A0374|46 50|STAT5
P08683108A0965|108 111|site
P08683108A1501|106 122|junB transcription
P08683983A0785|92 104|leukemia cells
P08683983A1163|208 224|cell growth control
P08684522A0415|121 124|wall
P08684742A0000|133 141|gestation
P08686381A0527|212 222|protein Swi3
P08688190A0000|146 166|Lysionotus pauciflorus
P08688556A0242|151 159|viability
P08689520T0000|61 65|goats
P08690118A0845|114 126|fertilization
P08690198A0346|202 206|study
P08691106A0733|98 104|protein
P08691962T0000|80 84|cells
P08692885A0663|65 80|zinc finger domain
P08692892A0330|148 159|alpha-factor
P08692924A0328|148 158|B-cell lines
P08697728A1199|40 40|%
P08698756A1240|188 193|damage
P08700531A1420|279 296|hamster fibroblasts
P08702517A0000|73 90|progenitor cell line
P08702543A0000|137 142|Cullen
P08702556A0000|155 155|J
P08702633A0164|144 185|Ras guanine nucleotide exchange factor activity
P08702644A0499|147 190|glycosylphosphatidylinositol anchor attachment
P08702728A1325|58 66|HIRc cells
P08702756A0000|128 144|muscle contraction
P08702807A0964|189 194|manner
P08702826A0870|102 110|MCF7 cells
P08702845A0000|232 243|COOH terminus
P08702936A0168|190 207|virus shuttle vector
P08702936A0984|94 105|granulocytes
P08703005A0645|128 134|protein
P08703010A0905|204 207|site
P08703908A1814|110 117|StAR gene
P08703959A0659|182 193|adduct duplex
P08704124A0420|70 98|Vigna radiata lambda gt11 library
P08704240A1111|93 110|PIXY321 stimulation
P08705056T0000|27 30|risk
P08706368A1024|104 107|FIO2
P08706662A1125|148 158|factor NF-P2
P08706731A1303|290 294|roles
P08707424A0709|117 127|development
P08707516A0194|76 91|handicap services
P08707825A0063|216 222|protein
P08707840A0753|109 111|p62
P08707846A2308|183 198|a-factor receptor
P08707922A0334|165 187|primer extension analysis
P08708984T0000|63 65|rat
P08709224T0000|81 90|hSNF5/Ini1
P08709245A1521|206 210|HDAgs
P08709251A0000|243 243|S
P08709637A1471|136 150|precursor B cells
P08709831A0599|60 65|tumors
P08710151A0782|107 113|patient
P08710371A0000|176 193|p53 transactivation
P08710371A0499|110 125|base pair deletion
P08710377A0577|124 137|BCR stimulation
P08710504A0995|49 58|cat1 mutant
P08711631A0989|38 53|cyclophosphamide
P08712799A0123|21 27|smoking
P08713933A0606|90 97|drainage
P08716757T0001|59 65|patient
P08717391A0466|195 199|HBcAg
P08717559A0223|82 91|micrograms
P08719155A0105|262 263|CS
P08719156A0953|86 92|protein
P08719697A0221|101 103|KCS
P08719832A0397|68 77|acromegaly
P08720407A1386|139 163|prostaglandin E2 production
P08721526A0000|69 78|pet animals
P08721989A1012|166 181|signal transducer
P08721999A0432|67 75|snoRNA U14
P08721999A0727|67 73|28S rRNA
P08722011A0103|171 180|protein L12
P08722568A1001|130 135|plants
P08723352A0084|142 144|pRb
P08723365T0000|69 83|nephrosclerosis
P08723883A0823|93 97|assay
P08723883A1684|176 182|species
P08726024A0244|42 46|study
P08726024A0532|187 192|plaque
P08726247A0175|85 94|path length
P08727192A0000|0 10|STUDY DESIGN
P08727992A0570|92 94|min
P08728040T0000|164 175|sarcoma cells
P08730470A0000|151 166|household contact
P08731155A0499|43 48|nerves
P08731222A0000|261 267|C7 level
P08731511A0625|122 128|animals
P08732665A0000|288 294|culture
P08733123A0000|154 156|arm
P08733123A0951|102 118|amino acid residues
P08733874A0000|169 175|serum TG
P08733881A0343|114 122|TSH levels
P08734538A0613|47 54|textures
P08738510A0254|67 77|meningiomas
P08739209A0700|166 169|dogs
P08739260T0000|25 42|amphetamine effects
P08740416A0239|124 137|signal sequence
P08740416A0919|63 67|Seb1p
P08741206A1551|107 117|hypotension
P08741280A0374|76 81|length
P08742135A0000|137 138|CS
P08742385A0211|104 113|head injury
P08745669A0000|189 205|methyl prednisolon
P08746605A0377|91 102|pancreatitis
P08746981A0154|50 67|mg probiotic/kg food
P08747078T0000|27 37|miscarriage
P08747343A0790|79 87|materials
P08748033A0874|133 136|DegP
P08749393A0783|208 215|C2 domain
P08749394A0874|145 159|Drosophila Notch
P08750173A0000|179 198|% liver resection model
P08750190A0000|152 159|isoforms
P08750702A0183|102 121|chloroethylclonidine
P08751635A0135|78 82|hilus
P08752714A0000|129 133|years
P08754777A1214|96 113|heterodimer binding
P08754802T0000|139 155|adipose expression
P08754827A0231|7 9|F.J
P08754834A1097|139 144|detail
P08754840A0793|84 98|deltabem4 mutant
P08754852A0960|137 144|sequence
P08755898A0339|117 122|avrBs2
P08756332A0000|197 203|Ral-GEF
P08756433A0282|136 144|MAP1B gene
P08756556A0406|62 79|acid signal sequence
P08756597A0854|62 69|psaB mRNA
P08756609A0498|137 140|gene
P08756617A1204|0 3|Biol
P08756636T0000|71 82|Srs2 helicase
P08756642A0230|79 86|leukemia
P08756712A0227|114 120|domains
P08757265A0466|47 53|effects
P08757943A0876|90 101|inducibility
P08759870A1128|103 120|Fur repressor dimers
P08760286A0696|266 285|Vav signaling pathways
P08760776A1559|166 171|asthma
P08760872A0696|131 141|CHR elements
P08760889A0170|76 79|H2A1
P08760889A0531|233 239|species
P08761169T0000|46 51|damage
P08761480A0331|337 349|fusion protein
P08762021A0156|120 126|rabbits
P08762172A0178|170 174|boxes
P08762472A0000|101 107|studies
P08763207A0402|149 151|CPE
P08763311A0189|145 155|bradycardia
P08763925A0588|145 152|proteins
P08763953A0805|66 69|traG
P08764136A0000|239 244|76R-30
P08766049A0000|183 192|Vancomycin
P08766781A0322|87 90|g/dl
P08768374A0765|50 56|regions
P08768377A1387|121 127|cloning
P08769132A0000|410 423|chromosome 2p16
P08769409A0114|192 194|A.M
P08769566A0000|160 162|ZD2
P08769568A0949|60 68|PLA2 genes
P08770021T0000|67 85|Ras signaling pathway
P08770896A1121|140 142|14K
P08770920A1220|208 228|TAAT-1 element reporter
P08770981A0328|147 157|circulation
P08771781A0103|214 228|leaf cDNA library
P08771781A1103|102 113|PMSR activity
P08771787T0000|90 101|pathogenesis
P08774732A0271|53 72|gel retardation assays
P08775674A0000|102 117|hydatidiform mole
P08776735A0000|250 263|responsiveness
P08776748T0000|30 42|schizophrenia
P08776792A0626|47 51|hours
P08776793A0811|29 33|males
P08776901A0000|135 141|fashion
P08777374A1471|89 97|exposures
P08778265A0422|149 163|recognition test
P08778700A0476|77 80|ARVD
P08780339A0142|233 235|RS3
P08781119A0723|109 124|rat Met-ase-1 gene
P08781144A1520|77 79|NPC
P08783180A0000|146 152|setting
P08783666A0957|78 84|cohorts
P08784787A0383|115 130|receptor cleavage
P08787110A0981|153 170|function laboratory
P08789441A0339|210 215|region
P08790288A0068|77 92|Hordeum vulgare cv
P08790291A1022|81 90|plant cells
P08790387A0299|60 66|whn gene
P08792217A1407|99 107|germ cells
P08793029A0246|53 58|groups
P08793693A0237|23 27|study
P08794254A2957|70 78|graft loss
P08794326A0405|111 115|SFV-1
P08794339A1162|193 204|CREB function
P08794348A1067|130 140|NIa proteins
P08794363A0259|102 107|origin
P08794547A0648|34 55|laser-doppler fluxmetry
P08794547A1403|73 75|SAH
P08794601A0000|106 128|H. pylori eradication rate
P08794869A0274|72 93|integrin gene expression
P08795304T0000|59 74|diabetes mellitus
P08797362T0037|68 74|January
P08798420A0207|189 191|src
P08798443A0660|221 236|herpes tk promoter
P08798443A1218|231 238|proteins
P08798512A1197|53 61|u-PAR gene
P08798610A0843|229 242|Dbl oncoprotein
P08798635A0870|106 119|myristoylation
P08798641A0400|0 3|Biol
P08798643T0000|116 121|T cells
P08798648A1816|67 80|enzyme activity
P08798700A0134|189 191|UAS
P08798762A1279|85 87|PKC
P08798782A0976|46 55|SH3 domains
P08798893A0611|141 145|cells
P08801403T0001|54 59|myelom
P08803710A0701|81 83|IVB
P08803845A0665|169 176|excision
P08804012A0662|105 108|rest
P08804389A0893|181 188|decrease
P08805338A1061|117 120|Ogg1
P08805824A1155|215 223|technique
P08806491A0542|108 111|hr p.
P08806693A0584|190 205|mouse fibroblasts
P08806817A0244|118 128|TR2 receptor
P08806817A0716|64 81|S. purpuratus genome
P08807245A0843|53 62|undercalls
P08807288T0000|57 70|ADH2 expression
P08807408A0524|133 157|radiofrequency application
P08808120A0774|262 280|serum aluminum levels
P08808275A1193|120 135|yeast counterpart
P08808707A0631|183 196|gene expression
P08808756A0587|215 218|mRNA
P08808924A0326|222 225|ProW
P08808927A0417|52 62|M. bovis PG45
P08808939A0000|137 160|phosphotransferase system
P08809680T0000|34 36|gap
P08810040A0955|117 117|%
P08810278A0682|247 254|controls
P08810323A0735|61 67|regions
P08812012T0000|45 57|Stroop effects
P08812020A0597|139 144|pieces
P08812106T0000|76 82|embryos
P08812490A0000|94 110|kidney cDNA library
P08812490A0542|168 176|deletions
P08812490A1509|124 143|chromosome locus 12q13
P08813766A0605|198 207|Emericella
P08813900A1088|181 186|tibias
P08814651A0000|141 149|paradigms
P08816052A0238|147 152|K-SNAP
P08816438A0316|164 183|plasmid loss phenotype
P08816443A1674|225 241|adhesion complexes
P08816452A0936|162 167|manner
P08816453A0000|73 83|Raf-1 kinase
P08816459A0090|150 152|RAR
P08816460A1769|122 126|Erk-2
P08816461A0892|104 122|nonsense suppression
P08816472T0000|58 72|response pathway
P08816482A0234|69 73|genes
P08816483A0869|34 37|RIC3
P08816498A0000|139 145|nucleus
P08816504T0000|151 161|Ras activity
P08816507A1125|190 198|induction
P08816759A0000|135 143|receptors
P08816792A0000|95 102|DNA-PKcs
P08817323A0714|98 101|ESTs
P08817324A1070|135 152|paralogy boundaries
P08818436A0557|142 146|death
P08818718A1229|156 161|organs
P08820324A1699|33 44|TOF responses
P08820642A0173|240 246|tobacco
P08820648A0123|186 191|oxygen
P08822208A1364|103 112|regulation
P08822399A0518|64 72|pregnancy
P08823163T0000|149 162|co-corepressor
P08823187A1020|134 147|disulfide bonds
P08823260A1161|125 133|infection
P08823646A1012|74 85|measurements
P08823709A0220|111 117|patient
P08824201A0270|21 31|publication
P08824585A0260|138 152|progenitor cells
P08824798A0761|120 126|rat CRIP
P08824800A0808|42 66|agarose gel electrophoresis
P08824805A0832|75 84|p55 protein
P08824881A0133|89 95|16p13.3
P08824884A0000|164 171|handicap
P08825087A0213|106 116|orientation
P08825178A0071|114 119|TB care
P08825554A0000|100 114|CCCH zinc fingers
P08825556A0522|120 128|homodimer
P08825633A0304|77 82|G alpha
P08825636T0000|171 188|signal transduction
P08825639A0827|108 114|cap site
P08827783A0499|33 42|monitoring
P08828142A0000|133 144|environments
P08828152A1238|188 200|relationships
P08828152A1825|143 149|subunit
P08828857A2423|158 166|pregnancy
P08829393A0083|62 69|patients
P08831364A1252|171 175|block
P08832146A0959|85 87|PTH
P08833153A0628|268 278|chromosomes
P08833653A0304|94 107|islet cell lines
P08833653A0783|214 225|G9 islet cells
P08835393A2829|126 128|SRE
P08835895A1292|92 100|infection
P08835969A0000|273 275|EPs
P08836032T0000|92 111|sequence requirements
P08836172A1382|143 157|serum withdrawal
P08836740A1025|53 66|deletion mutant
P08837503A0392|171 184|dicot extensins
P08837746A0951|112 122|specificity
P08838144A0107|102 121|S1 or/and S2 subdomains
P08838148A1218|116 131|L channel activity
P08838314A0129|172 177|AVPR1A
P08838585A0968|71 77|ras-p21
P08838805T0000|46 51|CTNNB1
P08839498A0507|149 151|fat
P08839832A0729|103 109|domains
P08839832A1220|81 83|32P
P08839911A0716|7 12|cycles
P08840501A0345|78 81|ACT4
P08840506A0544|75 79|G2850
P08840997A0765|106 116|resemblance
P08842143A0000|116 120|genes
P08843411A0801|86 97|dimerization
P08843412A0543|209 218|DNA binding
P08843419A1290|45 56|interactions
P08844448A0000|288 288|E
P08844577A0000|73 80|medicine
P08844712A0000|143 150|urethane
P08845378A0368|71 79|MZF-1 gene
P08846775A0110|113 116|CLN2
P08847138A0609|69 73|years
P08847403T0000|44 46|IVF
P08847723A2351|165 172|findings
P08848013A1469|90 98|promoter A
P08848052A0733|99 106|function
P08849208A1022|43 49|stature
P08849569A0615|99 106|cortisol
P08849778A0226|95 98|CopA
P08849778A0598|80 90|translation
P08849834A0000|85 114|colour Doppler ultrasound imaging
P08850585A0602|103 118|virulence factors
P08851337A1092|82 95|angina patients
P08851434A0383|54 57|half
P08853303A0431|212 219|T1/2 beta
P08853893A0158|92 102|fibroblasts
P08854459A0000|125 132|February
P08854844A0637|128 128|%
P08855804A1528|114 119|months
P08856077T0000|84 88|cells
P08856132T0000|103 110|abortion
P08858211A0694|135 137|GDP
P08858268A1307|188 194|effects
P08858463A0853|184 197|nephrotoxicity
P08861955A0927|195 198|TC21
P08861963A0375b|131 145|rrnBP1 UP element
P08861963T0000|93 110|DNA enhancer element
P08862522A0690|92 102|temperature
P08862743A0603|43 48|nmol/L
P08863824A0509|153 160|5-HT2C-R
P08864061A0000|62 70|cell cycle
P08864219A0178|167 176|techniques
P08866485A0125|143 147|cells
P08867519A0557|104 110|periods
P08868473A1287|128 136|cell cycle
P08868660A0087|240 246|results
P08868954A0648|173 184|hemodynamics
P08869358A0121|109 114|T cells
P08869763A0378|148 155|migraine
P08869825A0000|100 105|manner
P08870266A0651|149 167|secretion efficiency
P08871542A1352|134 152|Thbs3 gene expression
P08871567A0000|65 69|c-myc
P08871567A0629|0 3|Gene
P08871635A0000|96 99|CD40
P08872162A0884|67 78|T cell subsets
P08872671A0573|186 194|equations
P08873063A0493|71 78|amino end
P08873063A0875|117 141|LpS1 RNA accumulation levels
P08873159A0791|51 62|chemotherapy
P08874399A0277|131 131|B
P08874631A1133|54 61|presence
P08876167A0322|40 45|HiNF-D
P08876167A0717|181 194|p107 antibodies
P08876701A0177|39 42|DinB
P08877103A0081|117 123|J7.V2-1
P08877818A0184|97 111|His-Pro-Gly-Lys
P08878019A0357|131 134|case
P08878037A0000|22 49|catabolite control protein CcpA
P08878044A1390|178 183|strain
P08878045A0606|147 159|transcription
P08878573A1370|126 129|mice
P08879080A0265|84 92|LISREL VII
P08879237A0744|127 143|rice mitochondrion
P08880405A1170|82 90|daughters
P08881036A0351|39 41|CL2
P08881542T0000|63 90|serum potassium concentrations
P08882492A0000|189 197|organisms
P08882710A0000|128 131|IFNs
P08884273A1413|171 177|closure
P08884757A0653|309 311|SKT
P08885270A0428|48 51|PAO1
P08886845A1274|184 192|myoblasts
P08887643A1167|133 149|signaling pathways
P08887647T0000|30 50|chromosome segregation
P08887652A0341|232 234|hph
P08887659A0753|70 75|effect
P08887661A0138|54 62|repressor
P08887661A1061|140 145|manner
P08887667A0992|179 191|SPB separation
P08887674A0630|100 107|elements
P08887674A0920|136 145|mechanisms
P08887678A0000|122 130|cell death
P08890537A0355|51 58|bone cyst
P08891131A0000|200 203|pigs
P08891337A0614|162 175|binding protein
P08891341A0724|208 216|cell lines
P08891345A0684|194 198|uORFs
P08891346A1217|144 148|FGF8e
P08891474A0667|121 131|nerve fibers
P08892755A0186|123 131|% identity
P08892755A0981|200 209|pCAT-Basic
P08892757T0000|112 129|repression activity
P08892859A0563|142 152|c-myb allele
P08893779A0229|301 308|junction
P08893822A0560|105 111|tissues
P08894144A0330|128 132|mg/kg
P08894144A1173|26 37|bone turnover
P08894826A0228|215 219|study
P08895522T0000|82 101|cell adhesion molecule
P08895579A0583|84 88|mRNAs
P08895997A0336|0 6|Physiol
P08896272A0000|45 54|chromosome
P08896280A0860|143 156|yvh1 disruption
P08896402A0587|167 172|sugars
P08896473A0282|99 101|VGS
P08896590T0000|69 74|domain
P08896795A0166|127 136|air bubbles
P08896804A0000|356 363|solution
P08897663T0000|38 48|suicidology
P08897721A0000|119 127|immunogen
P08898336A0268|154 157|RNAs
P08898365A0274|151 159|cytoplasm
P08898866A0458|218 223|domain
P08898893A0202|206 210|cells
P08899719A0318|116 124|certainty
P08900164A0188|9 9|S
P08900190A0430|101 105|c-Jun
P08900296A0000|120 127|response
P08901135A1132|161 166|import
P08901635A0000|137 142|plants
P08901658A0498|126 128|GTN
P08902214A1486|101 111|Stat factors
P08902548A0144|114 117|mice
P08902641A0930|116 118|DAo
P08902847A1946|248 249|kw
P08902988A0258|68 77|thrombosis
P08903339A0264|75 85|spliceosome
P08905819A0531|52 57|cancer
P08906056A1290|110 130|health care utilization
P08906139A2935|147 153|periods
P08909546A0810|114 119|domain
P08910292T0000|95 114|protein kinase pathway
P08910373A0315|59 69|Y2 receptors
P08910550A0501|150 162|transcription
P08910567A2269|97 124|hepatocyte transfection system
P08912232A0260|71 75|girls
P08912807A0411|139 157|beta-casein promoter
P08913186A0431|115 144|convergence retraction nystagmus
P08913387A1010|52 57|agents
P08913974A0533|152 157|others
P08914388A1645|194 201|sequence
P08914522A0118|163 175|G beta mutation
P08914532A0598|40 64|endohydrolase isoenzyme X-I
P08915051T0000|38 46|arthritis
P08915508A0000|366 368|RNA
P08915559A0366|39 55|platform technique
P08916928A0950|117 134|PDGF beta-receptors
P08916960A0350|140 146|regions
P08916960A1331|199 205|FL cells
P08917270A0229|131 140|QT syndrome
P08917435A0481|195 208|PAI-1 synthesis
P08917449A0000|131 141|populations
P08917696A0485|341 348|promoter
P08918456A0455|105 111|leucine
P08918464A0225|151 159|apoptosis
P08918810A0967|97 127|protection pattern characteristic
P08918885A0811|60 71|yeast protein
P08918885A1087|164 176|growth pathway
P08918918T0000|109 112|cell
P08918934A0424|179 185|linkers
P08919289A0402|112 119|vena cava
P08919907A0763|94 101|promoter
P08919986A1262|146 155|literature
P08920499A0164|0 22|Blood sampling procedures
P08921387A1182|166 171|domain
P08921667A0294|146 155|volunteers
P08921865A1293|173 177|T4DNA
P08922344A1539|177 188|hypertension
P08922384A0466|99 109|carboxyl end
P08922385A0622|148 155|lysosome
P08922390A0361|124 128|motif
P08922390A0793|137 146|amino acids
P08922390A2076|212 223|localization
P08922391A0304|111 114|site
P08922488A0187|62 68|effects
P08923258A0353|46 54|Holsteins
P08923460A0565|114 120|cloning
P08923469A1391|140 151|half-element
P08923470A0458|40 58|nM TNF alpha treatment
P08924211A0941|102 109|AST cDNAs
P08924381T0000|58 77|breast cancer patients
P08925545T0001|66 71|myelom
P08927169A0178|120 126|Utrecht
P08927612T0000|39 52|adenocarcinoma
P08927841A0053|103 112|occurrence
P08929089A0231|78 83|demand
P08929563T0000|90 105|Ser-Lys-Leu motif
P08931388A0806|110 113|band
P08931991A1026|107 122|myosin expression
P08932363A0807|130 146|CBP binding ability
P08932385T0000|36 70|transcription factor TCF11/Nrf1/LCR-F
P08933487A0325|50 52|run
P08933640A0000|102 108|rabbits
P08934533A0784|67 75|chromatin
P08934540A0673|70 77|cell line
P08935931A0787|133 142|monitoring
P08935991A0844|150 156|introns
P08936128A0611|99 110|disagreement
P08936640A0105|110 119|lung cancer
P08937112A0561|44 47|mean
P08937631A1223|155 165|vasculature
P08937981A0840|131 137|nucleus
P08937989A1365|111 117|protein
P08938418A0099|6 18|embryo library
P08938420A0862|188 203|mRNA accumulation
P08939891A0285|103 105|Nrl
P08939966A0816|86 96|mRNA decline
P08940132A1120|212 229|DEVD-CHO inhibition
P08940134A0705|145 153|reticulum
P08940298A0962|156 163|activity
P08942999T0000|116 136|hamster ovary cell lines
P08943032A0000|175 183|selection
P08943354A0295|177 190|motheaten cells
P08943928A1137|45 52|outbreak
P08943934A0604|97 104|findings
P08944755A0211|0 3|Biol
P08945479T0000|58 80|tyrosine phosphorylation
P08945810T0001|61 66|mammal
P08946166A0568|44 51|FRDS gene
P08946668A0077|77 84|toxicity
P08947028A0992|85 89|Pkc1p
P08948440A0628|118 123|embryo
P08950144A0172|113 115|sec
P08950352A0525|147 158|significance
P08951815A0465|126 152|transcription activator Gcn4p
P08952483A0207|143 164|multisynthetase complex
P08952796A0743|23 29|relapse
P08952965A1182|221 224|CDR2
P08953340A0000|169 193|weight-training volunteers
P08954725A1175|117 122|source
P08955071T0000|62 73|fission yeast
P08955111A0989|132 154|activin betaA subunit gene
P08955136A0606|98 113|PIP5KI antibodies
P08955159A0000|56 57|EC
P08955189A1198|118 142|EGR-1 transcription factors
P08955306A0224|148 154|acetate
P08955402A0288|203 213|Hol1 protein
P08955928A0390|106 109|MCAo
P08958137A0534|68 72|study
P08958720A1204|88 90|VO2
P08959062A0372|125 132|syndrome
P08959117A0708|215 217|REF
P08959778A0292|126 143|retransplantations
P08960827A1169|155 160|factor
P08961873T0000|88 108|immunodeficiency virus
P08962614A0000|199 206|children
P08964067A0188|52 58|failure
P08964172A0221|137 146|background
P08967870A0000|46 61|Moscow hospitals N
P08967963A1735|181 194|alpha2c-AR gene
P08969495A0256|188 192|locus
P08969777A0771|147 155|paralysis
P08970352A0880|65 70|sepsis
P08970951A0823|124 142|HBV DNA intermediates
P08970979A1246|117 124|promoter
P08970984A0765|156 179|tumor necrosis factor alpha
P08970991A0747|91 95|cells
P08971009A0860|155 164|DNA genomes
P08971721A1314|58 61|HspA
P08971835A1057|124 140|reperfusion period
P08972182A0000|94 114|receptor cross-linking
P08972182A0527|199 233|tripeptide pan-ICE inhibitor Z-VAD-FMK
P08972211A0059|185 193|enhancers
P08972232A0365|81 85|yGCN5
P08973185T0061|60 72|AAC expression
P08973527A0000|117 120|HoMV
P08973630A0923|150 156|changes
P08973917A0632|35 42|PWP2 gene
P08973917T0000|98 104|21q22.3
P08974103A0451|113 119|pattern
P08974135A0052|173 184|control group
P08975532T0001|0 11|Liver injurie
P08975713A0454|172 184|p53p2 promoter
P08976253A0637|57 71|plasma PSA levels
P08977013A0788|113 118|vision
P08977235A0134|77 100|STAT transcription factors
P08977235A0588|170 200|receptor tyrosine phosphorylation
P08977401A0227|338 342|mRNAs
P08978690A0262|102 118|yeast model systems
P08978817A0620|190 196|pathway
P08978996A0000|187 199|patient groups
P08979089A1197|171 186|Ig kappa enhancers
P08979828A1561|47 54|behavior
P08980413A0500|77 79|PES
P08980522A0280|48 50|kDa
P08980533A1160|99 110|testis tissue
P08980536A1196|97 102|motifs
P08980819A0193|160 171|insemination
P08981371A2049a|64 77|CSF-1 treatment
P08981371A2049b|64 77|CSF-1 treatment
P08985109A1285|94 97|cone
P08985115A1571|232 241|metastasis
P08985122A0501|271 275|genes
P08985415A1096|90 98|monocytes
P08986190A0927|80 89|LDH release
P08986214A0000|201 203|AFP
P08986228A0000|107 119|malformations
P08986692A0306|85 90|IVF-ET
P08986770A0268|128 140|splice variant
P08986812A1214|112 118|effects
P08987009A0400|85 97|psychoanalyst
P08987225A0675|169 178|Queensland
P08988257A1256|152 161|truncation
P08988913A0821|143 151|processes
P08989025A0359|131 139|responses
P08989763A0605|60 68|diaphragm
P08990168A0688|77 80|GATE
P08990194A0000|173 185|hormone action
P08990397A1437|116 128|RNA processing
P08992115A0199|190 192|air
P08993393A0498|77 88|hPACAP-R gene
P08993393T0000|139 146|hPACAP-R
P08993831A0000|123 134|gene products
P08993836A0699|109 121|embryogenesis
P08994825A0000|77 100|Cdc2/28-cyclin B complexes
P08994832A0782|56 64|apoptosis
P08994968A0926|114 117|NADP
P08995054A0618|105 117|retroelements
P08995054A1368|99 115|nucleotide changes
P08995410A0000|178 192|ribosome subunit
P08995410A1109|151 153|p35
P08995614T0000|121 129|sequences
P08995652A0812|622 639|scaffold structures
P08995659A0563|152 163|splice region
P08995681A0518|55 61|protein
P08996730A1146|145 156|difficulties
P08997490A1127|137 167|cholesterol hydroxylase promoters
P08997532A0116|120 133|ELISA technique
P08998115A0114|130 136|disease
P08999414A0819|33 48|genus Dermacentor
P08999857A0801|131 150|collagen gene promoter
P08999882T0000|38 46|beta cells
P09000049A1341|91 107|cell proliferation
P09000108A0330|168 171|CG30
P09000146T0000|72 90|sequence alterations
P09000589A0000|77 82|agents
P09000632A2341|99 105|complex
P09001213A1111|177 184|var genes
P09001245A0187|66 66|E
P09001313A0000|74 78|women
P09001667A0312|52 54|day
P09001828A0222|138 142|study
P09002648A0202|101 109|cell death
P09002672A0439|196 208|TTGGGG repeats
P09003001A1593|76 82|factors
P09003001A1909|117 122|CANNTG
P09003311A0478|86 92|regions
P09003312A0740|210 214|light
P09003410A0000|83 89|antigen
P09003462A0792|74 83|nrdB intron
P09003463A0198|96 107|RII alpha gene
P09003617A0000|58 60|age
P09004304A0000|172 191|blood sample technique
P09004504A0000|125 151|Yersinia pestis plasmid pYP358
P09004987T0001|71 77|syndrom
P09005273A0322|138 161|neuropathy target esterase
P09005273A1558|150 173|neuropathy target esterase
P09005609A0299|44 49|period
P09005836A0977|43 55|antibody level
P09005979A0841|63 77|differentiation
P09006007A0997|246 253|ribosome
P09006010A0527|174 188|secretion signal
P09006022A0252|82 104|T7 RNA polymerase promoter
P09006051A1162|290 315|acetyl coenzyme A synthetases
P09006555A0738|213 219|studies
P09006902A0370|32 36|MEKK3
P09006910A0000|130 145|RXRgamma2 isoform
P09006914A0812|66 70|ATF-2
P09006914A1127|132 155|E-selectin gene expression
P09006935A0590|63 76|consensus GC box
P09006936T0000|80 98|glycoprotein IBalpha
P09008301A0193|127 133|studies
P09009208A0337|65 71|Tf1 mRNA
P09010223A0667|119 126|Egr1 SREI
P09010223A1850|179 186|Egr1 gene
P09011591A0309|40 46|smokers
P09011744A0790|268 271|mice
P09011745T0000|149 157|processes
P09012405A0785|113 121|DNA repair
P09012636A0723|146 160|atherosclerosis
P09013499A0198|222 229|controls
P09013760A0000|149 153|cells
P09015543A0210|43 46|flap
P09015757T0000|107 110|gene
P09015799T0000|43 52|depression
P09016566A0655|62 69|BiP mRNAs
P09017443A0734|118 131|stratification
P09018122A1389|100 115|tumor development
P09018133A0244|144 154|herpesvirus
P09019302A0600|107 111|phase
P09020138A0833|118 136|adapter molecule CrkL
P09020169A0552|55 57|AHR
P09020172A0964|209 216|Kd values
P09020856A0560|58 68|MCK promoter
P09021684A1418|175 197|transactivation activity
P09022040A0263|253 274|L-plastin gene promoters
P09022632T0000|36 42|surgery
P09023197T0000|15 30|Bacillus subtilis
P09023378A0959|157 166|DNA element
P09024039A0247|151 161|ventilation
P09024097A0000|118 125|ligation
P09024793A1325|162 166|BMP-2
P09024805A0905b|183 206|phorbol ester inducibility
P09025122A0374|122 132|performance
P09025549A0000|222 230|continent
P09027346A1957|149 151|LHR
P09027506T0000|110 115|eIF-4G
P09028089A0183|93 114|transplantation surgery
P09028308A0590|203 214|chemotherapy
P09028942A0000|128 132|egr-1
P09028998A0143|113 115|BCT
P09029091A0881|120 132|A2/HCP chimera
P09029104A0226|59 64|manner
P09029159A0000|130 136|effects
P09029713A1120|128 140|transcription
P09029956T0000|43 60|structure formation
P09030581A0990|85 92|JNK/SAPK
P09030688A0435|74 90|Rap1p localization
P09030781A0734|199 211|cdk6/cyclin D2
P09031639A0474|144 154|U1-C protein
P09032233T0000|88 101|gene expression
P09032248A0239|104 122|Cln1,2-Cdc28 kinases
P09032250A0257|124 138|HeLa cDNA library
P09032254A0724|55 63|sequences
P09032258A0395|121 137|B7-1 costimulation
P09032259A0150|117 133|Ras transformation
P09032259A0972|98 121|Rac1 transforming activity
P09032267A0850|98 105|p45/NF-E
P09032275A1133|86 89|date
P09032304T0000|88 98|protein ICP4
P09032328A0650|173 180|proteins
P09034337A0251|114 122|DNA damage
P09035307A0000|137 146|99mTc-MIBI
P09035612T0000|102 112|reperfusion
P09036529A0343|186 195|Aquagen ALK
P09037032T0000|169 183|differentiation
P09037064A0183|151 159|vaccinees
P09037163A1652|59 76|gpc4 gene expression
P09038166A0818|56 61|intron
P09038192A0846|33 38|Dudley
P09038202A1951|140 148|promoters
P09039744T0000|61 72|sinc function
P09040011A1316|169 187|Ras/Raf/MAPK pathway
P09041123A0195|140 146|complex
P09042078A0202|90 97|subjects
P09042269A1007|95 100|cancer
P09042683A0492|138 150|schizophrenia
P09042755T0000|105 112|heat shoc
P09042911A0626|163 170|sequence
P09043534A1600|61 67|minutes
P09043768A0139|54 59|In-111
P09045636A0789|65 70|T cells
P09045805A0945|161 171|gene product
P09045842T0000|74 82|mer operon
P09045919A1250|217 238|B lymphocyte development
P09046013A0000|235 243|occlusion
P09046090T0000|160 172|chromosome VII
P09046186A0189|59 68|trochanter
P09046384A0403|91 101|DDI subgroup
P09047252A0209|132 136|study
P09047344A0000|129 136|affinity
P09048617A0648|87 96|cAMP effect
P09049198A0289|164 176|liver diseases
P09049270A0488|185 187|MTs
P09049304A1193|161 182|VPF/VEGF gene expression
P09049306A0830|61 70|chromosome
P09049313A0116|100 120|initiation factor eIF4G
P09050689A0685|107 111|hours
P09050847A0180|176 183|promoter
P09050849A0000|145 160|protein transport
P09050849A1459|80 85|domain
P09050861A0903|47 56|pets factor
P09050867A0542|126 141|TN control element
P09051656A0390|129 136|subjects
P09053309A1103|82 101|floor plate inducer shh
P09053494A0612|179 192|reference group
P09053835A0865|61 73|protein levels
P09053973A1252|107 113|ascites
P09055221A0288|101 107|effects
P09056761A0000|212 215|exon
P09057325A0177|117 137|Bg/II/SmaI DNA fragment
P09057648A0422|390 397|mol/L PMA
P09057703A1389|41 59|treatment conditions
P09057840A0946|99 111|AMP-Sepharose
P09057841T0000|135 142|pathways
P09058002T0000|43 52|lobe damage
P09058250A0128|80 86|therapy
P09058323A1287|164 180|gene transcription
P09058373A0670|85 89|liver
P09058373A1620|159 166|receptor
P09058378A1134|90 104|transrepression
P09059039A0850|266 271|ml/min
P09060045A0576|89 104|endotoxin release
P09060444A0557|138 155|EGF-responsiveness
P09060622A1679|128 133|genome
P09060623A0961|43 50|SIV entry
P09060676A1634|75 84|properties
P09060971A0982|203 205|hip
P09061697A0629|256 263|occasion
P09061697T0000|83 100|day imaging protocol
P09061698A0177|132 146|blood pool agents
P09062130A0116|184 195|PTPase domain
P09064659A1055|134 138|HUPF1
P09064868T0001|18 24|solutio
P09065170A0853|42 49|transfer
P09065463A1012|65 67|RPA
P09065690A0463|118 137|nitrogen availability
P09065768A0862|95 105|lactase mRNA
P09067577A0307|39 46|tyrosine
P09067577A0721|84 88|c-ABL
P09068989T0000|69 74|system
P09071308A0376|127 130|NTMB
P09071407T0000|81 89|condition
P09072361A0357|147 151|SHRSR
P09073074T0000|58 69|developement
P09073582A0444|88 90|Mol
P09074508A0397|64 69|genome
P09075739A0827|63 67|ovary
P09076336A0281|170 180|GH secretion
P09077076A0219|8 14|CRP test
P09077108A0458|107 111|fluid
P09077437T0000|70 82|RNA polymerase
P09077438A0076|33 44|RNA synthesis
P09079625A0935|109 117|adhesions
P09079638A0883|202 216|ligand challenge
P09079650A0136|131 144|protein kinases
P09079689A0472|120 131|reading frame
P09079817A0928|77 88|NO synthetase
P09079878A0000|123 126|lasA
P09079902A0713|145 152|affinity
P09079904A0995|128 136|Bvg system
P09079915T0000|85 108|consensus sigma70 promoter
P09079928A0525|76 81|region
P09079928A1319|139 153|LysR superfamily
P09080250A0212|161 171|tumour cells
P09080517A0215|11 18|patients
P09081389A1088|37 42|cycles
P09081392A0174|31 45|salvage regimens
P09082335A0730|60 64|means
P09083291A1378|221 226|S phase
P09083345A0851|219 235|treatment efficacy
P09083563A0971|217 224|B. cereus
P09084174A0667|207 215|Vibrio spp
P09084176A0601|94 110|M. smegmatis clones
P09084227A0833|180 183|rats
P09084621A0374|146 162|movement variables
P09084621A2567|99 105|caudate
P09085842A0181|142 148|SF2/ASF
P09085842A1559|162 177|pre-mRNA splicing
P09086268A0611|74 86|RNA polymerase
P09087430A1046|64 66|PAP
P09088371T0000|76 86|haemorrhage
P09088416A0000|193 200|etiology
P09088737T0000|83 86|CMTF
P09089093A0373|68 83|enhancer elements
P09089653A0615|156 169|control plasmid
P09089653A1112|86 95|protection
P09090050A0419|48 52|mouse
P09090054A0186|186 192|cluster
P09090592A0175|150 160|orientation
P09091010A1003|73 79|disease
P09091125A0161|90 103|NBT-test values
P09091403T0001|94 107|microsatellite
P09092493A0861|109 117|mechanism
P09092580A1354|119 123|sites
P09092636A0802|182 189|YAC clone
P09092675A0283|91 97|strains
P09093867T0000|51 54|fate
P09094093A0578|45 49|cells
P09094315A0541|56 66|cyclin-Cdks
P09094671A1192|127 135|deletions
P09096229T0000|203 218|control sequences
P09096234T0000|107 128|phage lambda cI repressor
P09096958A0000|263 273|fibroblasts
P09098066A0119|238 240|crl
P09098899A0000|160 175|zinc-finger motif
P09098899A0435|233 238|center
P09099683A0000|129 132|acid
P09099702A0000|105 107|RTR
P09099702A0692|161 175|spermatogenesis
P09099743A0585|206 214|nucleolin
P09099745A1446|233 255|CDK inhibitor association
P09100202A0000|91 110|tissue graft procedure
P09101085A0686|96 105|cell growth
P09101910A0394|79 83|years
P09102113A0739|135 135|%
P09103382T0000|45 52|critique
P09104816A0610|100 101|VV
P09105042A1497|286 300|beta MHC function
P09105363A0636|72 96|tissue silicon measurements
P09105530A0000|62 78|cheese preparation
P09106057A0000|239 247|detection
P09108029A0399|141 154|AP endonuclease
P09108038A1128|103 117|binding proteins
P09108207A0306|42 64|oropharyngeal irritation
P09108279A0431|168 176|substrate
P09108451A0160|110 123|tumor cell lines
P09110176A0890|248 252|locus
P09111004A0732|191 209|autophosphorylation
P09111048X0000|181 193|cells/tissues
P09111059A0327|87 89|DNA
P09111309A0674|145 146|ER
P09111314A0970|49 67|184A1L5R cell lysates
P09111314A1243|237 252|kinase activation
P09111331A0119|93 99|pathway
P09111340A0240|252 254|CAT
P09111367A1098|532 538|protein
P09111863A0743|178 187|tumor cells
P09112400A1155|74 78|cells
P09112589A0078|26 32|pattern
P09114972A1366|19 27|viability
P09115242A0934|204 208|cells
P09115247A2069|273 281|imidazole
P09115265A1160|87 111|transcription factor GATA-1
P09115279A0345|95 104|Pch1 kinase
P09115357A0073|223 229|process
P09115365A0000|85 93|oncogenes
P09115395A0478|474 478|Xbr1b
P09115989A0993|76 92|initiation process
P09117345A0945|110 124|phosphorylation
P09118196A0281|186 194|education
P09118664A1734|145 154|conditions
P09118704A0771|150 166|bleomycin toxicity
P09119031A1036|207 217|sigma factor
P09119112A1350|122 125|lung
P09119391A0870|113 117|GPT-1
P09121424A0296|110 113|Sthl
P09121430A0132|113 119|residue
P09121430A1075|60 71|c-myc message
P09121432A0000|105 111|kinases
P09121433A0463|158 164|ACTACTA
P09121435A1183|75 93|protein footprinting
P09121452A0538|225 233|C/EBP site
P09121454A1328|144 165|transcription machinery
P09121476T0000|69 74|plants
P09121774A0611|88 102|MAP kinase family
P09121774T0000|103 120|cell transformation
P09121998A0663|208 210|F90
P09122168A1427|195 204|components
P09122176A0970|103 119|RA response element
P09122198A0478|106 116|conclusions
P09122215A0335|100 107|interest
P09123055T0000|60 70|HTK solution
P09123787A0486|195 204|R3 response
P09124054A1164|108 114|therapy
P09126487A1399|6 8|Hum
P09126622A0466|100 103|type
P09128730A0000|218 227|generation
P09129147A0644|125 144|phosphorylation sites
P09130595A0478|45 56|enhancer site
P09130700A0676|149 153|SPC98
P09130718A0497|106 108|ATG
P09130720A0417|116 132|intron recognition
P09131139T0000|63 69|disease
P09132011A0298|155 157|cdc
P09132057A0559|272 279|pathogen
P09132061A0828|128 131|ESTs
P09133122A0656|132 138|program
P09135066A0653|83 85|Ras
P09135149A0000|153 176|Pyp3 tyrosine phosphatases
P09135772T0000|75 82|subjects
P09135928A0912|135 143|metformin
P09136015A0529|89 103|diversification
P09136080A1469|161 164|gene
P09138076A1099|147 154|elements
P09138492A0806|189 207|epidermoid carcinoma
P09139665A0784|53 62|Gbetagamma
P09139694A0789|123 134|DNA fragments
P09139721A0183|138 146|apoptosis
P09139737A0000|255 259|acids
P09139892A1150|124 135|crp promoters
P09139910A0350|204 208|pOST2
P09139910A1572|73 77|R229I
P09140079A2528|44 46|TRE
P09140474T0000|81 85|years
P09142146A0887|155 159|hours
P09143328A1002|81 93|RNA polymerase
P09143465A0838|75 79|scale
P09144165A0614|162 189|Rel transcription factor family
P09144165A1275|91 120|AP-1 family transcription factors
P09144195A1051|100 105|PS1 CTF
P09144770A0906|77 96|FKBP12 binding surface
P09144958A0047|139 149|phytochrome
P09146027A0809|79 82|neck
P09146071T0001|51 66|pontine hemorrhag
P09147420A0623|68 75|HIV-1 LTR
P09147420T0000|94 115|cytomegalovirus IE1/IE2
P09147788A0458|11 29|chain enzyme activity
P09147832A0174|156 163|measures
P09148770A0977|84 95|Csk SH2 domain
P09148903A1715|246 252|pathway
P09148929A0372|106 114|Ctpct gene
P09148935A0805|127 155|c-Src binding site Phe-397 mutant
P09149825A0151|85 94|bone cement
P09149929A0750|95 104|separation
P09150334A0559|71 78|sampling
P09150566A0316|82 87|clouds
P09150595A0225|206 211|domain
P09150595T0000|113 120|reaction
P09150728A0596|86 91|muscle
P09150774A0616|49 58|inhalation
P09151152A0174|204 219|serum lipoprotein
P09151376A0000|166 169|gout
P09151806A1125|78 88|branch point
P09151828A0919|88 94|regions
P09151837A0723|222 252|transcription-translation system
P09151925A0479|131 134|PEIT
P09152656A0149|110 114|study
P09153010A0499|291 302|laboratories
P09153319A0844|96 100|water
P09153319A1332|162 187|control phosphorothioate ODN
P09153348A0647|175 187|HIV-infection
P09153795A0298|55 62|validity
P09154283A0307|127 136|dipivefrin
P09154621A1475|149 155|effects
P09154795A0628|111 122|gene promoter
P09154797A0777|124 129|strain
P09154819A0501|93 110|fibroblast cell line
P09154822T0000|79 83|cells
P09154827A0158|184 191|degrees C
P09155015A0140|151 161|hypertrophy
P09155024A0955|113 117|media
P09156883A0294|132 140|procedure
P09157100A0583|79 88|extinction
P09157337A0545|107 111|years
P09157760A0000|178 188|individuals
P09159111A0437|105 112|proteins
P09159160A0000|91 98|diseases
P09159183A0119|145 150|plants
P09160361A0858|55 55|%
P09160881A0491|94 105|interactions
P09162084A0956|84 108|GST-Src-SH2 affinity matrix
P09162092A0675|103 107|MEKK2
P09162097A0776|163 172|L-selectin
P09162097A1258|167 176|structures
P09163332A0275|133 142|efficiency
P09164543A0219|183 190|drainage
P09164856A0980|117 124|promoter
P09165004A1700|119 123|Elk-1
P09165035A0842|164 170|animals
P09165039A0728|75 82|LHR cDNAs
P09165039A1372|101 107|species
P09165118A0311|176 189|movement defect
P09167421A0234|108 116|fractions
P09168083A0987|30 30|P
P09168134A0858|151 165|snRNP components
P09168218A0216|153 165|ganglion block
P09168511A0640|146 153|steroids
P09168623A0614|161 169|succinate
P09168879A0219|82 90|TAAG sites
P09168892A1016|71 86|trans-activation
P09169127A0371|287 290|exon
P09169420A0000|149 151|PIK
P09169475A0272|81 108|transcription initiation sites
P09169475A0772|130 142|STAT complexes
P09169593T0000|153 166|gene expression
P09169852A0235|184 191|tyrosine
P09169853A0000|87 90|tube
P09170159A0348|77 86|tyrosinase
P09170159A0721|107 118|Zip structure
P09171038A0219|123 130|patients
P09171081T0000|86 106|plant Chenopodium album
P09171235A0851|127 132|TRbeta
P09171239A1118|163 166|AF-2
P09171239A2146|104 114|heterodimer
P09171363A0149|15 24|mechanisms
P09171389A0549|261 277|pyr gene expression
P09171468T0000|49 66|breathing apparatus
P09171969A1165|144 147|COPD
P09172312T0000|56 68|chicken genome
P09172414A0000|128 141|liver esterases
P09172641A0181|110 120|nucleotides
P09172812A0660|50 52|CLL
P09173733A0404|232 240|densities
P09174049A1788|145 153|cell death
P09175708A1526|158 164|nucleus
P09175858A1449|189 195|account
P09176340A1194|109 113|liver
P09176837A0211|117 131|P administration
P09177169A0935|86 93|bacteria
P09177857A0000|159 188|chemical vapour deposition method
P09178269A0107|6 10|genes
P09178491A0262|103 118|initiator element
P09178494A1123|255 265|replication
P09178752A0574|99 100|ER
P09180687A0096|142 167|alanine substitution mutants
P09181130A1067|113 114|r5
P09181130A1587a|180 191|inactivation
P09182281A0197|77 80|drug
P09182527A0443|87 92|Nedd-4
P09182707A0254|164 178|protein paxillin
P09182990A0245|195 199|yeast
P09183145T0001|138 146|infarctio
P09183406A0637|53 67|incompatibility
P09185183A0089|67 80|motor abilities
P09185183T0000|102 107|matter
P09185586A0000|53 61|mechanism
P09185645T0000|112 124|artery disease
P09186056A0514|118 125|enhancer
P09186430A0341|37 44|albinism
P09186507A0882|284 287|gene
P09187136A0000|178 178|X
P09187277A0118|95 98|type
P09187371A0450|128 132|liver
P09187637A1199|59 61|OP4
P09188094A0934|81 86|stress
P09188699A1388|99 110|SDS-PAGE gels
P09188863A0954|63 79|cell proliferation
P09189783A0000|179 182|rest
P09189896A0611|97 108|instructions
P09190202A0166|146 149|p150
P09190821A0707|70 74|P243L
P09190940A0127|97 105|switching
P09191052A0850|55 65|Hox proteins
P09192732A1384|109 112|part
P09192769T0000|120 124|CCR-4
P09192786T0000|61 82|blood group polymorphism
P09192842A0988|215 228|carcinogenesis
P09192998A0356|169 177|CJ signals
P09193072A0199|53 61|nucleolus
P09193077A0000|130 148|Petroselinum crispum
P09193080A0904|88 93|probes
P09193671A0347|66 72|ARF-GDP
P09194250A0708|129 140|inequalities
P09195923A0125|210 215|region
P09197241A0770|121 125|c-fgr
P09197342T0000|80 86|rabbits
P09197408A0126|274 282|activator
P09199167A0942|48 52|Vti1p
P09199286A0086|74 80|protein
P09199292A0536|111 117|kinases
P09199318A1147|62 80|muscle alpha-actinin
P09199322T0000|64 82|replication protein A
P09199327A1250|182 188|binding
P09199328T0000|71 73|DNA
P09199348A0156|168 175|analysis
P09199353A1924|180 190|replication
P09199413A0518|105 108|days
P09199626A0613|25 29|stage
P09199932A1357|225 228|exon
P09199970A1101|94 104|C3b cleavage
P09200029A0211|108 128|bone marrow examination
P09200498T0000|56 64|stability
P09200530A0411|76 90|gradient elution
P09200811T0000|81 106|pGKL1-plasmid DNA polymerase
P09201946A0000|216 234|termination sequence
P09201980A0910|73 79|species
P09202147A0866|137 142|stress
P09202669A0614|150 153|neoR
P09202669A1530|53 68|rat preproinsulin
P09202859A0091|84 87|PLAP
P09203585A0660|82 103|neo replacement cassette
P09203586A1197|93 109|activation process
P09203731A0497|168 179|transmission
P09204566T0000|65 96|Rhizobium leguminosarum strain VF39
P09204570A0110|59 59|J
P09205113A0587|134 146|mouse germ line
P09205677A0577|74 80|disease
P09205965A1249|144 169|spinal alpha 1-adrenoceptors
P09206230A0000|71 81|astigmatism
P09206968A0000|136 146|homeostasis
P09208214A0572|66 70|cases
P09208930T0000|111 119|proteases
P09209031A0350|49 71|serine carboxypeptidases
P09209312A0968|85 91|complex
P09209372A0345|160 167|affinity
P09209406A1021|110 118|c-cbl gene
P09209438A0994|132 139|GATA site
P09210012A0000|51 57|couples
P09210478A0000|110 114|genes
P09211354A0000|109 120|organ tissues
P09211605A0478|24 36|extensibility
P09211675A0392|327 342|hospitalizations
P09211913A0000|259 271|concentration
P09211934A0722|43 48|region
P09211981A0526|183 186|cdc2
P09212059A1356|126 139|hLBD constructs
P09212059A1856|231 246|homodimerization
P09212063A0425|103 109|VDR gene
P09214274T0001|67 84|metastasis resectio
P09215525A0581|93 105|C2C12 myocytes
P09215891A0000|121 128|function
P09216017A0621|51 55|holes
P09216936T0000|67 72|humans
P09218436A0443|103 107|sites
P09218459A0000|166 170|genes
P09218520A0075|102 106|IL-1R
P09218599A0184|84 87|IL-4
P09218775A0000|111 118|alginate
P09218775A1229|100 114|algD-xylE fusion
P09219526A0383|186 191|region
P09220158A0537|185 192|Sf9 cells
P09220177A0564|136 148|cardioversion
P09222057A0176|93 96|days
P09222115A0545|203 214|surroundings
P09223042A0000|71 75|drugs
P09223122A0774|46 51|groups
P09223229A0565|70 76|TATA box
P09223475A0898|198 208|IE86 protein
P09223479A1193|166 168|EBV
P09223506T0000|114 129|virus infectivity
P09223647T0000|128 137|activation
P09223667A0139|179 191|CTCCC sequence
P09223880A1147|65 74|anesthesia
P09224655T0000|118 123|ClC-6c
P09224811A0000|246 259|P450R mRNA level
P09225151T0000|109 119|wall defects
P09225506A0462|93 102|index group
P09225682A0579|143 148|Fisher
P09225686A0683|108 114|surgery
P09225998A0000|179 191|phase proteins
P09226113A0857|43 50|borehole
P09226345A0436|154 164|requirement
P09227099A0106|195 202|accuracy
P09227332A1798|85 91|effects
P09227799A0254|191 194|COPT
P09228042A0109|226 230|steps
P09228092A1779|135 139|exons
P09228202A0581|245 248|rats
P09229420A0158|141 154|chondromatosis
P09229595A0618|70 76|studies
P09230129A0039|223 228|enzyme
P09230216T0000|97 102|cancer
P09230307A0329|83 87|cells
P09230384A0725|93 96|days
P09230384A1056|180 184|sites
P09230894A0422|18 24|KmMig1p
P09230945A0089|57 60|slip
P09230986A0000|82 89|children
P09232593A0946|103 107|roles
P09233487A1386|119 127|Prom-EABR
P09233772A0136|437 462|E3 ubiquitin-protein ligases
P09233801A1180|89 96|receptor
P09233809A0381|191 200|regulation
P09233809A0815|217 225|intestine
P09233811A0072|101 114|protein Mat1-Mc
P09234677A0770|115 125|respiration
P09234690A0242|171 177|protein
P09234696A0238|79 85|kinases
P09234703A0192|57 61|Cdc42
P09234713A0754|171 177|Jdelta1
P09234717A0000|221 238|signal transduction
P09234720A1015|166 181|neurite outgrowth
P09234723A0846|92 101|splice site
P09234725A1892|111 122|AP-1 activity
P09234727A0770|99 109|DNA elements
P09234736A0999|202 212|goblet cells
P09234743A0475|121 135|binding proteins
P09235073A0000|52 65|Weaver syndrome
P09235424A1200|75 80|effect
P09235618A0000|255 266|erythrocytes
P09235995A0339|7 18|Biochemistry
P09235998A0788|114 129|HMG-CoA reductase
P09236118A1455|159 188|nucleoprotein activation complex
P09236224A0939|127 140|differentiatio
P09236441A0639|138 146|breathing
P09236656A0124|92 94|day
P09237695A0000|80 93|virus infection
P09237862A0782|94 97|iris
P09238467A0763|39 50|phentolamine
P09238850A0785|77 88|feedback loop
P09238850A2042|88 90|SCN
P09238860A0175|159 172|protein kinase A
P09238860A1974|179 192|protein kinase C
P09239635A0477|80 87|serum IgA
P09241092A1108|215 222|reaction
P09241232A0653|89 92|AP/C
P09241232A1154|86 89|Ogg1
P09242375A1313|211 224|MEN2B mutations
P09242499A0505|124 128|sites
P09242506A1033|62 71|DP proteins
P09242551A0653|155 167|lymphoma cells
P09243267A0401|141 144|RPCI
P09243385A1314|76 89|PC velocity data
P09243505A1194|272 279|proteins
P09243587A0000|160 192|abortion increases breast cancer risk
P09243840A0663|111 133|DNA Laboratory structures
P09244100A0194|33 38|groups
P09244282A1371|95 108|pec-1 phenotype
P09244350A0000|121 137|breast cancer cells
P09244430A0693|102 106|exons
P09246343T0000|19 21|man
P09246585T0000|26 35|cancer pain
P09247645A0000|258 263|sec4-8
P09248639A0152|182 185|FPCL
P09249039A0124|115 125|vertebrates
P09249070A0989|0 3|Cell
P09249710A0331|60 95|plaque reduction neutralization testing
P09250554A0402|91 97|therapy
P09251843A0189|157 164|lymphoma
P09252397A0081|217 224|promoter
P09252406A0511|156 159|SHP2
P09252879A0470|119 130|significance
P09254678A0106|270 276|PLP gene
P09254709T0000|65 78|amyO target site
P09255349A0836|60 63|IRA2
P09256973A0455|90 94|weeks
P09256973A0673|140 144|hours
P09257651T0000|105 109|Prp3p
P09257887A0457|103 117|neutrophil count
P09258439A1001|72 82|mutagenesis
P09258606A0822|87 96|malignancy
P09259052A0568|190 193|cJun
P09259313A0950|60 73|PRL stimulation
P09259315A0809|187 193|GC cells
P09259320A0830|89 92|DSBP
P09259328A0440|176 193|luciferase activity
P09261155A0833|133 137|IRS-3
P09261178T0000|44 47|gene
P09261184A0170|120 123|NF-Y
P09261200T0001|37 49|FLAIR techniqu
P09261397A0509|115 118|FeFV
P09263010T0000|102 106|bcl-2
P09263094A0799|330 331|mL
P09263856A0563|112 121|structures
P09264466A0947|104 118|phosphorylation
P09265534A0455|12 32|Gy/20 fractions/5 weeks
P09265642A0668|141 150|sop mutants
P09265932A0575|70 83|L2-3 interspace
P09267306A0381|158 169|laboratories
P09267431A0000|51 64|protein kinases
P09267439A0000|119 127|organisms
P09267542A0126|80 96|alcohol dependence
P09268298T0000|26 46|fungus Phaeosphaeria sp
P09268387A0293|128 144|elongation complex
P09268578A0225|83 85|mud
P09268631A0316|84 88|Igf2r
P09268638A0332|76 81|D8S285
P09268652A0116|86 90|dsRNA
P09268661A1405|113 123|CCA sequence
P09269879A0266|67 85|elimination profiles
P09269900A1035|153 160|response
P09271393A1333|194 215|transcription machinery
P09271394A0558|120 125|region
P09271397A1596|177 183|fashion
P09271400A0475|107 123|growth stimulation
P09271417A0585|120 124|acids
P09271417A1011|85 94|COS-7 cells
P09271496T0000|105 123|photo-cross-linking
P09272108A1295a|78 90|CAAT sequences
P09272108A1295b|78 90|CAAT sequences
P09272138A1153|144 144|P
P09275159T0000|81 102|mouse hepatitis virus RNA
P09275164A0000|160 176|methyltransferase
P09275990A0938|145 150|diesel
P09276882A0479|116 137|% carbohydrate treatment
P09277472A1070|85 92|DC shocks
P09277629A0268|88 97|memory task
P09278441A0163|0 3|Biol
P09278441A1160|199 209|development
P09278441A1777|82 100|factor transcription
P09278445T0000|40 57|yeast RNA polymerase
P09278450A1338|90 99|NF1 protein
P09278454A1261|128 160|DMS protection footprinting analysis
P09278475A0465|88 95|rpo26-31
P09278494A0762|80 94|Surf-1 direction
P09278758A1636|199 203|sites
P09279379A0310|120 133|H2B histone gene
P09279889A1124|105 117|% Azone systems
P09280747A0195|169 181|ACE inhibitors
P09282329A0527|205 219|progenitor cells
P09282911A0277|139 148|regulation
P09282985A0961|52 66|characteristics
P09283828A0484|48 51|cues
P09285715A1257|193 202|mRNA export
P09285789A0712|134 144|repeat units
P09286115T0000|96 104|RPL21 gene
P09286981A0147|71 72|Da
P09287036A0457|103 107|ng/ml
P09287352A0930|256 264|% increase
P09287362A0589|113 120|PTP-PEST
P09288848A0780|15 25|HbO2 changes
P09288916T0000|135 145|kidney cells
P09290207A0731|45 58|mating type loci
P09290571A0420|76 78|EPS
P09290571A0799|45 48|msec
P09291077T0000|39 49|shepherd dog
P09291098A0452|133 142|rat GGT gene
P09291098T0000|105 114|liver cells
P09292499A0887|127 158|UV crosslinking/competition assays
P09293006A1412|69 81|aphII promoter
P09294139A0729|242 252|possibility
P09294161A0650|156 161|assays
P09294161A1103|116 124|promoters
P09294262A0885|138 146|promoters
P09294422A1223|144 151|activity
P09294422A1376|187 190|form
P09294452A2107|64 83|reporter enzyme levels
P09294453A0949|77 94|T beta L biosynthesis
P09294471A1198|131 134|data
P09296251A0163|68 71|data
P09297698A0933|130 140|enolase gene
P09299696A1074|185 201|cryptosporidiosis
P09300323A1182|181 183|NTG
P09300697A0000|90 98|molecules
P09300698A1219|108 115|peptides
P09301114A0573|10 10|H
P09301350A0946|276 298|mean treatment difference
P09303437A0875|217 233|CAT gene expression
P09303635A0000|87 92|enzyme
P09304123A0079|158 165|material
P09305592A0000|103 113|p210bcr/abl
P09305631A0770|71 79|cell death
P09305755A0540|195 197|AP2
P09305870A0894|186 197|glycophorin C
P09305944A0621|197 209|GTP hydrolysis
P09307065A0553|217 222|microM
P09307312A0172|233 236|data
P09308234A0225|73 80|promoter
P09308738A1216|125 160|factor VIII/von Willebrand factor levels
P09309457A0680|158 163|months
P09310836A1019|109 116|elements
P09311164A0245|68 76|motor unit
P09311568A0595|51 51|G
P09311796A0218|123 141|transcription factor
P09311808A0341|31 40|p4 molecule
P09311810A0814|174 188|alpha0 sequences
P09311835A0147|152 167|ATP binding pocket
P09312025A0373|163 168|mutant
P09312025T0000|111 129|NF-kappaB activation
P09312028A0975|130 143|RAR AF-2 domains
P09312032A0165|112 124|intron lariats
P09312087A0000|344 350|Tyr-686
P09313755A0816|52 58|factors
P09314306A0571|45 48|g/dL
P09314487T0000|62 84|polymerase chain reaction
P09314537A1600|52 70|ezrin binding protein
P09314554A0149|199 232|influenza A PR/8/34 nucleoprotein gene
P09314570A0153|129 138|activities
P09315631A1064|181 187|mutants
P09315632A1137|188 196|neoplasia
P09315633A0333|91 94|IRFs
P09315651T0000|59 69|chick retina
P09315678A0278|186 186|U
P09316937A0133|84 110|API 20E identification systems
P09317131A0000|84 90|CH genes
P09317131A1332|132 146|IgE germline gene
P09317757T0000|77 85|LOCOMOTIO
P09317830T0000|27 32|CICADA
P09321406T0000|89 97|chromatin
P09321657A0439|185 190|effect
P09321930A0567|225 238|binding protein
P09322738A0510|98 107|S. lividans
P09322872A0745|90 102|recombination
P09323366A0000|110 121|growth medium
P09323366A0299|114 117|gene
P09323612A0374|206 222|language disorders
P09324720A0317|43 48|Alzoon
P09324878A0952|114 128|type B dissection
P09324922T0065|63 74|acid bacteria
P09324988X0000|55 60|series
P09325022A0192|105 110|microm
P09325135A0737|51 51|%
P09325273A1240|291 313|ubiquitin fusion proteins
P09325278A0458|196 224|Caenorhabditis elegans sequence
P09325284A0469|64 77|progelatinase B
P09325322A1293|92 110|InsP3 concentrations
P09326163A0942|74 76|% CI
P09326246A0567|139 155|bp reporter plasmid
P09326263A0410|230 231|1B
P09326317A0372|95 109|linkage analysis
P09326727T0000|31 40|injections
P09327881T0000|89 96|primates
P09328341A1449|132 146|transactivation
P09328343A0181|152 157|family
P09328349A1679|108 119|trophoblasts
P09328476A0068|105 115|spliceosome
P09328476A0374|67 85|splicing factor Prp3p
P09328824A0000|212 224|acid receptors
P09328833A0588|40 55|MCF-7 cDNA library
P09331119A0659|91 96|cycles
P09331864A0230|218 227|Finaplix-H
P09331864A0848|81 83|MGA
P09333018A0000|101 119|transcription factor
P09333026A0397|144 153|divergence
P09333026A0851|209 220|growth factor
P09333168A0310|90 92|men
P09333231T0018|16 22|species
P09334264A0540|90 93|mass
P09334330A0252|267 282|dauer development
P09334331A0910|110 113|Vein
P09334475A0327|265 276|thrombolysis
P09335267A0142|182 187|genome
P09335298A0529|70 70|M
P09335298A1227|250 255|operon
P09335298A2129|181 196|ParE toxin protein
P09335608T0000|96 114|chain gene transcript
P09335619A0583|243 252|orf221 gene
P09336455A0000|126 134|radiation
P09337861T0000|87 105|inhibitor wortmannin
P09338414A0430|94 107|thermodilution
P09339900A0939|185 194|expression
P09340641T0001|33 44|nCPAP pressur
P09341139A0690|127 139|beta-arrestin
P09341158A0167|175 188|sorting signals
P09341182A0605|83 94|PLZF-BTB/POZ
P09341192T0000|65 85|tyrosine kinase pathway
P09341193A0362|103 119|Tax responsiveness
P09343208A1405|236 240|wasps
P09343210A1112|287 302|adhesion molecule
P09343222A0415|48 48|%
P09343398A1193|153 161|structure
P09343426A0456|95 104|D-A complex
P09343432A0209|129 136|C termini
P09343433A0000|121 134|yeast telomeres
P09343433A0360|86 89|ADE2
P09343982A0890|93 100|controls
P09344650A0967|70 77|Casr-rs1
P09345037A0886|78 104|progenitor cell proliferation
P09345495A0000|50 62|brain function
P09346238T0000|65 90|SCF ubiquitin-ligase complex
P09346621A1181|131 138|APACHE II
P09346925A0660|149 157|Cos1 cells
P09346935A0459|204 207|form
P09346935A0927|250 277|KRAB multifinger protein family
P09346938A1680|127 150|cathepsin B mRNA expression
P09346953A0000|269 269|N
P09348226A0852|93 98|Crk-II
P09348931T0000|10 16|lottery
P09349501A0196|182 195|leukemogenesis
P09349967A0653|89 100|lamellar bone
P09351242A0719|211 231|aba1 Arabidopsis mutant
P09351823A0414|110 120|development
P09352016A1110|56 58|CAM
P09352127A0953|130 136|failure
P09353247A0922|122 130|inhibitor
P09353255A0159|103 114|pore proteins
P09353296A0510|158 165|cistrons
P09353304A0732|66 81|membrane ruffling
P09353328A0736|112 119|proteins
P09353343A0919|116 129|hnRNP A1 binding
P09353343T0000|87 98|T lymphocytes
P09354349A0338|211 218|DAKO B471
P09354644A0124|105 107|Gal
P09354676A1714|177 189|tumorigenesis
P09354684A1158|55 70|promoter activity
P09354757A1444|117 121|dsDNA
P09356645A0672|76 91|nerve enlargement
P09358045A0000|119 139|nematode Brugia pahangi
P09358055A0590|113 123|A-particles
P09358069T0000|77 81|cells
P09358837T0000|62 73|hypertension
P09359844A0674|43 52|adipocytes
P09359887A1168|105 113|sequences
P09360422A0135|237 246|volunteers
P09360953A1057|145 157|PTH-1 receptor
P09360956A0840|145 162|signal transduction
P09360993T0000|110 118|mast cells
P09361007A0922|56 73|pair enhancer region
P09362105X0422|123 125|HPV
P09362473A1540|271 291|twist expression domain
P09362480A0452|95 104|C-terminus
P09362499A0000|117 124|enhancer
P09363759A0000|78 95|signal transduction
P09364211A0319|68 74|binding
P09364440A2206|102 110|effectors
P09364750T0000|35 39|SUP45
P09365201A2018|123 126|ASCs
P09365272T0000|77 94|Xenopus egg extracts
P09365431A0314|50 91|acetylcholinesterase inhibitor physostigmine
P09366456A0234|147 158|body mas index
P09366517A0835|118 125|activity
P09366517A1828|73 87|phosphorylation
P09366628T0000|53 59|studies
P09367288A0115|145 155|adaptations
P09367392A0567|149 154|levels
P09367426A1354|134 145|polarization
P09367676A0275|129 139|mouse TS mRNA
P09367676A1115|135 142|elements
P09368006A1332|113 117|E2F-1
P09368014A0740|36 37|PU
P09368026A0000|93 106|mineralization
P09368026A0435|114 132|MC3T3-E1 osteoblasts
P09368057A1083|152 161|SRF binding
P09368058A0969|184 187|site
P09368097T0000|3 5|pen
P09368100A1354|42 46|exons
P09368190A1053|178 186|IFN-alpha
P09368419A0000|136 149|gene expression
P09368419A0628|123 129|rd22BP1
P09368760A0665|127 141|spermatogenesis
P09369450A1358|267 292|steroid receptor coactivator
P09369451A0693|183 192|OP-1 effect
P09369453A0273|182 189|envelope
P09369482A0690|118 137|G6Pase gene expression
P09370276A0781|38 53|amino acid protein
P09370307A0093|150 167|DNA binding proteins
P09371431A1172|83 100|thiCOGE gene cluster
P09371431T0000|90 102|Rhizobium etli
P09371455A0000|107 122|Vibrio cholerae O1
P09371564A0713|67 73|viruses
P09371566A1384|75 93|protein preparations
P09371596T0000|97 115|receptor superfamily
P09371612A1964|0 3|Acad
P09371622A0779|89 108|lac operator sequences
P09371626A1345|202 210|synthesis
P09371657A0165|110 132|triphosphatase component
P09371698A1254|192 196|sites
P09371731A0627|41 57|eIF-2alpha kinases
P09372287A0296|161 165|axons
P09372451T0000|105 111|subunit
P09372908A1068|185 193|silencing
P09372924A0758|173 175|XPC
P09372937T0000|49 66|partitions plasmids
P09372950A1283|136 140|U2 RNA
P09372960A0456|116 123|subunits
P09372968A0532|127 133|protein
P09372968A0996|112 116|Dlc-1
P09373140A0000|83 96|gene regulation
P09373155T0000|103 112|dynein gene
P09373651A0255|89 103|hydrogen cyanide
P09374082A0504|288 293|asthma
P09374541A0277|9 27|protein binding sites
P09374541T0000|86 105|cell cycle progression
P09376325A0167|98 115|transcription units
P09376626A0737|79 91|h postexposure
P09376782A0328|77 85|infection
P09377355A0362|148 152|tools
P09377374A0000|100 109|narcomania
P09379301A2036|70 79|proglottis
P09380504A1255|150 161|actinomycin D
P09380507A0514|108 137|DNA polymerase alpha gene promoter
P09380697T0000|124 134|cholesterol
P09380707A0714|106 109|dots
P09381261A0970|102 105|ones
P09381950A0209|80 90|reperfusion
P09382498A0618|77 81|tumor
P09382850A0000|69 78|DNA lesions
P09382886A1061|130 133|mice
P09382924A0131|237 241|PSMB7
P09383156A0691|91 96|PNPase
P09383188A0654|72 75|site
P09385169T0000|24 45|productivity indicators
P09386074A0694|78 78|%
P09387333T0001|51 56|nucleu
P09387999A1053|103 106|ears
P09388198A1396|164 177|autoregulation
P09388199A0948|151 157|regions
P09388200A0639|118 126|promoters
P09388201A1027|33 42|CAAT motifs
P09388246A0903|151 163|intermediates
P09388271A1243|138 149|kinase kinase
P09389137A0763|46 49|L2-4
P09389198A0363|139 147|threshold
P09389492A0520|120 127|activity
P09389666A0538|215 229|endoderm lineage
P09389669A1009|78 89|leg disc cells
P09389982A1383|124 141|regression analysis
P09390125A0379|78 85|quarters
P09390183A1027|147 149|kDa
P09391173A0811|121 128|cDNA ends
P09392979T0000|53 62|California
P09393706A1171|57 64|promoter
P09393717A1517|154 162|mutC cells
P09393771A1659|87 88|Mr
P09393875A0873|201 216|Fos protein levels
P09393966A0190|46 48|CHB
P09394650A0121|101 102|US
P09395456A0424|161 173|signal peptide
P09395470A0294|95 112|glycosylation sites
P09395525A0395|187 190|site
P09396402A0264|163 174|radiotherapy
P09396427A1488|170 177|geometry
P09396437A0878|102 102|P
P09396722A0185|85 96|organization
P09396796A1173|93 111|cell cycle regulation
P09396823T0000|69 89|RNA exonuclease domains
P09397261A0940|43 48|course
P09397723T0001|40 45|counci
P09398267A0440|142 148|species
P09398332A0732|184 198|CTLA-4 signaling
P09398598A0256|176 184|multimers
P09398855A0438|239 245|absence
P09400613A0594|286 298|lacZ reporters
P09400613A1209|81 91|PKR homologs
P09400738A1046|92 105|CB instillation
P09402029A1632|204 214|strain H37Rv
P09402088A2250|84 99|AVP gene precursor
P09402139A1121|239 255|glucose metabolism
P09403059A0209|68 100|medium reiteration frequency repeats
P09404725A0644|83 91|exception
P09405195A0320|149 162|intron excision
P09405380A0800|108 117|retrovirus
P09405536A0777|226 232|plateau
P09405685A0113|136 144|GPyPyPy-3
P09407026A0426|286 292|factors
P09407031A0557|135 148|Cdc2 activation
P09407031A0974|69 79|crb2 mutants
P09407036T0000|80 93|gene expression
P09407090T0000|46 54|SR-BI/CLA
P09407642A0305|65 78|identification
P09408516T0000|64 69|months
P09408796A0648|146 156|CVLT indices
P09409416A0111|93 102|TC-2 64B EME
P09409774A0214|148 156|VCSB1 gene
P09409821T0000|125 154|postreplication repair mechanism
P09411459A0729|190 201|CVCC material
P09412079T0001|36 47|stomach ulcer
P09413375A1486|106 114|cytokines
P09414074A0827|180 182|SSP
P09414287A0637|53 59|element
P09414319A1442|61 66|Surf-5
P09415711A1348|140 156|CRE binding protein
P09416467A0959|201 206|effect
P09416898A1798|91 98|subjects
P09417082A0127|40 56|urokinase receptor
P09417108A0000|81 88|promoter
P09417493A0823|123 137|prostaglandin E2
P09417870A0105|153 165|melanogenesis
P09417928A0980|117 123|binding
P09417941A1287|164 167|face
P09418040T0000|224 227|CHL I
P09418057A0684|45 53|locations
P09418861A0623|107 130|pleckstrin homology domain
P09418871A0620|50 81|coimmunoprecipitation experiments
P09418882A0760|103 115|yeast extracts
P09418905A1396|186 188|PKC
P09419415A0236|106 117|oncoproteins
P09419421A0385|90 95|S phase
P09419680A1112|115 131|irradiation injury
P09420219A0284|274 279|genome
P09420220A0070|125 125|J
P09420234A0654|87 105|chaperonin-60 family
P09420239A1937|266 283|glycosylation sites
P09420251A1363|0 0|C
P09420252A0092|189 205|auxiliary proteins
P09420269A0000|273 279|strands
P09420275A0682|170 178|sequences
P09420275A1111|60 72|CD23 promoters
P09420671A1190|141 155|adenosine stress
P09421507A0000|122 130|organisms
P09421508A0696|107 123|transfection assay
P09421511A0827|146 161|template sequence
P09421516A1516|186 202|deadenylation step
P09421521T0000|88 104|CCE1 homologue YDC2
P09422351A0000|169 188|transcription factors
P09422727A0196|227 233|process
P09423123A0000|39 48|oxygenator
P09423310A0251|208 212|cysts
P09423856A1098|249 257|molecules
P09423968A0039|254 257|rats
P09424012A1774|136 141|degree
P09425036A0649|122 133|Csk substrate
P09425038A0752|3 7|Swift
P09425676A0000|117 123|monkeys
P09426068A0826|166 174|c-myc HCCs
P09426143A1358|255 265|target genes
P09426183A0000|180 187|location
P09426239A0386|97 114|restriction enzymes
P09426595T0000|102 117|characterization
P09426907A0391|96 104|poloxamer
P09426958A0110|67 84|corneal cDNA library
P09427544A0000|130 133|TK24
P09427551A0501|93 107|linkage analysis
P09427627A0802|121 126|manner
P09427627A0930|145 150|FK1012
P09427627T0000|66 83|membrane attachment
P09427844A0739|147 150|dCyd
P09428389A1805|188 198|monotherapy
P09428787A0138|85 108|p69/71 2-5A synthetase gene
P09428799A0897|141 147|P450scc
P09429913A0528|127 135|disorders
P09430461A0742|460 469|infarction
P09430661A0796|125 147|cell attachment responses
P09430668A0172a|98 103|SREBPs
P09430730A0374|13 13|P
P09431812A0576|126 132|S2 cells
P09431828A1472|94 98|range
P09432752A0109|142 148|patient
P09434160A0767|54 72|bone marrow stem cells
P09434160A2078|89 97|stem cells
P09434185A0902|169 177|DNA phages
P09434979A0790|142 150|isocenter
P09435056A0128|202 204|MBP
P09435116A0437|49 85|trofluoroacetyl-biphenylol derivatives
P09435789A0961a|216 224|DNA damage
P09435806T0001|79 83|CA125
P09436657A0303|156 164|knowledge
P09436706A0168|239 252|gonadotrophins
P09436795A0350|128 135|children
P09436989A1011|135 160|spindle pole body duplication
P09437001A0769|86 93|degrees C
P09438165A0405|83 98|VOD manifestation
P09438427A0727|154 161|mutation
P09438427T0000|87 95|Hoxa1 gene
P09440166A0857|178 181|tail
P09440616A0422|20 29|activities
P09441664A0377|175 179|genes
P09441746A0546|56 60|GPR39
P09442017A0435|6 12|Science
P09442024A0236|10 10|J
P09442024A0708|169 177|O-glycans
P09442031A0586|190 196|residue
P09442072A0716|229 231|DNA
P09442080A0856|170 183|domain residues
P09442172A0908|128 140|pregnancy rate
P09443948A0000|217 225|Argentina
P09443972A1145|112 116|genes
P09443973A1028|42 50|tif1-A79V
P09443978A0262|172 180|initiator
P09444316A0388|90 92|sex
P09445056A0215|120 131|gp41 oligomer
P09445488A0230|154 173|Alu-PCR hybridization
P09445488A1169|168 180|DNA binding/EF
P09446600A0260|118 123|manner
P09446616A0780|70 78|cell lines
P09446815A1021|61 62|bp
P09447917A0000|23 30|Brain Res
P09447962A0452|20 25|rhis4l
P09447962A1027|226 238|HIS4 mRNA level
P09447963A0223|81 86|family
P09447973A0168|181 188|activity
P09447979A1430|104 107|GNEF
P09447994A0000|214 220|stimuli
P09448268A0186|68 71|gene
P09448574A0964|147 159|system atrophy
P09449018T0000|41 47|drug use
P09450932A0142|110 121|DNA synthesis
P09451003A0894|154 168|CRP-cAMP complex
P09451016A1037|185 188|gene
P09451857T0001|88 91|bloo
P09452421A1042|100 102|Tyr
P09452444A0000|113 125|hematopoiesis
P09452444A0450|134 153|transcription factors
P09453537A0863|102 104|SP1
P09453689A0000|146 168|bladder function recovery
P09454719A0181|240 245|vector
P09454735A1782|138 149|cell motility
P09455695A0762|79 95|vitamin E treatment
P09456312A1064|72 89|localization signal
P09458021A1373|32 40|AZA groups
P09458030A0192|54 74|bone mineral metabolism
P09459241A0707|39 42|mm Hg
P09459685T0001|76 83|children
P09459835A0297|65 69|FPMPA
P09460171T0000|82 105|thyroid hormone disruptors
P09461594A0000|186 213|inositol phospholipid turnover
P09463174A0670|85 90|months
P09463380A1050|76 80|Smad1
P09463560A0124|30 37|patients
P09463964A0243|140 148|antiserum
P09463991T0000|11 15|audit
P09464248A0289|10 16|TATA box
P09464525T0000|96 105|antibodies
P09465035A1032|81 88|activity
P09465783A0449|94 96|ASA
P09466267A1192|81 99|dmsA-lacZ expression
P09466931T0000|87 104|ng-2 intermolt genes
P09467044A0973|63 73|MGDET groups
P09467707T0000|119 136|Bogalusa Heart Study
P09467900A0701|186 198|binding domain
P09467955A0468|88 94|ability
P09468386A0594|126 131|manner
P09468509A0463|67 75|cytoplasm
P09468514A1065|81 85|heart
P09468515A0621|110 116|ability
P09469415A1337|197 205|injection
P09469820A0151|239 247|mRNA decay
P09469833A0533|78 87|bp sequence
P09469933A1060|78 83|Restin
P09471984A0000|74 90|contact dermatitis
P09472038T0000|100 108|mechanism
P09472608A0253|180 196|transfection assay
P09472616A1004|98 105|lineages
P09473040A1303a|77 83|mutants
P09473040A1303b|77 83|mutants
P09473317X2131|13 25|Academic Press
P09473483A0953|179 184|HTLV-1
P09473755A0318|50 51|St
P09474001A0825|147 147|%
P09474648A0298|71 78|controls
P09475378A1449|118 130|splice variant
P09475724T0000|51 60|cell growth
P09475898T0000|13 25|amnioinfusion
P09476399A0141|40 44|Kandy
P09476520A1326|197 205|molecules
P09477316A0140|193 199|signals
P09478921A0126|66 68|CML
P09478971A1896|129 150|mouse embryo fibroblasts
P09478976A0718|125 133|induction
P09478976T0000|97 123|metalloproteinase-1 promoter
P09479498A0000|70 76|protein
P09480831A0272|143 146|HAEC
P09480843A0848|143 149|rat RL14
P09480929T0000|106 133|baculovirus/insect cell system
P09481826T0000|83 95|somatotrophin
P09482107A0551|204 216|plasmid vector
P09482902A0423|134 136|p15
P09482902A0942|345 354|Pctr1 locus
P09483596A0626|136 150|rocuronium group
P09484463T0000|63 69|tobacco
P09484781A1233|90 96|PKB/Akt
P09485308A1165|74 81|reaction
P09485790T0000|0 22|Alison Bell Memorial Award
P09486035A0051|112 118|Lebanon
P09486531A0638|156 171|gut morphogenesis
P09486890A0234|110 122|visualization
P09487130A0383|154 157|type
P09487590A0657|33 37|weeks
P09487841A0132|89 95|changes
P09488441A0615|238 242|Bcl-3
P09488466A0695|100 128|precursor-product relationship
P09488486A0000|131 133|III
P09488486A0906|116 118|Pol
P09488491A0000|55 77|tumor suppressor proteins
P09488713A0886|104 107|SCAP
P09488725A0904|60 71|polypeptides
P09488725T0000|69 78|proton pump
P09489670A1157|253 268|Hst6p transporter
P09490676A0800|181 185|sites
P09490727A1041|106 114|apparatus
P09491074A0104|78 91|promoter region
P09492038A0352|158 170|binding assays
P09494078A1362|69 74|effect
P09495283A0000|124 128|yeast
P09495771A0379|142 150|septation
P09498553A0702|178 205|transcription initiation sites
P09498553T0000|82 98|P450 monooxygenase
P09498769A0095|175 185|plasma cells
P09499031A0000|182 193|reinitiation
P09499048A1003|120 135|replication cycle
P09499061A0000|148 157|host genome
P09499254A1309|166 178|investigation
P09501093A0071|112 132|Ras signal transduction
P09501169A0000|96 107|deacetylases
P09501982A1178|357 373|XNeuroD expression
P09502627A0705|278 283|Group B
P09502720A0214|92 98|domains
P09502720T0000|113 128|sea urchin embryos
P09503017A1021|159 180|lung carcinoma cell lines
P09503526A0614|65 90|diseases WFAg concentrations
P09504423A0114|281 294|alpha-thrombin
P09504514T0000|149 153|trial
P09504553T0000|16 23|cannabis
P09504906A0099|128 132|Hap1p
P09505135A0182|60 66|targets
P09505733A0246|154 161|patients
P09506439A2179|121 129|SVHK cells
P09506959T0000|120 129|regulators
P09506962A1000|101 103|YY1
P09506983A0304|69 80|RACE products
P09506990T0000|108 123|activator protein
P09507032A1144|117 125|apoptosis
P09508119A0498|70 77|syndrome
P09508377A0863|230 237|melanoma
P09508511A0588|109 114|urease
P09508775A0293|178 212|protooncogenes/transcription factors
P09509226A1235|189 196|outcomes
P09510189A0192|118 120|DNA
P09510398A1138|122 130|Secretion
P09510582A0157|137 141|agent
P09510925A0389|88 95|sulphate
P09511724A0483|105 109|media
P09511760A0221|221 224|ends
P09512416A0460|200 211|7TM receptors
P09512550T0000|86 92|pathway
P09512559T0000|102 117|chromosome vector
P09513759A0716|45 59|serum iPTH levels
P09514156A1147|170 174|state
P09514159A0562|54 57|Ptx1
P09514260A1083|229 236|EN motifs
P09514272A0482|100 102|P16
P09514962A0841|65 68|EL-4
P09515031A1020|79 92|SRF binding site
P09515032A1230|98 103|stages
P09515665T0000|45 64|CMV polyradiculopathy
P09515858A0000|111 121|neutrophils
P09515921A1662|76 84|pca operon
P09515924A0104|74 80|protein
P09515924A0553|123 124|Z.
P09516472A0292|87 105|Id4 promoter activity
P09517646A0149|138 151|pylori regimens
P09517989A0476|90 96|cells/l
P09518383A0000|206 212|condoms
P09518808T0000|39 54|quality assurance
P09519757A0482|160 172|heterozygotes
P09519828A0809|118 140|E2 transactivation domain
P09519830A0282|279 284|genome
P09520398A0124|74 85|core histones
P09521907A0190|99 108|phenotypes
P09521909A0081|172 177|organs
P09521913A0400|71 76|factor
P09522297A0744|87 95|karyotype
P09522979T0000|72 81|population
P09523478A0572|85 96|reactivation
P09523551A0367|81 89|receptors
P09524122A0336|65 72|RAS genes
P09524222A0769|320 342|calmodulin binding domain
P09524222A1113|153 159|tissues
P09524229A0000|337 348|cyclosporin A
P09524250A0767|40 42|AP1
P09524259A0301|168 173|system
P09524267A1023|240 249|plant cells
P09524273A0205|90 95|region
P09524276A0939|166 171|damage
P09525105A0298|85 100|glycoside linarin
P09525598A0325|126 133|activity
P09525888A1482|51 67|muscle cDNA library
P09525891T0000|106 110|CYP17
P09527921A1178|247 253|TATA box
P09528758T0000|133 137|Rox-1
P09528766A0915|95 120|CREB Ser-133 phosphorylation
P09528768A0000|133 149|chaperone proteins
P09528770A1379|216 222|acetate
P09528784A0000|74 88|complementation
P09528792A0000|178 186|cell types
P09528858A0205|86 97|gene activity
P09528950A0716|41 62|luciferase reporter gene
P09528987A1348|196 214|T/EBP gene expression
P09529156A1238|147 147|%
P09529216A0644|98 104|pedicle
P09529649A0307|68 75|children
P09529721A0000|273 281|follow-up
P09530251A0766|91 101|reperfusion
P09531538A0983|69 83|dU2AF38 RS domain
P09531549A0658|183 196|plasma membrane
P09531559A1153|132 135|ZO-2
P09533030T0000|190 194|11q23
P09533109A0449|166 177|significance
P09535082A0537|176 186|DNA fragment
P09535579A1105|130 131|kJ
P09535833A0228|128 140|Xenopus laevis
P09535835A0279|81 86|manner
P09535851A0591|142 145|acid
P09535892A0000|177 183|repeats
P09535908A0321|111 115|LNX-b
P09536028A0945|153 180|signal pathway probe inhibitors
P09536440A0000|105 112|movement
P09536901A0362|119 128|assessment
P09537295A0951|170 180|cDNA cloning
P09537295T0000|103 113|protein gene
P09537361A0149|175 183|depletion
P09537375A0198|122 130|regulator
P09537378A1227|58 75|gcv-lacZ expression
P09537651A0366|161 163|PMA
P09538156A0130|77 82|region
P09538220A0000|172 177|genome
P09538258A0200|117 121|cells
P09539421A0970|110 115|themes
P09539721A0599|88 97|pR promoter
P09539746A0781|73 77|cells
P09539779A0621|142 145|All1
P09540062A0755|190 198|cell types
P09541280A0404|85 98|plasma IgE level
P09541636T0000|74 79|tumors
P09541721A0894|106 110|LVEDP
P09543227A0815|105 105|C
P09544987A1583|57 60|NCoR
P09544991A0483|40 58|tyrosine phosphatase
P09544991A0750|194 217|transactivation potential
P09545146A0884|206 218|validation set
P09545293A0590|47 54|location
P09545312A1197|151 161|interaction
P09545323T0000|85 109|MLH1-PMS1 protein complexes
P09545332A0137|137 140|IL-4
P09545353A1071|195 204|expression
P09545638A0330a|58 61|HMT1
P09545638A0330b|58 61|HMT1
P09545638A0836|66 90|methyltransferase activity
P09545638A1181|42 48|disease
P09545638T0000|88 94|HRMT1L2
P09546424A1550|60 70|Crk proteins
P09547311A1394|245 251|domains
P09547349A0000|130 139|tumor cells
P09548481A0000|98 111|IL-5Ralpha gene
P09549179A0774|99 103|study
P09549398A1463|192 192|%
P09549632A1189|111 115|trial
P09549660A0782|71 82|data scenario
P09549783T0000|72 79|patients
P09550591A0454|131 134|OSAS
P09550919A0365|129 129|%
P09551096A0108|98 114|particle formation
P09551182A0212|209 224|DNA binding domain
P09551938A0318|79 94|CCR5 gene promoter
P09551972A1033|161 166|8q24.3
P09552469A0225|183 189|mixture
P09553040A0651|104 108|Stats
P09553134A0596|93 95|PP1
P09553143A0729|146 149|H2O2
P09553686A0000|283 289|patch 7D
P09555046A1617|140 146|mammals
P09556557A1238|21 27|regions
P09556561A0671|159 166|molecule
P09556566A0174|82 98|T cell line MT2 cells
P09556573A1062|203 206|SMRT
P09556861A1018|243 259|lipid peroxidation
P09557678A0140|181 201|G1/S phase growth arrest
P09557682A0490|161 163|LTR
P09557708A1426|148 156|vA33delta
P09557912A0699|304 314|respiration
P09560221A0282|141 150|animal CAKs
P09560325A1285|112 131|protein heterogeneity
P09560390A0771|103 108|stress
P09560430A0000|61 65|cells
P09561560A0579|217 225|positions
P09561616A0142|142 146|mg/m2
P09562398A0848|150 151|.1
P09562558T0000|86 91|family
P09564860A2139|119 126|proteins
P09564860A2315|205 220|Gs protein pathway
P09564917A0900|82 85|U/mL
P09565576T0000|28 43|DNA topoisomerase
P09565584A0770|186 204|mutagenesis analysis
P09565606A0520|115 118|site
P09566731A0458|143 148|clones
P09566871A0343|186 192|Ty1 cDNA
P09566871T0000|69 85|protein kinase Fus3
P09566876A0000|101 123|transcription activation
P09566882A0693|78 81|Pho4
P09566918A1115|178 185|elements
P09568445T0000|97 108|thrombolysis
P09568549A0188|117 125|histamine
P09570030T0000|47 57|development
P09570107A0355|52 57|boiler
P09570133A0474|140 148|promoters
P09570944T0000|91 106|chromosome 7q21.1
P09570952A0000|97 106|myofibrils
P09571563A0000|141 149|condition
P09572428A0526|153 159|ovaries
P09572491A1044|104 110|glycine
P09572511A0148|67 72|RBI-EM
P09572965A1235|135 141|species
P09572990A0630|156 162|agarose
P09573187T0000|72 83|binding sites
P09573202A0900|141 146|domain
P09573244A0523|44 67|polyadenylation site usage
P09573374A0687|182 190|structure
P09573378A0761|82 84|RNA
P09573884A0392|112 119|subjects
P09574799A1072|212 221|conditions
P09575143A1189|184 186|TCR
P09575187A1558|167 180|kappaB decoy DNA
P09575217A0000|125 133|signaling
P09575217A0971|112 136|Stat5 hyperphosphorylation
P09576230T0000|95 100|arrest
P09576915A0269|70 78|silencers
P09577365A0747|186 202|muscularis mucosae
P09577395A0000|168 176|rotations
P09578042A0363|144 146|TLE
P09578570A0200|174 180|library
P09579602A1720|130 136|results
P09579789A0974|158 165|controls
P09579808A0000|141 147|glycans
P09580062A0100|123 131|mg/kg/day
P09580563A0331|129 136|nidulans
P09580700A0841|151 162|footprinting
P09581552A1323|124 133|amino acids
P09581775A0185|180 188|signaling
P09581834A2578|204 211|G1 arrest
P09581872A0000|50 67|collagen expression
P09582267A0326|203 211|apoptosis
P09582306T0000|66 90|G protein signaling proteins
P09582308A1165|99 110|heterodimers
P09582326A0151|14 14|E
P09582327A0295|326 333|activity
P09582331A0506|134 141|elements
P09582343A0000|52 72|carcinoma cell line FM3A
P09582350A0165|140 149|activities
P09582635A0523|106 120|R.T.V. specimens
P09582953A0000|340 346|changes
P09582953A1097|138 143|horses
P09582953A1670|73 91|acute-phase proteins
P09583201A0759|9 16|patients
P09583208A0171|78 87|complement
P09583592A0263|17 25|Case study
P09583823A0238|167 176|laser group
P09584165T0000|120 130|NIH 3T3 cells
P09584179A0673|47 70|transcription factor Adf-1
P09584180A0701|120 139|I.29mu B lymphoma cells
P09584194A0000|121 132|cell adhesion
P09584194A1305|178 180|p55
P09585253A1147|173 187|MDA-MB-231 cells
P09585540A0440|88 111|agent 1,10-phenanthroline
P09586285A0551|61 65|years
P09586832A0229|59 67|receptors
P09587549T0001|67 75|hepatitis
P09588228A0370|99 108|MPM tissues
P09590294A0453|76 87|Notch pathway
P09590540A0513|230 241|pQE-30 vector
P09591221A0137|119 122|site
P09592125A0000|100 104|cells
P09592168T0000|63 96|nucleotide excision repair protein XPA
P09592208A0470|185 194|statistics
P09592219A0652|49 60|intervention
P09593302A1165|121 126|phenol
P09594299A0468|140 142|hip
P09595496A0000|108 114|surgery
P09596536A0219|91 111|cartilage degeneration
P09596542A0542|91 94|core
P09596638T0000|59 69|Arabidopsis
P09596738T0000|99 109|candidiasis
P09598205A0430|94 99|maltol
P09598894A0732|40 49|resorption
P09599102A1191|129 145|copper sensitivity
P09599664A0881|72 78|RXR beta
P09599724A0193|243 256|cancer findings
P09599897A0000|255 268|manifestations
P09601007A0223|197 212|CaCO3 dissolution
P09601510A0215|70 80|transcripts
P09601516A0695|133 149|surface expression
P09601921A0000|178 183|Canada
P09601940A0280|112 117|NF-IL6
P09602124A0127|8 8|M
P09603345A1257|157 174|genus Closterovirus
P09604052A0166|111 123|wrist fracture
P09605137A0677|140 150|Jurkat cells
P09605930A1428|123 129|ALS gene
P09605934A0801|124 143|transcription factors
P09606633A0523|40 44|weeks
P09606924T0000|120 146|matrix solid-phase dispersion
P09609342A0000|126 136|performance
P09609705A0895|86 86|V
P09609720A0357|142 147|region
P09610755A1731|83 83|p
P09611016A0652|124 132|pessaries
P09611229A1664|187 210|protein N-myristoy-lation
P09611234A0098|116 119|SMRT
P09611877A0455|39 42|ECHO
P09612351A0386|53 59|ULF band
P09612775A0726|75 82|patients
P09613574A0905|186 188|min
P09613946A0194|82 86|mm I.D
P09614065A0966|145 153|induction
P09614106T0000|109 118|expression
P09617765A0174|110 113|tail
P09617807A0929|197 202|plants
P09618150A0127|231 239|treatment
P09618150A1464|94 107|MEK-1 inhibitor
P09618164A0709|100 106|culture
P09618475A0747|94 97|Nrd1
P09618481T0000|92 108|Smad family members
P09619631A0344|105 115|p120 Ras-GAP
P09619777A1583|234 248|state conditions
P09620273A0189|111 133|E2F transcription factors
P09620606A0000|49 54|T cells
P09620873A1710|162 186|sHSP phosphorylation events
P09620955A0370|145 153|lac operon
P09621062A0810|140 185|chloramphenicol acetyltransferase reporter system
P09621372A0369|92 98|enzymes
P09621893A0000|83 102|alpha2-adrenoceptors
P09622055A0207|109 113|D-Cbl
P09622121A0525|72 97|supershift RNA-PTB complexes
P09622121T0000|147 158|branch points
P09623830A0000|54 63|popularity
P09625762A0426|76 81|manner
P09625807A0000|148 165|carcinoma cell lines
P09626662A1076|147 152|ligand
P09627285A0160|41 61|care infertility center
P09627285A0554|115 117|hMG
P09627598A0384|152 159|subjects
P09628375A0700|20 33|tissue coverage
P09628419A0812|66 69|ISIs
P09628821A1194|121 137|lineage commitment
P09628890A0455|91 98|HA trimer
P09629449A0540|146 150|cells
P09630245A0102|125 138|splicing events
P09630245A0903|154 168|U1 snRNP proteins
P09631366A0951|39 47|dose level
P09632217A0477|174 180|cocaine
P09632637A0361|198 206|stimulant
P09632709A0464|146 159|gene expression
P09632734A0081|142 159|GTP binding proteins
P09632734A0943|80 87|activity
P09632785A0000|114 132|splice site selection
P09633171A0321|164 177|testing machine
P09633274A0000|62 81|heart failure patients
P09633630A0740|110 120|fluorescens
P09633879A0246|125 126|L1
P09635149A1148|13 16|PaO2
P09635276A1608|91 100|mechanisms
P09636119T0000|68 74|pulleys
P09636358A0000|143 151|infection
P09636670T0000|91 102|breast cancer
P09636708A0460|193 203|degradation
P09637689A0150|146 153|promoter
P09638342T0000|65 92|membrane cytoskeleton assembly
P09638485A0111|157 163|workers
P09638650A0169|248 251|OFR5
P09638793A1446|168 174|carrier
P09639074A0707|117 120|site
P09639410A3282|57 66|strategies
P09639558A0957|68 79|erythrocytes
P09639565A0225|94 105|SV40 promoter
P09640162A0242|138 139|yr
P09640802A0467|98 107|flap choice
P09641167A1359|126 142|gene transcription
P09642042A0646|137 152|substrate binding
P09642200A0956|248 255|bacteria
P09642214A0244|155 164|COS-7 cells
P09642227A0000|58 71|keratan sulfate
P09642238A0532|40 55|enhancer activity
P09642238A1285|178 183|factor
P09642276A0881|113 120|function
P09642764A0469|152 156|assay
P09643153T0000|24 39|T2N breast cancers
P09643546A0436|126 141|stress conditions
P09643548A0000|71 104|cyanobacterium Synechocystis PCC6803
P09645576A0148|44 46|BMT
P09645942A1164|66 78|stoichiometry
P09645961A1158|109 116|nTPH gene
P09647233A0336|146 148|LTR
P09647240A0000|163 174|Val135 mutant
P09649069A0490|97 108|examinations
P09649265A1575|222 229|serum PSA
P09649315A0943|137 143|ability
P09649426A0636|62 74|Msn4p activity
P09649437A1140|113 142|eosinophil lineage determination
P09649438A0182|171 177|extract
P09649501A0358|255 271|HSF1 heptad repeats
P09649537A0000|61 65|yGCN2
P09650180A1130|86 93|mGy min-1
P09650186A1043|97 103|regions
P09650275T0000|80 100|biotechnology industry
P09650299A0000|78 85|transfer
P09650299A1334|82 92|integration
P09650403A0868|75 79|group
P09650789A0185|130 140|orientation
P09651321A0000|138 164|keratinocyte differentiation
P09651367T0000|71 80|myogenesis
P09651375T0000|99 104|domain
P09651383A0967|217 226|apoCII gene
P09652736A1205|154 161|activity
P09652737A1244|190 206|DNA binding complex
P09652742A0455|124 129|strain
P09653182A1298|122 127|plants
P09653641A0471|53 62|start codon
P09653648A0445|188 193|region
P09653745A0180|221 232|problem today
P09655248A0000|163 169|ligands
P09655916A0415|132 134|Gln
P09656414A0220|23 26|g/m2
P09656485A0351|55 74|restriction digestion
P09657003T0000|211 216|genome
P09658104T0000|96 117|repeat promoter activity
P09658122T0000|99 113|nematode protein
P09658403A1207|91 101|CAT activity
P09658405A0000|79 97|receptor superfamily
P09658769A0058|65 74|hepatitis C
P09660823A0934|57 67|p70 S6 kinase
P09660836A0983|164 171|PD098059
P09660838A0920|180 196|heat shock response
P09661676T0000|66 73|patients
P09662339A0744|128 134|protein
P09662443A0402|83 100|caveolin gene family
P09663062A0175|184 191|dentists
P09664033A1204|159 164|bodies
P09665361T0000|21 34|thyroid nodules
P09665503A0526|41 45|study
P09665720A0325|94 107|primer terminus
P09665720A1145|112 121|polymerase
P09666103A0496|145 153|phenotype
P09666114A0389|134 148|Sp1 binding sites
P09667482A0978|160 190|stress system disorder perspective
P09667795A0000|41 48|disorder
P09668063A0274|154 158|cells
P09668096A0806|61 68|partners
P09668098A0868|139 160|transcription start site
P09668108A1017|104 116|cancer therapy
P09668119A0496|197 203|CTCCT-3
P09669641A0425|49 55|amylase
P09670034A0340|83 88|Rad17p
P09670912T0000|16 23|seizures
P09670943T0000|82 107|Fc gamma RIIB1-BCR coligation
P09671313A0334|45 45|J
P09671464A0316|120 123|Snf1
P09671496A0557|158 167|appearance
P09671576A0900|50 68|streak morphogenesis
P09671579A1168|101 119|boundary development
P09671791T0000|143 148|L cells
P09673037A0358|127 132|Gomori
P09673436A0898|189 198|hypocapnia
P09675154A0690|187 191|W118R
P09675896A0959|56 65|activation
P09676349A0000|123 135|investigation
P09676419A0158|273 295|solid-phase immunoassays
P09677330A0584|124 127|unit
P09677405A0856|68 78|mutagenesis
P09677410A1059|188 195|function
P09678579A0768|53 64|blot analysis
P09678837A0736|163 178|blood eosinophils
P09679066A1352|85 93|pre-mRNAs
P09679750A0304|147 155|attention
P09680994A0169|182 193|Z. mays r genes
P09681822A0520|61 67|tissues
P09682897A0218|121 133|injury pattern
P09683576A0542|93 102|processing
P09685021A0127|398 407|attachment
P09685226A0000|185 187|BEN
P09685346A0419|116 133|transfection assays
P09686344T0000|36 70|ornithine transcarbamylase deficiency
P09686603A0124|147 165|TCR beta gene segments
P09687498A1173|161 174|overexpression
P09687511A1091|204 212|potential
P09687514A0521|129 137|complexes
P09688264A1029|87 100|rat hepatocytes
P09689047A0253|170 192|Golgi sialyltransferases
P09689919A1192|68 83|PEDF glycoprotein
P09691031A1050|93 100|pathways
P09691037A0355|74 90|Neurospora species
P09692965A0904|90 95|burial
P09693035T0000|120 129|assignment
P09693134A0782|255 262|position
P09693306T0000|53 63|schwannomas
P09694034A0713|189 193|drugs
P09694514A0000|258 268|eosinophils
P09694599A1355|105 113|hematuria
P09694725A0500|151 166|IL-1beta promoter
P09694860A0498|105 111|protein
P09694869A0932|190 208|STAT response element
P09694897T0000|129 133|motif
P09695194T0000|50 53|data
P09696164A0000|63 66|SIDS
P09696819A0450|159 165|complex
P09698457A0778|100 103|hair
P09698457A0976|235 241|binding
P09698512A0296|55 74|transplant recipients
P09700644T0000|82 91|correlates
P09701609A0116|114 123|Gbetagamma
P09701616A0108|98 123|sand shrimp Metapenaeus ensis
P09701821A1108|114 119|levels
P09701895A0119|110 116|anaemia
P09703021A0000|236 256|melatonin biosynthesis
P09703213A0280|98 109|facilitation
P09703276A2346|59 73|carcinogenicity
P09703816A0139|89 101|iliac arteries
P09704006A0224|90 93|acid
P09704296T0000|106 112|patient
P09704569T0000|81 106|steroid receptor superfamily
P09704857T0000|63 70|HIV/AIDS
P09704927A0479|99 108|box domains
P09705258A0837|124 131|lacZ gene
P09705324A0213|251 256|rat Std
P09705324A1602|356 372|DNA-AR interaction
P09705352A0879|113 124|fission yeast
P09705497A0227|132 156|DNA post-replication repair
P09705564T0000|62 73|E5 transcript
P09706565A1072|60 70|atipamezole
P09706643A0206|35 41|disease
P09707498A0262|49 62|seizure latency
P09707577A1047|37 43|markers
P09708450A0648|131 135|G-CSF
P09708565A0000|235 251|commercialization
P09710131A0374|81 99|laser printer formats
P09710582A0535|147 158|AP-1 activity
P09710589A1111|121 129|HTLV-1 LTR
P09710591A0981|143 159|block potentiation
P09710599A0310|129 140|ets-2 protein
P09710599T0000|128 136|signaling
P09710614T0000|125 148|phosphoinositide 3-kinase
P09710615T0000|85 102|protein trafficking
P09710621A0598|149 161|interreceptor
P09710641A0000|202 205|lens
P09712037A0470|210 230|lymphocyte Ag receptors
P09712297T0000|96 106|individuals
P09712644T0000|97 104|elements
P09712859A1110|111 122|blood T-cells
P09712898A0911|80 82|RIP
P09712898T0000|95 97|p38
P09712915A0672|118 121|NF-Y
P09712919A0307|117 122|T cells
P09713584A1193|107 112|groups
P09713990T0000|88 107|TP53 expression system
P09713996A0262|124 129|agents
P09713996T0000|177 179|ALL
P09714109A0000|107 109|SNA
P09714109A0785|108 116|muscle SNA
P09714835A0345|199 202|L.D.
P09715278A1079|154 164|NT2/D1 cells
P09715278A1526|119 138|control transfectants
P09715384A0235|88 88|%
P09716095T0000|0 13|Pressure ulcers
P09716179A0974|190 206|RB phosphorylation
P09716183A1036|168 173|domain
P09716435A1004|136 144|PR/CP diet
P09717246A0526|110 120|lipid weight
P09717835A0941|77 90|Xenopus homolog
P09717887A0239|185 194|population
P09718372T0000|91 102|fission yeast
P09718671A0000|137 144|patients
P09719636A1134|194 197|gp17
P09721207A0637|103 115|vacillans gene
P09721798A1734|124 128|death
P09722043A2070|70 76|enzymes
P09722161A3065|62 73|Igf2/Mpr gene
P09722508A0953|128 139|HEK-293 cells
P09722766A0706|99 102|rats
P09723896A0000|190 192|RXR
P09724654A0761|108 110|RPA
P09724654A1120|95 97|RPA
P09724754A0173|81 85|genes
P09724763T0000|101 103|DNA
P09724772A0840|130 143|metal-chelator
P09725292A1473|85 86|CT
P09725651A0077|114 130|Pentium processors
P09725854A1060|193 218|urf209 processing activities
P09726201T0000|12 24|interpretatio
P09726979T0000|53 69|sphingosine kinase
P09726987T0000|53 74|transcription factor IID
P09726988A0275|33 42|M-CPT I mRNA
P09726991T0000|50 72|transcription factor Mac1
P09727045A0817|147 165|ligand binding domain
P09727046A0000|162 164|Lam
P09727046A0784|84 87|TAL1
P09729481A0000|154 175|transcription start site
P09729481A1177|191 196|region
P09730413A0642|158 164|cancers
P09731354A0963|78 79|hr
P09731513A1090|130 138|HTLV-I Tax
P09731704A0000|123 144|U2-OS osteosarcoma cells
P09731704A1472|163 168|manner
P09731705A2126|100 110|interaction
P09733493A0493|118 125|solution
P09733647A1960|136 149|archeabacteria
P09733794A1323|132 133|Tg
P09733815T0000|105 116|virus latency
P09733854A0198|76 78|RNA
P09734808A0000|159 164|phases
P09735286A0599|99 107|target DNA
P09735366A1180|163 168|humans
P09735368A0636|110 122|K box sequences
P09735371A0227|147 161|differentiation
P09736239A0436|256 267|excitotoxins
P09736697A0783|107 121|Stat3 activation
P09736697A1107|218 224|pathway
P09736715A0729|149 150|Pi
P09736770A0351|114 116|Sp3
P09737453A0557|168 172|ELISA
P09737921T0000|113 123|specificity
P09738010A0305|110 125|base pair position
P09738087A0583|99 107|illnesses
P09738693T0000|71 74|rats
P09739401A0000|116 130|home environment
P09739913A0194|65 69|trunk
P09741391A0581|133 142|expiration
P09741783A0000|128 139|breast cancer
P09742129A0491|0 0|W
P09743128A0969|19 25|Bis-GMA
P09743233A0526|81 84|SMCs
P09743720A0268|40 41|DM
P09744095A1016|235 241|CAB gene
P09745797A0943|97 102|impact
P09747651A0000|68 76|emphysema
P09747873T0000|49 55|BCR-ABL
P09748261A0000|88 92|Faaps
P09748286A0000|167 177|nucleotides
P09748513X1360|13 30|Elsevier Science B.V
P09748669A0414|47 49|VaD
P09749533A0764|80 90|Arabidopsis
P09749988A0000|238 244|contour
P09750325A0000|206 215|serotype 4b
P09750540A0000|94 109|chemical exposure
P09751061A0000|254 258|genes
P09751114A0967|75 80|vector
P09751114A1987|101 111|mitogenesis
P09751166A1460|118 123|manner
P09751458A0845|0 19|desmethyltrimebutine
P09753241A0524|169 173|weeks
P09753730A0881|97 113|promoter mutations
P09753769A0362|85 97|PBAN precursor
P09753774A1642|126 128|GF4
P09753774A2246|165 183|plant invertase genes
P09753775A0734|81 103|histone H1 kinase activity
P09754571A0169|123 131|cell lines
P09754571A1257|51 55|10q26
P09755191A0553|148 159|reading frame
P09755199A0373|104 110|domains
P09755199A0559|117 123|alleles
P09755478A0366|149 153|pupae
P09756687A0981|126 131|values
P09756895A0322|88 93|intron
P09757012A0942|118 142|signal transduction pathway
P09759180A0000|77 91|cartilage damage
P09759691A1051|368 380|body mass index
P09759865A0673|262 272|PDGF-Ralpha
P09760243A0970|88 102|apoCIII promoter
P09760341T0000|61 64|FIO2
P09761711A0000|138 161|susceptibility anisotropy
P09761723A0226|55 59|brain
P09761791A0489|71 86|blot overlay assay
P09763421A1199|148 151|size
P09763446A0000|67 75|transport
P09763446A1234|59 67|fractions
P09763470A0000|139 157|neuroendocrine cells
P09763470A1756|166 172|DBH gene
P09763522A2545|149 155|animals
P09763607A0521|76 84|p38 kinase
P09764741A0092|106 110|basis
P09765261A0000|307 315|sequences
P09765271A1108|231 237|protein
P09765277A0000|119 130|trophoblasts
P09765285A0998|192 198|IRper-5
P09765285A1763|108 114|IRhsp-1
P09765372A0669|92 104|dorsal surface
P09765388T0000|77 88|oncoproteins
P09765394A0000|109 114|oriLyt
P09765394A1590|129 141|CAT expression
P09765411A0991|157 188|structure NH2-ubiquitin-S27a-COOH
P09765466A0231|0 0|J
P09765754A1727|35 37|PVI
P09767504A1371|68 81|administration
P09767575A0657|109 114|region
P09767593A0130|115 121|p130Cas
P09767687T0000|92 104|rbcL sequences
P09769209A0100|122 145|antitermination mechanism
P09769910A1700|117 125|mediators
P09770241A0000|79 84|system
P09770378A0641|0 9|EGFR levels
P09770415A0139|144 146|NLS
P09770493A0499|179 181|day
P09770686A0484|40 51|hypertension
P09771555A0499|48 52|rhein
P09771967A1052|95 98|DLBL
P09771985A0238|109 119|glutathione
P09773975A1873|288 292|S338D
P09773981A0415b|96 104|induction
P09774403A0107|23 23|G
P09774444A0351|137 158|Sp1 recognition sequence
P09774450A0000|121 124|LTD4
P09774484T0000|69 91|glutathione peroxidase-1
P09774641A0824|92 116|retinoblastoma gene product
P09774662A0958|96 103|RNA level
P09776293A0777|99 106|solution
P09776360A0620|36 58|transcription factor AP-1
P09776360A1781|116 125|DLD-1 cells
P09777477A0000|136 145|peppermint
P09777600A0000|98 105|detector
P09777999A0796|81 91|hypercapnia
P09778006A0718|245 261|baseline Vmca/mmHg
P09778068A1129|217 221|death
P09778191A0000|153 155|MRI
P09778197A0415|302 312|cholesterol
P09780002A0996|103 107|E2F-1
P09780228A0122|33 48|FK506 gene cluster
P09780228A0613|125 131|modules
P09780336A0771|186 212|messenger ribonucleoproteins
P09781761A0384|83 87|urine
P09781871A0404|296 312|Erwinia carotovora
P09781874A1061|124 128|cwg2p
P09784063A0621|108 118|nucleotides
P09784192A1027|48 70|surface plasmon resonance
P09784245T0000|71 104|protein kinase C phosphorylation sites
P09785114A1026|56 61|groups
P09786197A0322|196 202|systems
P09786404A0541|29 29|P
P09786926A0095|224 228|cells
P09786926A1372|123 126|site
P09786932A1042|183 200|IFNA gene expression
P09786949A0114|0 0|J
P09787323A0000|60 76|thrombocytopenias
P09788739A1096|132 154|MDA231 breast cancer cells
P09789025A0149|61 64|RhoA
P09789795A0607|60 73|concentrations
P09790499A0545|98 102|index
P09790767A0372|87 93|band q31
P09790768A0621|93 98|kidney
P09790771A0956|69 74|testes
P09790771A1032|79 88|chromosome
P09790986A0689|122 127|NRAMP2
P09792439T0000|74 90|40S hnRNP complexes
P09792627A0441|48 57|GR activity
P09792630A1127|215 219|genes
P09792682A0713|50 51|F0
P09792702A0754|104 122|HSP70 gene expression
P09792714A1408|118 131|gene expression
P09794414T0000|43 58|DRA transcription
P09794795A0183|319 322|SHP2
P09795130A0742|69 89|translation efficiency
P09795170A0774|88 103|kb transcript size
P09795213A0129|299 311|RNA polymerase
P09795341A0806|99 105|isoform
P09797189A0559|47 56|CCAAT motif
P09797456A0000|116 124|apoptosis
P09797456A0883|97 111|c-myc expression
P09798068A0290|185 192|receptor
P09798100A0705|63 64|IM
P09798263T0000|122 125|mice
P09799086A0725|164 173|LN patients
P09799237A0624|74 77|term
P09799362A0507|88 104|Zinc Finger protein
P09799362A1463|187 205|RNA polymerase mutant
P09799634A0161|113 119|protein
P09799793T0000|120 124|genes
P09800187A0100|199 207|mutations
P09801156A0220|87 93|gene E75
P09801333A0174|81 84|PA-8
P09802206A1058|119 127|protein S7
P09802902A0225|86 107|ARF6 nucleotide exchange
P09803081T0000|35 46|childhood SLE
P09804779A0000|50 63|protein kinases
P09804779A1163|183 188|Stat5a
P09804836A0000|269 276|pressure
P09805052A0119|134 137|dose
P09805977A0143|154 166|xenoestrogens
P09806516A1212|76 85|recurrence
P09806516A1689|149 156|excision
P09806546A1270|68 82|MHC-II promoters
P09806826A0244|74 81|Vwf locus
P09806826A1773|172 181|lung injury
P09806830X1174|13 25|Academic Press
P09806857A0854|124 138|Pac25I R-M operon
P09806858T0000|57 64|rnaI gene
P09806919A0447|127 143|puparium formation
P09807755A0146|56 65|muscle flap
P09808155A0813|168 169|bp
P09808216A0000|101 106|ratios
P09808366A0828|129 135|animals
P09808441A0320|188 200|cell carcinoma
P09810087A0379|120 124|humor
P09811695A1146|87 105|MuLV TM Env protein p15
P09811718A0979a|79 85|TCRzeta
P09811730A1396|167 191|transfection reporter assay
P09811730T0000|152 171|protein kinase pkr gene
P09813041A1122|75 84|conditions
P09813063T0000|86 94|forebrain
P09813093A0624|76 79|GIN4
P09813098A0521|109 114|manner
P09813110A0982|120 125|region
P09813203T0000|96 110|envelope protein
P09813207A0434|283 286|lef2
P09813254A0000|99 106|proteins
P09813259A1097|109 111|IBG
P09813635A0678|105 111|complex
P09814637A1214|80 82|MRI
P09814905A0598|86 94|nutrition
P09815578A1245|118 139|prostate carcinogenesis
P09815948A1065|89 103|peak plasma level
P09817131A0296|52 69|translation process
P09817190A0074|81 106|kidney transplant recipients
P09817373A0000|206 227|constrictor eicosanoids
P09817601T0000|98 107|expression
P09819038A0448|84 98|body temperature
P09819110A0703|74 79|time LD
P09819216A0220|6 17|Biochemistry
P09819288A0578|80 85|season
P09819377A1209|147 151|range
P09819391A1123|162 170|processes
P09819411A0897|87 98|CTTCCCTGGAAG
P09819414A1103|90 103|medium isoforms
P09819421A0000|110 112|CsA
P09819422A0768|104 107|Cns1
P09819430A0000|109 113|state
P09819440A0000|113 116|ways
P09819440A0783|93 97|cells
P09819507A0000|161 171|mitomycin-C
P09820163A0565|45 63|restriction analysis
P09820205A0000|100 116|gamete interaction
P09820611T0000|129 139|nephropathy
P09820621A0067|113 124|leptin levels
P09821978A1255|67 68|SE
P09822602A0237|226 240|p300 coactivator
P09822602A1172|153 162|HIF-1alpha
P09822647A0000|67 71|brain
P09822652A1118|72 74|Sp1
P09822661T0073|51 64|quinone binding
P09822685A0596|151 152|i.
P09822690A0000|97 110|protein kinase A
P09822825A0141|125 130|medium
P09823014T0000|118 122|NIDDM
P09823561T0001|54 74|Gastrospirillum homini
P09823775A1122|126 131|action
P09824001A1665|92 101|techniques
P09824021A1263|125 134|parameters
P09824158A1336|89 101|transcription
P09826434T0000|94 104|mutagenesis
P09826658A0691|136 149|BPV-1 pre-mRNAs
P09826778A0943|112 118|COUP-TF
P09827446T0001|30 40|C4 deficienc
P09827724A1362|32 39|adenomas
P09827878A0091|176 182|workers
P09827993A0000|145 160|RNA encapsidation
P09828137A0000|133 146|DNA replication
P09829836A0000|131 134|CDKs
P09829836A0815|95 108|yeast LEU2 genes
P09829843A0119|187 197|neutropenia
P09829843A0819|312 334|chemiluminescence system
P09829916T0000|99 104|fusion
P09832099A0000|117 135|color kinesis imaging
P09832436A0738|128 138|differences
P09832436T0000|93 100|protein H
P09832504A0596|108 115|proteins
P09832505A0903|84 103|transcription complex
P09832511A0269|125 131|neurons
P09832518A0615|152 167|database searches
P09833610A0626|88 93|signal
P09833740A1112|226 240|provirus latency
P09834070A0793|189 201|B cell function
P09834521A0000|37 40|site
P09835615A0574|100 101|R2
P09836881A0441|84 99|Motor Proficiency
P09837714A1068|150 162|Dictyostelium
P09837715A0581|178 206|SL3-3 LTR-CAT reporter construct
P09837824A0419|188 192|T274I
P09837907A0857|173 187|kinase induction
P09837913A0000|70 85|triiodothyronine
P09837913A0419|108 111|cDNA
P09837914A0844|0 3|Biol
P09837920A0222|121 123|JNK
P09837933T0000|117 125|endosomes
P09837945A0820|170 177|material
P09837978T0093|73 80|JNK/SAPK
P09838122A0489|65 68|MPP3
P09840822A0462|68 95|magnetization transfer effects
P09840928A0884|135 142|extracts
P09840932A0365|68 79|cyclin A/Cdk2
P09840934A0435|209 213|cells
P09840943A0144|64 71|homology
P09842517A0497|98 100|MRI
P09843378A0187|86 102|SH3 binding domains
P09843412A0130|107 108|AD
P09843572A0944|99 109|cell lysates
P09843577A0000|67 85|G2/M cell size control
P09843944A0976|129 145|UP element function
P09844106A0835|73 75|ST2
P09844921A0000|98 120|differentiation messages
P09845043A0000|203 211|component
P09845662A0085|135 142|SDS-PAGE
P09845856A0560|55 67|ulcer diseases
P09846033A0488|44 56|posttreatment
P09846482A0441|104 122|actin polymerization
P09846927A0227|70 74|death
P09847371A0000|112 114|BIV
P09847397A0935|188 196|TATA boxes
P09848653A0597|67 74|proteins
P09849421A0332|179 182|mail
P09849722A0797|240 261|emotion processing tasks
P09849961A0387|194 209|myoblast cell line
P09849965A0000|114 116|hPR
P09851614A0109|144 148|mRNAs
P09851700A0000|89 94|manner
P09851988A0085|72 78|pathway
P09852005A1287|247 257|OP4 sequence
P09852068A0150b|160 183|HepG2 hepatoblastoma cells
P09852109A1475|238 244|control
P09852136A0174|153 160|COS cells
P09852136A0507|116 131|ADP-ribosylation
P09852752A0950|72 73|RA
P09854034A0536|94 104|mRNA species
P09855111A0905|325 330|manner
P09856397A0099|119 125|tissues
P09856732A0114|86 94|lidocaine
P09857038A1374|9 9|J
P09857197A0289|119 124|RanGTP
P09857265A0669|155 155|%
P09858094A0583|102 107|period
P09858531A1017|86 90|c-fos
P09858571T0000|119 135|dolichol synthesis
P09858572A0000|69 77|chromatin
P09858577A1186|149 158|HOG pathway
P09858581A0183|140 146|prp38-1
P09858588A1046|98 101|G2/M
P09858593A0334|118 129|neurogenesis
P09858599A0392|112 125|PBX interaction
P09858619A0356|56 69|ZAP-70 function
P09858713A1174|219 225|mutants
P09858714A1171|88 90|srd
P09858745A1350|213 215|DNA
P09858745A2033|123 136|clcA transcript
P09858883A1106|60 64|T84.1
P09860979A0521|78 90|JNK activation
P09861099A1011|152 162|kcal/kg/day
P09861365A0000|105 109|serum
P09862343A0225|167 178|B lymphocytes
P09862481A0000|67 71|yeast
P09862496A0187|108 114|pattern
P09863624A0629|170 174|ovine
P09863624A2301|209 213|oCRF1
P09863720T0000|49 66|protein S deficiency
P09864141A0528|167 170|Y764
P09864335A1226|201 205|Fcr1p
P09864689A1408|107 109|DCM
P09865775A0162|87 96|properties
P09866068A1058|171 184|pregnancy rates
P09867159A1444|89 94|FDG PET
P09867253A0229|92 114|transcription factor AP-1
P09867855T0000|53 105|rabbit beta-galactoside alpha1,2-fucosyltransferase gene
P09868412A1628|284 301|grip muscle strength
P09869297A1807|81 91|development
P09869356A0926|37 43|defects
P09869400A0203|109 119|wheat germin
P09869528T0000|30 37|RF energy
P09871353A0174|112 115|loch
P09872326A0566|104 111|promoter
P09872337A0000|258 265|Dalacin T
P09872832A1262|204 214|differences
P09873060A0901|108 111|FosB
P09873291A0620|86 98|patient groups
P09874803A0000|165 179|disease episodes
P09875541A0210|133 136|SELF
P09876794T0000|27 37|anaesthesia
P09877417A0704|38 46|intervals
P09878256A0000|171 175|death
P09878437A0967|75 78|Glu9
P09878542A1151|99 113|osteopontin VDRE
P09879766A0402|45 52|map units
P09880029A0703|236 237|C6
P09880103A0387|73 89|M hydrogen peroxide
P09880327A0322|140 147|vesicles
P09880512A1251|74 76|Sp1
P09880513A1013|53 59|tubulin
P09880543A0570|60 69|yeast cells
P09880544A0693|171 180|DT-40 cells
P09881666A0535|77 79|ER2
P09881692A0094|101 116|Ckappa1 gene locus
P09881692A1109|149 164|Southern blotting
P09882303A1413|151 155|cells
P09882303A1984|157 166|activities
P09882303T0000|125 129|TRAF2
P09882321A0948|137 146|EBNA-3 cDNA
P09882334A0822|214 218|virus
P09882337A0000|113 131|gI Fc receptor complex
P09882348A0611|144 151|oncogene
P09882451A0195|136 148|transformants
P09882489A0451|170 176|signals
P09882499A0231|127 130|Pax6
P09882593A0996|162 174|pompholyx type
P09882638A0235|80 87|erection
P09883639A0000|89 93|years
P09884232A0286|151 163|integrase gene
P09884275T0000|87 102|organ transplants
P09884747A0477|187 200|serum IgE levels
P09885431A0000|158 166|stock tray
P09886602A0000|300 309|care center
P09886843A0339|115 123|fragments
P09886850A0145|125 147|MEK/ERK signaling pathway
P09887544A0000|135 142|epilepsy
P09888711A0781|169 181|round vacuoles
P09888994A0858|93 98|embryo
P09889202T0000|144 151|proteins
P09889306A0321|191 199|cell types
P09890778T0000|42 48|methods
P09891009T0000|18 38|mouse glycolate oxidase
P09891046A0269|89 100|PKR signaling
P09891046A0554|47 49|PKR
P09891049A0761|96 100|Rat1p
P09891061A0373|157 166|cis element
P09891061A1240|132 148|sea urchin blastula
P09891065A1493|86 96|PKC-epsilon
P09891085A0815|89 101|27S precursors
P09891092A1000|77 88|end formation
P09891707A0000|43 45|SpA
P09892017A2151|71 78|receptor
P09892021A0712|125 129|tumor
P09892422A1096|192 204|purkinje fibre
P09892642A0172|62 72|replication
P09892662A0334|123 129|cyclase
P09892736A0343|148 150|KSR
P09893060A0767|60 61|kb
P09893262A1272|84 100|TGF-beta responses
P09893913A0656|83 92|atracurium
P09894962T0000|42 54|malformations
P09895323T0000|70 79|Hoxb3 genes
P09897032T0000|50 58|resonator
P09900679T0000|76 84|phenomena
P09903722T0000|64 65|H2
P09904139T0000|37 45|operators
P09911328T0000|46 52|problem
P09913308T0000|71 81|laser pulses
P09914156A1496|227 238|RNA start site
P09914500A0000|208 217|conditions
P09914518A1217|174 176|ICI
P09914525A0890|37 44|degreesC
P09915118T0000|51 54|bulb
P09915798A1077|134 159|steroid receptor interaction
P09915860A0000|102 117|consensus Sp1 site
P09915860A0119|70 83|Schneider cells
P09916786A0811|238 251|chromatography
P09916809A0405|98 123|transmembrane signal peptide
P09917064T0000|78 84|masking
P09917387T0000|95 103|start site
P09917389A1239|94 101|cleavage
P09917391A0380|67 71|event
P09917555T0001|58 69|cancer center
P09918096A0520|27 30|cyst
P09918715A0304|46 53|position
P09918715A1158|148 168|core promoter sequences
P09918720A0998|135 141|contact
P09918842A0184|110 123|RNA replication
P09920539A0272|80 102|gonadotropin stimulation
P09920775A0075|141 148|P19 cells
P09920882A0287|0 3|Chem
P09920896A1230|166 175|structures
P09920903A1045|50 66|p53 gene regulation
P09920930A0521|103 117|c-Fos expression
P09920930A0959|193 202|Ro-31-8220
P09920982A0253|163 177|Rap ID ANA II panel
P09921179T0001|66 71|vessel
P09922230A1482|102 111|C. albicans
P09922856A0459|129 150|Laboratoires Synthelabo
P09923245A0482|70 77|patients
P09924675A0412|227 238|intervention
P09924987A0000|176 186|prokaryotes
P09925120A0074|112 117|fibers
P09925372A0458|105 108|KRAB
P09925372A1063|110 120|development
P09925777A1195|135 135|%
P09927193A0107|62 72|oncogenesis
P09927449A0421|96 104|CLN2 genes
P09927570A0507|176 186|kDa proteins
P09927585A0796|131 139|factor Sp1
P09927589T0000|142 151|mechanisms
P09929088A0000|96 110|cancer screening
P09929811A0000|301 306|artery
P09931118A1072|56 63|IL-1beta
P09931191A0434|121 130|resistance
P09931216A0566|91 96|module
P09931252A1055|114 131|scaffolding protein
P09931391A0944|40 46|surgery
P09931435A0357|146 148|UTR
P09932288A0378|104 114|cDNA library
P09933428A0351|89 97|treatment
P09933641A0241|94 98|clone
P09933848A1008|74 87|autoantibodies
P09934611A1054|82 89|pressure
P09935377T0108|17 22|August
P09936001T0000|56 67|Sc impurities
P09938097T0000|72 75|ZnTe
P09940132T0000|68 77|properties
P09943651T0000|16 22|soliton
P09944066T0073|0 1|II
P09945838T0000|52 66|heterojunctions
P09947191T0000|67 81|antiferromagnet
P09949160A0600|204 209|growth
P09949178A0264|108 112|1A9-M
P09949312A0524|43 52|vacuum pump
P09950213A1660|132 140|TbetaRIII
P09950394A0336|75 83|diagnosis
P09952378A0529|123 132|covariates
P09952425A0893|219 224|degree
P09959737T0000|23 29|SN 1987A
P09961326T0000|57 62|models
P09961682T0000|31 46|stick-slip motion
P09964171T0000|76 80|field
P09964770T0000|43 60|laminate composites
P09965234T0000|52 64|liquid crystal
P09965909T0000|26 45|soliton perturbations
P09971776A0838|208 214|protein
P09971790A0856|148 175|AAV hairpin DNA binding activity
P09971806A1585|91 107|tumor pathogenesis
P09971815A2094|337 354|gammaherpesviruses
P09971822A1542|51 68|splicing inhibition
P09973351A1522|52 61|substrates
P09973607A0254|138 146|Sp100 gene
P09974642T0000|67 74|dynamics
P09976626T0000|84 89|Li meta
P09980944T0000|78 86|resonance
P09982923T0000|47 52|bulk Si
P09983871T0000|20 41|YBa2-xLaxCu3O7 ceramics
P09984526T0000|42 55|semiconductors
P09985302T0000|54 60|antidot
P09986796A1761|65 71|effects
P09987176A0260|94 99|levels
P09987634A1265|82 90|PRK effect
P09987961A0093|93 103|fibroblasts
P09988682T0033|87 90|core
P09988767A1496|174 184|site markers
P09988850A0000|319 334|autopsy materials
P09989334A0964|133 138|intron
P09989339A0968|47 55|clearance
P09990057T0000|131 153|matrix attachment regions
P09990060A0803|121 132|CD18 promoter
P09990060A0937|169 174|T cells
P09990315A0205|190 202|PKC activation
P09990507A0000|121 131|degradation
P09990507A0763|99 121|F-box/WD-repeat proteins
P09994942T0000|31 46|antiferromagnets
P09995847T0000|97 98|Na
P09995897T0000|59 74|Si/SiO2 interface
P09999256T0000|37 54|transport phenomena
P09999742T0000|36 43|surfaces
P10000253T0000|71 77|XY model
P10001333T0038|21 25|YAlO3
P10001541T0000|59 65|silicon
P10002245T0000|71 82|delta crystal
P10006319T0000|55 64|anisotropy
P10007469T0000|47 49|C60
P10007564T0000|60 66|surface
P10008261T0000|62 70|YBa2Cu3O6
P10009565T0000|63 72|insulators
P10013227T0000|43 45|m pi
P10019841T0000|55 62|approach
P10021333A0674|96 100|genes
P10021350A0093|213 217|genes
P10022032A0000|244 255|interactions
P10022210A0620|39 49|SPME process
P10022850A0929|112 131|reactivation function
P10022858A0985|90 96|protein
P10022867A1069a|133 149|lysine prototrophy
P10022867A1069b|133 149|lysine prototrophy
P10022875A1265|91 93|Pak
P10022880A0000|147 172|signal transduction pathways
P10022905A0446|176 182|tissues
P10022921A0608|72 84|cell viability
P10022925A0870|68 75|function
P10022978A1261|119 132|chromosome arms
P10024383T0000|111 117|twy/twy
P10024498A0783|123 131|HNF-3beta
P10024882A0541|99 113|promoter opening
P10025050A1052|89 100|lansoprazole
P10025506A0079|29 43|plastin isoforms
P10025506A1078|8 18|Inr sequence
P10026146A0680|223 235|Calpha subunit
P10026211A0136|115 120|family
P10026211A0543|147 167|H4IIE rat hepatoma cells
P10026229A0950|160 167|fragment
P10026275A0549|16 32|structure elements
P10026784A0331|119 123|roles
P10026784A0929|100 114|POU-homeodomain
P10026784A2166|152 157|strand
P10026824A0309|237 238|Gs
P10027498A0536|75 85|U.S. program
P10027904A0768|51 56|region
P10029337A0406|157 157|U
P10029860A0605|91 97|filling
P10029917A0366|168 185|portal vein branches
P10031854T0000|70 72|top
P10032519T0000|57 66|generation
P10032581T0000|58 66|radiation
P10033973T0000|48 62|Bose condensates
P10034615T0000|74 77|H/Ni
P10035841T0000|38 45|hydrogen
P10036181A0603|87 101|rat brain regions
P10036191A0000|206 217|cell lineages
P10037004A0000|167 171|study
P10037378A0176|56 64|lidocaine
P10037460A0221|81 99|ligand acetylcholine
P10037576T0000|76 83|melanoma
P10037681A0494|143 152|RhoAVal-14
P10037774A0366|82 98|LDLR transcription
P10041728T0000|78 89|observations
P10043466T0000|62 81|polydiacetylene 4BCMU
P10044519T0000|31 38|polymers
P10046849T0000|20 40|structure calculations
P10047970T0013|7 21|world literature
P10049357A0608|92 101|repression
P10049359A1073|87 100|rhinovirus IRES
P10049742T0000|62 64|ZF5
P10049775T0000|34 53|Anion Channel isoforms
P10049912T0000|89 112|DNA exonuclease deficiency
P10050883A0967|134 142|viability
P10051030A1080|89 96|regimens
P10051400A0000|69 87|cranio-rachischisis
P10051488A1293|118 123|HMAP-1
P10051488A1610|117 120|HSCs
P10052371A0171|140 148|cessation
P10052878A0135|31 45|reproducibility
P10053852T0000|33 61|Gerasimov-Drell-Hearn sum rules
P10054976T0000|59 77|Raman coupling regime
P10055173T0000|54 66|quasicrystals
P10059496T0000|32 45|Penrose lattice
P10063122T0000|36 40|Metal
P10063739A0601|162 164|EVL
P10064604A0824|68 73|repair
P10065176A0657|129 143|macrometastases
P10065684A0916|225 235|abnormality
P10066790A0497|220 226|epsilon
P10066798A0391|130 133|mice
P10066815T0000|137 158|B cell receptor signaling
P10068040A0136|47 55|ubc-9 gene
P10068418A1194|133 150|alendronate therapy
P10068446A0124|113 128|cysteine residues
P10068637A1320|14 21|Csx/Nkx2
P10068674A0644|49 52|Lyp2
P10068834A0713|55 56|MR
P10069815A0285|72 81|proteasome
P10070158A0573|110 128|transmembrane domain
P10071205A0833|99 105|cistron
P10071212A0399|18 32|O. australiensis
P10071761A2374|200 206|factors
P10071806A0377|36 43|survival
P10072205A0167|111 123|density values
P10072774A0537|132 138|Bge cDNA
P10073899A0740|82 84|CVS
P10073940A0335|42 50|signaling
P10073947A1110|37 41|PAI-1
P10074135T0000|91 94|RNA1
P10074282A0236|119 125|changes
P10074425A0729|130 136|p27 gene
P10074520T0000|116 118|PCR
P10074903A0915|153 168|p21 protein levels
P10074921A1169|72 74|p53
P10075415A1178|106 117|plasmid pPSR1
P10076007A0656|83 89|oocytes
P10077188A1172|185 188|mRNA
P10077533A0976|72 79|MUL genes
P10078734A0480|96 114|flexor carpi radialis
P10078876A0000|237 247|oxygenation
P10079173A0000|71 74|RRMs
P10080436T0000|93 95|use
P10080875A0772|251 256|NF-IL6
P10080901A0271|114 122|protein L9
P10082137A0262|216 221|donors
P10082554T0000|85 104|cell growth regulation
P10082570A0440|25 33|gene UBP43
P10082573A1015|186 190|DNase
P10082585A0512|134 146|reporter genes
P10084294A0219|172 172|%
P10085088A0918|148 155|activity
P10085120A0000|77 85|hypericin
P10085140A1004|108 119|TAK1 pathways
P10085383A1367|58 74|Regulation schedul
P10085505A1184|70 74|cases
P10085605A0239|70 72|hCG
P10085697T0000|0 39|FASEB Federal Funding Consensus Conference FY
P10086544A0504|457 466|furosemide
P10086725A0000|154 160|tissues
P10087213A0878|158 180|H. pylori plasmid proteins
P10087549A0720|146 157|control group
P10087993A0782|79 88|expression
P10087993A1352|146 161|promoter activity
P10090125A0750|62 71|relaxation
P10090146T0000|83 104|R-FABP promoter activity
P10090535A1194|87 92|groups
P10090943A1426|108 108|P
P10090943A1976|140 144|B-CLL
P10091594A0284|195 203|anti-K159
P10091619A0104|56 56|%
P10092132A0285|159 163|13q34
P10092847A0455|181 195|metal regulation
P10092856A0798|75 100|phosphate isomerase promoter
P10094314A0935|131 133|RBD
P10094396A0000|61 65|PK CK2
P10094701A0000|122 140|phosphate limitation
P10095059A1003|50 64|HIV-1 transcript
P10095061A0592|158 167|structures
P10095062A0558|102 103|kb
P10096469T0000|63 69|neurons
P10096573A0207|158 159|bp
P10097120T0000|36 39|mRNA
P10097932A0915|166 174|follow-up
P10098601A1320|107 118|SF-1 sequence
P10098744A0630|229 250|differentiation markers
P10099247A1051|181 182|MB
P10099576A0666|115 124|conditions
P10100605A0392|137 149|flow cytometry
P10101159A0742|120 124|mRNAs
P10101198A0632|120 126|binding
P10101198A0946|210 221|interactions
P10101744A0917|50 58|treatment
P10102000A1206|94 94|%
P10102136A0220|68 71|sera
P10102136A0646|53 55|PSA
P10102627A0217|70 74|cells
P10103002A0705|140 154|type glycan chain
P10103057A0251|129 135|studies
P10119827T0000|19 33|Chicago hospital
P10120952T0000|27 47|gall bladder guidelines
P10125354T0000|38 40|gas
P10132730T0000|52 54|Wis
P10134977T0000|22 29|patience
P10146207A0223|64 73|cord injury
P10153759A0360|46 65|NHBC organ procurement
P10171173A0955|241 251|circulation
P10181397A0641|117 128|United States
P10184191T0045|0 5|Holger
P10187317T0000|20 34|AHERF physicians
P10187798A1098|131 134|U2OS
P10187842A1155|134 142|PPARalpha
P10187864A1372|82 85|KCC1
P10190324A0000|120 127|families
P10191090A0000|61 71|development
P10192134A1088|107 119|turkey rations
P10192432A0214|132 138|core set
P10192638T0000|120 132|Alzheimer type
P10193950A0478|194 215|staging lymphadenectomy
P10194225A1132|88 97|glycerol Ra
P10194230A0817|88 89|nM
P10194451A0000|260 274|progenitor cells
P10194762A0648|226 232|alanine
P10194769A0146|131 144|element binding
P10195425T0000|122 140|metal stress response
P10195690A0000|73 98|hormone receptor superfamily
P10195697A0456|63 79|enhancing activity
P10196127A1059|82 100|pyroglutamyl residue
P10196248A0482|153 153|%
P10196266A0000|121 125|MuLVs
P10196316A0715|114 122|Oka strain
P10196318T0000|86 96|E1 promoters
P10196597A0510|85 96|drink drivers
P10197763A0580|107 107|%
P10197985A0145|255 270|complex formation
P10198003A1505|96 99|rsmB
P10198056A0000|97 99|GPI
P10198061A0339|110 116|ATP/GTP
P10199539A1353|120 121|r2
P10200473A0171|140 143|MRIT
P10201468A0297|95 98|OGTT
P10202006A0546|76 78|SPA
P10202006A1266|209 222|B cell selection
P10203611T0000|76 87|breast masses
P10205099A0377|204 205|I4
P10205176A0000|175 183|evolution
P10205176A0704|60 72|transcription
P10205588A0000|179 186|features
P10205933A0699|168 178|Lyme Disease
P10206152A1024|107 118|messenger RNA
P10206698A2041|138 142|tract
P10206959A0368|0 5|Pathol
P10207041A0065|151 157|kinases
P10207049A0693|89 92|Glc7
P10207049A1001|104 120|CUP1 transcription
P10207087A0956|150 157|AML1/ETO
P10207090A0801|88 95|molecule
P10207092A0924|103 118|sea urchin nucleus
P10207115A0389|83 91|mechanism
P10208865A1246|97 109|dentine slices
P10208893A0839|60 76|WAD goat population
P10209021A0212|73 82|mRNA export
P10209031A0832|164 187|zeta ITAM phosphotyrosines
P10209119A0076|190 200|proteolysis
P10209119A0594|207 217|proteolysis
P10209759T0000|69 72|rats
P10210952A0261|55 62|criteria
P10211329A0457|135 142|disorder
P10211422T0000|34 52|polyarteritis nodosa
P10211919A0846|179 194|CGI Severity scale
P10212278A0387|215 223|molecules
P10212284A0000|100 104|cells
P10212332T0000|34 40|disease
P10212426A1067|124 128|study
P10212969A0470|72 79|subjects
P10214610A0900|58 60|age
P10215485A0837|93 97|mI/Cr
P10215594A1728|151 153|pO2
P10215608A0161|79 89|subunit gene
P10215803T0000|45 60|calcium gluconate
P10215811A0635|77 79|EVL
P10215850A0754|133 147|position 22q11.2
P10216052A0105|348 358|reliability
P10216052A1682|213 220|subgroup
P10216161A1530|208 233|B. stearothermophilus enzyme
P10217683A0509|36 44|treatment
P10218109T0000|34 57|MutT pyrophosphohydrolase
P10218200A0534|112 114|hrs
P10218357A0486|123 125|N2O
P10219091A0246|44 49|enzyme
P10220275A0694|112 118|Gialpha
P10220364A0087|61 70|hypernovae
P10221467T0000|100 108|Parkinson
P10221820A0902|111 121|coexistence
P10223338A1601|125 131|HIV-1RF
P10223338A2186|95 109|HIV/AIDS vaccine
P10223498A0479|161 164|IIEF
P10224244T0000|88 104|INO1 transcription
P10224257A0079|141 146|intron
P10224289T0000|69 90|T cell receptor zeta chain
P10224293A0000|150 155|motifs
P10224293A2021|69 86|RPTP-kappa function
P10224513A0240|105 114|interviews
P10224758A0202|67 77|pregnancies
P10225279A0450|143 159|pseudorabies virus
P10225945A0436|163 174|kinetochores
P10226029A0905|131 135|serum
P10226074A0637|66 85|translation start site
P10226838A1011|115 120|energy
P10228009A0600|92 96|TRAF2
P10228155A1293|72 99|beta-catenin protein stability
P10228157T0000|72 76|yeast
P10228561A0539|120 126|modules
P10228795A0842|96 98|IAS
P10229084A0000|340 347|SLAP-130
P10229668A0190|39 40|G1
P10229668A0560|147 155|cell cycle
P10229682A1151|203 208|region
P10231026A0253|62 68|introns
P10231454A0731|131 137|U/liter
P10231485A0342|184 202|quinol oxidation site
P10231513T0000|77 79|rat
P10231581A1125|105 120|promoter activity
P10231862A1117|184 187|pool
P10232078A0552|70 73|TXB2
P10232600T0000|97 119|prostate cancer cell lines
P10232872A0081|67 76|population
P10233147A0218|152 165|Cyr1p/cAMP/PKA
P10233885A0899|137 147|p30 isoforms
P10233946A0000|254 261|proteins
P10234698A0728|166 171|injury
P10235265A0197|130 142|cyclin subunit
P10236651T0000|48 64|admission criteria
P10240361T0000|51 60|physicians
P10243927A0000|175 179|gases
P10271171A0458|88 101|resource center
P10281637A0000|101 105|issue
P10304090T0000|0 18|Medicare SNF benefits
P10308312A0203|145 151|effects
P10318806A0000|239 244|agents
P10318806A0476|96 104|responses
P10318806A0918|312 314|p38
P10318859A0535|98 105|paxillin
P10318900A0637|203 210|particle
P10318918A0824|106 117|HCV genotypes
P10319320A1022|156 167|angiogenesis
P10319327A1237|151 164|protein E12/E47
P10319955A0941|109 109|P
P10320177A0487|217 224|fentanyl
P10320480A0451|101 113|RNA polymerase
P10320579A1831|135 140|export
P10321158T0000|77 81|dowel
P10322022A0263|193 206|pAMbeta1 family
P10322629A0198|92 101|gene family
P10323225A0244|85 86|mM
P10323463T0000a|129 136|activity
P10323463T0000b|129 136|activity
P10323863A0852|123 147|ribonucleoprotein assembly
P10325413A1211|184 194|interaction
P10326221A0531|64 72|fulminans
P10326654A0351|310 319|difference
P10326856T0000|50 67|purse-string device
P10327051A0688|154 160|complex
P10328351A0443|39 59|supplementation period
P10329135A1326|97 109|protein import
P10329566A0610|175 186|tetraviruses
P10329574A1733|124 132|deletions
P10329586A0414|127 140|prostate cancer
P10329625A0715|143 146|FTOC
P10329736A0681|80 107|phosphatidylinositol 3-kinase
P10329736A1106|67 69|Shc
P10330134A0765|194 199|manner
P10330146A0730|158 162|sites
P10330159A1258|173 175|DNA
P10330168A0135|156 169|DNA replication
P10330396A0387|134 143|Can/Nup214
P10331276A0298|33 41|structure
P10331646A0595|296 301|export
P10331730A0504|145 151|centres
P10331875A0523|156 162|trimers
P10332733A0000|40 53|membrane fusion
P10333481A1102|200 213|promoter region
P10333526A0459|50 54|exons
P10333529A0277|43 49|trisomy
P10334888A0960|108 119|nondiabetics
P10336495A0547|149 153|cells
P10339552A0361|130 133|gene
P10339566A0602|85 90|Cnm67p
P10340447A0424|69 77|QIT system
P10340883A1266|30 30|%
P10341219A0481|123 136|mass aggregates
P10342511A0909|43 48|scores
P10342536A0954|227 242|amino acid formula
P10342829A0236|152 163|reproduction
P10342829A1370|148 157|GSE element
P10343189A0911|29 35|patient
P10344736A0796|83 104|cyclin E immunocomplexes
P10347144A0516|122 126|AVQGP
P10347197A0502|108 130|Sos1 expression construct
P10347203A0832|146 158|proliferation
P10347220A1477|281 301|methyltransferase Hcm1
P10347839A0434|53 53|M
P10348859A0292|124 129|Cys126
P10349084T0000|121 127|purpura
P10349443A0358|97 97|%
P10350027A0942|108 110|day
P10350454A0000|81 83|G.A
P10350484A0346|137 140|Vmax
P10350638A0000|118 120|rat
P10353073A0118|47 53|factors
P10353880A0257|100 100|P
P10355085A1119|134 145|nonsurvivors
P10355536A0172|23 27|range
P10355910A0369|28 32|years
P10357751A0866|223 229|disease
P10358031A0303|126 139|cell separation
P10358075A0984|150 152|PKB
P10358079A0391|76 80|Stat5
P10358080A1114|214 242|HSF1 monomer-trimer equilibrium
P10358080T0000|50 61|linker domain
P10358083A0263|200 204|sites
P10358138A0672|139 161|signaling adaptor protein
P10359014A1077|160 176|threonine residues
P10359575A0317|105 114|bFcgamma2R
P10359603A0430|22 41|Sec1p homologue Vps45p
P10359663A0425|201 231|oIFNtau-SV40-CAT transactivation
P10359663A1280|126 131|GATA-3
P10359664A0579|91 104|electrospray MS
P10359673A0000|110 132|GCN4 transcription factor
P10359792A0610|153 171|histone deacetylases
P10360454A0916|152 163|control group
P10360839A1338|123 134|cell lineages
P10360947A1113|172 178|protein
P10361038A0281|68 79|protein genes
P10362652A0350|43 55|Ras activation
P10362652A1456|101 101|%
P10362897A0545|139 144|effect
P10363517A0401|48 62|ultrasonography
P10364076A0429|90 99|affinities
P10364159A0813|130 135|4E-BP1
P10364163A0092|139 145|traffic
P10364202A0646|210 216|process
P10364314A0919|70 76|NS2 gene
P10364319A0109|106 116|control loop
P10364425A0610|104 108|STAT3
P10364523A0826|137 147|breakpoints
P10364523T0000|98 110|control region
P10365883A1355|143 151|pathogens
P10366446A0893|90 95|FLI LRR
P10366503A0812|207 231|terminase interaction sites
P10366503A1506|248 263|packasome complex
P10366559A0605|78 84|virions
P10366722T0000|83 89|subunit
P10367240A1354|212 225|sperm injection
P10367385A0000|74 77|food
P10367460A0191|154 164|Hz frequency
P10367646A0569|199 205|protein
P10369418A0644|198 200|p65
P10369625A0942|19 21|ODA
P10369757A0000|322 343|plasmid dimer resolution
P10369775A0178|97 101|rat GR
P10369926A0251|115 131|CXC chemokine genes
P10369965A0000|73 96|mushroom Agrocybe aegerita
P10370675A0649|101 111|combination
P10370778A0000|247 253|Janssen
P10371097A0963|138 147|Turbuhaler
P10372627A0530|28 36|snowboard
P10373029A0204|86 95|volunteers
P10373507A0680|159 198|SRF promoter-luciferase reporter activities
P10373523A0924|46 54|apoptosis
P10374632A0818|60 62|NBP
P10374632A0897|78 86|RMCAO rats
P10375107A1138|96 105|metastasis
P10375638A0859|123 139|translation system
P10375640A0153|129 131|kDa
P10375694T0000|97 106|comparison
P10375718A0000|102 115|administration
P10376065A0881|109 118|RF02 filter
P10376446A0000|138 142|cycle
P10376873A0706|28 30|UTR
P10376874A0759|190 197|presence
P10376877A0611|180 186|18S rRNA
P10376991A0977|25 32|tegument
P10377345A0740|109 115|regions
P10377438A0647|49 51|TEL
P10378989A0000|179 186|December
P10379547A0000|54 58|MASER
P10379899A0446|132 133|i.
P10379942A0956|88 102|MDV2 UL10 protein
P10379942T0000|111 129|Herpesviridae family
P10380232A0000|289 296|patients
P10380659A0545|30 35|adults
P10380800A0194|213 220|ancestor
P10380878A0542|114 131|histone deacetylase
P10380890A0619|48 49|IR
P10381257A0000|111 123|mitochondrion
P10381377T0000|89 104|insulin signaling
P10381570A1355|146 158|embryogenesis
P10383764A1809|252 264|export machine
P10383966A0000|104 111|cell wall
P10384129A0000|113 123|individuals
P10385384A0654|54 76|pentose phosphate pathway
P10385395A0000|155 160|gonads
P10385915A1341|120 123|side
P10388670A1976|133 140|adhesion
P10390158A1150|68 87|tiGH promoter activity
P10390538T0000|58 66|sequences
P10391075A0000|110 120|MRI findings
P10391246A0756|59 74|kinase activities
P10391277A0000|80 91|fibrillation
P10391903T0000|97 101|Elk-1
P10392266A0111|109 122|immunoglobulin
P10392669A0935|776 786|gastropathy
P10392710A1000|77 96|peptide growth factors
P10392900A1020|124 136|RNA polymerase
P10392903A0000|153 155|DNA
P10392903A0889|120 127|mimosine
P10392914A0000|152 166|tract malignancy
P10393192A0792|82 87|defect
P10393197A0543|60 70|neuroblasts
P10393201A0654|175 185|exonuclease
P10393251A0283|56 74|restriction analysis
P10393251T0000|78 90|T-ALL cell line
P10393422A0476|91 96|LAMB2L
P10393910A0705|130 136|element
P10393969A0000|148 159|transfection
P10394116T0000|53 64|oscillometry
P10394900A1166|104 114|35S promoter
P10394919A1058|53 63|oscillation
P10395199A0792|308 309|B.
P10395283A0960|171 179|responses
P10395378A1198|131 144|fusion activity
P10395827A1297|98 114|parallel beta sheet
P10395908A0236|162 170|receptors
P10395911A0288|60 65|region
P10395920A1424|160 166|element
P10396343A0754|155 169|T. b. rhodesiense
P10396343T0000|76 88|TrypTect CIATT
P10396793A0815|167 167|%
P10397257A1142|154 173|cell cycle periodicity
P10398286A0678|124 126|S2p
P10398682A0365|55 64|resolution
P10399136A0389|96 98|HPC
P10400032A0304|102 111|management
P10400593A1084|91 95|virE2
P10400712A0000|96 105|RNA viruses
P10400712A0577|268 287|counterpart sequences
P10400757A0000|122 129|isolates
P10400757A1498|201 213|fusion process
P10400760A0663|136 153|cleavage efficiency
P10400774A0240|0 0|y
P10400785A0912|107 127|nucleoporin CAN/Nup214
P10400794T0000|129 130|2A
P10402022A0432|26 29|rate
P10402467T0000|142 147|manner
P10403575A1401|87 99|control levels
P10403690A0000|416 419|days
P10403839A0140|170 173|gene
P10403839A1459|158 165|subclass
P10405635A0374|155 159|cells
P10406047A1244|300 307|age group
P10406122T0000|149 157|elicitors
P10406459A0000|220 230|NIH 3T3 cells
P10406462A1127|79 90|OR1/RXRalpha
P10406464A0687|149 154|manner
P10406465A0589|66 73|promoter
P10406466A0000|77 88|acid receptor
P10406843A1265|56 61|RT-PCR
P10406954A0715|125 132|residues
P10407184A0149|100 113|neuropathology
P10407184A0520|304 319|hbetaAPP promoter
P10407269A0000a|159 181|genome sequencing project
P10407269A0000b|159 181|genome sequencing project
P10407985A0574|100 105|cycles
P10409656A1016|153 155|LPS
P10409699A0292|250 272|polymerase chain reaction
P10409724A1021|63 75|response genes
P10409730A0597|88 97|initiation
P10409741A0382|105 116|cdc20-1 cells
P10409749T0000|71 80|activators
P10409755A1846|84 94|JT/Neo cells
P10411139A0887|66 71|Prp44p
P10411139A1344|104 113|U4/U6 helix
P10411140A0499|100 109|terminator
P10411160T0000|48 66|skin cancer incidence
P10413604A0063|138 149|DNA synthesis
P10413607A0085|197 214|signal transduction
P10413662A0193|204 212|vibriosis
P10413676A0000|87 101|signaling events
P10413676A0595|247 261|paxillin binding
P10413676A1193|112 123|contact sites
P10414451A0093|204 218|ATIII activities
P10416429A0221|117 130|population data
P10416558A0000|281 295|exercise relapse
P10417331A1008|74 75|pH
P10417703A1326|200 208|functions
P10419006A0378|83 98|breast cancer risk
P10419521A0136|151 163|transcription
P10422291A0572|50 60|involvement
P10422342A0535|224 228|111In
P10422468A0524|236 247|fibrosis gene
P10423156A0265|86 88|kDa
P10423193A1309|123 125|CTS
P10423292A0782|131 137|element
P10425094A1006|44 45|mM
P10425445T0000|27 84|mouse growth hormone receptor/growth hormone binding protein gene
P10426450A1458|105 107|ILK
P10426878A0367|163 172|prevention
P10427654A0000|191 197|surgery
P10428091A0322|119 123|women
P10428294A0227|92 96|women
P10428759A0743|81 89|receptors
P10428811A0628|131 138|activity
P10428811A1067|92 94|Src
P10428862A0834|163 172|BaF/3 cells
P10429184A0000|113 121|mechanism
P10429740A0000|89 91|IBS
P10429946A0473|147 154|elements
P10429946A0988|76 91|complex formation
P10430421T0000|73 88|Cache County Study
P10430580A0000|108 112|yeast
P10430583A0000|59 62|RecA
P10430883A0000|293 321|horseradish peroxidase reaction
P10430886A0838|105 113|activator
P10430890A1059|115 129|partner proteins
P10430944A1298|57 68|malignancies
P10430980A0465|20 24|women
P10433729A1559|26 26|C
P10433970A0279|100 120|transactivation domain
P10435595A0203|35 50|trans-activation
P10436016A0337|116 120|Mad1p
P10437043A0164|43 50|biopsies
P10438540A1185|108 114|protein
P10438593A0000|87 111|RNA polymerase processivity
P10438607A0330|57 68|gene fork head
P10438627A0885|156 160|yeast
P10438924A1009|107 111|GSK-3
P10438924T0000|98 125|phosphatidylinositol 3-kinase
P10438941A1197|116 120|genes
P10438950A0580|81 99|fibroblast cell lines
P10439040A0658|139 148|constructs
P10440923A0684|272 274|pRb
P10441243A0443|85 92|subjects
P10441449X1212|13 25|Academic Press
P10441483A0454|118 125|proteins
P10441506A0098|238 248|D region/HR2
P10442493A0815|99 122|plasma cyclosporine levels
P10443990A0000|72 81|bone health
P10444597A0586|142 148|nucleus
P10444813A0448|74 94|somatostatin analogues
P10445161A1565|147 151|sexes
P10445506A0073|54 63|body length
P10445945T0000|11 15|dawso
P10446131A0132|75 78|ATII
P10446149A0809|137 140|Rin1
P10446206A0000|184 201|hepatoma HepG2 cells
P10446833T0000|49 53|shock
P10446910A0147|237 251|transactivation
P10446912A0883|121 130|JEG-3 cells
P10446998A0375|106 122|c-fos inducibility
P10446998A0955|231 241|protein SP-1
P10446998T0000|90 110|serum response elements
P10447593A0144|116 127|sigma factors
P10447597A1004|48 59|GIY-YIG motif
P10448036A0748|200 206|protein
P10448095A0865|139 155|expression profile
P10448285A1035|72 77|months
P10448440T0020|86 104|personality disorder
P10448902A0921|98 101|rats
P10449072A0560|62 63|PD
P10449899A0881|61 75|integration site
P10450815A0180|264 275|inflammation
P10451209A0000|149 152|MPSS
P10452306A0502|170 199|heart catheterization parameters
P10452951A0000|101 107|species
P10452991A0331|70 80|T cell clones
P10453006A0000|196 199|PSMB
P10453006A0478|139 144|humans
P10453248A0094|127 135|behaviour
P10453371A0640|54 64|BMD z-scores
P10453721A0445|90 111|ADAPT II software package
P10454533A0859|140 151|conformation
P10454540A0392|63 81|exonuclease activity
P10454550A0960|91 107|Snf1 kinase complex
P10454557A0000|214 238|replication origin activity
P10454557A0975|189 198|components
P10454561A0594|262 264|p65
P10454568A0815|198 204|fashion
P10454570A0846|373 383|uPA enhancer
P10455087A1400|96 104|threshold
P10455143T0000|51 72|glucocorticoid receptor
P10455183A0530|106 113|capacity
P10455183A0930|179 190|U6 snRNA genes
P10455189A0104|80 95|integrin ligation
P10455189A0427|84 89|manner
P10457075A1198|110 121|peak decrease
P10458905A0000|80 87|8p22-p23
P10458907A0543|90 95|testis
P10458914A0674|117 121|exons
P10459809A1262|65 71|biofilm
P10460015A0465|119 125|bone age
P10460171A0842|103 106|step
P10460172A0823|146 160|heterotetramers
P10463057A0534|37 44|plasmids
P10463242A0316|41 46|region
P10464185T0000|81 109|Streptococcus agalactiae type Ia
P10464250A0275|6 11|FASEB J
P10464291A0597|126 131|manner
P10464302A1109b|247 258|cytoskeleton
P10464310A0218|222 237|complex formation
P10466306A0000|96 103|function
P10466825T0000|80 84|genes
P10467004A0116|131 136|Michel
P10467004A0683|152 153|bp
P10467403A0000|138 147|PI 3-kinase
P10467465T0000|53 64|alternatives
P10468033T0000|70 77|solvents
P10468585A0980|154 169|hsp70 interaction
P10469140A0336|176 191|mutation analyses
P10469174A0678|156 162|MBF1CTD
P10469656T0000|122 134|histone H3/HMG
P10470220A1011|164 166|LIA
P10471587A0239|249 259|amoxicillin
P10471696A0734|101 116|Rap1p binding site
P10471721A0141|125 135|pollen S gene
P10471743A0000|61 92|Arabidopsis thaliana cDNA libraries
P10471746A1102|98 118|Myogenin transcription
P10472314A0717|54 58|women
P10472836A0189|70 70|M
P10473589A0189|78 86|C terminus
P10473598A0691|149 165|competition assays
P10473623A0081|159 161|ARF
P10474898A0629|178 185|primates
P10475610A1289|0 3|Natl
P10475972A0269|67 72|deaths
P10476970A0542|141 150|G-proteins
P10477545T0000|84 95|HIV-1 strains
P10477583A0000a|102 110|mechanism
P10477583A0000b|102 110|mechanism
P10477597A0126|142 152|SAPK pathway
P10477599T0000|156 160|T cell
P10477620A0580|166 182|curcumin treatment
P10477748A1076|47 53|spindle
P10478275A1230|185 192|contrast
P10478844A1604|204 215|coactivators
P10478848A0331|27 35|AF1 domain
P10479025A0528|115 123|responses
P10479382A1098|110 116|fitness
P10479492A0000|99 132|corpus uteri adenocarcinoma FIGO stage
P10480937A0000|196 196|E
P10482516A1158|134 157|transcription readthrough
P10482516T0000|92 122|Bacillus subtilis trpEDCFBA operon
P10482565A0469|83 88|fusion
P10482620A1009|174 180|MMTV LTR
P10483124T0000|144 161|cDNA scanning method
P10483945A0641|72 73|5x
P10484695A0791|103 120|language impairment
P10484818A0292|41 65|cross-correlation analysis
P10485353T0000|142 151|serosurvey
P10485470A0242|187 203|binding activities
P10485585A0175|58 70|neurohormones
P10486210A0126|68 75|promoter
P10487040A0453|77 84|reaction
P10487217A0735|112 121|N-terminus
P10487307A0768|106 110|order
P10487744T0000|134 142|migration
P10487753A0788|67 78|cell division
P10487759A0630|139 150|reporter gene
P10487760A0336|91 95|yeast
P10487762A0252|35 37|MDa
P10487921A0132|64 69|oxygen
P10487953A0765|107 115|operation
P10488087A0340|161 177|SP-A gene sequences
P10488088T0000|103 109|protein
P10488129T0058|65 70|intron
P10488147A1176|125 133|phenomena
P10488148A0111|162 170|infection
P10488148A1267|169 176|HIV-1 LTR
P10488148T0000|111 119|NF-kappaB
P10488337T0000|97 108|bZIP proteins
P10488875A0000|90 92|ITW
P10489680A0927|63 78|grain dust-asthma
P10489822T0000|79 83|trial
P10490065T0000|46 52|therapy
P10490604A0601|92 105|NFAT activation
P10490609A0413|187 197|ARS activity
P10490639A0000|177 180|Pcls
P10490662A0431|92 102|compound eye
P10490662A0819|83 90|antibody
P10490816A0000|111 115|MEN 2B
P10490822A1167|68 75|approach
P10490826T0000|112 130|oncoprotein E2a-Pbx1
P10490835T0000|95 124|tyrosine kinase signaling pathway
P10490843A0159|153 156|PLZF
P10490955T0000|135 158|thrombospondin-1 peptides
P10491133A0365|102 109|NO donors
P10491187T0000|140 147|gene ptsH
P10491213A0263|390 394|years
P10492127A0914|149 160|saline intake
P10492169A0939|134 140|EST-YD1
P10493203T0000|102 104|ECG
P10493575T0000|125 127|p53
P10493580A1126|118 138|esterase/lipase family
P10493876A0000|576 587|calculations
P10495573A0365|160 169|acceptance
P10496161A0503|79 82|rats
P10496284A0115|112 127|IgG synthesis rate
P10496303A1968|149 153|mg/kg
P10496388A1956a|98 104|concern
P10496388A1956b|98 104|concern
P10496553A1004|132 155|immunodeficiency syndrome
P10497117A0358|35 42|V protein
P10497199A0559|149 157|COUP-TFII
P10497262A0000|138 148|cDNA cloning
P10497800A0000|101 107|bulimia
P10497874A0925|117 133|PLC-gamma1 isozyme
P10498616A0157|198 213|expression levels
P10498616A1280|188 193|p21 Ras
P10498706A1219|103 106|KdgR
P10498717A1048|90 103|RsmA production
P10499121A0542|123 127|study
P10499357A0439|217 229|neurotoxicity
P10501034A0839|191 197|embryos
P10501656A1415|82 95|tumor cell lines
P10501936T0000|149 158|morphology
P10501965A0879|178 185|receptor
P10501969A1329|121 133|cardiogenesis
P10502216A0289|155 156|MI
P10502402A0129|173 182|regulation
P10502402A0533|117 137|T lymphocyte activation
P10502434A0367|150 158|treatment
P10502434A0604|53 63|ICG3 disease
P10502522A0000|125 133|cell lines
P10503540A0602|103 120|polyacrylamide gels
P10503812A1450|163 189|cyclosporin pharmacokinetics
P10504332A0701|176 190|RAP fluorescence
P10505694A0000|155 166|cytotoxicity
P10505694A0739|109 109|P
P10506143A0610|222 228|Cdc42Hs
P10506160A0297|0 0|J
P10508522A1598|47 54|EWS-FLI1
P10509768A1118|106 126|serum cholesterol level
P10510295A0606|129 136|GLK1 gene
P10510379A0105|83 100|cytokine activation
P10511216A0654|54 58|cause
P10511554T0000|58 88|clone Caenorhabditis elegans cdf-1
P10512699A0364|181 191|translation
P10512699T0000|183 191|selC genes
P10512857A0000|100 119|transcription factors
P10512882A0137|122 130|Src family
P10513756A0584|122 126|alpha
P10513922A1237|135 140|groups
P10514493A0199|139 160|NTR-1 promoter sequences
P10514808T0000|31 45|epileptogenesis
P10516011A0471|106 128|pAP phosphorylation sites
P10516026A0270|19 24|clones
P10516072A0146|8 8|F
P10516738A0925|50 64|irbesartan/HCTZ
P10516878T0000|87 89|PET
P10517666A1069|96 99|nGRE
P10517672A1417|203 213|CAT activity
P10517675A0809|152 158|p27kip1
P10518496A0952|196 208|organogenesis
P10518502T0000|97 117|Caenorhabditis elegans
P10518561A0261|119 125|enzymes
P10518561A0885|73 84|kinase domain
P10518822A1037|120 143|CCR3 receptor ligand system
P10518937A0572|169 176|K. lactis
P10518956A0137|165 180|deiodinase system
P10518956A1212|55 58|form
P10520800A0307|145 147|ECG
P10521345A0202|230 235|system
P10521443A0486|219 239|NF-kappaB c-Rel subunit
P10521447A0606|96 132|AML/CBFalpha transcription factor family
P10521447A1190|56 73|AML1-ETO repression
P10521450A0437|80 83|mice
P10521509A0000|193 197|RGS11
P10521544T0000|110 121|biosynthesis
P10521796A0872|319 321|CAG
P10523319A0209|58 64|domains
P10523520A0986|59 63|phyla
P10523634A1404|171 181|interaction
P10523640A0367|141 161|serine phosphorylation
P10523647A0000|179 187|cell death
P10523647A1001|110 124|AP-1 target genes
P10523663A0404|114 123|modulators
P10523674A0000|117 131|S rRNA processing
P10524258A0286|96 115|Northern blot analysis
P10524258T0000|84 104|muscle differentiation
P10525413A1408|110 125|N NMR spectroscopy
P10526670A0236|127 142|membrane ruffling
P10526670A1828|154 170|Ras transformation
P10527106A0384|142 150|depiction
P10527158T0000|65 80|USDOE Pantex Plant
P10527180A0869|653 660|response
P10527426A0521|158 166|sequences
P10527475A0643|42 48|grooves
P10528035A1102|46 79|serum alanine aminotransferase levels
P10529198A0068|86 88|Sos
P10529354A0375|120 131|26S particles
P10531334A0525|107 109|cGK
P10531340A1275|25 25|J
P10531342A0348|133 148|psa2/gp46 complex
P10531342A1111|129 151|promastigote cell surface
P10531360A0958|133 139|hypoxia
P10531446A0203|65 87|receptor tyrosine kinases
P10532354A1374|204 213|yeast cells
P10532805A0792|83 87|nrg-1
P10532805A1084|118 126|nrg-1 mRNA
P10533066A0758|64 78|splice mutations
P10533066A1197|88 91|TSC2
P10534048A0297|204 217|attenuation map
P10534402A0126|129 140|Spo11p family
P10534402A0659|186 189|mRNA
P10534691A0542|144 152|infection
P10535715A0268|122 127|phases
P10536125A0093|100 127|influenzavirus neuraminidases
P10536369A0662|86 92|element
P10536369A1280|76 81|manner
P10536788A0931|132 132|%
P10540015A0664|133 133|%
P10540292A1179|170 175|inputs
P10540553A0980|161 166|growth
P10540915A0697|78 81|n.s.
P10541432A0185|185 201|glioblastoma cells
P10541550A0487|143 155|follicle cells
P10541865A1301|129 134|tumors
P10542237A0357|164 176|IL-6 secretion
P10542249A0415|137 145|C/EBPbeta
P10542260A0832|83 91|receptors
P10542269A0000|185 187|APP
P10542274A1376|111 126|promoter activity
P10542277A0000|89 107|localization signals
P10542281A0382|130 137|G1 domain
P10542281A2021|123 127|sites
P10543270A1054|95 103|discharge
P10543727A0282|362 368|EnA-TRE
P10543728A0358|131 138|E1A cells
P10543730A0000|137 143|meiosis
P10543949A0686|61 66|cavity
P10544037A0617|85 85|%
P10544088A0308|117 119|Tat
P10544089A1208|214 219|MP gene
P10544113A0293|79 87|U3 segment
P10545192T0000|122 140|agent vanadyl sulfate
P10545248A0567|151 164|muscle lineages
P10545281A0836|128 146|protein accumulation
P10548434A1549|133 144|p38 signaling
P10548622A0906|202 210|procedure
P10548722A0099|164 170|element
P10549354A1782|223 236|Axin/Conductin
P10549354A2371|107 112|cancer
P10549912A0136|256 261|artery
P10550139A0191|120 127|patients
P10550571A0000|164 169|thiols
P10550574A1038|122 127|cycles
P10551788A0229|75 90|trophoblast cells
P10551796T0000|12 29|HIV-1 transcription
P10551816A0162|36 40|forms
P10551848A0000|64 64|D
P10551867A0350|109 124|rat cDNA libraries
P10551879T0000|134 154|protein fusion proteins
P10552357A1936|232 234|AIR
P10553551A0000|72 78|pathway
P10553959A0812|51 56|levels
P10554946A0082|167 172|lipids
P10555079A0254|24 33|morphology
P10555285A1065|205 217|globin cluster
P10555964A0778|3 5|Kim
P10556028A0292|155 158|BD-2
P10556029A0852|102 111|precursors
P10556033A0000|141 146|region
P10556044A0913|88 96|LG modules
P10556046A0328|98 110|Xenopus embryo
P10556063A0092|45 56|Trk subfamily
P10556089A0901|203 208|CUG-bp
P10556145A1034|94 102|magnitude
P10556263A1035|75 76|AC
P10556595A0391|91 96|region
P10556751A0758|157 161|staff
P10557008T0000|60 64|child
P10557072A0127|70 73|ULK1
P10557072A0418|99 100|PS
P10557072A1218|92 96|cells
P10557308A0000|59 70|RAS signaling
P10559207A0207|164 172|evolution
P10559303A0000|99 110|B lymphocytes
P10559320A0080|115 118|RNAs
P10559324A0716|62 69|rat cells
P10559364A0846|262 265|BrdU
P10560014A0000|127 136|myocardium
P10560997A1072|71 79|ovulation
P10561095A2141|131 148|hypoparathyroidism
P10561153A0225|130 134|month
P10561251A0000|248 271|stem-cell transplantation
P10561460A0615|128 145|GPI signal sequences
P10561546A0000|138 156|NF-kappaB p65 subunit
P10562418A0238|42 46|cells
P10562456T0000|99 105|walbaum
P10562495A0188|136 140|virus
P10563212A0514|106 113|controls
P10563605A0773|91 91|p
P10563789A1951|83 94|FSH receptors
P10563836A1234|98 114|AP-2 protein levels
P10564231A0315|13 13|M
P10564280A0140|197 201|Sam68
P10564472A0853|63 68|system
P10564474T0000|93 112|polymyxin B resistance
P10564479A0384|137 143|absence
P10564484A0859|123 130|function
P10564495A0444|195 199|CD66c
P10564593A0428|154 166|translocation
P10564593A1618|195 207|drug transport
P10564939A0981|50 53|data
P10566630A0371|110 115|months
P10566862A0000|153 162|strabismus
P10567430A0785|189 192|GRK6
P10567524T0000|57 61|yeast
P10567533A0818|113 127|tyrosine kinases
P10567538A1028|135 140|region
P10567581A0119|240 245|S phase
P10567582A1334|76 88|embryogenesis
P10567589A1268|87 102|Pmt3p conjugation
P10568275A0679|87 92|GEOMAR
P10568455A0000|151 152|CL
P10568728A1445|82 85|week
P10568744A0728|145 163|mating type switching
P10570262A0000|74 90|signaling cascades
P10570996A1213|183 189|insulin
P10571047A1009|120 121|kb
P10571474A0571|56 65|tianeptine
P10572087A0326|85 93|screening
P10572130A1623|141 151|DNA geometry
P10572131A0000|73 87|nasFEDCBA operon
P10572866A0481|88 112|aspartate aminotransferase
P10573781A0631|75 80|excess
P10574913A1108|177 189|ERK activation
P10574929A0583|41 53|P-CIP2 protein
P10574982A1075|88 96|complexes
P10574992A0901|163 199|PARP chemical inhibitor 3-aminobenzamide
P10575231A0355|78 84|introns
P10575545A0147|23 32|CAAT motifs
P10575642T0000|27 39|iontophoresis
P10576177A0308|107 117|implication
P10576545A0926|125 134|transgenes
P10578528A0730|121 134|symptomatology
P10579331A1225|172 175|gene
P10579722T0000|64 73|Rho-kinase
P10580071A0436|49 63|transplantation
P10580438A0508|118 130|preadipocytes
P10582831T0000|75 82|patients
P10584138T0001|71 79|neck tumor
P10584704A0913|183 190|sections
P10585311A0494|125 130|biopsy
P10585311A1542|87 90|MPGN
P10585417A1412|127 134|function
P10585440A0204|99 108|chromosome
P10585453A1029|158 163|hGH LCR
P10585463A0859|44 74|baculovirus-Sf9 expression system
P10585480A0157|83 85|Rac
P10585480A0265|56 66|interaction
P10585491A0945|360 368|cytokinin
P10585808A0000|80 88|detection
P10586074A0129|120 136|encephalitis virus
P10586107A0160|73 92|cell surface receptors
P10586115A0477|212 215|% FCS
P10586626A0607|130 133|ADEM
P10587460A0302|183 190|bacteria
P10587461A0341|96 99|site
P10587576A0596|86 100|SH3GL pseudogene
P10588946A0432|68 72|ORP-6
P10589562A1208|82 100|RF power requirements
P10589711A1228|185 190|milieu
P10590092A0124|52 54|CNS
P10590368X0000|237 237|%
P10591633A0138|179 192|membrane fusion
P10591933A0798|150 157|distance
P10591976A0317|72 79|patients
P10591990A0178|95 97|PAS
P10592791A0370|421 436|research purposes
P10592791T0001|55 66|enterotoxins
P10592824A1157|257 265|trend test
P10593939A0747|230 234|U-70K
P10593950A1113|106 112|hnRNP A1
P10594130A0652|76 83|staining
P10594239A0614|154 160|alleles
P10594239T0000|113 120|location
P10594903A0000|166 175|laboratory
P10595315A0344|76 85|blood gases
P10596955A1032|114 119|Immuno
P10597222A1371|89 91|p21
P10597223A0339|191 210|transcription factors
P10597232A0000|123 139|thyroid carcinomas
P10597317A1156|215 221|RS cells
P10598101A0000|105 124|kDa zein gene promoters
P10598101A0754|207 225|maize endosperm cells
P10598316A1534|32 41|substances
P10599013A0505|11 16|deaths
P10599727A1567|106 110|peers
P10600171A1066|91 107|CYP3A2 DexRE-1 site
P10600171A1432|93 129|bHLH/leucine zipper transcription factor
P10601280A0674|100 109|activation
P10601290A0742|198 217|MHC-peptide complexes
P10601335A0892|63 70|degrees C
P10601344A1653|173 177|Cdc42
P10601410A0977|113 126|conduction time
P10601606A0152|83 90|degrees C
P10601747A0482|141 149|word onset
P10602419A1253|16 22|effects
P10602502A0422|65 71|S phases
P10602507A0652|183 195|p53 expression
P10602516A0182|104 111|function
P10602838A0127|26 30|males
P10603349A1667|170 182|mesencephalon
P10604246A0523|227 232|donors
P10604583T0000|167 172|toxins
P10604945A0731|197 211|ethanol response
P10606245A0906|126 130|OC box
P10606272A1241|129 136|metazoan
P10606515A0389|131 136|strand
P10606664A0000|108 128|cell fate determination
P10607566A0880|166 184|beta-catenin binding
P10607899A0605|114 140|estrogen receptor binding site
P10607900T0000|40 49|regulation
P10608053A0923|174 176|p NS
P10608893A0727|62 72|specificity
P10610716A1127|89 98|FD patients
P10611225A1127|162 165|role
P10611228A1388|66 71|assays
P10611235A1927|140 153|plasma membrane
P10611242A0541|104 107|Spt8
P10611320A0816|128 131|Cdk7
P10611353A0458|195 214|Northern blot analysis
P10612044A1180|135 147|Aal-rpL8 genes
P10612505A1317|91 105|treatment effect
P10612773A1210|92 98|surgery
P10612805A0716|48 54|cancers
P10612918A0318|44 49|screws
P10613816X0000|225 235|osteoporosi
P10613843A0107|112 122|ion channels
P10613863T0000|115 126|pfoA promoter
P10613874A0663|150 161|GlnA proteins
P10614676A0000|191 215|hormone replacement therapy
P10614857A0584|192 201|rhinovirus
P10616948A0998|74 94|seizure threshold level
P10617126A1005|168 170|CA3
P10617144A0386|99 99|%
P10617232A0393|117 124|patients
P10617613A1192|0 3|Chem
P10618645A0750|61 64|CalC
P10619062T0000|25 28|n. sp
P10619169A0411|58 67|time period
P10619254A1055|87 98|image quality
P10619353T0000|131 137|COUP-TF
P10620010A1155|151 156|T-loop
P10620335A0749|52 60|CV-1 cells
P10620777A1399|0 7|AB004534
P10622574A0000|120 124|world
P10622576A0552|134 144|drug abusers
P10623758A0947|149 154|months
P10623804A0808|130 150|Fc gamma RIIB1 signaling
P10624787A0432|190 203|waist-hip ratio
P10625438A1429|199 212|control samples
P10625494A1059|75 87|HL60/VCR cells
P10625683A0091|125 132|function
P10625721T0101|35 44|Study Group
P10627518A0544|112 115|UTRs
P10627532A0739|152 174|transcription factor ATF2
P10627834A0178|155 161|Stanley
P10628490T0000|19 24|artery
P10628748A0344|107 110|SF-1
P10628748A0746|132 134|CRE
P10628750A0298|163 173|x NF-kappaB1
P10628750T0000|136 154|NF-kappaB activation
P10628755A0000|133 137|GHS-R
P10628971A0824|144 166|dynamin family member VPS1
P10628971A1165|270 303|inositol polyphosphate 5-phosphatase
P10629035A0827|186 194|synthesis
P10629176A0887|74 81|FBP1 gene
P10629938A1352|143 153|development
P10630471T0000|77 88|cell behavior
P10630630A0614|77 89|CFI mRNA levels
P10633075A1111|89 94|effect
P10633499A1306|172 176|hooks
P10634007A0202|112 124|drug clearance
P10635209A0419|35 42|adhesive
P10637149A0806|118 120|A-A
P10637230A0332|91 94|IFNs
P10637238A0291|66 73|question
P10637337A0545|51 59|mutations
P10638607A0000|176 189|adenocarcinoma
P10639585A0157|82 96|differentiation
P10640683A0204|81 100|expression constructs
P10640683A0670|315 327|transcription
P10640701T0000|91 100|expression
P10640734A0190|153 164|cell activity
P10641037A1371|0 7|AF154055
P10641688A0341|54 64|disc changes
P10642524A0156|136 142|regions
P10642531A2322|76 94|RGD recognition sites
P10642889A0393|93 99|TATA box
P10643313A0345|110 114|ml SF6
P10644357A0935|124 126|VP3
P10644414T0000|57 85|mosquito ultraspiracle isoforms
P10644753A0725|116 133|glycosaminoglycans
P10644760A0000|119 127|machinery
P10644760A0956|82 97|repression domain
P10645921A0000|73 84|morphologies
P10645921A1320|149 165|circumflex disease
P10646820T0000|104 112|carcinoma
P10646863A0838|85 104|topoisomerase IIalpha
P10647177A0599|146 154|formation
P10647633A1685|120 125|rectum
P10647817T0000|74 77|PTA1
P10647859A0000|356 358|gas
P10648020A0151|241 242|RA
P10648211A0000|76 86|ion channels
P10648489A1117|96 113|peak concentrations
P10648619A0000|265 266|SG
P10649449A0413|158 164|domains
P10649456A1061|85 93|Frankfurt
P10649738A0953|72 85|patient-months
P10650104X0284|30 41|Radiologists
P10650938T0000|83 93|trout ER gene
P10650939A0789|61 64|AP-1
P10650939A1542|111 114|luc3
P10650958A1315|144 161|mobility shift assay
P10651076T0000|66 74|arthritis
P10651805A1600|197 208|methotrexate
P10651805T0000|111 123|leukemia cells
P10652093A0139|139 150|DNA molecules
P10652102A0620|100 105|growth
P10652228A0759|105 107|Dbl
P10652324A0177|26 40|collagen binding
P10652362A0933|196 203|vesicles
P10652800A0984|187 189|BMI
P10653359A1297|21 24|mice
P10653400A0000|47 49|LDN
P10653550A1120|93 100|meniscus
P10653693A0429|101 110|components
P10653693A0903|148 156|functions
P10653697A0133|75 82|sequence
P10653733A0596|49 56|peptides
P10654032A1133|72 82|performance
P10655164A0546|164 169|x10-10
P10655230A0685|105 110|domain
P10656154A0722|30 32|PMS
P10656161A0316|108 116|AUC values
P10656802A1724|95 98|site
P10657238A0541|201 208|activity
P10657658A0165|189 194|manner
P10657899A0685|147 150|mice
P10658425A1567|53 56|dogs
P10658445A0208|182 195|prostaglandins
P10658588A0304|139 158|Plasmodium falciparum
P10660069A0819|113 142|Hog1p signal transduction pathway
P10660304A0522|217 223|context
P10660604A0748|51 84|HD-PPRE luciferase reporter construct
P10660676A0000|97 101|mouse
P10662550A0679|78 91|ATR-16 patients
P10662614A0000|203 214|polyproteins
P10662614A0972|96 107|interactions
P10663558T0000|112 113|Ig
P10664876A0000|290 295|esters
P10665308T0001|51 57|duratio
P10665798A0598|186 197|tissue damage
P10665949A1131|76 82|feedlot
P10666222A0330|95 110|survivin proteins
P10666238A1322|111 131|E2F-1 promoter activity
P10666253A1291|82 84|PBS
P10666509A0494|69 85|propranolol groups
P10667597A0668|29 42|splice variants
P10668701A1311|114 126|atherogenesis
P10669319A1722|86 90|trial
P10669594A0000|206 224|metalloprotease gp63
P10669594A0969|80 87|fimbriae
P10669596A0430|251 256|enzyme
P10669633A0391|115 124|THP-1 cells
P10669736A0903|110 112|PTB
P10669751T0000|110 123|transformation
P10670358A0143|15 23|exception
P10671224A0254|60 74|CD95L expression
P10671519A0641|184 189|emerin
P10671520T0000|114 128|HIV-1 expression
P10671554A0492|166 181|Edman degradation
P10671606A0884|140 142|BAH
P10672433A0199|206 211|person
P10672899A0078|0 3|Acad
P10673335X0782|13 25|Academic Press
P10673426A0168|197 208|cytotoxicity
P10674395A0262|229 241|cell line GT1-7
P10674484A0633|133 138|memory
P10675154T0000|16 29|botulinum toxin
P10675331A0600|142 146|Stat3
P10675610A0279|108 119|C-MYC protein
P10677214A1045|330 336|complex
P10677214A2842|165 174|site region
P10677297A0933|147 151|cells
P10678144A0509|5 6|i.
P10678968A1096|186 191|season
P10679015A0216|84 91|proteins
P10679065A0711|222 241|phosphoacceptor motif
P10679065A1217|112 119|SB203580
P10679190A0693|114 117|mORF
P10679649A0311|190 194|range
P10679781A1183|117 129|phorbol esters
P10679922A1110|103 112|neck cancer
P10681520A0525|157 166|Gbetagamma
P10681562A0263|125 139|PPARgamma action
P10681588A0899a|249 255|factor Y
P10681588A0899b|249 255|factor Y
P10681679A0220|112 120|diagnosis
P10682570A0453|57 65|operation
P10683072T0000|116 128|cell carcinoma
P10683244A0939|112 129|sieve chomatography
P10683244A1860|228 242|phosphorylation
P10683244X2359|13 25|Academic Press
P10683259A0774|196 210|splice junctions
P10683989A0251|106 117|Qs/Q tau ratio
P10684069A0508|133 145|aminophylline
P10684097A0175|163 164|g B
P10684111A1411|87 103|MAPK family members
P10684265T0000|130 135|hSMT3b
P10684304A1242|23 23|L
P10684534A0634|90 102|clotting times
P10684646A0224|94 101|caveolin
P10684660A1266|115 121|enzymes
P10684941A0722|119 122|nick
P10684967A0000|157 169|lung phenotype
P10687366A0000|110 114|weeks
P10687855A1197|133 147|differentiation
P10687855T0000|123 130|rat Zn-15
P10687862A1980|81 96|promoter activity
P10687945A0000|37 43|infants
P10688639A1310|84 97|p300 expression
P10688646A0535|165 182|expression analysis
P10688660A0992|185 203|reporter DNA template
P10688661A0237|182 186|genes
P10688663A0207|187 189|DNA
P10688666A1010|52 71|homo-oligomerization
P10690702A0065|94 109|myasthenia gravis
P10690725A1037|25 28|PRFR
P10690866A0783|77 84|neonates
P10691972T0000|148 151|MRP3
P10692167A0364|63 72|M. synoviae
P10692374A1873|250 257|reaction
P10692433A0000|90 98|cell cycle
P10693246A0252|167 177|mediastinum
P10693314A0521|77 79|AMI
P10694189A0469|56 68|noradrenaline
P10694210A0385|178 178|%
P10694511A0570|119 132|uptake activity
P10694605A1327|117 122|months
P10694609A0309|187 195|operation
P10695685T0000|74 85|consequences
P10696007A1325|76 83|response
P10698516T0000|69 83|SAPK/JNK pathway
P10698937T0000|77 81|genes
P10698974A0951|249 256|deletion
P10699354A0557|19 22|P300
P10699653A0967|127 134|solution
P10699684A0661|104 104|M
P10699896A0455|41 41|P
P10700262A0000|90 104|brain structures
P10701534A0164|108 110|age
P10702241A0357|107 112|spleen
P10702253A0357|156 169|HIF-1alpha gene
P10702285A0855|235 257|GLUT4-EGFP translocation
P10702389A1148|83 91|cytoplasm
P10702794A1495|141 157|feedback mechanism
P10702926T0089|46 68|alpha beta T cell receptors
P10703633A0747|264 273|time points
P10704196A1051|145 151|helices
P10704283A0649a|150 172|IL-4 cytokine gene cluster
P10704285A0536|103 115|AP-2alpha gene
P10704338A0354|244 255|P-position-L
P10704410T0000|41 74|replication initiator proteins Mcm2-7
P10704499A0682|219 221|PMA
P10704853T0000|92 100|zebrafish
P10704975A0479|157 164|controls
P10705380A0629|175 181|genesis
P10705783A0433|123 127|mg/mL
P10706475A0644|50 52|DPP
P10706513A0843|64 74|ventilation
P10706688A0376|107 122|NF-kappaB binding
P10706736A1091|143 150|epitopes
P10706887A0281|117 129|ALK expression
P10706887A1457|137 148|methotrexate
P10708243A0000|101 104|role
P10708424A0800|92 99|activity
P10708769A0433|99 109|tunicamycin
P10709705T0000|40 50|information
P10710499A0000|81 94|edema formation
P10710742T0000|38 66|gonadotropin stimulation cycles
P10710985T0000|51 70|strengths perspective
P10711674A0000|117 127|keratoconus
P10712512A0506|67 79|thioacylation
P10712599A0349|56 62|pathway
P10712618A0181|86 110|Bacillus subtilis aspartase
P10713083A0170|80 83|TraM
P10713083A0560|135 152|DNA recognition site
P10713155A0151|169 175|HeLa-NE
P10713161A0985|92 113|Smt3-protein conjugates
P10713175A1399|144 158|cell cycle arrest
P10713176A0422|225 241|mitogen withdrawal
P10713176A0885|169 185|cell proliferation
P10713239A0988|79 86|IOL optic
P10713453A0172|127 132|Hrb57A
P10714985A1057|107 126|leader RNA association
P10715322A0000|89 94|plants
P10715325A0834|176 183|pathways
P10715602A0149|172 176|rSP-C
P10717612A0000|225 237|cell carcinoma
P10720434A0291|116 118|UTR
P10721698A1195|141 153|transcription
P10721704A1155|190 198|cell types
P10721704X0000|270 282|mRNA stability
P10721714A1087|105 111|Sp1 site
P10721717A0676|68 84|amino acid residues
P10721726T0000|18 43|mouse thioredoxin reductases
P10722063A0328|150 151|nm
P10722509A0392|52 61|body weight
P10722661A0146|92 102|PHO80 cyclin
P10722661A0406|193 199|control
P10722737A1726|157 161|S gene
P10722969A0510|32 35|area
P10723723A0781|105 108|exon
P10723727A0713|74 103|polyadenylation signal sequences
P10724436A0085|71 76|system
P10724483A0540|80 89|HOG pathway
P10724519A1185|67 74|elements
P10725017A0673|145 172|Healthcare Record Architecture
P10725382A0398|111 114|SOS2
P10725433A0543|183 198|promoter function
P10727247A0461|123 132|TEF-1gamma
P10727413A1244|238 244|insulin
P10727426A1280|69 79|roscovitine
P10727428A0000|138 148|hypertrophy
P10727433A0560|210 231|protein kinase C pathways
P10727433T0000|173 180|receptor
P10727511A0294|124 133|regulation
P10727515A1202|159 172|pertussis toxin
P10728945A0233|95 99|trial
P10728986A0000|76 92|cell fate decisions
P10729151A1160|73 90|reporter expression
P10729155A0653|170 176|subunit
P10729220A0000|102 106|mouse
P10729220A1569|95 99|brain
P10729221A0798|67 84|subtype specificity
P10730292T0000|44 55|malocclusion
P10730763A1491|162 168|studies
P10731411A0958|94 113|DEAD-box RNA helicases
P10731926A0775|120 128|carcinoma
P10732669A0510|186 203|HD-Zip binding sites
P10732669A1336|180 185|family
P10733569A0364|125 138|stress response
P10733581A1391|100 112|TTF-1 activity
P10733591A0146|159 175|cell proliferation
P10733591A0533|148 156|cytoplasm
P10733880X1783|13 25|Academic Press
P10734312A0503|153 162|C-terminus
P10735272A0649|194 231|chromosome 19q glioma tumor suppressor gene
P10735848A1440|41 58|tol-oprL expression
P10736161T0000|32 60|sugar phosphotransferase system
P10736223A1227|176 188|mRNA stability
P10737366A0280|123 126|rats
P10738139A0681|64 67|KSHV
P10739408A0896|91 97|support
P10739671A0136|327 334|proteins
P10740602A0141|135 142|analysis
P10741850A0452|170 177|exposure
P10741947T0000|61 68|hemoclip
P10742114A0486|99 110|SD phenotypes
P10742216A0555|9 9|J
P10743608A1154|226 237|microtubules
P10743719A0223|105 124|rejection nephropathy
P10744026A0000|61 67|glucose
P10744749A0315|165 171|factors
P10744749T0000|130 133|p300
P10744974T0000|95 99|yeast
P10745563A0409|168 182|neo-endothelium
P10747053A1102|187 189|MBF
P10747099A0507|229 242|collagen matrix
P10747782A0390|169 179|core domains
P10747879A0607|88 94|domains
P10747890A1096|145 151|lesions
P10747987A0658|28 35|monomers
P10748054T0048|57 67|calcium flux
P10748113A0187|97 101|brain
P10748125A0000|94 96|PP1
P10748164A1284|137 142|probes
P10748175A0000|129 140|transporters
P10748194T0000|79 95|trafficking signal
P10748204A0238|6 6|J
P10748672A0130|92 98|failure
P10749145T0000|150 159|kinase ERK1
P10749166A0991|164 176|A. tumefaciens
P10749849A0000|165 168|gene
P10749932A0000|33 49|integrin signaling
P10750020A0843|132 139|ER action
P10750021A0728|106 111|region
P10750524A0724|122 126|group
P10751398A1135|99 113|membrane protein
P10752450A0288|116 121|market
P10752475A1376|308 313|trials
P10752807A1598|155 172|organ failure scores
P10753553T0000|58 61|mice
P10754312A0798|28 35|proteins
P10756007A0575|74 79|genome
P10756007A1512|58 71|ch-19 target DNA
P10756020A0571|147 151|cells
P10756032A0599|130 134|cells
P10756094A0671|92 93|kb
P10756100A0457|59 66|diabetes
P10756225A1464|145 158|ethmoid sinuses
P10757975A0509|0 3|Biol
P10757983A0733|156 175|mouse ZBP-89 homologue
P10758289A0141|121 129|specimens
P10758489A0206|103 109|Cdc2bAt
P10758726T0000|28 39|arrangements
P10759693A0201|262 273|theophylline
P10760109A1050|180 194|blood hemoglobin
P10760132A1169|112 130|vesicle polarization
P10760169A1142|56 83|transcription initiation sites
P10760950A1133|93 109|actin stress fibers
P10761263A1108|123 138|prostate patients
P10762254A0954|162 171|amber codon
P10762348A0269|86 93|activity
P10763823A0824|106 114|cell death
P10763827A1158|139 155|senescence program
P10764150A0000|110 120|FDC-P1 cells
P10764574A0718|152 167|alignment methods
P10764729A1846|71 85|accession number
P10764760T0000|64 82|JNK signaling pathway
P10764802A1258|257 271|differentiation
P10764970A1009|210 217|practice
P10765095A0308|192 196|tests
P10766246A0000|152 159|survival
P10766493T0000|49 55|harmony
P10766556T0000|45 50|valves
P10767091A0133|193 202|techniques
P10767251A1046|146 154|pressures
P10767338T0000|67 70|pump
P10767553A0100|120 127|HNF3beta
P10767560A0105|172 184|transcription
P10769144A0000|102 115|gene expression
P10770041A0731|105 105|p
P10770065A0264|79 79|b
P10770471T0000|33 43|night sweats
P10771528T0036|39 45|childre
P10771709A0291|202 214|questionnaire
P10772856X1492|13 25|Academic Press
P10772977A0222|55 72|Nicotiana tabacum cv
P10773351A0672|131 138|elements
P10773455A1268|257 267|specificity
P10773458A0000|73 77|cells
P10773667A0351|65 65|%
P10773951A0000|73 86|O group husbands
P10775038A0142|106 112|protein
P10775267A0363|170 177|lymphoma
P10775585A0754|178 190|kinase pathway
P10775623A0120|50 57|env genes
P10777217A0536|100 107|residues
P10777499A0883|117 123|element
P10777586A1022|213 227|band shift assays
P10777669A0582|76 84|RH mapping
P10778740A1493|164 168|locus
P10778757A0000|157 161|INCW2
P10779313A1842|189 190|AR
P10779329T0000|70 90|cell morphology changes
P10779352T0000|90 99|Rb proteins
P10779508A0452|75 121|glutathione S-transferase-ERRalpha1 fusion protein
P10779508A0897|89 96|activity
P10779508T0000|125 139|lactoferrin gene
P10780018A0539|47 58|response time
P10780518A1270|57 67|examination
P10780764A0722|133 136|x m-3
P10780883T0000|115 130|interferon-alpha
P10781109T0000|61 79|Arabidopsis thaliana
P10781423A0993|131 135|TTF-1
P10781541A1063|146 158|transcription
P10781552A0000|126 134|oxidation
P10781604A0827|137 142|assays
P10781611A1023|100 109|comparison
P10781990A0455|98 111|globus pallidus
P10782640A0444|101 111|astigmatism
P10782989A0575|87 104|amino acid sequences
P10784367A0133|180 187|patients
P10784393A0000|128 136|anomalies
P10785294A0720|113 126|resin composite
P10785668A0000|146 155|ecologists
P10785880A0947|102 114|HELLP syndrome
P10786671A0182|150 153|gene
P10786742A0670|49 55|surgery
P10787437A1616|69 73|SRE-1
P10787804T0000|57 60|SNFs
P10788320A1034|193 201|particles
P10788476A0891|158 166|cell assay
P10788480T0000|116 125|drosophila
P10790390X0000|290 298|cell death
P10791251A0110|75 80|humans
P10791819A0771|124 129|codons
P10791901A0609|234 242|etoposide
P10792583A0000|142 147|stress
P10792718T0000|150 174|virginiamycin M1 resistance
P10793143A1533|165 178|DNA replication
P10793991A0569|90 101|telemedicine
P10794405A0000|131 139|chromatin
P10794936A0241|161 181|M. tuberculosis complex
P10795098A0253|61 70|phenomenon
P10796465A0373|98 105|symptoms
P10796486A0817|114 129|asthma medication
P10797125A0000|248 255|exercise
P10797586A0402|82 88|bladder
P10798607A1359|157 164|patients
P10799501A1391|90 94|Cdc42
P10799576A0196|0 0|M
P10799590A0431|204 212|mechanism
P10799595A1454|102 113|HPV life cycle
P10799863T0000|110 128|antigen presentation
P10799879T0000|111 125|T cell activation
P10801244A0578|102 109|software
P10801330A1714|133 135|FAK
P10801482A0968|118 130|kappaB targets
P10801809T0000|75 86|PHO5 promoter
P10801860A0000|118 122|acids
P10802669A1434|77 79|NBS
P10802909A0478|48 55|criteria
P10804379T0001|51 64|cytomegaloviru
P10805286A0233|211 217|tissues
P10805286A0914|103 110|androgen
P10805390A0340|60 86|GaAs/AlGaAs heterostructures
P10805729A0987|151 169|acid binding surfaces
P10805737T0000|117 128|eIF5 function
P10805738A0799|370 376|embryos
P10805739A0343|54 66|eIF2B subunits
P10805739A0640|124 134|interaction
P10805747A0633|116 133|septin organization
P10805823A1920|121 126|causes
P10807900A0933|175 186|hypertension
P10807903A0362|301 308|agonists
P10809233A0606|101 103|H11
P10810083A1283|58 72|zinc finger motif
P10810294A0730|50 70|reporter gene induction
P10810745A0677|49 59|environment
P10811079A0555|135 158|carbamazepine monotherapy
P10811079A1277|50 55|groups
P10811804A0000|139 148|MAP kinases
P10811804A0800|134 138|MKP-3
P10811908A0938|114 116|I-1
P10812294X0000|117 126|ingredient
P10814989T0000|72 76|study
P10815410A0000|135 141|effects
P10815807A1271|104 114|T-cell lines
P10817754T0000|87 92|region
P10819327T0000|65 100|mouse KIF3A/KIFB/KAP3 kinesin complexes
P10820829T0000|14 32|Brosimum acutifolium
P10820904A0000|137 147|anastomosis
P10821836A0842|21 32|S transcripts
P10822117A1386|114 127|subject-models
P10823630A1124|99 108|prediction
P10823837A1213|253 261|GPI anchor
P10823961A0664|138 149|interactions
P10824485A0393|107 115|illnesses
P10824958A1109|119 121|age
P10825000A1245|27 34|Coquelle
P10825200T0000|143 156|STAT activation
P10825293T0000|123 129|signals
P10825294A0473|206 222|pentapeptide VWRPY
P10826861A0000|164 170|failure
P10826946A1198|132 132|H
P10827885T0059|31 35|trial
P10827952A0158|126 142|histone H4 peptides
P10828022A0877|101 109|complexes
P10828319A0342|85 93|psoriasis
P10828591A0080|177 183|disease
P10828751A2258|84 92|treatment
P10829973T0000|27 36|Bangladesh
P10830395A0408|55 64|Flory model
P10831972A0744|102 109|controls
P10831972A1091|112 137|leuprolide acetate injection
P10833461A0603|118 119|kb
P10833486A0598|171 178|fibrosis
P10834707A1533|95 107|treatment time
P10834781A0693|147 147|P
P10835355A0225|150 153|SSA3
P10835485A0941|150 154|mouse
P10835732A0911|67 73|aymaras
P10836542A0363|62 63|nm
P10836786A0516|145 153|RNase P RNA
P10837126A1004|121 129|phenotype
P10838139A1447|68 73|tumors
P10838399A0525|74 95|reconstruction artifact
P10838531A0675|54 61|patients
P10839470A1148|145 150|change
P10839547A0978|47 60|DNA methylation
P10839593A0000|142 153|HIV infection
P10840001A0188|107 111|tract
P10841537A0669|114 123|structures
P10841593A0780|92 106|nicotine patches
P10841601T0000|0 9|Paper alert
P10843716A0406|108 113|humans
P10843810A0802|165 167|LTR
P10845522A0000|187 197|examination
P10846054A0573|178 195|LIYV RNA replication
P10846069T0000|96 106|replication
P10848605T0000|118 129|Eph receptors
P10848848A0413|18 25|gangrene
P10848993A0000|209 211|amk
P10850329A0248|140 152|cell carcinoma
P10850453A0713|165 185|V12Ha-Ras transfection
P10850453A1292|127 145|TGF-beta1 production
P10850719A0680|129 140|Jbeta12-RSSs
P10850849A0730|241 241|%
P10850942A0989|145 148|days
P10850997A1016|59 61|Fur
P10851089A1248|111 118|proteins
P10851267A0000|64 70|S-phase
P10851745A0624|76 83|capacity
P10852221A0422|147 153|neurons
P10852460A0170|202 216|SENIEUR protocol
P10852485A0477|95 97|5AL
P10852953A0000|176 179|beta
P10853059X0751|9 12|Base
P10853778A0316|44 53|bone grafts
P10853850A1103|82 102|inhalation provocation
P10854004A0788|109 121|nitroprusside
P10854699A0424|113 126|FGF-AS sequence
P10855690A0870|94 100|pathway
P10855793A1418|166 174|disorders
P10855796A1160|145 155|development
P10856298A0798|121 125|T339I
P10856491A0178|98 108|pregnancies
P10856805T0000|62 66|level
P10857215A0000|48 55|practice
P10857215A0806|71 80|population
P10857262A0186|168 168|%
P10857751A0304|114 128|GenBank database
P10858355A0920|76 100|Enterococcus faecalis WH245
P10858988A0786|64 72|challenge
P10860131A0847|83 85|% CI
P10860196A0876|89 93|years
P10860752A1601|145 148|mRNA
P10860827A0399|117 130|cardiomyocytes
P10860846A0480|166 188|HGF gene promoter activity
P10861080A0433|127 127|%
P10861086A0259|238 243|manner
P10861086A0904|115 135|phagocytosis signaling
P10861906A0999|198 209|DNA synthesis
P10861906A1479|166 171|medium
P10861909A0502|327 342|restriction sites
P10862289A0289|101 110|A60 antigen
P10863048A0000|182 185|rats
P10863352T0001|31 37|disease
P10864271A0504|162 169|behavior
P10864496A0401|108 117|conditions
P10864641A1400|167 172|Asn123
P10864989A0484|194 207|separation time
P10865422A0138|95 113|iron supplementation
P10865838A0000|100 107|division
P10865940A0000|142 160|NF-kappaB activation
P10866323A0666|69 82|STAT activation
P10866677A1839|87 94|extracts
P10866689A0295|194 213|tal-1-E12 heterodimer
P10866886A1277|61 78|mu-receptor agonist
P10867199A0230|129 140|insect orders
P10867496T0001|42 63|Morbus von Recklinghause
P10868488A0921|73 89|testosterone level
P10869076A1384|142 165|transcription termination
P10869465A1054|165 171|Sertoli
P10870043A0621|94 105|control group
P10870391T0034|44 56|travel diarrhe
P10871045A1221|204 215|acetaldehyde
P10871347A0477|59 74|PyRo1 interaction
P10871379A0261|61 63|HCF
P10871412A0369|79 83|Rz007
P10871615A0368|11 11|C
P10871842A0988|142 154|proliferation
P10872473A2286|124 137|gene expression
P10872535A0000|295 298|life
P10872756A1325|150 165|dose control group
P10872827A0000|97 103|subunit
P10872831A0000|97 107|EST database
P10872851A0714|121 125|LVEDP
P10873158A0000|128 133|stress
P10873286X0000|23 29|PREFACE
P10873386A0000|74 86|20S proteasome
P10873387A0816|125 128|Xp11
P10873388A0623|189 199|lung tissues
P10874044A0647|120 134|pE1-luc activity
P10874151A0000|92 98|lesions
P10878398A0542|91 102|CAPD patients
P10878606A0876|97 108|interactions
P10878675A1278|122 129|subjects
P10878944A0000|157 158|St
P10880486A0790|101 109|RhoA locus
P10880702A0966|173 180|behavior
P10881275T0000|51 58|practice
P10882163A1077|154 172|aromatase inhibitors
P10882213A0163|492 497|damage
P10882462T0000|12 28|tissue engineering
P10882850A0000|86 107|pyrimidine base residues
P10884978A0633|109 111|age
P10885708T0000|68 74|abscess
P10885731A0915|151 158|polymers
P10885750A0236|81 95|organ physiology
P10886067A0520|46 47|mm
P10887912A0740|160 163|side
P10887921A0718|173 180|glaucoma
P10888570A0678|119 128|food safety
P10889399A0243|64 66|MEK
P10890911A0470|155 158|Xtwn
P10891093A0000|225 228|msds
P10891266A0421|31 35|H type
P10891286A0000|144 151|function
P10891399A1185|195 199|genes
P10891441A0871|150 165|mass spectrometry
P10891489A0152|174 183|malignancy
P10891632A0435|204 215|side-effects
P10892300A0268|83 104|locomotor abnormalities
P10892823A1040|102 108|HBP care
P10893243T0000|138 167|factor family zinc finger proteins
P10893258T0000|103 125|reticulum quality control
P10894149T0000|193 207|receptor alpha-1
P10894816A0836|122 125|IL-6
P10894886A0375|64 68|genes
P10895417A0000|164 172|analgesia
P10895417A0669|131 145|body temperature
P10895851A0696|74 74|g
P10896008A0531|150 157|controls
P10896859A0000|165 176|steroid sheep
P10896859A0838|48 58|Na retention
P10897233A1057|30 41|Nazareth area
P10897973T0001|78 89|antithrombin
P10898795A0527|113 119|classes
P10899128A0661|159 172|gene expression
P10899142A0000|232 235|cDNA
P10900129A0138|90 96|RT-PCRs
P10900269A0396|169 178|background
P10901133A0381|36 43|standard
P10902348A0566|135 148|glass jar method
P10903440A0515|147 152|stages
P10903495A0533|95 98|band
P10903583T0000|98 105|subjects
P10903733A0540|125 144|TRAF3 adaptor proteins
P10903837A1208|84 108|Gene Nomenclature Committee
P10903843A0447|119 128|Kcnq1 genes
P10903877A0879|155 158|CRAC
P10904191A0000|179 181|FVU
P10905349A0329|44 69|XPF endonuclease superfamily
P10905349A0609|101 109|DNA damage
P10905352A0000|152 157|primer
P10906176A0000|88 98|mouse genome
P10906317A0351|129 129|%
P10906999T0000|42 58|chemiluminescence
P10907348A0508|129 130|AP
P10907971A0806|36 60|HMG-CoA reductase inhibitor
P10907971T0000|81 91|CURVES study
P10908317A1459|185 199|transactivation
P10908364A0000|62 66|roles
P10908462A3159|96 101|smoker
P10908478A0717|166 173|outcomes
P10908822A0519|16 18|.3%
P10909973A1508|150 164|phosphorylation
P10910073A0876|129 138|patient RNA
P10910439A1196|111 119|treatment
P10910908A0767|91 93|EPO
P10913094A0424|99 124|gel mobility shift-PCR method
P10913172A0442|97 103|residue
P10913276A0510|77 95|PLC-gamma1 SH3 domain
P10913276A0684|109 112|SOS1
P10913304A0894|67 69|PE1
P10913304A1180|186 188|ERF
P10915728A0216|155 164|IFN therapy
P10915780A1063|154 167|cyclin D1 levels
P10917402T0000|69 78|depression
P10918059A0569|54 63|activation
P10918164A0878|171 171|P
P10918440T0000|97 114|blood stem cell donor
P10918572A0794|65 69|ErbB4
P10918572A1547|187 199|ErbB signaling
P10918596A0000|94 101|molecule
P10918599A0071|146 147|Rb
P10918612A0000|110 123|gene expression
P10918943T0000|65 68|mice
P10918948A0110|118 125|diseases
P10919971A0606|174 185|muscle repair
P10920186A0528|125 127|PCR
P10920906A0759|114 115|cm
P10921197A0179|102 102|b
P10924061A0588|49 57|treatment
P10925159A1353|149 168|salt-wash preparation
P10925207A0634|114 117|UTRs
P10926776A0731|93 99|protein
P10928179A0101|86 91|debate
P10928337A0590|94 99|volume
P10928477A0764|149 166|patient populations
P10930526A0174|72 82|mouse origin
P10931524A0313|107 111|assay
P10931927A0655|240 250|template DNA
P10931950A0869|94 104|T187A mutant
P10931960A0630|154 164|protein VP16
P10932196A0359|85 98|linkage studies
P10932329A0597|95 103|ventralis
P10932527A0947|96 107|inflammation
P10932527T0000|87 92|ponies
P10932679A0049|139 148|food intake
P10933154A1118|92 100|rejection
P10933728A1398|227 240|responsiveness
P10933732A0000|176 181|family
P10934073A1433|110 113|home
P10934310A0698|94 104|angiography
P10934640A1114|90 94|TB BMC
P10934751T0001|31 41|significanc
P10935488A1033|145 172|bladder cancer differentiation
P10935880A1049|71 76|BVHV-1
P10936051T0000|100 107|promoter
P10936920A0105|83 92|prediction
P10938102A0265|82 99|translation factors
P10938102A1359|180 203|influenza virus messengers
P10938102T0000|96 109|influenza virus
P10938105A0000|149 158|splice site
P10938109A1361|111 117|signals
P10938113A0388|191 200|activities
P10938120A1093|124 128|sites
P10938130A0338|91 99|interface
P10938135A0259|185 204|growth factor receptor
P10938556A0248|75 84|ventricles
P10939030A0986|141 152|neutropenia p
P10939785A0540|182 188|placebo
P10940413A1153|158 163|defect
P10940553A0912|96 117|hPer1 gene transcription
P10940557A1687|114 118|genes
P10940562A0379|65 74|pseudogene
P10940562T0000|143 161|Arabidopsis thaliana
P10940892A0573|105 113|progenies
P10942587A0981|218 227|antibodies
P10942599A1298|150 162|embryogenesis
P10943891A1062|166 176|spliceosome
P10944466A0451|33 42|WNT-2B gene
P10945010T0001|59 65|leukemi
P10945781A0412|63 81|enterotoxin activity
P10946303A0000|123 127|cells
P10947274A0839|98 100|10B
P10947840A0762|93 100|coupling
P10950398T0100|23 30|Endpoint
P10950415A0866|126 131|vision
P10950924A0393|110 115|cortex
P10950935A0111|153 156|YACs
P10951579A1238|120 122|DNA
P10951848A0230|187 202|megachemotherapy
P10952828A2638|190 201|image quality
P10954093A0000|95 117|fungus Podospora anserina
P10954525A1161|80 84|TRE-2
P10954564A1262|72 82|gene product
P10954913A0152|68 83|liver cDNA library
P10955313A0000|54 61|children
P10955913A0827|52 59|heparins
P10955998A1124|96 107|DNA mutations
P10958271A0365|270 285|echocardiography
P10958456A0529|119 139|polyadenylation signal
P10958673A0142|122 128|mammals
P10958688A0265|136 147|conformation
P10958698A0280|85 92|function
P10958698A0485|111 123|Cse4p function
P10959676A0200|14 23|comparison
P10959838A0153|65 84|nitrilase superfamily
P10961046A0342|96 101|sample
P10961585A0273|71 79|hemolysis
P10962564A0883|167 172|manner
P10962593A0580|17 23|AFP rate
P10962738A0000|54 63|perception
P10962881A0900|50 52|% CI
P10963577T0016|10 14|smell
P10963735A0193|184 212|polyacrylonitrile membrane AN69
P10963735A0651|51 60|acid levels
P10964833A1696|132 135|mmHg
P10964995A2152|141 145|HER-2
P10965135A0735|197 212|inhibitor PD98059
P10965135A1207|153 180|transcription factor complexes
P10965830A0305|155 164|conditions
P10965905A1618|290 298|mediation
P10965905T0000|86 108|protein kinase activation
P10967361A0000|132 141|resolution
P10967531A1025|151 154|type
P10967890A1120|100 110|development
P10970048A0352|133 136|drop
P10972688A1272|68 83|hospitalizations
P10972894A0488|122 128|library
P10972980A0295|186 195|amino acids
P10972990A0196|59 67|stability
P10972990A0526|182 185|HPRT
P10972990A0966|173 186|translocations
P10972990A1518|109 114|repair
P10973151A0883|152 162|environment
P10973385A1423|186 196|gastrectomy
P10973400A0664|119 123|range
P10974541A0389|64 68|MZF1C
P10975465A0134|172 188|amino acid residues
P10976413A0514|207 215|pregnancy
P10980416T0000|142 159|rat BSP gene promoter
P10981094A0779|164 179|pretreatment risk
P10982076A0000|171 187|influenza activity
P10982143A0346|28 35|T. gondii
P10982391A0425|277 284|elements
P10982825A0363|66 68|OpA
P10983344A0000|70 78|intestine
P10983857A0923|162 165|rats
P10983979T0000|91 109|spliceosome assembly
P10984122A0911|72 77|mU6-C2
P10987280A0604|119 125|feature
P10987301A0332|319 329|development
P10989777A1286|88 97|assignment
P10991383A0289|121 125|state
P10991648T0000|38 50|half syndromes
P10992299A0745|169 170|H4
P10992983T0000|48 57|penile size
P10993773A0717|132 141|myocardium
P10993787A0369|162 168|factors
P10995121A0569|127 135|variation
P10995751A0093|112 129|IFN response element
P10997330A0361|99 105|PML gene
P10997863A0753|70 80|FLE patients
P10997904A1258|153 181|response regulator-kinase pairs
P10998679A0500|136 139|pain
P10999205A0607|137 143|spectra
P10999301A0000|161 165|scale
P10999369A0192|108 109|mA
P11000203A0752|178 187|activities
P11000250A0200|131 134|CD40
P11000266T0000|71 91|alpha-fetoprotein gene
P11000521A0588|282 288|PKB/AKT
P11002236A0328|142 156|Oncology centers
P11003471A1149|112 116|India
P11003641A0811|209 216|promoter
P11003652A0961|116 119|role
P11003653A0198|169 178|PYR complex
P11003669A0000|131 134|bait
P11003805A0443|118 129|oesophagitis
P11003807A0303|104 120|oesophageal damage
P11004369A0000|166 174|carcinoma
P11005808A1082|93 101|heat shock
P11005831A0242|162 182|element binding protein
P11006283A1180|122 146|mRNA maturation/metabolism
P11006284T0000|99 126|phosphatidylinositol 3-kinase
P11006331A0319|72 84|abnormalities
P11007509A1271|147 161|stress perfusion
P11007777A0813|149 152|gene
P11007949A1395|72 77|tumors
P11007949A1607|74 78|cells
P11007954A0170|209 218|activation
P11007961A0930|150 153|drug
P11007968A0255|121 127|regions
P11008139T0000|22 46|pattern discrimination task
P11008420A0580|145 150|events
P11011139A0000|177 194|chromatin structure
P11012568A0192|43 49|obesity
P11012671A0576|163 182|reporter gene analysis
P11012680A0676|71 79|inhibitor
P11012680A1020|201 219|ERK2 phosphorylation
P11013079A0927|193 204|SV40 promoter
P11014197A0339|106 116|subfamilies
P11014213A1019|281 295|CAT reporter gene
P11014215A1092|213 233|GnRHR promoter activity
P11014465A0479|90 92|PVL
P11014821T0000|152 162|development
P11015197A0310|71 73|TM4
P11015200A0156|6 6|J
P11016014A0181|182 195|angina pectoris
P11016724A0536|102 109|aliquots
P11016737A0275|65 70|status
P11016850A0423|132 136|LTTRs
P11016954A0438|58 61|RNAi
P11017876A0787|147 152|matrix
P11018028A0263|164 172|membranes
P11018264A0397|109 117|cell lines
P11019257A0159|174 184|distortions
P11020375A0134|187 190|days
P11023074A1105|42 46|PACE2
P11023832A1038|165 183|NF-kappaB signalling
P11023853A0188|279 288|components
P11023934A0855|106 111|events
P11024026A0133|98 109|dissociation
P11024036A0984|117 126|constructs
P11024047A0626|104 112|treatment
P11024182A0781|182 184|pCI
P11024300A1579|195 203|TIG-1 mRNA
P11025367A1009|80 87|emptying
P11027027A0061|85 106|electrospray ionization
P11027267A0752|84 88|cells
P11027274A1682|123 129|isoform
P11027280A0536|74 78|Smad3
P11027289A0000|218 223|region
P11027289A0321|92 93|SU
P11027294A0483|138 155|chromatin structure
P11027724A0335|78 82|p-Ser
P11027833A0362|22 38|cell cycle analysis
P11028131A1374|121 124|RRMS
P11028131T0000|54 83|sclerosis disability progression
P11028944A1020|55 58|dose
P11029045A0000|91 101|catastrophe
P11029262T0000|0 4|Diary
P11029458A0000|50 56|stimuli
P11029459A0000|124 127|cell
P11029467T0000|163 175|cell line THP-1
P11029656A0640|67 74|proteins
P11029700A0295|105 109|cells
P11029700A0746|85 92|rice CDKs
P11029704A0378|245 249|G-box
P11030066A0142|70 82|motor deficits
P11030476A0685|65 73|spores/mL
P11030744A0763|95 113|DPM synthase activity
P11031252A0646|150 157|PKC delta
P11031366T0001|56 58|vie
P11031773A0174|65 68|mice
P11032599T0000|100 117|practice guidelines
P11032677A0230|189 197|glossitis
P11034392A1072|138 150|proliferation
P11034547A0674|119 145|homeodomain recognition sites
P11034547A1355|118 128|DBH promoter
P11034933A0389|143 159|nmol/L domperidone
P11035037A0183|75 85|TBP function
P11035867A0000|287 305|blood pressure curves
P11036786A0628|102 108|Animals
P11036938A1162|180 192|gonadotropins
P11036939A2149|53 73|planar polarity pathway
P11037759T0000|104 107|rats
P11037823A1134|168 174|hearing
P11038042A0948|81 98|platelet nadir count
P11038118A0000|124 126|BSA
P11038317A0000|130 134|cells
P11038366A1322|89 93|Rts1p
P11038366A1417|100 111|PP2A function
P11039341A0180|157 160|task
P11039780A0770|212 217|future
P11040101A1180|225 229|sites
P11040219A0548|65 80|S1 homology region
P11041308A0156|125 128|SOGS
P11042197A0386|68 79|dimerization
P11042199A0572|217 220|CREB
P11042204A0186|126 136|neutrophils
P11042703A0875|100 103|boys
P11043469A0440|152 164|Amadoriopines
P11044097A0422|98 116|transcription factor
P11044097T0000|124 131|promoter
P11044105A0616|82 91|splice site
P11045180A1892|109 122|classification
P11045607A0239|91 99|start site
P11046146A1202|189 194|levels
P11046148A0716|133 149|Lyn tyrosine kinase
P11046153A1052|76 90|p300 coactivator
P11046517A0619|34 34|Z
P11048832A0271|58 65|analysis
P11049241A0659|161 164|days
P11049889A1271|107 119|weight heparin
P11050084A0000|138 151|lipid oxidation
P11050084A0888|60 65|nuclei
P11050168A1185|164 184|stability determinants
P11051364A0890|98 103|group B
P11051370A1906|54 64|HCV genotype
P11053009A0000|92 113|prostaglandin synthesis
P11053263A0200|56 58|end
P11053370A0708|124 135|Uhp signaling
P11054011A1685|189 195|Ecuador
P11054341A0599|89 105|SWAP abnormalities
P11054539A0114|135 151|amino acid residues
P11054565A0654|207 215|p190 genes
P11054571A0230|93 101|locus Xq25
P11054970A0282|76 78|NF1
P11055513A0564|94 100|testing
P11055786A0306|37 41|steps
P11056007A0224|180 183|rMTM
P11056019A0926|102 115|ethyl carbamate
P11058008A0159|61 72|tip ischaemia
P11058119A0957|83 85|XPA
P11058120A0256|89 97|potential
P11058132A0264|154 163|B.subtilis
P11058406A0447|96 113|tobramycin solution
P11059492A0376|0 8|Bacteriol
P11059777A0813|182 191|expression
P11059786A0682|141 142|PI
P11059786T0000|200 206|hypoxia
P11062047A1208|157 162|PstDNV
P11062067A0000|144 151|stresses
P11062068T0000|142 151|regulation
P11062257A0977|163 178|transport process
P11062274T0000|88 93|stroke
P11062705A0658|56 69|cancer cell line
P11063127A0000|151 157|effects
P11063169T0000|79 86|outcomes
P11063252A0437|37 59|HSL translation start site
P11063742A0000|110 119|reductants
P11064829T0058|44 52|treatment
P11066245T0000|59 62|SNFs
P11067797A1306|170 179|components
P11067928A0532|71 81|Jkappa genes
P11069011A0224|152 160|pesticide
P11069075T0000|102 117|vertebrate embryo
P11069223A0593|40 54|marrow functions
P11069307A0546|174 185|DED1 function
P11069756A2618|520 521|SH
P11069788A0531|159 164|dyn ref
P11069791A0226|190 197|Regimen C
P11069825A0530|73 81|incidence
P11069897A1112|81 91|interaction
P11069999A1602|49 54|HIV LTR
P11070007A0136|147 152|genome
P11070056A0704|79 93|retrotransposon
P11070078A1153|187 193|signals
P11071651A1308|111 127|FR-beta expression
P11071789T0000|52 63|heart failure
P11071852A0297|126 135|muscle mRNA
P11071924A0588|143 147|c-Cbl
P11071974A0155|179 187|treatment
P11072155A0764|86 98|lymphocyte SF2
P11072388T0000|66 78|schizophrenia
P11073163A0131|133 144|cell survival
P11073218A0800|78 83|region
P11073539A0866|137 145|cytoplasm
P11073870A0375|159 170|memory delays
P11073919A0631|347 362|S. ruminantium LDC
P11073954A0337|50 66|CP2 family proteins
P11074003A0741|73 77|CGNPs
P11074210A0623|87 104|insulin sensitivity
P11075678A0298|180 189|force field
P11075929A1657|124 127|ThlB
P11075944A0691|96 104|SC-3 cells
P11076860A0872|174 185|localization
P11078726X0000|290 303|gene expression
P11080796A0883|73 80|IKKgamma
P11080796A1277|161 168|activity
P11081962T0000|51 55|Avena
P11082185A0415|124 131|activity
P11082587X0000|170 173|SBBS
P11082715X0001|194 201|caffeine
P11083154A0881|110 118|shrinkage
P11083358A1071|71 80|aspiration
P11083432A0332|57 60|FK-3
P11083868A0386|113 133|transactivation domain
P11084022A1178|123 135|cell processes
P11084334A0590|161 171|interaction
P11084556T0000|111 119|cord blood
P11084649A0497|179 184|streak
P11085267A0562|61 69|phenotype
P11085600A0123|137 147|information
P11086872A0000|86 103|Citrus aurantifolia
P11087141A0977|179 184|manner
P11088635A0200|137 142|system
P11089911A1267|118 129|ATLN elements
P11090172A0612|103 114|FHV virion RNA
P11090272A1240|52 55|GAIP
P11090762A0527|177 189|parietal locus
P11092770A0238|136 146|sensitivity
P11092809A0823|74 81|mesoderm
P11092850A1023|149 155|lineage
P11092886A0341|132 135|gene
P11093745A0563|92 98|element
P11094066A0505|140 145|manner
P11094066A1194|181 193|proliferation
P11094072A0842|77 83|fashion
P11094072A1234|88 91|site
P11094073A0000|146 154|screening
P11094075A0257|172 180|phenotype
P11094087T0000|121 133|kinase pathway
P11094091A0000|127 132|Ser133
P11094109A0600|39 43|years
P11094590A0617|204 208|value
P11095248A0423|157 160|gp27
P11095248A1523|92 99|activity
P11095981A0254|142 150|deletions
P11096662T0000|31 43|Artery Disease
P11097040A0000|239 246|degrees C
P11097079A0525|50 58|clinician
P11098217A0674|63 75|hybridization
P11098420A0175|120 126|suicide
P11099377T0000|108 119|isoform XT-II
P11100515A0282|151 170|amiodarone withdrawal
P11101008A0649|43 60|cell cycle processes
P11101847A0159|99 102|refs
P11102367A1170|221 227|screens
P11102458A0000|196 201|PKA RII
P11103472A0802|101 110|amplitudes
P11103601T0025|5 9|UMDNJ
P11103792A0755|242 252|fibroblasts
P11105129T0000|116 121|Brazil
P11105716A0782|182 199|MR perfusion studies
P11105717A0123|177 192|microvasculature
P11106216A0918|72 77|FOT Rrs
P11106428A0635|166 168|GST
P11106667A1061|91 102|mitochondria
P11106668A0875|136 144|apoptosis
P11107637X0001|268 279|use titration
P11108151A0560|170 178|induction
P11108523A0326|181 185|angle
P11108548A0710|150 162|APcI interface
P11108616A0000|130 131|hg
P11108720A0124|187 204|localization signal
P11108720A1130|154 157|S6K1
P11108839A0401|93 104|localisation
P11110040A0000|216 227|ketanserinol
P11110528A0414|123 126|cm/s
P11111051A0051|63 70|activity
P11112417A1126|198 211|mRNA processing
P11112438X0847|13 25|Academic Press
P11112700A1936|149 151|MTs
P11112700T0000|138 145|proteins
P11112790A0989|62 64|UPR
P11113179A0541|135 138|p300
P11113179A1020|144 149|assays
P11113199A0800|146 150|cells
P11113201A1114|83 96|target proteins
P11113546A0728|111 121|Giardia cyst
P11113692A0169|214 217|mm Hg
P11113822A0999|76 86|jaw pathoses
P11113823A0197|19 32|chondromatosis
P11114294A0075|195 202|T84 cells
P11114521A0282|98 106|migration
P11114718A0349|105 111|cyclin E
P11114924A0808|56 78|primer extension analysis
P11116084A0000|86 93|function
P11116131A0863|35 41|culture
P11116148A0741|113 134|transactivation domains
P11117263A0570|255 263|S. cereale
P11117523A0650|120 126|neurons
P11117826A0788|150 153|data
P11118062A1691|131 139|phenotype
P11118438A0411|198 201|case
P11118440T0000|123 140|corepressor complex
P11118619A0835|160 173|transformation
P11118712A1296|275 282|herd size
P11119611A0428|140 148|KS lesions
P11120441A1193|114 123|complexity
P11121043A0074|65 76|neurogenesis
P11121118A0075|70 75|region
P11121118T0000|29 55|phosphodiesterase PDE11A gene
P11121397A0587|145 158|heparan sulfate
P11121434A0915|147 150|HR12
P11121490A0000|87 95|apoptosis
P11122381A0908|141 145|STAT5
P11122588A0549|210 215|weight
P11123054T0000|23 31|syndromes
P11123089A0362|154 167|tissue diseases
P11123316T0000|73 99|Tec pleckstrin homology domain
P11123701A0442|277 285|DNA duplex
P11123912A0306|138 139|MT
P11124024A1098|142 147|strand
P11124902X1337|13 25|Academic Press
P11125151T0000|94 100|virus-2
P11125363A0525|159 170|radiotherapy
P11125411A0857|132 136|canal
P11125872A0133|163 176|administration
P11126275A1068|59 66|bleeding
P11126353A0582|76 77|3y
P11126806A0206|74 84|circulation
P11127161T0000|14 29|smoking cessation
P11127200A1024|279 286|receptor
P11127250A1111|129 133|India
P11127955X0001|91 102|colon cancers
P11128312A1238|175 177|FD2
P11128925A0000|196 197|AP
P11129515A0000|128 130|PMS
P11129724A0904|115 122|neonates
P11131321T0000|65 91|homidum chloride chemotherapy
P11131634A0955|71 77|Y8 cells
P11132063A0250|218 228|dysfunction
P11132148A0162|107 110|loci
P11132195A0000|235 242|memories
P11132790A0609|152 163|risk children
P11133741A0617|141 156|promoter activity
P11133830A0174|160 178|proto-oncogene c-Cbl
P11133927T0000|81 88|exercise
P11133986A0350|189 196|3T3 cells
P11134033A0000|113 143|translation initiation factor eIF3
P11134033A0639|62 67|medium
P11134351A1405|56 60|MBP-1
P11134508A0317|68 71|gene
P11134822A0629|26 44|accelerations/30 min
P11137296A0923|286 291|levels
P11137296A1216|66 75|PFK-C genes
P11137367A0297|83 89|circuit
P11137551A0437|75 79|limit
P11138009A1032|71 81|USH1 patient
P11138231T0000|20 25|nurses
P11138694A0000|231 233|PET
P11139148A0421|155 163|fractions
P11139336A0257|53 59|mitosis
P11139469A0402|159 164|agents
P11139473A0696|135 151|Hex responsiveness
P11139567A1440|100 124|G protein beta gamma subunits
P11139605A0811|195 200|region
P11139974A0762|77 84|RV pacing
P11140472A0497|201 216|cases improvement
P11141003T0000|60 64|users
P11142380A0389|157 163|regions
P11143384A0267|72 86|microphone input
P11145562A0000|107 120|transformation
P11145562A0468|96 103|T antigen
P11145563A0202|93 98|SREBPs
P11145563A0303|82 102|granulosa-lutein cells
P11145566A0000|161 175|HDL-R regulation
P11145571A0788|122 124|GAS
P11145590A0217|155 174|transcription factors
P11145717A0936|98 101|K713
P11145743A0170|183 201|deiodinase promoters
P11145813A0668|83 93|L6 vertebrae
P11145887A1393|161 163|Tax
P11145955A0189|278 284|control
P11146961T0000|66 71|PADCAB
P11148042A1258|126 141|gel state bilayers
P11148589A1124|198 217|liver carcinoma deaths
P11149472A1257|73 79|rat bone
P11150114T0000|32 42|association
P11150315A0226|235 242|extracts
P11150315A0844|82 88|reports
P11150315A1126|65 69|Fra-2
P11150439A0701|168 185|regression equation
P11151826T0000|9 12|UAPs
P11152070A0573|196 205|transcript
P11152081A0413|79 93|sulfur oxidation
P11152283A0223|117 121|genes
P11152344A0416|172 175|cord
P11152451A0529|111 120|antibodies
P11152451A1580|218 231|TGF-beta effect
P11152521A0181|174 179|intron
P11152963A0000|151 155|brain
P11153302A0000|100 113|detoxification
P11154491A0322|160 166|needles
P11155096A0222|206 207|T4
P11156303A1098|171 179|infection
P11156413T0000|132 149|cancer therapeutics
P11156484A0223|153 160|diabetes
P11156618T0000|146 154|sequences
P11156789A1669|280 285|uptake
P11157035A1405|142 148|therapy
P11157334A1107|47 53|WM group
P11157763T0000|83 94|dimer mimicry
P11157774A0789|62 70|sterility
P11157784A0141|143 149|sc11.1b
P11157879A0192|86 96|fluorometry
P11158236A0000|64 72|PC12 cells
P11158288T0000|102 120|CREB phosphorylation
P11158290A0728|96 102|epsilon
P11158295A0158|78 87|SH2 regions
P11158310A0993|117 119|UPR
P11158324A1073|471 493|anion transporter protein
P11158326A1032|66 69|R47G
P11158337A0000|245 255|binding site
P11158456A0223|190 200|termination
P11159081A1155|98 107|reexcision
P11159363A1251|107 113|complex
P11160096A1067|63 71|phenotype
P11160280A1275|59 68|IRF element
P11160307A0394|226 228|Fab
P11160656A0000|272 274|NT2
P11160683A1220|102 114|ATF/CREB sites
P11160688A1726|100 108|cytoplasm
P11160721A0932|110 120|T-cell lines
P11160732A0464|157 166|SIVmac1A11
P11160732A1199|233 238|import
P11160738A1414|89 97|infection
P11160742A0696|56 60|cells
P11160860A0662|181 207|IkappaBalpha phosphorylation
P11160896A0713|112 126|differentiation
P11160902A0962|129 136|settings
P11160929T0000|51 63|endonucleases
P11161455A1286|98 107|chromosome
P11161720X1294|13 25|Academic Press
P11161793A1033|122 133|EGFR activity
P11161816A0851|141 146|action
P11162278A0629|104 108|gyrus
P11162576A0213|103 111|PDE5A gene
P11162666A0442|76 80|acids
P11162936A2727|216 227|breast cancer
P11163932A0000|196 209|air temperature
P11163968A0152|202 237|restriction-modification gene homologs
P11164078A0833|70 87|treatment-response
P11166478T0000|60 68|pain model
P11166863A0167|72 75|RTOG
P11167019A1249|50 81|ATPsynCF6 transcription start sites
P11167111A0957|105 106|TX
P11167778T0000|32 37|sepsis
P11168366A0569|94 103|HepG2 cells
P11168422A0248|117 119|Kp2
P11168446T0000|97 109|haemodynamics
P11168588T0000|92 107|kinase activation
P11169080T0000|51 53|Law
P11169113A0555|73 76|gene
P11169149A0097|24 28|SNTCS
P11170476A1546|168 178|recognition
P11171118A0836|123 132|antibodies
P11171320A0894|249 261|EalphaCL cells
P11172610A0508|65 73|promoters
P11172944A0548|34 44|pneumonitis
P11172944A0826|72 91|radiation pneumonitis
P11175333A0336|64 71|proteins
P11176098A0342|51 61|shock groups
P11176290T0000|90 92|MRI
P11177538A0655|50 72|% gene transfer efficiency
P11177686A0243|114 121|dilation
P11178248A1042|103 111|positives
P11178696A0301|148 151|PD US
P11178765A0642|135 139|cells
P11179272T0000|136 150|ultrasound study
P11179400T0000|54 57|rats
P11179664T0000|74 102|transcription factor RUNX1/AML1
P11179668A0869|53 62|PLTP family
P11179687A0280|164 168|RPTPs
P11179687A1118|127 131|group
P11179689A0000|152 161|DNA binding
P11179956A1818|180 194|proton transport
P11180027A1306|74 81|morphine
P11180255A0776|141 145|space
P11180688A0000|212 216|years
P11181516A0119|224 228|A2/A3
P11181525T0000|100 107|enhancer
P11181531A0464|162 174|interleukin-1
P11181548A0214|128 138|DNA fragment
P11181564A0733|50 59|chromosome
P11181995A1093|176 187|mouse matches
P11182520A0889|65 69|assay
P11182746A0872|55 65|drug therapy
P11185475T0034|2 8|Caveman
P11187016T0000|68 77|mechanisms
P11188971A0000|104 109|target
P11188993A0298|124 146|methenamine silver stains
P11189314A1000|78 81|GLCM
P11191208A0000|236 244|PDR3 genes
P11191365A0682|248 248|P
P11193045A1193|89 99|development
P11193666A1269|82 85|herd
P11193704A0000|56 61|Africa
P11194101A0532|315 319|femur
P11194147A1496|64 75|HIDD villages
P11194183A0866|347 351|t test
P11195338A0494|65 73|phenotype
P11195401A1030|92 96|SIADH
P11196191A1789|99 115|MAPK/PI3K pathways
P11196199T0000|147 149|p53
P11196340A1046|125 132|validity
P11197288A0855|112 119|regimens
P11197328T0000|143 156|mesophyll cells
P11197549A0748|70 80|arrhythmias
P11197926A0000|184 192|intervals
P11198053T0000|101 109|responses
P11198289T0000|52 59|dystonia
P11198385A0000|128 145|Gharbia Governorate
P11198424T0000|101 121|rice cell proliferation
P11200568A0830|99 108|M. pulmonis
P11201250A0849|90 93|skin
P11202434T0000|137 150|ankyrin repeats
P11202705A1112|94 110|Posidonia oceanica
P11203702A1307|200 208|organizer
P11204897A0797|53 71|bridge simulator task
P11207216A0296|91 110|cDNA library screening
P11207216A0719|140 141|nM
P11207261A1421|279 288|BCR complex
P11207269A0745|61 72|p95 component
P11207282A0729|172 189|IgH gene transcripts
P11207288A0897|129 144|class Ia molecules
P11207308A0999|210 227|p38 phosphorylation
P11207609A0994|212 222|trafficking
P11208017A0070|67 73|soybean
P11208814A0673|184 192|subdomain
P11209100A0069|173 178|IL-1ra
P11209814A0243|177 187|bioceramics
P11210401A0000|135 146|hemodialysis
P11210401A0544|105 113|sevelamer
P11210839A0282|134 145|oprofloxacin
P11210988T0000|54 67|prostate cancer
P11211759A0165|183 197|cancer operation
P11211936A1490|157 168|growth arrest
P11212249A0993|88 95|activity
P11212327A1564|192 199|caveolin
P11213342A0492|73 82|test period
P11214177A1125|103 111|satellite
P11214354A1104|132 141|CON animals
P11215622A0949|63 68|strain
P11216247T0000|3 7|child
P11218739A0811|39 43|cases
P11220166A0616|274 282|behaviour
P11220306A0911|106 111|strain
P11220306A1753|117 120|hexA
P11220486A0686|6 10|IL-12
P11220487T0000|43 56|trichomoniasis
P11220857T0000|22 36|Veterans Affairs
P11221836A0981|126 131|tumors
P11221845A0295|194 203|loci/spots
P11221845A0800|234 237|half
P11221845A1370|81 85|liver
P11221845A1713|245 256|SV40 T antigen
P11222387A1497|148 155|leukemia
P11222639A1273|73 85|L1 endocytosis
P11222720A1699|109 126|corepressor complex
P11223131A0000|171 173|use
P11223153A0533|147 157|color schema
P11223164A0000|115 119|cells
P11223186A1095|113 120|sequence
P11223199A0751|96 101|horses
P11223240A0655|86 93|messages
P11223246A0359|128 133|region
P11223255A1034|40 69|serine threonine receptor kinases
P11223256A1212|53 64|pea 33RNP gene
P11223257A0404|304 319|protein synthesis
P11223938X1218|28 30|Ltd
P11224226A0000|186 193|paradigm
P11226228A0899|37 40|gene
P11226752A0750|221 224|DTX1
P11227039A0953|88 93|groups
P11227182A1475|105 109|serum
P11227484T0000|95 100|iodide
P11228700T0000|44 48|today
P11230145A0732|156 165|conversion
P11230169A0480|190 205|marker chromosome
P11230534A0688|44 50|species
P11230889A1151|124 127|HBO2
P11231287A0158|73 84|thapsigargin
P11232947A1451|125 132|survival
P11233643A0000|152 156|mg/kg
P11234223A1451|172 175|MEPM
P11235335T0000|8 10|HIV
P11235777A0878|89 113|dihydrotestosterone levels
P11235817A0000|174 179|adults
P11236056A0374|32 39|children
P11237038A0889|107 131|bladder outflow obstruction
P11237491A0000|245 255|individuals
P11237598A0962|114 122|mechanism
P11238105A0959|206 209|CD86
P11238375A0617|126 130|MAPKs
P11238402A0191|59 79|DAN/TIR gene expression
P11238405A0817|177 186|activation
P11238447A0524|170 174|nup62
P11238586A0000|255 261|binding
P11238882A0157|62 65|gene
P11238884A0892|123 128|palate
P11238916A0838|146 151|domain
P11238947A0636|89 100|RNA transport
P11239184A1340|150 159|artery sign
P11239529A0981|64 76|localizations
P11240600A0523|64 76|VGB medication
P11241166A0677|236 238|CIS
P11241215A0566|188 199|enterokinase
P11241243A0693|120 132|p53 expression
P11241332A0393|210 218|densities
P11241356T0000|125 137|stellate cells
P11241672T0000|128 133|STAT-6
P11243306A0961|129 136|presence
P11243336A0000|110 131|brachytherapy dosimetry
P11243494A0833|98 108|performance
P11243777A0000|53 67|promoter regions
P11243980A0510|55 71|staging procedures
P11244568A0506|99 104|larvae
P11244733A0782|83 87|death
P11245986T0000|50 73|rat aldolase B gene promoter
P11246679A0000|96 102|disease
P11246887A0000|290 297|diabetes
P11247663A1447|60 70|individuals
P11248463A0187|35 44|amino acids
P11248626T0000|148 155|surgeons
P11250196A0455|142 149|Protein S
P11250942A0626|149 155|regions
P11251083T0000|100 117|MEK/ERK activations
P11251104A0526|52 75|transcription factor GAMyb
P11251252A0494|110 116|3D views
P11251276A0793|27 33|surgery
P11251697T0000|115 128|spin trap method
P11251951A0000|172 175|CMIS
P11254134A0648|123 138|background levels
P11254504A0766|216 239|Cdx protein-2 binding sites
P11254713A1029|180 200|IL-2 gene transcription
P11254864T0000|33 44|breast cancer
P11255035A0331|109 117|phenotype
P11255252A0961|99 111|yeast extracts
P11255423A0211|115 119|women
P11256845A0340|272 277|pounds
P11256944A1144|104 126|ER stress response element
P11256962A0233|227 238|GlyR beta mRNA
P11257870A0000|237 239|HRT
P11258906A0743|106 109|RecA
P11259347A0000|128 136|chemicals
P11259503A0212|73 82|luciferase
P11259593A1094|85 90|growth
P11260468A1179|131 141|protein H-NS
P11260662X0000|11 11|D
P11263622A0683|101 114|histopathology
P11263664A1085|65 72|mesoderm
P11263664T0000|116 125|repressors
P11264176A0181|71 90|cyclin A2/cdk2 complex
P11264177T0000|115 122|leukemia
P11264182A0000|154 167|leukemogenesis
P11264372T0000|75 92|herpes simplex virus
P11264375A0000|134 143|infections
P11264561A0167|74 82|occlusion
P11265853A0000|131 143|configuration
P11266184A0000|162 163|SE
P11266194A0743|51 60|tomography
P11266227A0295|51 63|donor solution
P11266540A0328|103 122|Tcf/Lef family members
P11266558A1470|157 173|SL RNA gene promoter
P11266615A0258|76 92|amino acid residues
P11267679A0102|112 121|amino acids
P11268459A0167|193 201|prognosis
P11268887A1174|106 109|FEV1
P11271297T0000|79 86|patients
P11273995A1148|122 135|relaxation time
P11274109A0129|61 73|carbon sources
P11274149A0625|112 120|E2 enzymes
P11274179A0610|90 99|disruption
P11274184A0000|99 112|detoxification
P11274184A1068|130 133|Nrf2
P11274357A0724|266 272|GTPases
P11274368A0469|76 101|histone deacetylase activity
P11274368A0818|79 83|c-Myc
P11274563T0000|45 51|results
P11275986A0091|98 108|degradation
P11276426A0501|97 100|gene
P11277913T0000|83 97|mRNA translation
P11278286A0456|233 242|inhibition
P11278286A1083|68 78|combination
P11278290A1220|161 165|level
P11278310A1516|109 118|cell number
P11278390A0632|118 123|levels
P11278400A0668|122 139|mobility shift assay
P11278440A0095|102 112|S0-S1 linker
P11278461A0637|189 207|Western blot analysis
P11278488T0000|73 86|adhesion kinase
P11278521A0849|157 177|lacZ reporter construct
P11278563A0917|107 117|interaction
P11278583A0873|298 300|Sos
P11278594A0618|184 198|MIC-1 propeptide
P11278604A0300|209 217|acceptors
P11278610A0902|70 77|TEL-JAK2
P11278671T0000|114 118|cells
P11278713A1054|143 165|coding region determinant
P11278819A0565|164 174|MOK2 binding
P11278848A1316|126 145|Sp1 consensus sequence
P11278855A0205|138 141|cell
P11278870A0123|193 215|transcription factor Cuf1
P11278928A1634|142 144|p30
P11279038A0194|76 92|Holliday junctions
P11279086A1350|172 183|cell adhesion
P11279108T0000|113 123|muscle cells
P11279207A0904|50 61|TCR signaling
P11279217A0273|0 3|Biol
P11279324A0710|62 67|method
P11279385A3917|189 194|method
P11279720A0844|159 173|levodopa therapy
P11280495A1330|110 113|AGEs
P11280799A1025|111 120|antibodies
P11281201T0000|13 19|effects
P11281268A0000|175 204|clam Pseudocardium sachalinensis
P11282029A0075|115 127|transcription
P11282088A0837|37 37|P
P11282394A0841|109 126|cross-reactivities
P11282395A0530|130 162|DNA repair proteins Nbs1/Mre11/Rad50
P11282395A1073|167 177|individuals
P11282433T0000|90 103|cell lung cancer
P11282761A0531|99 110|NO production
P11283010A0701|30 38|CGS 12066A
P11283014A0921|122 140|actin polymerization
P11283168A0738|149 156|anthesis
P11283256A0258|60 68|complexes
P11283354A0548|130 152|heterochromatin assembly
P11285054A0781|147 155|NREM sleep
P11285235A0466|85 95|GATA factors
P11285329A0682|39 39|P
P11286833A0959|147 151|range
P11287555A1057|98 105|MT4 cells
P11287578A1311|152 153|E6
P11287579A1084|68 86|late-gene expression
P11287611A0802|139 150|cyclin D1 gene
P11287623A0286|184 197|mouse cell lines
P11287654A0150|72 80|C terminus
P11288208A0712|120 123|life
P11288930A0000|173 181|lactation
P11289135A0975|288 296|apoptosis
P11289149A0658|121 123|CBP
P11290415A0288|100 110|PCR analysis
P11290906T0000|64 73|infarction
P11291552A0156|46 48|MFH
P11292335A0852|147 164|frameshift mutation
P11292839A0531|203 207|TBPwt
P11292844A0081|34 40|trimers
P11294895A0292|150 154|yeast
P11295470A0954|107 109|UTR
P11295523A0218|42 50|mid-1970s
P11295760A1374|79 82|W/cm
P11296288A1107|127 130|foci
P11296442A0565|114 123|anesthesia
P11297419A0894|104 110|residue
P11297514A0218|131 135|genes
P11297545A0948|205 210|manner
P11297866A0484|74 83|propulsion
P11298326A0677|123 136|point mutations
P11301189A1396|90 103|B-lineage cells
P11302072A0508|157 168|significance
P11302566A1318|78 95|psychomotor slowing
P11302704T0000|44 66|mouse histone deacetylase
P11303027A0954|111 120|cross-talk
P11303638A0559|49 49|%
P11303890A0996|64 71|microg/l
P11305129T0000|106 113|globulin
P11306101A0000|166 187|3alpha-hydroxysteroids
P11306463A0383|72 93|cdk4/D1 phosphorylation
P11306511A1476|105 124|progesterone receptor
P11306845A0168|86 98|keratinocytes
P11308851A0333|143 149|network
P11308877A0213|146 175|orientation preserving circle map
P11309077A0953|72 75|ones
P11309373A0783|166 172|lengths
P11309389A0273|280 290|GH signaling
P11309400T0000|66 81|protein synthesis
P11309677A0000|144 147|GV-H
P11309678A0489|100 107|splicing
P11310937A0548|203 210|tertiles
P11311153T0000|161 172|arthroplasty
P11311464A0362|130 147|bladder dysfunction
P11311480A0079|163 168|fibers
P11311550A0253|221 236|myoblast cell line
P11311563A0423|62 72|OA induction
P11311687A0231|117 125|morbidity
P11311909A0938|73 86|A1 fenestration
P11311980A1049|46 52|tissues
P11312108A2853|5 5|P
P11312120A1311|149 157|potential
P11312326A0169|205 220|virus replication
P11312584X1846|13 25|Academic Press
P11313249T0000|88 103|activation domain
P11313342A0224|140 142|PAP
P11313386A0704|72 92|B cell receptor ligation
P11313398A0687|96 103|PKBalpha
P11313946A0449|82 87|p21 Ras
P11313946T0000|89 98|cell growth
P11313961A1323|127 133|p53 gene
P11314030A1264|196 204|SH3 domain
P11314046A0000|47 66|cell cycle progression
P11314373T0000|38 44|problem
P11314428A0651|167 169|RHS
P11315633A0920|142 154|sobemoviruses
P11316127A0485|74 86|Control groups
P11317256A0361|113 119|abscess
P11318363A0085|20 24|study
P11318608A0669|230 236|regions
P11318608A1155|94 102|nucleolus
P11319098A0164|177 191|LacI-GalR family
P11319880A1108|107 110|band
P11321187A0355|121 128|controls
P11323411A0505|154 164|C-SH2 domain
P11323419T0000|167 171|tract
P11323716A0413|46 57|interactions
P11324516A0159|154 155|AA
P11325195A0661|61 75|pork longissimus
P11325391A0498|77 85|schedules
P11325685A1624|149 168|hemodialysis patients
P11325944A0511|199 204|strain
P11327292A0190|82 87|vision
P11327698A0191|380 384|U0126
P11327858A0087|76 78|p53
P11328699A0000|120 132|test situation
P11328853A0644|107 123|promoter sequences
P11331589A0113|69 78|expression
P11331596A0710|75 81|protein
P11331604A0267|103 114|srb10 mutants
P11331613A0827|68 75|subclass
P11333263A0240|108 123|promoter activity
P11333268A1521|259 273|GDP dissociation
P11334124A0903|120 127|Respimat
P11335116A1099|243 256|vitellogenesis
P11335710A0320|44 56|Erk activation
P11336211A0132|38 41|Appl
P11336698A0075|58 81|yeast remodeler RSC complex
P11337859A0651|190 199|H2O2 dosage
P11340048A0432|98 108|differences
P11340080A0096|128 134|studies
P11340085A0211|246 266|transactivation domain
P11340516A0509|86 94|Tisuacryl
P11340525A0737|137 161|treatment success criterion
P11341349T0000|70 74|women
P11341405A0146|74 89|MCB abnormalities
P11341405A1154|287 292|tracks
P11341828A0744|81 89|molecules
P11342479A0430|131 141|evaporation
P11344530A0320|67 67|%
P11345435A0199|90 101|localization
P11345445A0533|139 140|Zn
P11347201X0001|134 138|acids
P11348318A0940|113 118|masses
P11349796A0950|121 123|D30
P11350038A0459|126 138|export process
P11350165A1606|84 104|translation efficiency
P11350175A0173|77 93|chaperone activity
P11350812A0829|132 151|stress fiber formation
P11350957A0457|96 104|cytoplasm
P11350982A0560|70 79|activation
P11352423A0084|92 101|situations
P11352663A0138|109 117|NF-kappaB
P11352671A0492|187 192|rPIV2V
P11353392A1127|96 107|ASIP mutation
P11353770A0085|156 161|places
P11353774A0255|212 218|protein
P11354406A1373|97 107|ICP waveform
P11354975A0850|106 114|Venezuela
P11355576A1125|239 255|cell proliferation
P11355615A0766|98 105|practice
P11355668T0000|113 125|syndrome virus
P11356214A0794|193 198|dentin
P11356716A0372|54 66|GHS-R variants
P11356835A0000|137 155|amino acid starvation
P11356853A0429|115 122|pHO15luc
P11356853A0554|84 88|StREs
P11356853A0873|64 67|StRE
P11357063A0138|174 202|LHbeta-CGbeta gene cluster locus
P11357063A1053|120 140|translation start codon
P11358801A1046|112 118|studies
P11358958A0878|116 124|apoptosis
P11358962A0344|112 127|airway epithelium
P11359568T0000|137 140|parS
P11359827T0000|90 94|SPE-J
P11359907A0099|89 92|VEGF
P11360190A0178|107 111|cells
P11361338A0093|104 116|tripeptide SKL
P11361338A0447|106 119|Pex5p chimaeras
P11361493T0000|74 84|Buenos Aires
P11367523A1684|76 83|proteins
P11367523A2624|103 110|C4A genes
P11368363A0129|249 256|proteins
P11368363A1103|162 171|rat protein
P11368787A0180|137 160|transcription start points
P11368901A0327|81 87|portion
P11368911T0000|60 68|C. elegans
P11368914T0071|121 128|promoter
P11369066A1210|148 166|radiation dermatitis
P11369106A0428|117 124|food webs
P11369410A0949|136 147|participants
P11369453A1083|58 73|peptide treatment
P11369700A0074|132 142|region genes
P11369700A0616|158 179|luciferase reporter gene
P11369759A0605|0 3|Cell
P11370174A0447|77 79|MMF
P11371115A0962|94 104|MPGN pattern
P11371160A0193|111 118|molecule
P11371160A0854|125 136|tyrosylation
P11371343A0125|83 89|securin
P11371417A0744|359 360|LA
P11372882A1143|79 82|PCBs
P11372959A1447|197 209|tick abundance
P11373277A0812|205 220|corepressor CtBP1
P11374051A0437|153 160|bleeding
P11374559A0103|92 115|colloidal silver solutions
P11374866X0914|13 25|Academic Press
P11375392T0000|164 167|gene
P11376007A0584|253 263|microcystin
P11376119A0346|109 115|GHR gene
P11376134A1506|84 88|sites
P11376165T0000|30 43|Xenopus embryos
P11376279A0000|105 121|volume acquisition
P11376687A0344|219 233|targeting signal
P11376946A0000|224 225|P1
P11377975A0898|140 144|study
P11378898A0164|25 35|Accession No
P11379106A0372|95 104|pilot plant
P11380028A0000|170 181|blood samples
P11380370A0000|60 61|KS
P11380837A1505|128 144|access dysfunction
P11381094A0797|40 53|synaptotagmins
P11382701A0688|81 105|plasma sodium concentration
P11382948A0793|183 192|tumor grade
P11383860A0661|121 131|liver uptake
P11384225A0634|136 144|sequences
P11384229A1669|143 153|PR7 mutation
P11384576A1132|68 78|retinopathy
P11384880A0719|93 109|breast cancer cells
P11385840A1684|114 133|optimization routines
P11387208T0000|62 84|plant SCF ubiquitin ligase
P11387351A0092|193 195|MDS
P11387940A0647|57 66|percussion
P11387950X0001|388 399|TNF secretion
P11389077A0000|95 104|regulators
P11389085A0290|92 98|nucleus
P11389085A1032|121 131|NIH 3T3 cells
P11390395A1018|94 108|transactivation
P11390581A1203|155 162|promoter
P11390650A0562|125 133|P-1 domain
P11390663A1400|123 127|cells
P11390684A1170|77 95|jadomycin B synthesis
P11391303A0807|46 73|intraobserver reproducibility
P11391303A1023|90 115|Tl-201 lung uptake evaluation
P11391531A1157|66 74|TNF-alpha
P11391793A0856|175 180|clones
P11392306T0000|24 33|techniques
P11392772A0182|206 210|times
P11393463A0274|245 257|month interval
P11393791A1153|199 203|assay
P11395469A1373|111 114|iron
P11396685A0477|185 191|cheeses
P11397652A0381|193 196|etc.
P11398134A1565|119 131|hyperuricemia
P11398899A1183|118 122|areas
P11399064T0000|90 102|transcription
P11399834T0000|63 77|HCV NAT screening
P11400644A0435|117 124|g I-TEQ/y
P11401105T0000|37 50|cancer patients
P11401611A1703|114 122|fractures
P11402674T0000|42 66|serum calcium concentration
P11403173A0192|31 42|brain tumours
P11403663A0359|92 100|2-D theory
P11403719A1257|76 82|insulin
P11404010A0235|42 47|repeat
P11404016A1922|173 176|NRPS
P11404019A0532|73 86|promoter region
P11404312A0660|19 19|P
P11406007A0292|157 161|years
P11406025A0204|114 123|spermicide
P11406277A0598|167 191|parent Hlx promoter sequence
P11406642A0792|43 47|genes
P11407289A1507|162 167|agents
P11407448A0815|251 264|speech training
P11407650A0661|154 166|thyroid cancer
P11408099A0518|108 112|heart
P11408338A1686|133 144|neurologists
P11408575A0000|120 123|form
P11408591A0000|89 100|v-src mutants
P11408604A1440|183 204|receptor tyrosine kinase
P11408774X0893|9 12|Base
P11409425A0000|314 324|t-PA therapy
P11410110A0190|107 114|subjects
P11410563A0363|168 170|OSF
P11410664A0963|225 240|repair activities
P11410679A0000|233 240|LOX sites
P11411198A0711|149 156|lymphoma
P11411623T0000|84 91|exercise
P11411961A0735|130 134|tests
P11413148A0573|76 98|tyrosine phosphorylation
P11413277A1121|77 81|PCNSL
P11413310A0148|211 222|RSV infection
P11413319A0000|87 91|tails
P11413641A0373|57 67|quadrat area
P11413760A0000|115 121|synapse
P11414754X1099|13 25|Academic Press
P11415633A1253|80 90|compression
P11415952A0369|167 168|Q5
P11415958A0000|155 162|approach
P11416012A1982|235 254|sarcoma virus promoter
P11416012A2511|380 384|U0124
P11416012T0000|226 255|protein kinase signaling pathways
P11416132A1351|116 124|silencing
P11416144A1324|106 115|p53 protein
P11416260A0000|149 160|data analysis
P11416393A0000|520 537|tobacco consumption
P11416650T0000|31 36|Update
P11416737T0000|56 65|case report
P11416879A1589|44 59|ventilation modes
P11418130A0499|66 78|recombination
P11418662A0917|101 109|NF-kappaB
P11419938T0000|130 153|diphtheria toxin repressor
P11420612A0303|129 136|interest
P11422200A0000|130 137|microbes
P11422757A0737|69 76|baseline
P11423991A1393|146 160|cancer therapies
P11424992A0712|95 102|criteria
P11425076A0364|232 236|model
P11425877A1026|220 233|F-actin content
P11427329A1077|127 132|sample
P11427611A0000|352 361|microscopy
P11428276A0352|90 99|phosphates
P11428283A0228|68 75|distress
P11428435A0446|99 106|December
P11428487T0000|53 64|vein stenosis
P11428897A0318|196 201|repeat
P11429702A0917|232 254|receptor phosphorylation
P11430042A0000|142 145|RTIL
P11430976X0000|70 79|substances
P11431348A0000|179 195|leukemia cell lines
P11431472A0540|67 71|Rab1B
P11431857A0186|94 97|days
P11432112A0000|131 152|embryo selection process
P11432748T0000|50 64|cancer cell lines
P11432776A0421|113 118|muscle
P11433014A0683|134 140|protein
P11433018A0756|134 143|components
P11433024A0260|101 108|template
P11433379A0000|115 125|lymphocytes
P11434084A0508|71 77|d-dimer
P11435428A0000|86 99|lipid synthesis
P11435517A0396|156 166|control diet
P11435560A1322|83 95|target HFV mRNA
P11435578A0760|151 158|TGACCTCA
P11435578A2231|148 160|transcription
P11435605A0587|193 207|Ad41L fiber knobs
P11435688A0262|91 111|transmembrane segments
P11435983T0000|78 86|follow-up
P11437439A0201|71 83|prestalk cells
P11437660A1219|127 137|replication
P11438651A1365|137 156|replication initiator
P11438654A1237|83 111|c-Akt/Pak1 cell survival pathway
P11438666A0555|143 156|TFIID component
P11438838A0788|73 76|U6-P
P11439343A0785|67 69|AF9
P11441163T0000|0 9|Foreigners
P11441311X0001|180 182|NHL
P11441952A0414|162 174|avoidance test
P11441974A0320|156 161|mmol x l
P11443509A0293|132 136|NHEFS
P11443999A0573|167 177|consumption
P11444762A0373|84 89|action
P11445008A0816|113 126|RNA pool samples
P11447490A0598|66 75|assessment
P11448051A0093|196 208|Eudragit RS100
P11449014A0000|183 185|E/B
P11450490A0565|175 175|P
P11450776T0000|37 47|peritonitis
P11451447A0205|6 6|F
P11451682A0190|108 118|albendazole
P11451995T0000|83 130|isoprenylcysteine carboxyl methyltransferase family
P11454004T0000|158 166|promoter B
P11454190A0000|107 118|United States
P11454239A0478|261 265|scale
P11454703A0000|196 208|tumorigenesis
P11456259A0142|102 106|weeks
P11457139A0604|85 94|D1D3 isomer
P11459048A0485|132 145|rotation states
P11459304T0078|65 70|plasma
P11459794A1172|110 124|GnRH-II promoter
P11459960A1109|67 76|heat labile
P11459962A0785|186 191|growth
P11460035A0548|74 85|imputability
P11461595A0000|142 146|flows
P11462004A0886|80 94|complementation
P11462004A1500|157 168|localization
P11462024A0306|4 4|V
P11462952A1040|71 74|mean
P11463359A0167|165 182|H4IIE hepatoma cells
P11463834A0606|124 137|Tax interaction
P11464997A0566|84 89|family
P11465518A0000|188 192|risks
P11465655A0439|77 82|mg/day
P11465844T0000|108 135|Ehrlichia phagocytophila group
P11466227A1665|75 90|mTf-CAT construct
P11467349A0452|47 56|ISF glucose
P11468958A0122|220 227|concerns
P11469701A0377|186 189|vein
P11469737A1791|68 68|%
P11469853A0702|101 105|yeast
P11469853A1053|110 114|yeast
P11469926T0000|43 53|crystal ball
P11469970A0873|180 186|therapy
P11470914A0305|83 96|gene expression
P11471077A0382|124 129|survey
P11471231A0964|165 174|procedures
P11472523A0535|94 107|metabisulphite
P11472696A0387|78 80|ACS
P11473254A0000|100 102|Leu
P11473261A0587|68 70|GEF
P11474642A1451|94 100|control
P11478627A0573|145 153|criterion
P11479104A0446|239 243|cause
P11479501A0744|167 181|Omnicarbon valve
P11480490A0443|109 118|arrhythmia
P11480497T0000|94 96|rat
P11480555A0928|55 63|cell death
P11481625A0202|161 169|microg/kg
P11484028T0000|2 14|cross purposes
P11484578A1132|141 153|design program
P11486032A1261|108 114|E2A-HLF
P11486141A0424|136 140|error
P11486399A0000|103 109|disease
P11486476A0147|282 290|admission
P11486476A1512|105 107|ECG
P11489597A0379|168 180|malformations
P11489597A0561|120 124|group
P11490862A0141|120 126|support
P11494391A0579|128 140|bile secretion
P11495833T0000|90 99|properties
P11495920A0504|91 106|enhancer activity
P11496495A0000|108 115|children
P11496617A0301|364 370|placebo
P11498795A0716|115 130|S phase transition
P11500377A0518|43 52|Wnt pathway
P11500512A0000|141 150|oxysterols
P11500571A0976|60 75|gPAL1 transcripts
P11500913A1238|129 136|hormones
P11502738A1457|105 120|cyclin D1 promoter
P11502758A0869|66 78|FGFR signaling
P11502778A0941|135 155|bone resorption markers
P11504545A0393|133 139|BKV-MLP
P11504709A0981|199 204|kinase
P11505407A0461|123 130|TNFalpha
P11509266A0955|171 178|survival
P11509615T0000|89 100|IL-2 receptor
P11509673A0574|172 180|apoptosis
P11511544T0000|88 97|heat stress
P11512925A0000|124 129|Ge atom
P11513121T0000|134 138|PCOCs
P11513180A1257|90 94|bowel
P11513579A0372|142 157|complex formation
P11516890A0236|109 113|SSRIs
P11517190A0352|150 159|expression
P11517190T0000|89 96|receptor
P11517269A0472|196 200|genes
P11517399A0858|190 196|species
P11517445A0221|35 46|V. cholerae O1
P11518505A0107|74 79|organs
P11518868A0559|98 128|healthcare provider communication
P11519466A0196|37 42|impact
P11520436A0705|132 137|asthma
P11521191A0000|162 182|retinoblastoma protein
P11522431A0673|121 131|nondrinkers
P11522584A0882|89 89|P
P11522626A1374|116 132|estrogen receptors
P11522658A0086|141 157|breast cancer cells
P11522658A0870|132 145|kinase activity
P11523446A0523|120 126|LC-CLND
P11524015A0937|65 87|CAT reporter gene activity
P11524815A0753|83 92|2N0M0 cases
P11524823X0001|199 204|adults
P11525102A0970|105 106|CI
P11525486A0350|65 66|pH
P11525640A0560|187 200|GADD45 promoter
P11528127A1402|117 121|L1/L2
P11528253X1211|13 13|S
P11528500A0571|43 50|families
P11529914T0000|77 82|T cells
P11530684A0667|313 340|drive NMDA-receptor mechanisms
P11530829A0000|131 139|equipment
P11532556A0000|99 105|thalami
P11532856A1175|220 234|HIF-1 activation
P11533238A1137|97 121|HLA-DRA promoter activation
P11533340A1285|117 138|Bayley motor score scales
P11533863A0125|94 100|therapy
P11534132A0219|75 81|experts
P11534900A0000|185 200|Lymnaea acuminata
P11535014A1157|161 168|patients
P11535140T0000|22 30|pregnancy
P11535532A0189|66 73|function
P11535832A0586|47 55|C terminus
P11536063A0178|74 91|heart-lung-machine
P11538437A0568|230 248|% CH4 post-discharges
P11539522A0612|65 78|space dosimetry
P11540991A0127|156 181|Shuttle Atlantis mission 61-B
P11542677A0411|112 118|control
P11542780A0086|188 200|energy tranfer
P11543154T0000|79 92|space radiation
P11543317A0203|141 144|PNTD
P11543662A0562|88 95|L protein
P11545594A1556|145 151|protein
P11547819A0532|327 342|vessel wall injury
P11548027A0163|162 180|personnel indicators
P11550795A2583|132 142|interleukin
P11552058A0235|71 74|days
P11552058A0833|122 133|barbiturates
P11552724A0527|252 264|contrast media
P11552922A0361|33 99|polymerase chain reaction-restriction fragment length polymorphism method
P11553091A1472|117 121|Class
P11553704A0674|102 115|MAPK activation
P11554469A1386|168 173|plants
P11554566A0668|156 163|company B
P11554566A0833|109 117|locations
P11554727A0890|108 112|PTHSR
P11555516A0639|127 130|risk
P11555669A0464|47 62|Vrinnevi Hospital
P11555669A0983|70 74|pairs
P11556809A2085|203 222|hydrocarbon substrate
P11557127A0991|102 109|MRP2 gene
P11559366T0000|77 80|gene
P11559547T0000|102 110|receptors
P11559564A0459|125 131|SF2/ASF
P11559789A0314|233 239|inducer
P11559821A1315|111 132|repeat oligonucleotides
P11560292A0557|66 86|dipslide urine cultures
P11560509T0000|53 59|binding
P11560990A0272|144 153|transition
P11560992A0000|240 246|stimuli
P11560992A0651|192 204|stress stimuli
P11560992A1184|150 162|proliferation
P11561623A0897|182 187|spring
P11561626A0197|269 271|air
P11562278A0169|156 164|apoptosis
P11562870A0892|103 107|years
P11564871A1184|195 203|promoters
P11564893A1068|163 170|mutagens
P11565747A1020|194 205|P element IVS3
P11566874T0000|31 36|dynein
P11566948A1217|112 117|events
P11566961A0472|76 95|blood pressure control
P11566996A1391|158 159|pH
P11568988A0960|104 113|Pa elastase
P11569800T0000|36 42|systems
P11569900A0660|87 107|factor V Leiden mutation
P11569949A2087|62 67|Spring
P11570735A1097|227 233|control
P11570820T0000|70 78|cytoplasm
P11572377T0000|62 76|cavitation field
P11572388A0000|188 204|method development
P11572467A0658|81 91|plasminogen
P11572467T0000|119 127|exchanger
P11573771T0000|40 46|cheeses
P11573891A0525|126 134|exposures
P11574088A1687|77 89|PAK recipients
P11574105A0727|314 327|antibody titers
P11575109A0214|127 135|treatment
P11575977A1133|76 88|complications
P11576158A1371|74 81|controls
P11576776T0081|20 44|microcrystalline cellulose
P11577094A1226|84 96|hematopoiesis
P11578685A0077|44 45|GO
P11579100T0000|78 95|cell transformation
P11580173A0181|150 154|paper
P11580301A1161|86 98|polyarthritis
P11580757A0304|213 222|recordings
P11580941A0815|123 126|time
P11583428A0191|2 4|Exp
P11583621A0301|145 151|complex
P11583880T0000|33 49|AneuRx stent-graft
P11584107T0000|67 71|field
P11584328A0532|77 83|statins
P11585856A0285|159 172|backprojection
P11586096A0699|97 104|patients
P11587514A0758|74 90|alpha-amylase gene
P11587980A1039|197 211|bronchodilation
P11589568A0744|130 141|kinetochores
P11589779T0000|52 67|strongyloidiasis
P11590364A1056|47 52|retina
P11592315A0325|81 84|calf
P11592532A0188|126 131|method
P11593394A0000|203 224|cyclin kinase inhibitors
P11595170A0582|180 186|introns
P11595176T0000|90 110|AF1q translocation gene
P11595478A1014|103 117|cancer relatives
P11595813A0633|180 196|androgen receptors
P11595840A0000|78 94|blood glucose level
P11596104A0614|110 118|cell lines
P11596838A1357|151 163|beta2-agonist
P11597185A0477|134 155|metapopulation dynamics
P11597936A0570|199 206|controls
P11599079A1040|67 69|API
P11599797A0732|14 17|gene
P11599840A0813|111 117|section
P11600252A0795|115 123|mortality
P11600314A0000|144 145|B6
P11600365A0471|129 146|reference compounds
P11600467A1436|58 69|permeability
P11602353A0770|128 131|gene
P11603271T0001|39 44|elderl
P11604152A0526|244 251|mean CCFs
P11605207T0001|36 41|elderl
P11605598A0785|133 150|prevention programs
P11606538A1002|97 110|neuropeptidase
P11614398T0000|42 50|Mormonism
P11626110T0000|3 10|Availabl
P11639485A0478|126 133|scholars
P11642687T0000|86 100|prostate disease
P11653491T0000|21 32|DNA violation
P11669281A0653|84 92|synergism
P11669476A0346|143 159|insulin resistance
P11675912A0131|120 128|headaches
P11676899A0704|152 163|wood industry
P11677363A0775|122 134|PP variability
P11677839A0876|37 44|controls
P11678437A0000|186 192|gravity
P11679441A0429|157 161|urine
P11680835A0756|84 94|pamidronate
P11683558A0446|78 88|differences
P11684665A0000|120 135|nematode body plan
P11685047A0301|65 79|substrate S-2238
P11685284X0000|30 36|B37-B44
P11686239A0464|195 212|Dictyostelium genes
P11686378A0326|330 332|EHD
P11687083A0218|103 108|labour
P11687180A3209|89 93|onset
P11687352A0215|67 75|September
P11687517A1619|29 41|mouse promoter
P11687737A0000|121 123|age
P11687869A0000|59 69|sarcoidosis
P11689217T0000|89 99|angiography
P11691585A1174|115 132|cKrox family members
P11691585T0000|49 59|matrix genes
P11692004A1200|128 136|aneurysms
P11693461A1649|109 118|population
P11695481A0310|79 87|ozonation
P11697760A0000|138 144|OVX rats
P11703464A0560|152 164|reinforcement
P11703558A0000|68 73|tumors
P11704380A1608|98 106|Sta-nrMFP
P11704829A0312|133 145|melanoma cells
P11705093A2016|57 62|effect
P11706668A0000|97 108|intervention
P11706949T0000|82 84|rat
P11707977A0750|66 75|H3 patients
P11708032A0183|233 243|infuser pump
P11708362A0889|49 57|operation
P11708431A0904|120 132|patient groups
P11708761A1388|94 109|diabetes mellitus
P11709561T0000|100 112|neuroblastoma
P11709890T0000|74 99|health protection strategies
P11710233T0000|12 28|tissue engineering
P11710685A0994a|100 115|Papanicolaou test
P11710685A0994b|100 115|Papanicolaou test
P11711701A0602|231 257|pertechnetate thyroid imaging
P11714429X0000|274 284|Events trial
P11715079A1016|255 260|organs
P11716043A0380|84 116|Helsinki University Central Hospital
P11716441A0585|72 80|admission
P11718197A1282|3 11|procedure
P11722993A0276|139 143|utero
P11723500X0000|161 170|population
P11723511A0780|150 158|category X
P11723675A1022|128 140|APACHE II score
P11723928A0294|76 80|China
P11724510T0000|31 39|apheresis
P11726022A0909|144 148|model
P11726068A0539|62 65|data
P11726164A0215|162 172|food allergy
P11726262A0692|86 88|CON
P11726413A1756|62 68|opioids
P11726574A1304|60 64|model
P11727073A0842|129 135|results
P11727209A0502|91 101|orthostasia
P11728771A0187|50 65|contrast material
P11730182A0984|254 258|Rumex
P11730262A0874|205 220|calcium/vitamin D
P11730712A0416|88 88|P
P11732088A0471|211 219|diagnosis
P11732417A0571|169 176|ELISA kit
P11736254A0000|144 153|structures
P11736792A0204|131 140|morphology
P11737056A0680|92 98|subsets
P11737158A1517|165 174|dimensions
P11737900A0700|62 63|r2
P11738404A0120|445 448|data
P11740571A0114|212 220|processes
P11740806X0810|0 14|Saunders Company
P11741259A1233|109 117|intestine
P11741554T0000|87 99|artery disease
P11742432A0798|342 353|cells/microL
P11743360A2491|111 112|ml
P11743612A1179|113 124|CF population
P11744290T0045|11 21|waste matter
P11744953A0878|82 92|age patients
P11752821A1365|85 91|disease
P11755894A0466|213 224|hospital stay
P11760398A0553|189 199|ISG criteria
P11760796A0698|131 140|background
P11761601A0133|135 153|inhalation exposures
P11763176A0918|123 123|%
P11764062A0000|193 197|Behav
P11764226A0798|137 149|EULAR criteria
P11765448A0588|41 48|patients
P11766747A0000|72 79|teratoma
P11768467A0000|58 67|households
P11769229A0357|58 64|process
P11771979A1141|233 243|vasculature
P11773168A0915|108 111|arm B
P11773921A0397|366 371|groups
P11775180A0379|54 73|gamma-detecting probe
P11775301A0797|27 42|depression scores
P11776922A0830|62 68|lesions
P11777575A0363|139 142|ANNs
P11777632A1678|197 208|breast cancer
P11778044A0000|223 241|climate observations
P11778804A0179|60 62|FDT
P11781615A0000|83 101|cell transplantation
P11782218A0349|187 200|learning effect
P11783457A0000|136 139|drug
P11785085X0001|212 219|PVM-R-01
P11785827A0986|198 210|communication
P11786248A1162|130 141|sham controls
P11786945A0958|75 80|group A
P11787041A0167|6 16|development
P11787322X0001|286 293|diseases
P11787720A1313|103 105|C20
P11787746A0374|109 116|patients
P11789206A1182|75 84|principles
P11789216T0001|99 106|gastriti
P11790897T0000|105 116|breast cancer
P11791292A0193|72 78|problem
P11791571T0000|97 118|plasma mass spectrometry
P11791585A0287|121 127|surface
P11791853A0532|128 137|wastewater
P11792586A0290|85 96|tissue matrix
P11793172A0545|72 90|friction coefficient
P11793614A0000|182 196|anticoagulation
P11796977T0000|26 39|mainland Europe
P11800119A0814|33 45|vibration mode
P11800586A1090|138 149|tuberculosis
P11800878T0000|40 62|ultrashort UV laser pulses
P11801459T0000|52 67|atherothrombosis
P11802580A0000|154 171|health research tool
P11802601A0107|94 110|aldicarb sulfoxide
P11803325A0868|86 93|GIK group
P11804081A0552|84 93|Everglades
P11804100A0365a|104 112|TP removal
P11804100A0365b|104 112|TP removal
P11804510A0730|152 157|levels
P11806132A0253|78 81|rate
P11810685A0147|191 196|DT-MRI
P11811743A0800|109 117|clinician
P11811825A0972|133 148|sensitivity level
P11815644A0081|140 151|echolocation
P11816458A0319|179 189|experiments
P11816779A0343|53 67|chloramphenicol
P11818675X0897|9 12|Base
P11819326A0000|219 228|volunteers
P11821098A0269|56 56|B
P11822790A0907|194 213|reproducibility noise
P11822811A0319|109 120|intoxication
P11824701A0894|94 101|patients
P11824801A0661|150 165|organ involvement
P11825801A1212|67 72|months
P11826141T0000|140 143|rats
P11828186A0239|166 174|NHANES III
P11830544A0335|189 200|angiogenesis
P11831512A0468|218 222|DE-42
P11832019A0668|43 58|emergency disease
P11833863A0987|59 67|positions
P11834476A1187|234 243|protection
P11835109A0000|169 174|trials
P11836046A0549|250 255|group B
P11836303A0518|40 58|culture supernatants
P11836303A1191|138 142|stage
P11837409A0584|117 124|interval
P11838058A0084|138 142|study
P11838102T0001|9 21|granulomatosi
P11840365A0949|72 72|P
P11842037A0327|72 76|value
P11842728X0001|92 107|Schistosoma genus
P11843252A0907|94 99|months
P11844591A0329|55 57|APT
P11844812A0915|147 160|prostate volume
P11845547A0449|62 77|21-aminosteroids
P11846167A0000|61 74|microorganisms
P11846187A0894|81 102|permeability directions
P11847580T0000|38 45|findings
P11849417A0900|144 153|HD patients
P11849796A0452|102 111|IMRT fields
P11851941A0372|184 186|HES
P11852907A0871|120 128|magnitude
P11853943A0122|45 65|R-R interval estimation
P11858256A0102|47 52|effect
P11858548A0241|77 92|mass spectrometry
P11858635A0896|61 79|LOO cross-validation
P11859400A0229|195 208|HSV prophylaxis
P11859943A0150|101 126|General Health Questionnaire
P11860097A1695|119 127|non-users
P11860723A0182|65 77|Gynecologists
P11860876A0409|35 35|%
P11861092A0730|299 300|WA
P11862350T0000|131 137|traffic
P11863811A0259|79 88|experiment
P11864173T0000|67 76|bronchitis
P11865218A0069|68 72|agent
P11866130A0419|96 113|quinaldine sulphate
P11867388A0502|202 202|P
P11870646A0668|110 115|damage
P11872359A0000|184 194|Australians
P11872570T0000|36 39|care
P11873003X0000|252 257|Uganda
P11874637A0212|211 222|malignancies
P11875695A0718|87 89|% CI
P11876937A0261|96 101|N group
P11879108A0719|177 179|HIV
P11881268A0000|122 126|women
P11881923A1256|149 158|treatments
P11882054A0568|212 223|mirror region
P11882054A1250|192 206|epileptogenesis
P11882747A0354|23 42|Farnsworth D-15 method
P11883682A0162|88 105|estuarine sediments
P11883763A1062|211 222|East China Sea
P11884014A0665|64 70|effects
P11885053A1897|139 152|memorial shrine
P11885737A1713|81 88|criteria
P11886473A0796|138 143|corpus
P11887803A1455|192 198|Balance
P11888183A0541|110 115|maxima
P11888867A0000|210 218|melanomas
P11890354A0000|80 83|form
P11890438A0838|74 82|dressings
P11893403A0252|130 139|toxicology
P11893767A0356|169 171|day
P11894605A1429|195 205|advertising
P11895024A1054|76 91|hospital searches
P11895184A0000|127 150|cheeseboard maze apparatus
P11897449A0566|171 174|mean
P11897888A0590|50 60|supplements
P11897950A0617|82 97|drainage pathways
P11898018T0000|30 37|research
P11898797A0124|174 184|innervation
P11899479A0122|276 287|kit AuxaColor
P11899489A0119|106 110|stage
P11900770T0000|67 92|dopamine receptor antagonism
P11902068T0000|15 21|journey
P11902738A0185|187 192|period
P11902781A0550|108 113|season
P11904017A0000|149 154|system
P11907691A0214|81 84|mass
P11908529A0553|153 159|objects
P11909404A0000|47 50|sign
P11910310A0279|53 57|trial
P11910344A1119|147 154|survival
P11911552A0776|120 123|mg/d
P11912261A0284|117 126|experience
P11912677A0281|85 91|data set
P11913427A0290|96 100|error
P11915436A0491|64 73|population
P11917061A0922|144 144|P
P11917882A0326|86 92|systems
P11920455X1195|50 54|.1031
P11920896A0298|140 140|%
P11921126A1196|73 80|patients
